<SEC-DOCUMENT>0001193125-26-119973.txt : 20260323
<SEC-HEADER>0001193125-26-119973.hdr.sgml : 20260323
<ACCEPTANCE-DATETIME>20260323171037
ACCESSION NUMBER:		0001193125-26-119973
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		22
FILED AS OF DATE:		20260323
DATE AS OF CHANGE:		20260323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aardvark Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001774857
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				821606367
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-294537
		FILM NUMBER:		26783197

	BUSINESS ADDRESS:	
		STREET 1:		4370 LA JOLLA VILLAGE DRIVE
		STREET 2:		SUITE 1050
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		(858) 225-7696

	MAIL ADDRESS:	
		STREET 1:		4370 LA JOLLA VILLAGE DRIVE
		STREET 2:		SUITE 1050
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ck0001774857-20260323.htm
<DESCRIPTION>S-3
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-03-23T16:54:03.0487+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>S-3</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As filed with the Securities and Exchange Commission on March 23, 2026</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration No. 333-</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:center;"><font style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</font></p><p style="margin-left:30.667%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:30.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM S-3</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>REGISTRATION STATEMENT<br>UNDER<br>THE SECURITIES ACT OF 1933</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</font></p><p style="margin-left:30.667%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:30.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:3.25in;box-sizing:content-box;"></td>
     <td style="width:3.25in;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of<br>incorporation or organization)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">82-1606367</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(I.R.S. Employer<br>Identification Number)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4370 La Jolla Village Drive, Suite 1050</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, CA 92122</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(858) 225-7696</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address, including zip code, and telephone number, including area code, of registrant&#x2019;s principal executive offices)</font></p><p style="margin-left:30.667%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:30.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tien-Li Lee, M.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer<br>Aardvark Therapeutics, Inc.<br>4370 La Jolla Village Drive, Suite 1050</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, CA 92122</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(858) 225-7696</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></p><p style="margin-left:30.667%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:30.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">With copies to:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Jeffrey T. Hartlin, Esq.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Samantha H. Eldredge, Esq.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Paul Hastings LLP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1117 S. California Avenue</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Palo Alto, CA 94304</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(650) 320-1800</font></p><p style="margin-left:30.667%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:30.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Approximate date of commencement of proposed sale to the public:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>From time to time after the effective date of this Registration Statement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:1.4298611111111112in;box-sizing:content-box;"></td>
     <td style="width:0.1951388888888889in;box-sizing:content-box;"></td>
     <td style="width:3.120138888888889in;box-sizing:content-box;"></td>
     <td style="width:1.5597222222222222in;box-sizing:content-box;"></td>
     <td style="width:0.1951388888888889in;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXPLANATORY NOTE</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This registration statement contains:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a base prospectus, which covers the offering, issuance and sale by us of up to $400,000,000 in the aggregate of the securities identified herein from time to time in one or more offerings; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a sales agreement prospectus covering the offering, issuance and sale by us of up to a maximum aggregate offering price of $150,000,000 of our common stock that may be issued and sold from time to time under an Equity Distribution Agreement, dated March 23, 2026 (the Equity Distribution Agreement), through Piper Sandler &amp; Co. acting as sales agent.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in a prospectus supplement to the base prospectus. The equity distribution agreement prospectus immediately follows the base prospectus.  The $150,000,000 of common stock that may be offered, issued and sold by us pursuant to the Equity Distribution Agreement and under the equity distribution agreement prospectus is included in the $400,000,000 of securities that may be offered, issued and sold by us under the base prospectus. Upon termination of the Equity Distribution Agreement or the equity distribution agreement prospectus, any portion of the $150,000,000 included in the equity distribution agreement prospectus that is not sold pursuant to the Equity Distribution Agreement will be available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no shares are sold under the Equity Distribution Agreement and the equity distribution agreement prospectus, the full $400,000,000 of securities may be sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUBJECT TO COMPLETION &#x2014; DATED MARCH 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROSPECTUS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><img src="img8190679_0.jpg" alt="img8190679_0.jpg" style="width:290px;height:62px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$400,000,000</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Stock</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Debt Securities</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrants</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Units</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depositary Shares</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may offer and sell any combination of the securities described in this prospectus, either individually or in combination with other securities, in one or more offerings. We may also offer common stock or preferred stock upon conversion of debt securities, common stock upon conversion of preferred stock, or common stock, preferred stock or debt securities upon the exercise of warrants, rights, depositary shares or units. The aggregate initial offering price of all securities sold under this prospectus will not exceed $400,000,000.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus provides a general description of the securities we may offer. Each time we sell securities pursuant to this prospectus, we will provide the specific terms of these offerings and securities in one or more supplements to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference herein or therein before you invest in any of the securities being offered.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">About this Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Plan of Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is listed on the Nasdaq Global Select Market under the trading symbol &#x201c;AARD.&#x201d; On March 20, 2026, the last reported sale price of our common stock was $4.07 per share. The applicable prospectus supplement will contain information, where applicable, as to other listings, if any, on the Nasdaq Global Select Market or other securities exchange of the securities covered by the applicable prospectus supplement.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an &#x201c;emerging growth company&#x201d; as that term is used in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act) and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings with the Securities and Exchange Commission (SEC). See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prospectus Summary&#x2014;Implications of Being an Emerging Growth Company and a Smaller Reporting Company</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#x201c;Risk Factors&#x201d; on page 10 of this prospectus and contained in any applicable prospectus supplement and in any free writing prospectuses we have authorized for use in connection with a specific offering, and under similar headings in the documents that are incorporated by reference into this prospectus.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus may not be used to consummate a sale of securities unless accompanied by a prospectus supplement.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The securities may be offered and sold from time to time, through agents designated by us or to or through underwriters, brokers or dealers, on a continuous or delayed basis. For additional information on the methods of sale, you should refer to the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Plan of Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; in this prospectus. If any agents, underwriters, brokers or dealers are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of such agents, underwriters, brokers or dealers and any applicable fees, commissions, discounts and over allotment options will be set forth in a prospectus supplement or a related free writing prospectus. When applicable, the price to the public of such securities and the net proceeds we expect to receive from such sale, if any, will also be set forth in a prospectus supplement or a related free writing prospectus.</font></p><p style="margin-left:32%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:4.5pt;border-bottom:0.75pt solid;margin-right:32%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:1.5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></p><p style="margin-left:32%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:32%;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The date of this prospectus is                 , 2026.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.75in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="margin-left:1.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;margin-right:1.065%;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:1.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:6.096527777777777in;box-sizing:content-box;"></td>
     <td style="width:0.06527777777777778in;box-sizing:content-box;"></td>
     <td style="width:0.33819444444444446in;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Page</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#about_this_prospectus"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ABOUT THIS PROSPECTUS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#special_note_regarding_forward_looking"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#prospectus_summary"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PROSPECTUS SUMMARY</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#risk_factors"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RISK FACTORS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#use_of_proceeds"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">USE OF PROCEEDS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#description_of_capital_stock"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DESCRIPTION OF CAPITAL STOCK</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#description_of_debt_securities"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DESCRIPTION OF DEBT SECURITIES</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#description_of_warrants"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DESCRIPTION OF WARRANTS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#description_of_rights"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DESCRIPTION OF RIGHTS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#description_of_units"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DESCRIPTION OF UNITS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#description_of_depositary_shares"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DESCRIPTION OF DEPOSITARY SHARES</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#legal_ownership_of_securities"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LEGAL OWNERSHIP OF SECURITIES</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#plan_of_distribution"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PLAN OF DISTRIBUTION</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#legal_matters"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LEGAL MATTERS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#experts"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">EXPERTS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#where_you_can_find_additional_informat"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#incorporation_of_certain_information_by"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="about_this_prospectus"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ABOUT THI</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">S PROSPECTUS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus is part of a registration statement on Form S-3 that we filed with the SEC under the Securities Act of 1933, as amended (the Securities Act), utilizing a &#x201c;shelf&#x201d; registration process.  Under this shelf registration process, we may offer and sell securities from time to time and in one or more offerings up to a total dollar amount of $400,000,000 as described in this prospectus.  This prospectus provides you with a general description of the securities we may offer.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each time we offer to sell securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of that offering.  We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings.  The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in any documents that we have incorporated by reference into this prospectus.  To the extent that any statement that we make in a prospectus supplement is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded by those made in a prospectus supplement.  We urge you to read carefully this prospectus, any applicable prospectus supplement and any related free writing prospectus we have authorized for use in connection with a specific offering, together with the information incorporated herein by reference as described under the headings &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Where You Can Find Additional Information</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Incorporation of Certain Information by Reference</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; before buying any of the securities being offered.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus may not be used to consummate a sale of securities unless it is accompanied by a prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any applicable prospectus supplement or any related free writing prospectuses prepared by or on behalf of us or to which we have referred you.  We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.  This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should not assume that the information appearing in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any information we have incorporated by reference herein or therein is correct on any date subsequent to the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, the applicable prospectus supplement or any related free writing prospectus, or any sale of a security.  Our business, financial condition, results of operations and prospects may have changed since those dates.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information.  All of the summaries are qualified in their entirety by the actual documents.  Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the section entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Where You Can Find Additional Information</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For investors outside the United States: neither we nor any of our respective affiliates have done anything that would permit this offering or the possession or distribution of this prospectus in any jurisdiction where action for those purposes is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, this offering of securities and the distribution of this prospectus outside the United States.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless the context requires otherwise, references in this prospectus to &#x201c;Aardvark,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to Aardvark Therapeutics, Inc. and its subsidiaries, unless otherwise specified.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="special_note_regarding_forward_looking"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REG</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARDING FORWARD-LOOKING STATEMENTS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus, including the documents incorporated by reference herein, contains forward-looking statements about us and our industry within the meaning of Section 21E of the Exchange Act and Section 27A of the Securities Act, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy, product candidates, planned preclinical studies and clinical trials, results of preclinical studies and clinical trials, research and development plans and costs, plans for manufacturing, regulatory approvals, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;expects,&#x201d; &#x201c;plans,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;could,&#x201d; &#x201c;intends,&#x201d; &#x201c;target,&#x201d; &#x201c;projects,&#x201d; &#x201c;contemplates,&#x201d; &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;predicts,&#x201d; &#x201c;potential&#x201d; or &#x201c;continue&#x201d; or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements contained in this prospectus and the documents incorporated by reference herein may include, but are not limited to, statements about:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation, timing, progress and results of our preclinical studies, clinical trials and research and development programs for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to demonstrate, and the timing of, preclinical proof-of-concept in vivo for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully complete our clinical trials;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to quickly leverage our initial product candidates and to progress additional candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence of certain diseases and conditions we intend to treat and the size of the market opportunity for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of the number of patients with certain diseases and conditions we intend to treat and the number of subjects that we intend to enroll in our clinical trials; </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the likelihood of our clinical trials demonstrating safety and efficacy of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the beneficial characteristics, including safety, efficacy and therapeutic effects, and potential advantages of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing or likelihood of regulatory filings and approval for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to meet future regulatory standards with respect to our product candidates, if approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans relating to the further development and manufacturing of our product candidates, including additional indications that we may pursue;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to identify additional product candidates or technologies with significant commercial potential that are consistent with our commercial objectives;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rate and degree of market acceptance and therapeutic benefits of our product candidates, if approved, and any other product candidates we may develop;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the implementation of our strategic plans for our business, product candidates, research programs and technologies;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">anticipated developments related to our competitors and our industry;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our competitive position and ability to leverage the clinical, regulatory and manufacturing advancements to accelerate our clinical trials and regulatory approval of product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the success of competing therapies that are or may become available;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to identify and enter into future license agreements and collaborations;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expected potential benefits of strategic collaborations with third parties and our ability to attract collaborators with development, regulatory, manufacturing or commercialization expertise;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to efficiently and cost-effectively conduct our current and future clinical trials;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reliance on third parties to conduct clinical trials of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reliance on third parties for the manufacture of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans relating to sales strategy, manufacturing and commercializing our product candidates, if approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract and retain sales personnel, or to contract with a sales organization, if our product candidates are approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">anticipated regulatory and legal developments in the United States and foreign countries in which we may seek regulatory approval for our product candidates in the future;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract and retain key scientific and management personnel;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expected or anticipated financial performance;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain funding for our operations necessary to complete further development and commercialization of our product candidates, if approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain existing, and establish new, strategic collaborations, licensing, or other arrangements, including our ability to comply with our financial obligations pursuant to the terms of such agreements;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sufficiency of our existing capital resources to fund our future operating expenses and capital expenditure requirements;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the period during which we will qualify as an emerging growth company under the JOBS Act or a smaller reporting company; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of our expenses, capital requirements and needs for additional financing.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We caution you that the forward-looking statements highlighted above do not encompass all of the forward-looking statements made in this prospectus or in the documents incorporated by reference in this prospectus.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects.  There can be no assurance that future developments affecting us will be those that we have anticipated.  These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.  These risks and uncertainties include, but are not limited to, those factors described under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; in this prospectus, in our </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001774857/000119312526119770/ck0001774857-20251231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Report on Form 10-K for the year ended December 31, 2025</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as filed with the SEC on March 23, 2026, as updated by our subsequent annual, quarterly and other reports and documents that are incorporated by reference into this prospectus, and elsewhere in the documents incorporated by reference into this prospectus.  Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.  There may be additional risks that we consider immaterial or which are unknown.  It is not possible to predict or identify all such risks.  Readers are cautioned not to place undue reliance on forward-looking statements because of the risks and uncertainties related to them and to the risk factors.  We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this prospectus, except as may be required under applicable securities laws. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make or enter into.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, statements that &#x201c;we believe&#x201d; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of the statement is made, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;margin-right:0.0pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-top:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;padding-right:7.0%;margin-right:-0.5pt;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="prospectus_summary"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROSPE</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CTUS SUMMARY</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">This summary highlights selected information that is presented in greater detail elsewhere in this prospectus or in the documents incorporated by reference in this prospectus.  Because it is only a summary, it does not contain all of the information you should consider before investing in our securities and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information included elsewhere in this prospectus and the documents incorporated by reference in this prospectus.  Before you decide whether to purchase our securities, you should read this entire prospectus carefully, including the sections of this prospectus entitled &#x201c;Risk Factors&#x201d; and similar headings in the other documents that are incorporated by reference in this prospectus.  You should also carefully read the information incorporated by reference into this prospectus, including our consolidated financial statements and the related notes, as well as the exhibits to the registration statement of which this prospectus is a part.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients. We have focused our efforts on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Our initial compounds target TAS2Rs expressed in the gut lumen, which normally respond to the chemicals in food and participate in the gut-brain axis. Our research has shown that activating these receptors can induce the secretion of endogenous signaling molecules, including cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TAS2Rs are a family of 26 different nutrient-sensing G protein-coupled receptors (GPCRs) that are broadly expressed among vertebrates. TAS2Rs are present in the oral cavity to convey bitter taste and are highly expressed in many other tissues throughout the body where they are key in regulating metabolic and inflammatory pathways. CCK has long been recognized as a promising pharmaceutical target because its release is triggered with food and it helps suppress hunger, which is the feeling of discomfort that comes from a perception of not having eaten recently. We believe suppression of hunger could be complementary to the suppression of appetite reported from patients on GLP-1 receptor targeted treatments, which reduce the desirability of food. Previous approaches to directly agonize CCK receptors through exogenous molecules have been limited by safety concerns driven by systemic exposure, resulting in on-target, off-tissue toxicity, and in turn leading to adverse effects, such as pancreatitis. Our wholly-owned lead product candidate, ARD-101, is an oral, largely gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen. ARD-101, in contrast to previous approaches to directly agonize CCK receptors, elicits the endogenous release of CCK by leveraging the body&#x2019;s natural response to TAS2R agonism. Besides our product candidates, we are not aware of any approved or other clinical-stage candidates targeting certain TAS2Rs.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARD-101 has limited systemic absorption, which we believe reduces the potential for systemic toxicity and has contributed to ARD-101 being well-tolerated in our Phase 1 and 2 trials. We have completed a Phase 1 clinical trial of ARD-101 in healthy volunteers and a Phase 2 clinical trial in subjects with hyperphagia associated with Prader-Willi Syndrome (PWS). The Phase 2 clinical trial in hyperphagia associated with PWS evaluated two dosing regimens over 28 days followed by a 14-day withdrawal period. In Part 1 of the trial, 12 subjects completed the treatment period at a fixed dose of 200 mg delivered orally twice daily (BID). These 12 subjects that completed treatment had no significant treatment-related adverse events and, of these subjects, eight completed the Hyperphagia for Clinical Trial Questionnaire-9 (HQ-CT 9), with seven having complete post&#x2013;database lock datasets. In this subgroup of seven, the mean decline at day 28 was approximately 9 points. In Part 2 of the trial, four subjects were dosed under a revised protocol: 400 mg BID for seven days, followed by 600 mg BID for seven days and ending with 800 mg BID for 14 days. The four subjects that completed the trial per protocol had only grade 1 treatment-related adverse events and showed a decrease in HQ-CT 9 of approximately eight points at 28 days. In our completed Phase 2 clinical trial in subjects with hyperphagia associated with PWS, ARD-101 was shown to be well-tolerated and demonstrated clinical activity through a reduction in Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the second quarter of 2025, we initiated dosing for a Phase 3 clinical trial for hyperphagia associated with PWS, which we refer to as the HERO (</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">H</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unger </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limination or </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eduction </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bjective) trial. We previously reached alignment with the FDA on a protocol for a Phase 3 clinical trial, which we initiated in December 2024. In August 2025, we submitted a protocol amendment to remove the use of anti-psychotics and insulin-requiring type 2 diabetes as exclusion criteria for the clinical trial. In October 2025, we reached alignment with the FDA on a protocol amendment to lower the minimum age of eligibility to participate in the trial from 13 to 10 years of age. This change broadened the eligible trial population and expanded the potential addressable opportunity within PWS. In</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-bottom:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;margin-right:0.0pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-top:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;padding-right:7.0%;margin-right:-0.5pt;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2025, we submitted an additional protocol amendment seeking to further lower the minimum age of eligibility to participate in the trial to 7 years of age. During the third quarter of 2025, we commenced enrollment for the HERO Open Label Extension (OLE) trial, which was available to patients completing the HERO trial and we initiated our first clinical sites in Australia.  In January 2026, we announced over 50% completion of the target enrollment of 90 patients in the HERO trial and within the first quarter of 2026, we initiated clinical sites in the UK, South Korea and Canada.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 27, 2026, we voluntarily paused enrollment and dosing in the HERO and OLE trials following reversible cardiac observations in a healthy volunteer study and are currently reviewing the data and collaborating with the FDA to determine next steps. As a result, aspects of the trial design, development timeline and future clinical plans may change. Following the voluntary pause, we are reviewing the trial designs and protocols in collaboration with the FDA and the previously agreed protocol elements may be revisited.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our second TAS2R program, ARD-201, was planned to be a fixed-dose combination of ARD-101 and a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of obesity and obesity-related conditions. We previously initiated a Phase 2 clinical trial, which we referred to as the POWER (Prevention Of WEight Regain) trial, in December 2025, to explore the efficacy of ARD-201 in the prevention of weight regain among patients who have successfully lost over 15% of body weight on GLP-1RA therapy.  In addition, we previously planned to initiate a second Phase 2 trial for ARD-201 in the first half of 2026, which we referred to as the STRENGTH (Sitagliptin and TAS2R for weight Reduction with Exercise, Nutrition, and GLP-1RA Trial and Hunger assessment) trial.  Because ARD-201 contains ARD-101 as a component of the planned combination therapy, we are assessing the potential implications of the voluntary pause of the HERO trial on the ARD-201 program. Following this assessment, we have voluntarily paused the STRENGTH and POWER clinical trials while we complete our ongoing evaluation of the safety observations identified in the healthy volunteer study of ARD-101 and continue discussions with the FDA regarding next steps for the ARD-101 program. We expect to provide further guidance in the second quarter of 2026.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In preparation for these trials, we expanded our clinical management and regulatory capabilities, including hiring clinical, regulatory and quality personnel, and we expect to continue to need to expand our clinical management and regulatory capabilities and to rely on third parties to conduct our later stage or pivotal clinical trials in the future. However, the timing of additional staffing and operational expansion may be delayed as we evaluate next steps following the voluntary pause of the HERO trial and related clinical programs.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Pipeline</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing the below portfolio of wholly-owned novel and proprietary small-molecule programs that we believe can induce satiety in patients with hunger-associated indications, as outlined below. As discussed above, certain clinical programs, including the HERO trial for ARD-101 and the POWER and STRENGTH trials for ARD-201, are currently paused while we evaluate safety observations and continue discussions with the FDA regarding next steps.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-bottom:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;margin-right:0.0pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-top:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;padding-right:7.0%;margin-right:-0.5pt;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Hunger Associated TAS2R Pipeline</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img8190679_1.gif" alt="img8190679_1.gif" style="width:624px;height:230px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implications of Being an Emerging Growth Company and a Smaller Reporting Company</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We qualify as an &#x201c;emerging growth company&#x201d; as that term is defined in the JOBS Act.  For as long as we continue to be an emerging growth company, we intend to take advantage of exemptions from various reporting requirements applicable to other public companies but not to &#x201c;emerging growth companies,&#x201d; including:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, as amended;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">permission to delay adopting new or revised accounting standards until such time as those standards apply to private companies;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced disclosure obligations regarding executive compensation in our periodic reports and Annual Reports on Form 10-K; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exemptions from the requirements of holding non-binding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the JOBS Act, we will remain an emerging growth company until the earliest of:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the last day of the fiscal year during which we have total annual gross revenues of $1.235 billion or more;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the last day of the fiscal year following the fifth anniversary of the Initial Public Offering, or December 31, 2030;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which we have issued, during the previous three-year period, more than $1.0 billion in non-convertible debt securities; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which we are deemed to be a &#x201c;large accelerated filer&#x201d; under the Securities Exchange Act of 1934, as amended (the Exchange Act) (</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">i.e.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the first day of the fiscal year after we have (1) more than $700.0 million in outstanding common equity held by our non-affiliates, measured each year on the last day of our second fiscal quarter, (2) been public for at least 12 months, and (3) are not eligible to be deemed a &#x201c;smaller reporting company&#x201d; because we do not meet the revenue test of the definition of &#x201c;smaller reporting company&#x201d;, which includes an initial determination that our annual revenues are more than $100.0 million for the most recently completed fiscal year).</font></div></div></div></div><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-bottom:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;margin-right:0.0pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-top:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;padding-right:7.0%;margin-right:-0.5pt;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a &#x201c;smaller reporting company,&#x201d; meaning that the market value of our common stock held by non-affiliates is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our common stock held by non-affiliates is less than $250.0 million or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our common stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have elected to take advantage of certain of the reduced disclosure obligations regarding executive compensation in this prospectus and may elect to take advantage of other reduced reporting requirements in future filings with the SEC.  As a result, the information that we provide to our stockholders may be different from the information you receive from other public reporting companies.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We were incorporated in Delaware on May 17, 2017. Our principal executive offices are located at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122 and our telephone number is (858) 225-7696. We have two wholly-owned subsidiaries, Artisan Therapeutics, Inc., incorporated in Delaware in October 2024, and Ardia Therapeutics, Inc, incorporated in Delaware in February 2026. Our website address is https://aardvarktherapeutics.com. Information contained on or connected to our website is not a part of, and is not incorporated into, this prospectus or the registration statement of which this prospectus is a part or any prospectus supplement and the inclusion of our website address in this prospectus is an inactive textual reference only.  We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC.  You may obtain any of the documents filed by us with the SEC at no cost from the SEC&#x2019;s website at http://www.sec.gov</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Description of Securities</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may offer shares of our common stock and preferred stock, depositary shares, various series of debt securities and warrants or rights to purchase any of such securities, either individually or in combination with other securities or in units, up to a total aggregate offering price of $400,000,000 from time to time in one or more offerings under this prospectus, together with the applicable prospectus supplement and any related free writing prospectus, at prices and on terms to be determined by market conditions at the time of any relevant offering.  This prospectus provides you with a general description of the securities we may offer.  Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">designation or classification;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">aggregate principal amount or aggregate offering price;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maturity date, if applicable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">original issue discount, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rates and times of payment of interest or dividends, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">redemption, conversion, exercise, exchange or sinking fund terms, if any;</font></div></div></div></div><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-bottom:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;margin-right:0.0pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-top:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;padding-right:7.0%;margin-right:-0.5pt;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ranking;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictive covenants, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">voting or other rights, if any; </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conversion or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange prices or rates and in the securities or other property receivable upon conversion or exchange; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">material or special U.S. federal income tax considerations, if any.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The applicable prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents we have incorporated by reference.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The securities may be offered directly to investors from time to time, through agents designated by us or to or through agents, underwriters, brokers or dealers.  We, and our agents, underwriters, brokers or dealers, reserve the right to accept or reject all or part of any proposed purchase of securities.  If we do offer securities to or through agents, underwriters, brokers or dealers, we will include in the applicable prospectus supplement:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the names of those agents, underwriters, brokers or dealers;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">applicable fees, discounts and commissions to be paid to them;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">details regarding over-allotment or other options to purchase additional securities, if any; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the net proceeds to us, if any.</font></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as described in any applicable prospectus supplement or in any free writing prospectus we have authorized for use in connection with a specific offering, we intend to use the net proceeds from the sale of the securities under this prospectus for general corporate purposes, which may include funding research and development, capital expenditures, working capital and general and administrative expenses. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; on page 11 of this prospectus.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nasdaq Global Select Market Exchange Listing</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#x201c;AARD.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div><div class="page-border-spacing" style="margin-left:-0.5pt;padding-left:7.0%;margin-bottom:-0.5pt;padding-right:7.0%;margin-right:-0.5pt;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="risk_factors"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK </font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FACTORS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing in our securities involves a high degree of risk.  Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed above under &#x201c;Special Note Regarding Forward-Looking Statements&#x201d;, you should carefully consider the risks and uncertainties described under the section titled &#x201c;Risk Factors&#x201d; contained in our most recent Annual Report on Form 10-K, together with all of the other information appearing in or incorporated by reference into this prospectus, as updated by our subsequent filings with the SEC, as well as the risk factors and other information contained in any applicable prospectus supplement and any applicable free writing prospectus before deciding to invest in our securities. If any of these risks actually occur, it may materially harm our business, financial condition, liquidity and results of operations.  As a result, the market price of our securities could decline, and you could lose all or part of your investment.  Additionally, the risks and uncertainties described in this prospectus, any prospectus supplement, any free writing prospectus, any post-effective amendment or in any filing or document incorporated by reference herein or therein are not the only risks and uncertainties that we face.  Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may become material and adversely affect our business.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="use_of_proceeds"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">USE OF PR</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OCEEDS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as described in any applicable prospectus supplement or in any free writing prospectus we have authorized for use in connection with a specific offering, we currently intend to use the net proceeds from the sale of the securities under this prospectus for general corporate purposes, which may include funding research and development, capital expenditures, working capital and general and administrative expenses. We may also use a portion of the net proceeds to in-license, acquire, or invest in complementary businesses, technology platforms, products, services, technologies or other assets. However, we do not have any agreements or commitments to enter into any material acquisitions or investments at this time.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts of and timing of our use of the net proceeds from the sale of securities under this prospectus will depend on a number of factors. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from the sale of securities under this prospectus or any applicable prospectus supplement. Accordingly, we will retain broad discretion over the use of such proceeds.  We will set forth in the applicable prospectus supplement or free writing prospectus our intended use for the net proceeds, if any, received from the sale of any securities sold pursuant to such prospectus supplement or free writing prospectus.  Pending application of the net proceeds as described above, we intend to invest the net proceeds from the offering that are not used as described above in U.S. federal government or agency-issued obligations, FDIC-insured certificates of deposit, municipal bonds and money market accounts.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="description_of_capital_stock"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DESCRIPTION O</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F CAPITAL STOCK</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of the material terms of our capital stock, as well as other material terms of our fourth amended and restated certificate of incorporation, as may be amended or restated from time to time (our Certificate of Incorporation) and amended and restated bylaws, as may be amended or restated from time to time (our Bylaws) and certain provisions of Delaware law. This summary does not purport to be complete and is qualified in its entirety by the provisions of our Certificate of Incorporation and Bylaws, copies of which are filed as exhibits to the registration statement of which this prospectus is a part. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Where You Can Find Additional Information</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d; The summary below is also qualified by reference to the provisions of the General Corporation Law of the State of Delaware (the DGCL), as applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our authorized capital stock consists of 490,000,000 shares of common stock, $0.00001 par value per share, and 10,000,000 shares of undesignated preferred stock, $0.00001 par value per share. Our board of directors is authorized, without stockholder approval except as required by the rules and listing standards of The Nasdaq Stock Market LLC, to issue additional shares of our capital stock. As of December 31, 2025, we had 21,815,353 shares of common stock outstanding and no shares of preferred stock outstanding.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dividend Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voting Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. Our Certificate of Incorporation does not provide for cumulative voting for the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors. In addition, the affirmative vote of holders of 66-2/3% of the voting power of all of the then outstanding capital stock is required to take certain actions, including amending certain provisions of our Certificate of Incorporation, including the provisions relating to amending our Bylaws, the classified board and director liability. Our Certificate of Incorporation provides for a classified board of directors that is divided into three classes with staggered three-year terms. Only the directors in one class is subject to election at each annual meeting of our stockholders, with the directors in the other classes continuing for the remainder of their respective three-year terms.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Preemptive or Similar Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is not entitled to preemptive rights, and is not subject to conversion, redemption, or sinking fund provisions.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Right to Receive Liquidation Distributions</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we become subject to a liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fully Paid and Non-Assessable</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the outstanding shares of our common stock are, and the shares of our common stock to be issued pursuant to this prospectus or which may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, or upon exercise of warrants, units or rights to be issued pursuant to this prospectus, will be, fully paid and non-assessable.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Stock</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue up to 10,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences, and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company or other corporate action and might adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. We have no current plan to issue any shares of preferred stock.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Rights</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investors&#x2019; Rights Agreement</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, in connection with our Series C preferred stock financing, we entered into an Amended and Restated Investors&#x2019; Rights Agreement, as subsequently amended (the Rights Agreement). The Rights Agreement granted certain rights to the holders of our then-outstanding convertible preferred stock, including certain registration rights with respect to the registrable securities held by them.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain holders of the shares of our common stock that were issued upon the automatic conversion of our convertible preferred stock in connection with our initial public offering completed in February 2025 (IPO) are entitled to these demand, piggyback and Form S-3 registration rights pursuant to the Rights Agreement. We will pay the registration expenses, other than the underwriting discounts, selling commissions stock transfer taxes and certain fees and disbursements of counsel for the holders of the shares registered pursuant to the demand, piggyback and Form S-3 registrations described below.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares the holders may include. The demand, piggyback and Form S-3 registration rights described below will expire no later than February 14, 2028 (the date that is three years after the completion of our IPO) or, with respect to any particular holder, at such time that such holder may immediately sell all of its shares of registrable securities under Rule 144 of the Securities Act during any 90-day period.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Demand Registration Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain holders of the shares of our common stock that were issued upon the automatic conversion of our convertible preferred stock in connection with our IPO are entitled to certain demand registration rights pursuant to the Rights Agreement. The holders of a majority of the registrable securities then outstanding may request that we register all or a portion of their shares. Such request for registration must cover registrable securities with an anticipated aggregate offering price, after deduction for underwriters&#x2019; discounts and expenses related to the issuance, of at least $20.0 million.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Piggyback Registration Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that we propose to register any of our securities under the Securities Act, either for our own account or for the account of other security holders, the holders of registrable securities subject to the Rights Agreement will be entitled to certain piggyback registration rights pursuant thereto allowing such holders to include their shares in such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to: (i) a demand registration as described above; (ii) a registration on Form S-3 as described below; (iii) a registration relating solely to employee benefit plans; (iv) a registration relating to the offer and sale of debt securities; (v) a registration relating to a corporate reorganization or other transaction under Rule 145 of the Securities Act; or (vi) a registration on any registration form that does not permit secondary sales, then holders of these shares are entitled to notice of the registration and have the right to include their shares in the registration, subject to limitations that the underwriters may impose on the number of shares included in the offering.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">S-3 Registration Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain holders of the shares of our common stock that were issued upon the automatic conversion of our convertible preferred stock in connection with our IPO are entitled to certain Form S-3 registration rights pursuant to the Rights Agreement. Such holders of registrable securities can make a request that we register their shares on Form S-3, provided that (i) such holders must hold an aggregate of not less than 15% of the registrable securities then outstanding and (ii) such holders, together with the holders of any other securities entitled to inclusion in such registration, propose to sell securities at an aggregate price of at least $1.0 million. We will not be required to effect a registration on Form S-3 within 60 days of a registration initiated by us, to effect more than two registrations on Form S-3 within any 12-month period or to effect any registration that our board of directors deems in good faith to be materially detrimental to our company and our stockholders, subject to certain limitations.  If the holders requesting registration intend to distribute their shares by means of an underwritten offering, the underwriter of such offering will have the right to limit the number of shares to be underwritten.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Election and Removal of Directors; Vacancies</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The exact number of directors will be fixed from time to time by resolution of our board of directors. Directors are elected by a plurality of the votes of the shares of our capital stock present in person or represented by proxy at the stockholders&#x2019; meeting and entitled to vote on the election of directors.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No director may be removed except for cause, and directors may be removed for cause only by an affirmative vote of shares representing not less than 66-2/3% of the then-outstanding shares then entitled to vote at an election of directors, voting together as a single class.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any vacancy occurring on our board of directors and any newly created directorship may be filled only by a majority of the remaining directors in office.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Staggered Board</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors is divided into three classes serving staggered three-year terms. At each annual meeting of stockholders, directors will be elected to succeed the class of directors whose terms have expired. This classification of our board of directors could have the effect of increasing the length of time necessary to change the composition of a majority of our board of directors. In general, at least two annual meetings of stockholders will typically be necessary for stockholders to effect a change in a majority of the members of our board of directors.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitation on Action by Written Consent</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Certificate of Incorporation and our Bylaws provide that holders of our common stock are not able to act by written consent without a meeting.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stockholder Meetings</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Certificate of Incorporation and our Bylaws provide that special meetings of our stockholders may be called only by the Chairperson of our board of directors, our Chief Executive Officer (or President, in the absence of a Chief Executive Officer) or a majority of the directors. Our Certificate of Incorporation and our Bylaws specifically deny any power of any other person to call a special meeting.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment of the Certificate of Incorporation</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions of our Certificate of Incorporation under Part B of Article V, Article VI, Article VII, Article VIII, Article IX, Article X and Article XI may be amended only by the affirmative vote of holders of at least 66-2/3% of the voting power of our then-outstanding shares of voting stock entitled to vote generally in an election of directors, voting together as a single class. The affirmative vote of holders of at least a majority of the voting power of our outstanding shares of capital stock is generally required to amend other provisions of our Certificate of Incorporation.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment of Bylaws</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions of our Bylaws may be amended or repealed, and new bylaws may be adopted by (i) our board of directors, with the affirmative vote of a majority of directors present at any regular or special meeting of our board of directors called for that purpose, or (ii) our stockholders, with the affirmative vote of holders of at least 66-2/3% of the voting power of our then-outstanding shares of voting stock entitled to vote generally in an election of directors, voting together as a single class.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Limitations on Stockholder Actions</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Bylaws impose some procedural requirements on stockholders who wish to:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">make nominations in the election of directors;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">propose that a director be removed;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">propose any repeal or change in our Bylaws; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">propose any other business to be brought before an annual or special meeting of stockholders.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under these procedural requirements, in order to bring a proposal before a meeting of stockholders, a stockholder must deliver timely notice of a proposal pertaining to a proper subject for presentation at the meeting to our corporate secretary along with the following:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a description of the business or nomination to be brought before the meeting and the reasons for conducting such business at the meeting;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the stockholder&#x2019;s name and address;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any material interest of the stockholder in the proposal;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of shares beneficially owned by the stockholder, the date or dates such shares were acquired and the investment intent of such acquisition; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any pledge by the stockholder with respect to such shares.</font></div></div><p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To be timely, a stockholder must generally deliver notice:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in connection with an annual meeting of stockholders, not less than 90 nor more than 120 days prior to the date on which the annual meeting of stockholders was held in the immediately preceding year, but in the event that the date of the annual meeting is more than 30 days before or more than 60 days after the anniversary date of the preceding annual meeting of stockholders, a stockholder notice will be timely if received by us not later than the 120th day prior to the date of the annual meeting and not later than (i) the 90th day prior to such annual meeting or; (ii) if later, the 10th day following the day on which we first publicly announce the date of the annual meeting; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in connection with the election of a director at a special meeting of stockholders, during the period not less than 90 nor more than 120 days prior to the date of the special meeting, or, if later, the 10th day following the day on which public disclosure of such special meeting was first made.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to submit a nomination for our board of directors, a stockholder must also submit all information with respect to the nominee that would be required to be included in a proxy statement, as well as other information. If a stockholder fails to follow the required procedures, the stockholder&#x2019;s proposal or nominee will be ineligible and will not be voted on by our stockholders.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitation of Liability of Directors and Officers</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Certificate of Incorporation provides that no director or officer will be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director or officer, except as required by applicable law, as in effect from time to time. Section 102(b)(7) of the DGCL, permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability for:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any breach of the director&#x2019;s or officer&#x2019;s duty of loyalty to the corporation or its stockholders;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as a director, unlawful payments of dividends or unlawful stock repurchases or redemptions;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as an officer, derivative claims brought on behalf of the corporation by a stockholder; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any transaction from which the director or officer derived an improper personal benefit.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, neither we nor our stockholders have the right, through stockholders&#x2019; derivative suits on our behalf, to recover monetary damages against a director or officer for breach of fiduciary duty as a director or officer, including breaches resulting from grossly negligent behavior, except in the situations described above.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Certificate of Incorporation and Bylaws also provide that, to the fullest extent permitted by law, we will indemnify any officer or director of our company against all damages, claims and liabilities arising out of the fact that the person is or was our director or officer, or served any other enterprise at our request as a director or officer. Amending these provisions will not reduce our indemnification obligations relating to actions taken before an amendment.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forum Selection</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Certificate of Incorporation provides that the Court of Chancery of the State of Delaware is the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (i) any derivative action or proceeding brought on behalf of us; (ii) any action asserting a claim of breach of fiduciary duty owed to us or our stockholders by any director, officer or other employee of our company; (iii) any action asserting a claim arising pursuant to any provision of the DGCL or our Certificate of Incorporation and our Bylaws; or (iv) any action asserting a claim governed by the internal affairs doctrine. This provision would not apply to claims brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, our Certificate of Incorporation also provides that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in our shares of capital stock shall be deemed to have notice of and consented to the foregoing forum selection provisions. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder.  Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Although our Certificate of Incorporation contains the choice of forum provision described above, it is possible that a court could rule that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our exclusive forum provision will not relieve us of our duties to comply with the federal securities laws and the rules and regulations thereunder, and our stockholders will not be deemed to have waived our compliance with these laws, rules and regulations.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The enforceability of similar federal court choice of forum provisions in other companies&#x2019; certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find this type of provision to be inapplicable or unenforceable. If a court were to find either of the choice of forum provisions contained in our Certificate of Incorporation or our Bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The choice of forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company or our directors, officers or other employees, which may discourage such lawsuits against our company and our directors, officers and other employees and result in increased costs for investors to bring a claim.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Anti-Takeover Provisions</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain provisions of Delaware law, along with our Certificate of Incorporation and our Bylaws, may have the effect of delaying, deferring, or discouraging (i) acquiring control of our company by means of a proxy contest, tender offer or otherwise; or (ii) removing our incumbent officers and directors. These provisions, as well as our ability to issue preferred stock, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed, in part, to encourage persons seeking to acquire control of our company to first negotiate with our board of directors. However, these provisions could have the effect of delaying, discouraging or preventing attempts to acquire us, which could deprive our stockholders of opportunities to sell their shares of our common stock at prices higher than prevailing market prices.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delaware Law</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are governed by the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a public Delaware corporation from engaging in a &#x201c;business combination&#x201d; with an &#x201c;interested stockholder&#x201d; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#x201c;business combination&#x201d; includes mergers, asset sales, or other transactions resulting in a financial benefit to the stockholder. An &#x201c;interested stockholder&#x201d; is a person who, together with affiliates and associates, owns, or within three years did own, 15% or more of the corporation&#x2019;s outstanding voting stock. These provisions may have the effect of delaying, deferring or preventing a change in control of our company.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent and Registrar</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC. The transfer agent and registrar&#x2019;s address is 48 Wall Street, Floor 23, New York, New York 10005.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Listing</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#x201c;AARD&#x201d;.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="description_of_debt_securities"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DESCRIPTION</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> OF DEBT SECURITIES</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus describes the general terms and provisions of our debt securities that may be offered pursuant to this prospectus.  When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus.  We will also indicate in the prospectus supplement whether the general terms and provisions described in this prospectus apply to a particular series of debt securities.  To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information in the prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and will rank equally with all of our other unsecured and unsubordinated indebtedness.  In the event that any series of debt securities will be subordinated to other indebtedness that we have outstanding or may incur, the terms of the subordination will be set forth in the prospectus supplement relating to the subordinated debt securities.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The debt securities will be issued under an indenture to be entered into between us and the trustee named therein. A form of the indenture is attached as an exhibit to the registration statement of which this prospectus forms a part. The terms of the debt securities will include those set forth in the indenture and those made a part of the indenture by the Trust Indenture Act of 1939. You should read the summary below, any accompanying prospectus supplement and the provisions of the indenture in their entirety before investing in our debt securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the manner provided in a resolution of our board of directors, in an officer&#x2019;s certificate or by a supplemental indenture.  The particular terms of each series of debt securities will be described in a prospectus supplement relating to such series, including any pricing supplement or term sheet.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We can issue an unlimited amount of debt securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium, or at a discount.  We will set forth in a prospectus supplement, including any pricing supplement or term sheet, relating to any series of debt securities being offered, the aggregate principal amount and the following terms of the debt securities, to the extent applicable:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the title of the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the price or prices (expressed as a percentage of the principal amount) at which we will issue the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any limit on the aggregate principal amount of the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date or dates on which we will pay the principal on the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the form of the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable and any regular record date for the interest payable on any interest payment date;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the place or places where principal of and interest on the debt securities will be payable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the applicability of any guarantees;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms and conditions upon which we may redeem the debt securities;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a United States person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the dates on which and the price or prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the debt securities will be issued in the form of certificated debt securities or global debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if the debt securities of the series will be issued in whole or in part in the form of a global debt security, the terms and conditions, if any, upon which such global debt security may be exchanged in whole or in part for other individual debt securities in definitive registered form, the depositary (as defined in the applicable prospectus supplement) for such global security and the form of any legend or legends to be borne by any such global security in addition to or in lieu of the legend referred to in the indenture; </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the principal amount due at maturity, and whether the debt securities will be issued with original issue discount;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the currency of denomination of the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the designation of the currency, currencies or currency units in which payment of principal of and interest on the debt securities will be made;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if payments of principal of or interest on the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the manner in which the amounts of payment of principal of or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies other than that in which the debt securities are denominated or designated to be payable or by reference to a commodity, commodity index, stock exchange index or financial index;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any provisions relating to any security provided for the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms of the subordination of any series of the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on transfer, sale or other assignment of the debt securities, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if the principal amount payable at the stated maturity of debt securities of the series will not be determinable as of any one or more dates prior to such stated maturity, the amount that will be deemed to be such principal amount as of any such date for any purpose, including the principal amount thereof which will be due and payable upon any maturity other than the stated maturity or which will be deemed to be outstanding as of any such date (or, in any such case, the manner in which such deemed principal amount is to be determined), and if necessary, the manner of determining the equivalent thereof in U.S. dollars;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the right, if any, to extend the interest payment periods or defer the payment of interest and maximum length of any such deferral period;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">with regard to the debt securities that do not bear interest, the dates for certain required reports to the trustee;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any provisions granting special rights to holders when a specified event occurs;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any addition to or change in the provisions relating to or dealing with defeasance;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any addition to or change in the events of default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any addition to or change in the covenants described in this prospectus or in the indenture with respect to the debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as it applies to that series; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to the debt securities.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the indenture does not limit our ability to issue convertible or subordinated debt securities.  Any conversion or subordination provisions of a particular series of debt securities will be set forth in the resolution of our board of directors, the officer&#x2019;s certificate or supplemental indenture related to that series of debt securities and will be described in the relevant prospectus supplement.  Such terms may include provisions for conversion, either mandatory, at the option of the holder or at our option, in which case the number of shares of common stock or other securities to be received by the holders of debt securities would be calculated as of a time and in the manner stated in the prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture.  We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the restrictions, elections, general tax considerations, specific terms and other information with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus supplement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer and Exchange</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each debt security will be represented by either one or more global securities registered in the name of The Depository Trust Company, as depositary, or a nominee (we will refer to any debt security represented by a global debt security as a book-entry debt security), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated security as a certificated debt security) as set forth in the applicable prospectus supplement.  Except as set forth under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x2014;Global Debt Securities and Book-Entry System</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, book-entry debt securities will not be issuable in certificated form.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Certificated Debt Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with the terms of the indenture.  No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection with a transfer or exchange.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may effect the transfer of certificated debt securities and the right to receive the principal of and interest on, certificated debt securities only by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of a new certificate to the new holder.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Global Debt Securities and Book-Entry System</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Each global debt security representing book-entry debt securities will be deposited with, or on behalf of, the depositary, and registered in the name of the depositary or a nominee of the depositary.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require the depositary to agree to follow the following procedures with respect to book-entry debt securities.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ownership of beneficial interests in book-entry debt securities will be limited to persons who have accounts with the depositary for the related global debt security, which we refer to as participants, or persons who may hold interests through participants.  Upon the issuance of a global debt security, the depositary will credit, on its book-entry registration and transfer system, the participants&#x2019; accounts with the respective principal amounts of the book-entry debt securities represented by such global debt security beneficially owned by such participants.  The accounts to be credited will be designated by any dealers, underwriters or agents participating in the distribution of the book-entry debt securities.  Ownership of book-entry debt securities will be shown on, and the transfer of such ownership interests will be effected only through, records maintained by the depositary for the related global debt security (with respect to interests of participants) and on the records of participants (with respect to interests of persons holding through participants).  The laws of some states may require that certain purchasers of securities take physical delivery of such securities in definitive form.  These laws may impair the ability to own, transfer or pledge beneficial interests in book-entry debt securities.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">So long as the depositary for a global debt security, or its nominee, is the registered owner of that global debt security, the depositary or its nominee, as the case may be, will be considered the sole owner or holder of the book-entry debt securities represented by such global debt security for all purposes under the indenture.  Except as described below, beneficial owners of book-entry debt securities will not be entitled to have securities registered in their names, will not receive or be entitled to receive physical delivery of a certificate in definitive form representing securities and will not be considered the owners or holders of those securities under the indenture.  Accordingly, each person beneficially owning book-entry debt securities must rely on the procedures of the depositary for the related global debt security and, if such person is not a participant, on the procedures of the participant through which such person owns its interest, to exercise any rights of a holder under the indenture.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We understand, however, that under existing industry practice, the depositary will authorize the persons on whose behalf it holds a global debt security to exercise certain rights of holders of debt securities, and the indenture provides that we, the trustee and our respective agents will treat as the holder of a debt security the persons specified in a written statement of the depositary with respect to that global debt security for purposes of obtaining any consents or directions required to be given by holders of the debt securities pursuant to the indenture.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will make payments of principal of, and premium and interest on, book-entry debt securities to the depositary or its nominee, as the case may be, as the registered holder of the related global debt security.  Aardvark, the trustee and any other agent of ours or agent of the trustee will not have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in a global debt security or for maintaining, supervising or reviewing any records relating to beneficial ownership interests.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that the depositary, upon receipt of any payment of principal of, and premium or interest on, a global debt security, will immediately credit participants&#x2019; accounts with payments in amounts proportionate to the respective amounts of book-entry debt securities held by each participant as shown on the records of such depositary.  We also expect that payments by participants to owners of beneficial interests in book-entry debt securities held through those participants will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts of customers in bearer form or registered in &#x201c;street name,&#x201d; and will be the responsibility of those participants.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will issue certificated debt securities in exchange for each global debt security if the depositary is at any time unwilling or unable to continue as depositary or ceases to be a clearing agency registered under the Exchange Act and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us within 90 days.  In addition, we may at any time and in our sole discretion determine not to have the book-entry debt securities of any series represented by one or more global debt securities and, in that event, will issue certificated debt securities in exchange for the global debt securities of that series.  Global debt securities will also be exchangeable by the holders for certificated debt securities if an event of default with respect to the book-entry debt securities represented by those global debt securities has occurred and is continuing.  Any certificated debt securities issued in exchange for a global debt security will be registered in such name or names as the depositary shall instruct the trustee.  We expect that such instructions will be based upon directions received by the depositary from participants with respect to ownership of book-entry debt securities relating to such global debt security.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have obtained the foregoing information concerning the depositary and the depositary&#x2019;s book-entry system from sources we believe to be reliable, but we take no responsibility for the accuracy of this information.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Protection in the Event of a Change of Control</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions that may afford holders of the debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) that could adversely affect holders of debt securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Covenants</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will set forth in the applicable prospectus supplement any restrictive covenants applicable to any issue of debt securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subordination</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Debt securities of a series may be subordinated, which we refer to as subordinated debt securities, to senior indebtedness (as defined in the applicable prospectus supplement) to the extent set forth in the prospectus supplement relating thereto.  To the extent we conduct operations through subsidiaries, the holders of debt securities (whether or not subordinated debt securities) will be structurally subordinated to the creditors of our subsidiaries.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidation, Merger or Sale of Assets</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our properties and assets to, any person, which we refer to as a successor person, unless:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we are the surviving corporation or the successor person (if other than our Company) is a corporation organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">immediately after giving effect to the transaction, no event of default, and no event which, after notice or lapse of time, or both, would become an event of default, shall have occurred and be continuing under the indenture; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">certain other conditions are met.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its properties to us.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Events of Default</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Event of default means, with respect to any series of debt securities, any of the following:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance of that default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period);</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">default in the payment of principal of any debt security of that series when due and payable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">default in the performance or breach of any other covenant or warranty by us in the indenture or any debt security (other than a covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee or we and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">certain events of bankruptcy, insolvency or reorganization of our company; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other event of default provided with respect to debt securities of that series that is described in the applicable prospectus supplement accompanying this prospectus.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No event of default with respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an event of default with respect to any other series of debt securities.  The occurrence of certain events of default or an acceleration under the indenture may constitute an event of default under certain of our other indebtedness outstanding from time to time.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an event of default with respect to debt securities of any series outstanding at the time occurs and is continuing, then the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare to be due and payable immediately the principal (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) of, and accrued and unpaid interest, if any, on all debt securities of that series.  In the case of an event of default resulting from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid interest, if any, on all outstanding debt securities will become and be immediately due and payable without any declaration or other act on the part of the trustee or any holder of outstanding debt securities.  At any time after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree for payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind and annul the acceleration if all events of default, other than the non-payment of accelerated principal and interest, if any, with respect to debt securities of that series, have been cured or waived as provided in the indenture.  We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an event of default.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture provides that the trustee will be under no obligation to exercise any of its rights or powers under the indenture, unless the trustee receives indemnity satisfactory to it against any loss, liability or expense.  Subject to certain rights of the trustee, the holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No holder of any debt security of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a receiver or trustee, or for any remedy under the indenture, unless:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that holder has previously given to the trustee written notice of a continuing event of default with respect to debt securities of that series; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made written request, and offered reasonable indemnity, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than 25% in principal amount of the outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal of and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture.  The indenture provides that the trustee may withhold notice to the holders of debt securities of any series of any default or event of default (except in payment on any debt securities of that series) with respect to debt securities of that series if it in good faith determines that withholding notice is in the interest of the holders of those debt securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Modification and Waiver</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may modify and amend the indenture with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series affected by the modifications or amendments.  We may not make any modification or amendment without the consent of the holders of each affected debt security then outstanding if that amendment will:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduce the principal of or change the fixed maturity of any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduce the principal amount of discount securities payable upon acceleration of maturity;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">waive a default in the payment of the principal of or interest on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration);</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">make the principal of or interest on any debt security payable in currency other than that stated in the debt security;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of and interest on those debt securities and to institute a suit for the enforcement of any such payment and to waivers or amendments; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">waive a redemption payment with respect to any debt security.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all debt securities of that series waive our compliance with provisions of the indenture.  The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of or any interest on, any debt security of that series; </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided, however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Defeasance of Debt Securities and Certain Covenants in Certain Circumstances</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Defeasance</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged from any and all obligations in respect of the debt securities of any series (except for certain obligations to register the transfer or exchange of debt securities of such series, to replace stolen, lost or mutilated debt securities of such series, and to maintain paying agencies and certain provisions relating to the treatment of funds held by paying agents).  We will be so discharged upon the deposit with the trustee, in trust, of money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. dollars, foreign government obligations, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent certified public accountants to pay and discharge each installment of principal and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Defeasance of Certain Covenants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon compliance with certain conditions:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may omit to comply with the covenant described under the heading </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;&#x2014;Consolidation, Merger or Sale of Assets</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and certain other covenants set forth in the indenture, as well as any additional covenants that may be set forth in the applicable prospectus supplement; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any omission to comply with those covenants will not constitute a default or an event of default with respect to the debt securities of that series, or covenant defeasance.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The conditions include:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. dollars, foreign government obligations, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent certified public accountants to pay and discharge each installment of principal of and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covenant Defeasance and Events of Default</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In the event we exercise our option to effect covenant defeasance with respect to any series of debt securities and the debt securities of that series are declared due and payable because of the occurrence of any event of default, the amount of money and/or U.S. government obligations or foreign government obligations on deposit with the trustee will be sufficient to pay amounts due on the debt securities of that series at the time of their stated maturity but may not be sufficient to pay amounts due on the debt securities of that series at the time of the acceleration resulting from the event of default.  In such a case, we would remain liable for those payments.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Government Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, with respect to debt securities of any series that are denominated in a currency other than U.S. dollars:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">direct obligations of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged which are not callable or redeemable at the option of the issuer thereof; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obligations of a person controlled or supervised by or acting as an agency or instrumentality of that government, the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by that government which are not callable or redeemable at the option of the issuer thereof.</font></div></div><p style="font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regarding the Trustee</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture provides that, except during the continuance of an event of default, the trustee will perform only such duties as are specifically set forth in the indenture.  During the existence of an event of default, the trustee will exercise such rights and powers vested in it under the indenture and use the same degree of care and skill in its exercise as a prudent person would exercise or use under the circumstances in the conduct of such person&#x2019;s own affairs.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture and provisions of the Trust Indenture Act of 1939, as amended, that are incorporated by reference therein contain limitations on the rights of the trustee, should it become one of our creditors, to obtain payment of claims in certain cases or to realize on certain property received by it in respect of any such claim as security or otherwise.  The trustee is permitted to engage in other transactions with us or any of our affiliates; </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if it acquires any conflicting interest (as defined in the indentures or in the Trust Indenture Act of 1939, as amended), it must eliminate such conflict or resign.</font></p><p style="font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regarding Payments and Paying Agents</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless we state otherwise in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities are registered at the close of business on the regular record date for the interest payment.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agent designated by us, except that unless we indicate otherwise in the applicable prospectus supplement, we will make interest payments by check that we will mail to the holder or by wire transfer to certain holders.  Unless we indicate otherwise in the applicable prospectus supplement, we will designate the corporate trust office of the debenture trustee as our sole paying agent for payments with respect to debt securities of each series.  We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series.  We will maintain a paying agent in each place of payment for the debt securities of a particular series.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof.</font></p><p style="font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governing Law</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The indenture and the debt securities will be governed by, and construed in accordance with, the internal laws of the State of New York.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="description_of_warrants"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DESCRIPTIO</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">N OF WARRANTS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue warrants to purchase debt securities, preferred stock or common stock.  We may issue warrants independently or together with any other securities we offer under a prospectus supplement.  The warrants may be attached to or separate from the securities.  We will issue each series of warrants under a separate warrant agreement that we will enter into with a bank or trust company, as warrant agent.  The statements made in this section relating to the warrant agreement are summaries only.  These summaries are not complete.  When we issue warrants, we will provide the specific terms of the warrants and the applicable warrant agreement in a prospectus supplement.  To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information in the prospectus supplement.  For more detail, we refer you to the applicable warrant agreement itself, which we will file as an exhibit to, or incorporate by reference in, the registration statement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Debt Warrants</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will describe in the applicable prospectus supplement the terms of the debt warrants being offered, the warrant agreement relating to the debt warrants and the debt warrant certificates representing the debt warrants, including:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the title of the debt warrants;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the aggregate number of the debt warrants;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the price or prices at which the debt warrants will be issued;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the currencies in which the debt warrants are being offered;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the designation, aggregate principal amount and terms of the debt securities purchasable upon exercise of the debt warrants, and the procedures and conditions relating to the exercise of the debt warrants;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the designation and terms of any related debt securities with which the debt warrants are issued, and the number of the debt warrants issued with each security;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date, if any, on and after which the debt warrants and the related debt securities will be separately transferable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the principal amount of debt securities purchasable upon exercise of each debt warrant, and the price at which the principal amount of the debt securities may be purchased upon exercise;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms of any rights to redeem or call the debt warrants;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which the right to exercise the debt warrants will commence, and the date on which the right will expire;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the maximum or minimum number of the debt warrants that may be exercised at any time;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information with respect to book-entry procedures, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the manner in which the warrant agreements and warrants may be modified;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a discussion of the material United States federal income tax considerations applicable to the exercise of the debt warrants; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other terms of the debt warrants and terms, procedures and limitations relating to the exercise of the debt warrants.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders may exchange debt warrant certificates for new debt warrant certificates of different denominations, and may exercise debt warrants at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement.  Prior to the exercise of their debt warrants, holders of debt warrants will not have any of the rights of holders of the securities purchasable upon the exercise and will not be entitled to payments of principal, premium or interest on the securities purchasable upon the exercise of debt warrants.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Warrants</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will describe in the applicable prospectus supplement the terms of the preferred stock warrants or common stock warrants being offered, the warrant agreement relating to the preferred stock warrants or common stock warrants and the warrant certificates representing the preferred stock warrants or common stock warrants, including:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the title of the warrants;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the securities for which the warrants are exercisable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the price or prices at which the warrants will be issued and exercisable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the currencies in which the warrants are being offered;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if applicable, the number of warrants issued with each share of preferred stock or share of common stock;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if applicable, the date on and after which the warrants and the related preferred stock or common stock will be separately transferable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms of any rights to redeem or call the warrants;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which the right to exercise the warrants will commence, and the date on which the right will expire;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the maximum or minimum number of warrants which may be exercised at any time;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information with respect to book-entry procedures, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the manner in which the warrant agreements and warrants may be modified;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a discussion of the material United States federal income tax considerations applicable to exercise of the warrants; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided in the applicable prospectus supplement, holders of equity warrants will not be entitled, by virtue of being such holders, to vote, consent, receive dividends, receive notice as stockholders with respect to any meeting of stockholders for the election of our directors or any other matter, or to exercise any rights whatsoever as stockholders.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as provided in the applicable prospectus supplement, the exercise price payable and the number of shares of common stock or preferred stock purchasable upon the exercise of each warrant will be subject to adjustment in certain events, including the issuance of a stock dividend to holders of common stock or preferred stock or a stock split, reverse stock split, combination, subdivision or reclassification of common stock or preferred stock.  In lieu of adjusting the number of shares of common stock or preferred stock purchasable upon exercise of each warrant, we may elect to adjust the number of warrants.  Unless otherwise provided in the applicable prospectus supplement, no adjustments in the number of shares purchasable upon exercise of the warrants will be required until all cumulative adjustments require an adjustment of at least 1% thereof.  We may, at our option, reduce the exercise price at any time.  No fractional shares will be issued upon exercise of warrants, but we will pay the cash value of any fractional shares otherwise issuable.  Notwithstanding the foregoing, except as otherwise provided in the applicable prospectus supplement, in case of any consolidation, merger, or sale or conveyance of our property as an entirety or substantially as an entirety, the holder of each outstanding warrant will have the right to the kind and amount of shares of stock and other securities and property, including cash, receivable by a holder of the number of shares of common stock or preferred stock into which each warrant was exercisable immediately prior to the particular triggering event.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Warrants</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each warrant will entitle the holder of the warrant to purchase for cash at the exercise price, or on a cashless basis if applicable, provided in the applicable prospectus supplement the principal amount of debt securities or shares of preferred stock or common stock being offered.  Holders may exercise warrants at any time up to the close of business on the expiration date provided in the applicable prospectus supplement.  After the close of business on the expiration date, unexercised warrants are void.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders may exercise warrants as described in the prospectus supplement relating to the warrants being offered.  Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the debt securities, shares of preferred stock or shares of common stock purchasable upon the exercise of the warrant.  If less than all of the warrants represented by the warrant certificate are exercised, we will issue a new warrant certificate for the remaining warrants.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governing Law</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless we provide otherwise in the applicable prospectus supplement, the warrants and any warrant agreements will be governed by and construed in accordance with the internal laws of the State of New York.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enforceability of Rights by Holders of Warrants</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each warrant agent, if any, will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="description_of_rights"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DESCRIPT</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ION OF RIGHTS</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue rights to purchase common stock, preferred stock, debt securities, warrants, units and/or any of the other securities described in this prospectus. We may offer rights separately or together with one or more additional rights, preferred stock, common stock, debt securities, warrants, units or any combination of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. This prospectus and any accompanying prospectus supplement will contain the material terms and conditions for each right.  The accompanying prospectus supplement may add, update or change the terms and conditions of the rights as described in this prospectus.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will describe in the applicable prospectus supplement the terms and conditions of the issue of rights being offered, the rights agreement relating to the rights and the rights certificates representing the rights, including, as applicable:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the title of the rights;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date of determining the stockholders entitled to the rights distribution;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the title, aggregate number or amount of underlying securities purchasable upon exercise of the rights;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the exercise price;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the currencies in which the rights are being offered;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the aggregate number of rights issued;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the rights are transferable and the date, if any, on and after which the rights will be separately transferable;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which the right to exercise the rights will commence and the date on which the right to exercise the rights will expire; </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the method by which holders of rights will be entitled to exercise;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the conditions to the completion of the offering, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the withdrawal, termination and cancellation rights, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether there are backstop or standby purchaser or purchases and the terms of their commitment, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether stockholders are entitled to oversubscription rights, if any; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights, as applicable, including any provisions for modifying any of the terms of the rights.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Rights</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each right will entitle the holder of rights to purchase for cash the principal amount of shares of common stock, preferred stock, debt securities, warrants, units or other securities, as applicable, at the exercise price provided in the applicable prospectus supplement.  Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus supplement.  After the close of business on the expiration date, all unexercised rights will be void.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders may exercise rights as described in the applicable prospectus supplement.  Upon receipt of payment and the rights certificate properly completed and duly executed at the corporate trust office of the rights or subscription agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the shares of common stock, preferred stock, debt securities, warrants, units or other securities, as applicable, purchasable upon exercise of the rights.  If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters, brokers or dealers or through a combination of such methods, including pursuant to standby underwriting arrangements, as described in the applicable prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rights agent for any rights we offer will be set forth in the applicable prospectus supplement.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="description_of_units"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DESCRI</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PTION OF UNITS</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue units comprised of one or more debt securities, shares of common stock, shares of preferred stock, depositary shares, warrants and/or rights in any combination.  Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit.  Thus, the holder of a unit will have the rights and obligations of a holder of each included security.  The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.  The statements made in this section relating to the unit agreement are summaries only.  These summaries are not complete.  When we issue units, we will provide the specific terms of the units and the applicable unit agreement in a prospectus supplement.  To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information in the prospectus supplement.  For more detail, we refer you to the applicable unit agreement itself, which we will file as an exhibit to, or incorporate by reference in, the registration statement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will describe in the applicable prospectus supplement the terms of the series of units being offered, including:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any provisions of the governing unit agreement that differ from those described below; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions described in this section, as well as those described under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Capital Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Debt Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Depositary Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; will apply to each unit and to any debt securities, shares of common stock, shares of preferred stock, depositary shares, warrants or rights included in each unit, respectively.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issuance in Series</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue units in such amounts and in such numerous distinct series as we determine.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enforceability of Rights by Holders of Units</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any unit.  A single bank or trust company may act as unit agent for more than one series of units.  A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us.  Any holder of a unit may, without the consent of the related unit agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any security included in the unit.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, the unit agents and any of their agents may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any purpose and as the person entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Ownership of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="description_of_depositary_shares"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DESCRIPTION OF D</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EPOSITARY SHARES</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue depositary shares, each of which will represent a fractional interest of a share of a particular series of preferred stock, as specified in the applicable prospectus supplement.  We will deposit with a depositary, referred to as the preferred stock depositary, shares of preferred stock of each series represented by depositary shares.  We will enter into a deposit agreement with the preferred stock depositary and holders from time to time of the depositary receipts issued by the preferred stock depositary which evidence the depositary shares.  Subject to the terms of the deposit agreement, each owner of a depositary receipt will be entitled, in proportion to the holder&#x2019;s fractional interest in the preferred stock, to all the rights and preferences of the series of the preferred stock represented by the depositary shares, including dividend, voting, conversion, redemption and liquidation rights.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately after we issue and deliver the preferred stock to a preferred stock depositary, we will cause the preferred stock depositary to issue the depositary receipts on our behalf.  You may obtain copies of the applicable form of deposit agreement and depositary receipt from us upon request.  The statements made in this section relating to the deposit agreement and the depositary receipts are summaries only.  These summaries are not complete and we may modify any of the terms of the depositary shares described in this prospectus in a prospectus supplement.  To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information in the prospectus supplement.  For more detail, we refer you to the deposit agreement, which we will file as an exhibit to, or incorporate by reference in, the registration statement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends and Other Distributions</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preferred stock depositary will distribute all cash dividends or other cash distributions received relating to the preferred stock to the record holders of depositary receipts in proportion to the number of the depositary receipts owned by the holders, subject to the obligations of holders to file proofs, certificates and other information and to pay certain charges and expenses to the preferred stock depositary.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of a distribution other than in cash, the preferred stock depositary will distribute property received by it to the record holders of depositary receipts in proportion to the number of the depositary receipts owned by the holders, unless the preferred stock depositary determines that it is not feasible to make the distribution, in which case the preferred stock depositary may, with our approval, sell the property and distribute the net proceeds from the sale to the holders.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No distribution will be made relating to any depositary share that represents any preferred stock converted into other securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Withdrawal of Stock</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assuming we have not previously called for redemption or converted into other securities the related depositary shares, upon surrender of the depositary receipts at the corporate trust office of the preferred stock depositary, the holders will be entitled to delivery at that office of the number of whole or fractional shares of the preferred stock and any money or other property represented by the depositary shares.  Holders of depositary receipts will be entitled to receive shares of the related preferred stock as specified in the applicable prospectus supplement, but holders of the shares of preferred stock will no longer be entitled to receive depositary shares.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Redemption of Depositary Shares</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whenever we redeem shares of preferred stock held by the preferred stock depositary, the preferred stock depositary will concurrently redeem the number of depositary shares representing shares of the preferred stock so redeemed, provided we have paid the applicable redemption price for the preferred stock to be redeemed plus an amount equal to any accrued and unpaid dividends to the date fixed for redemption.  The redemption price per depositary share will be equal to the corresponding proportion of the redemption price and any other amounts per share payable relating to the preferred stock.  If fewer than all the depositary shares are to be redeemed, the depositary shares to be redeemed will be selected pro rata or by any other equitable method determined by us.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From and after the date fixed for redemption:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all dividends relating to the shares of preferred stock called for redemption will cease to accrue;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the depositary shares called for redemption will no longer be deemed to be outstanding; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all rights of the holders of the depositary receipts evidencing the depositary shares called for redemption will cease, except the right to receive any moneys payable upon the redemption and any money or other property to which the holders of the depositary receipts were entitled upon redemption and surrender to the preferred stock depositary.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any funds we deposit with the preferred stock depositary for redemption of depositary shares that the holders fail to redeem will be returned to us after a period of two years from the date the funds are deposited.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Voting of the Preferred Stock</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon receipt of notice of any meeting at which the holders of the preferred stock are entitled to vote, the preferred stock depositary will mail the information contained in the notice of meeting to the record holders of the depositary receipts.  Each record holder of these depositary receipts on the record date, which will be the same date as the record date for the preferred stock, will be entitled to instruct the preferred stock depositary as to the exercise of the voting rights pertaining to the amount of preferred stock represented by the holder&#x2019;s depositary shares.  The preferred stock depositary will vote the amount of preferred stock represented by the depositary shares in accordance with the instructions, and we will agree to take all reasonable action necessary to enable the preferred stock depositary to do so.  The preferred stock depositary will abstain from voting the amount of preferred stock represented by the depositary shares for which it does not receive specific instructions from the holders of depositary receipts evidencing the depositary shares.  The preferred stock depositary will not be responsible for any failure to carry out any instruction to vote, or for the manner or effect of any vote made, as long as the action or non-action is in good faith and does not result from the preferred stock depositary&#x2019;s negligence or willful misconduct.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidation Preference</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that we voluntarily or involuntarily liquidate, dissolve or wind up, the holders of each depositary receipt will be entitled to the fraction of the liquidation preference accorded each share of preferred stock represented by the depositary shares, as specified in the applicable prospectus supplement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conversion of Depositary Shares</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The depositary shares will not be convertible into common stock or any of our other securities or property, unless we so specify in the applicable prospectus supplement relating to an offering of depositary shares.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment and Termination of the Deposit Agreement</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may amend the form of depositary receipt and any provision of the deposit agreement at any time by agreement with the preferred stock depositary.  However, any amendment that imposes or increases any fees, taxes or other charges payable by the holders of depositary receipts, other than taxes and other governmental charges, fees and other expenses payable by the holders as described below under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Charges of Preferred Stock Depositary</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; or that otherwise prejudices any substantial existing right of holders of depositary receipts, will not take effect as to outstanding depositary receipts until the expiration of 30 days after notice of the amendment has been mailed to the record holders of outstanding depositary receipts.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When we direct the preferred stock depositary to do so, the preferred stock depositary will terminate the deposit agreement by mailing a notice of termination to the record holders of all depositary receipts then outstanding at least 30 days prior to the date fixed in the notice for termination.  In addition, the preferred stock depositary may terminate the deposit agreement if at any time 45 days have passed since the preferred stock depositary has delivered to us a written notice of its election to resign and a successor depositary has not been appointed and accepted its</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">appointment.  If any depositary receipts remain outstanding after the date of termination, the preferred stock depositary thereafter will discontinue the transfer of depositary receipts, will suspend the distribution of dividends to the holders thereof, and will not give any further notices, other than the notice of termination, or perform any further acts under the deposit agreement, except as provided below and except that the preferred stock depositary will continue to collect dividends on the preferred stock and other distributions with respect to the preferred stock and will continue to deliver the preferred stock together with any dividends and distributions and the net proceeds of any sales of rights, preferences, privileges or other property, without liability for interest thereon, in exchange for any depositary receipts that are surrendered.  At any time after the expiration of two years from the date of termination, the preferred stock depositary may sell the preferred stock then held by it at public or private sales, at such place or places and upon such terms as it deems proper and may thereafter hold the net proceeds of any such sale, together with any money or other property then held by it, without liability for interest thereon, for the pro rata benefit of the holders of depositary receipts that have not been surrendered.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the deposit agreement will automatically terminate if:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all outstanding depositary shares have been redeemed; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there has been a final distribution of the related preferred stock in connection with our liquidation, dissolution or winding up and the distribution has been distributed to the holders of depositary receipts evidencing the depositary shares representing the preferred stock.</font></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charges of Preferred Stock Depositary</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will pay all fees, charges and expenses of the preferred stock depositary in connection with its performance of the deposit agreement, except for any taxes and other governmental charges and except as provided in the deposit agreement.  Holders of depositary receipts will pay the fees and expenses of the preferred stock depositary for any duties requested by the holders to be performed which are outside those expressly provided for in the deposit agreement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Resignation and Removal of Depositary</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preferred stock depositary may resign at any time by delivering to us notice of its election to do so, and we may at any time remove the preferred stock depositary.  Any resignation or removal of the acting preferred stock depositary will take effect upon our appointment of a successor preferred stock depositary.  We must appoint a successor preferred stock depositary within 45 days after delivery of the notice of resignation or removal.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miscellaneous</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preferred stock depositary will make available for inspection to holders of depositary receipts any reports and communications the preferred stock depositary receives from us relating to the preferred stock.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will not be liable, nor will the preferred stock depositary be liable, if we are prevented from or delayed in, by law or any circumstances beyond our control, performing our obligations under the deposit agreement.  Our obligations and the obligations of the preferred stock depositary under the deposit agreement will be limited to performing our duties in good faith and without negligence or willful misconduct.  We will not be obligated, nor will the preferred stock depositary be obligated, to prosecute or defend any legal proceeding relating to any depositary receipts, depositary shares or shares of preferred stock represented by depositary shares unless satisfactory indemnity is furnished to us.  We may rely, and the preferred stock depositary may rely, on written advice of counsel or accountants, or information provided by persons presenting shares of preferred stock represented by depositary shares for deposit, holders of depositary receipts or other persons we believe in good faith to be competent to give this information, and on documents we believe in good faith to be genuine and signed by a proper party.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="legal_ownership_of_securities"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LEGAL OWN</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ERSHIP OF SECURITIES</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue securities in registered form or in the form of one or more global securities.  We describe global securities in greater detail below.  We refer to those persons who have securities registered in their own names on the books that we or any applicable trustee, depositary, warrant agent or other agent maintain for this purpose as the &#x201c;holders&#x201d; of those securities.  These persons are the legal holders of the securities.  We refer to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their own names, as &#x201c;indirect holders&#x201d; of those securities.  As we discuss below, indirect holders are not legal holders, and investors in securities issued in book-entry form or in street name will be indirect holders.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Book-Entry Holders</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue securities in book-entry form only, as we will specify in the applicable prospectus supplement.  This means securities may be represented by one or more global securities registered in the name of a financial institution that holds them as depositary on behalf of other financial institutions that participate in the depositary&#x2019;s book-entry system.  These participating institutions, which are referred to as participants, in turn, hold beneficial interests in the securities on behalf of themselves or their customers.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Only the person in whose name a security is registered is recognized as the holder of that security.  Securities issued in global form will be registered in the name of the depositary or its participants.  Consequently, for securities issued in global form, we will recognize only the depositary as the holder of the securities, and we will make all payments on the securities to the depositary.  The depositary passes along the payments it receives to its participants, which in turn pass the payments along to their customers who are the beneficial owners.  The depositary and its participants do so under agreements they have made with one another or with their customers; they are not obligated to do so under the terms of the securities.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, investors in a global security will not own securities directly.  Instead, they will own beneficial interests in a global security, through a bank, broker or other financial institution that participates in the depositary&#x2019;s book-entry system or holds an interest through a participant.  As long as the securities are issued in global form, investors will be indirect holders, and not legal holders, of the securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Street Name Holders</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may terminate a global security in certain situations, as described under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x2014;Special Situations When a Global Security Will Be Terminated</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;, or issue securities that are not issued in global form.  In these cases, investors may choose to hold their securities in their own names or in &#x201c;street name.&#x201d; Securities held by an investor in street name would be registered in the name of a bank, broker or other financial institution that the investor chooses, and the investor would hold only a beneficial interest in those securities through an account he or she maintains at that institution.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For securities held in street name, we or any applicable trustee or depositary will recognize only the intermediary banks, brokers and other financial institutions in whose names the securities are registered as the holders of those securities, and we or any such trustee or depositary will make all payments on those securities to them.  These institutions pass along the payments they receive to their customers who are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so.  Investors who hold securities in street name will be indirect holders, not legal holders, of those securities.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Holders</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our obligations, as well as the obligations of any applicable trustee, agent or third party employed by us or a trustee or any agents, run only to the legal holders of the securities.  We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means.  This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are issuing the securities only in global form.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, once we make a payment or give a notice to the legal holder, we have no further responsibility for the payment or notice even if that legal holder is required, under agreements with its participants or customers or by law, to pass it along to the indirect holders but does not do so.  Similarly, we may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our obligation to comply with a particular provision of an indenture, or for other purposes.  In such an event, we would seek approval only from the legal holders, and not the indirect holders, of the securities.  Whether and how the legal holders contact the indirect holders is up to the legal holders.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When we refer to &#x201c;you&#x201d; in this prospectus, we mean those who invest in the securities being offered by this prospectus, whether they are the holders or only indirect holders of those securities.  When we refer to &#x201c;your securities&#x201d; in this prospectus, we mean the securities in which you will hold a direct or indirect interest.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special Considerations for Indirect Holders</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you hold securities through a bank, broker or other financial institution, either in book-entry form because the securities are represented by one or more global securities or in street name, you should check with your own institution to find out:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">how it handles securities payments and notices;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether it imposes fees or charges;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">how it would handle a request for the holders&#x2019; consent, if ever required;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether and how you can instruct it to send you securities registered in your own name so you can be a legal holder, if that is permitted in the future;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">how it would exercise rights under the securities if there were a default or other event triggering the need for holders to act to protect their interests; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if the securities are in book-entry form, how the depositary&#x2019;s rules and procedures will affect these matters.</font></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Global Securities</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A global security is a security that represents one or any other number of individual securities held by a depositary.  Generally, all securities represented by the same global securities will have the same terms.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each security issued in book-entry form will be represented by a global security that we issue to, deposit with and register in the name of a financial institution or its nominee that we select.  The financial institution that we select for this purpose is called the depositary.  Unless we specify otherwise in the applicable prospectus supplement, The Depository Trust Company, New York, New York, known as DTC, will be the depositary for all securities issued in book-entry form.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A global security may not be transferred to or registered in the name of anyone other than the depositary, its nominee or a successor depositary, unless special termination situations arise.  We describe those situations below under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x2014; Special Situations When a Global Security Will Be Terminated.&#x201d; </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and legal holder of all securities represented by a global security, and investors will be permitted to own only beneficial interests in a global security.  Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with the depositary or with another institution that does.  Thus, an investor whose security is represented by a global security will not be a legal holder of the security, but only an indirect holder of a beneficial interest in the global security.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the prospectus supplement for a particular security indicates that the security will be issued as a global security, then the security will be represented by a global security at all times unless and until the global security is terminated.  If termination occurs, we may issue the securities through another book-entry clearing system or decide that the securities may no longer be held through any book-entry clearing system.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special Considerations for Global Securities</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rights of an indirect holder relating to a global security will be governed by the account rules of the investor&#x2019;s financial institution and of the depositary, as well as general laws relating to securities transfers.  We do not recognize an indirect holder as a holder of securities and instead deal only with the depositary that holds the global security.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are issued only in the form of a global security, an investor should be aware of the following:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an investor cannot cause the securities to be registered in his or her name, and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations described below;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an investor will be an indirect holder and must look to his or her own bank or broker for payments on the securities and protection of his or her legal rights relating to the securities, as we described above;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an investor may not be able to sell interests in the securities to some insurance companies and to other institutions that are required by law to own their securities in non-book-entry form;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an investor may not be able to pledge his or her interest in a global security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the depositary&#x2019;s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor&#x2019;s interest in a global security.  We and any applicable trustee have no responsibility for any aspect of the depositary&#x2019;s actions or for its records of ownership interests in a global security.  We and the trustee also do not supervise the depositary in any way;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the depositary may, and we understand that DTC will, require that those who purchase and sell interests in a global security within its book-entry system use immediately available funds, and your broker or bank may require you to do so as well; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financial institutions that participate in the depositary&#x2019;s book-entry system, and through which an investor holds its interest in global security, may also have their own policies affecting payments, notices and other matters relating to the securities.  There may be more than one financial intermediary in the chain of ownership for an investor.  We do not monitor and are not responsible for the actions of any of those intermediaries.</font></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special Situations When a Global Security Will Be Terminated</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In a few special situations described below, a global security will terminate and interests in it will be exchanged for physical certificates representing those interests.  After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor.  Investors must consult their own banks or brokers to find out how to have their interests in securities transferred to their own names, so that they will be direct holders.  The rights of holders and street name investors are described above.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless we provide otherwise in the applicable prospectus supplement, a global security will terminate when the following special situations occur:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary for that global security and we do not appoint another institution to act as depositary within 90 days;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if we notify any applicable trustee that we wish to terminate that global security; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if an event of default has occurred with regard to securities represented by that global security and has not been cured or waived.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The applicable prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of securities covered by the prospectus supplement.  When a global security is terminated, only the depositary, and not we, the trustee, the agent or other third party, as applicable, is responsible for deciding the names of the institutions in whose names the securities represented by the global security will be registered and, therefore, who will be the direct holders of those securities.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="plan_of_distribution"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PLAN OF D</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ISTRIBUTION</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may sell the securities from time to time pursuant to underwritten public offerings, direct sales to the public, &#x201c;at-the-market&#x201d; offerings within the meaning of Rule 415(a)(4) of the Securities Act or into an existing trading market on an exchange or otherwise, negotiated transactions, block trades or a combination of these methods.  We may sell the securities to or through one or more underwriters or dealers (acting as principal or agent), through agents, or directly to one or more purchasers.  We may distribute securities from time to time in one or more transactions:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at a fixed price or prices, which may be changed;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at market prices prevailing at the time of sale;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at prices related to such prevailing market prices; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at negotiated prices.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each time we offer and sell securities, we will provide a prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) that will describe the method of distribution of the securities and any applicable restrictions, and the terms of the offering of the securities, including, to the extent applicable:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the name or names of any agents or underwriters, brokers or dealers and the amount of shares underwritten or purchased by each of them, if any;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the purchase price of the securities or other consideration therefor and the proceeds, if any, we will receive from the sale;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any over-allotment or other options under which underwriters may purchase additional securities from us;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any agency fees or underwriting discounts and other items constituting agents&#x2019; or underwriters&#x2019; compensation;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any public offering price of the securities;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any discounts or concessions allowed or reallowed or paid to brokers or dealers; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any securities exchanges or markets on which such securities may be listed.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Only underwriters named in a prospectus supplement will be underwriters of the securities offered by the prospectus supplement.  Dealers and agents participating in the distribution of the securities may be deemed to be underwriters, and compensation received by them on resale of the securities may be deemed to be underwriting discounts.  If such dealers or agents were deemed to be underwriters, they may be subject to statutory liabilities under the Securities Act.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may designate agents who agree to use their reasonable efforts to solicit purchases of our securities for the period of their appointment or to sell our securities on a continuing basis.  We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay to the agent in the prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If underwriters are used in the sale of securities, the underwriters will acquire the securities for their own account and may resell the securities from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price, at varying prices determined at the time of sale, at prices related to prevailing market prices or at negotiated prices.  The obligations of the underwriters to purchase the securities will be subject to the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conditions set forth in the applicable underwriting agreement.  We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate.  Subject to certain conditions, the underwriters will be obligated to purchase all of the securities offered by the prospectus supplement, other than securities covered by any over-allotment or other option.  If a dealer is used in the sale of securities, we or an underwriter will sell the securities to the dealer, as principal.  The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.  To the extent required, we will set forth in the prospectus supplement the name of the dealer and the terms of the transaction.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales to or through one or more underwriters or agents in at-the-market offerings, as such term is defined in Rule 415(a)(4) under the Securities Act, will be made pursuant to the terms of an agreement with the underwriters or agents. Such underwriters or agents may act on an agency basis or on a principal basis. During the term of any such agreement, shares of common stock may be sold on a daily basis on any stock exchange, market or trading facility on which the common stock is traded, in negotiated transactions or otherwise as agreed with the underwriters or agents. The agreement will provide that any shares of common stock sold will be sold at negotiated prices or at prices related to the then prevailing market prices for the common stock. Therefore, exact figures regarding proceeds that will be raised or commissions to be paid cannot be determined at this time and will be described in a prospectus supplement. Subject to the terms of the relevant agreement, we may also agree to sell, and the relevant underwriters or agents may agree to solicit offers to purchase, blocks of the common stock or other securities. The terms of each such agreement will be described in a prospectus supplement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may change from time to time any initial public offering price and any discounts or concessions the underwriters allow or reallow or pay to brokers or dealers.  We may use underwriters, dealers or agents with whom we have a material relationship.  We will describe in the prospectus supplement, naming the underwriter, dealer or agent, the nature of any such relationship.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may sell securities directly to one or more purchasers without using underwriters or agents.  Underwriters, brokers, dealers and agents that participate in the distribution of the securities may be underwriters as defined in the Securities Act, and any discounts or commissions they receive from us and any profit on their resale of the securities may be treated as underwriting discounts and commissions under the Securities Act.  We will identify in the applicable prospectus supplement any underwriters, brokers, dealers or agents and will describe their compensation.  We may have agreements with the underwriters, brokers, dealers and agents to indemnify them against specified civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which they may be required to make with respect to these liabilities.  Agents, underwriters, brokers and dealers, and their affiliates, may engage in transactions with, or perform services for, us in the ordinary course of business.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may authorize underwriters, brokers, dealers or agents to solicit offers by certain purchasers to purchase the securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future.  The contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions we pay for solicitation of these contracts.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise specified in the applicable prospectus supplement, each class or series of securities we may offer will be a new issue of securities with no established trading market, other than our common stock, which is listed on the Nasdaq Global Select Market.  We may elect to list any other class or series of securities on any exchange or market, but we are not obligated to do so.  It is possible that one or more underwriters may make a market in these securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice.  We cannot guarantee the liquidity of the trading markets for any securities.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any underwriter or agent may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Exchange Act.  Overallotment involves sales in excess of the offering size, which create a short position.  Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price.  Syndicate-covering or other short covering transactions involve purchases of the securities, either through exercise of the over-allotment option or in the open market after the distribution is completed to cover short positions.  Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">covering transaction to cover short positions.  Those activities may cause the price of the securities to be higher than it would otherwise be.  If commenced, the underwriters may discontinue any of these activities at any time.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any underwriters or agents that are qualified market makers on the Nasdaq Global Select Market may engage in passive market making transactions in the common stock on the Nasdaq Global Select Market in accordance with Rule 103 of Regulation M under the Exchange Act, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the securities.  Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers.  In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security.  If all independent bids are lowered below the passive market maker&#x2019;s bid, however, the passive market maker&#x2019;s bid must then be lowered when certain purchase limits are exceeded.  Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="legal_matters"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LEGAL M</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATTERS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered by this prospectus, and any supplement thereto, will be passed upon for us by Paul Hastings LLP, Palo Alto, California. Any underwriters will be advised about legal matters by their own counsel, which will be named in an accompanying prospectus supplement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="experts"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXP</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ERTS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements of Aardvark Therapeutics, Inc. as of December 31, 2025 and 2024 and for the years then ended, incorporated by reference in this Prospectus and in the Registration Statement have been so incorporated in reliance on the report of BDO USA, P.C., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="where_you_can_find_additional_informat"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHERE YOU CAN FIND AD</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DITIONAL INFORMATION</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have filed with the SEC a registration statement on Form S-3 under the Securities Act with respect to the securities being offered under this prospectus.  This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth or incorporated by reference in the registration statement of which this prospectus is a part and the exhibits to such registration statement.  For further information with respect to us and the securities offered by this prospectus, we refer you to the registration statement of which this prospectus is a part and the exhibits to such registration statement.  Statements contained in this prospectus as to the contents of any contract or any other document are not necessarily complete.  If a contract or document has been filed as an exhibit to the registration statement or an exhibit to the reports or other documents incorporated by reference into this prospectus, please see the copy of the contract or document that has been filed.  Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC maintains an internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC.  The address of that website is </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.sec.gov</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may also request a copy of these filings, at no cost, by writing us at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122 or telephoning us at (858) 225-7696.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, file periodic reports, proxy statements and other information with the SEC.  These periodic reports, proxy statements and other information are available at the website of the SEC referred to above.  We also maintain a website at </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">https://aardvarktherapeutics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC.  Information contained on or connected to our website is not a part of, and is not incorporated into, this prospectus or the registration statement of which this prospectus is a part or any prospectus supplement and the inclusion of our website address in this prospectus is an inactive textual reference.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="incorporation_of_certain_information_by"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INCORPORATION OF CERT</font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AIN INFORMATION BY REFERENCE</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC allows us to incorporate by reference the information and reports we file with it into this prospectus and any applicable prospectus supplement, which means that we can disclose important information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus and any applicable prospectus supplement, and information we file later with the SEC will automatically update and supersede this information. We are incorporating by reference the documents listed below as of their respective dates of filing, which we have already filed with the SEC. Any report or information within any of the documents referred below that is furnished, but not filed, shall not be incorporated by reference into this prospectus.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001774857/000119312526119770/ck0001774857-20251231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Report on Form 10-K for the fiscal year ended December 31, 2025</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, filed with the SEC on March 23, 2026;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our Current Reports on Form 8-K filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526009862/ck0001774857-20260112.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 12, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526043764/ck0001774857-20260210.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 10, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526047757/ck0001774857-20260209.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 12, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526082787/ck0001774857-20260227.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 27, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the description of our common stock set forth in our Registration Statement on </font><a href="https://www.sec.gov/Archives/edgar/data/1774857/000119312525023571/d912100d8a12b.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Form 8-A</font><font style="color:#0563c1;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(File No. 001-42513), filed with the SEC under Section 12(b) of the Exchange Act on February 10, 2025, including any amendments or reports filed for the purpose of updating such description, including the description of our common stock included as </font><a href="https://www.sec.gov/Archives/edgar/data/1774857/000095017025047835/ck0001774857-ex4_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.2</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 31, 2025.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also incorporate by reference any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including those made after the date of the initial filing of the registration statement of which this prospectus is a part and prior to effectiveness of such registration statement, until we file a post-effective amendment that indicates the termination of the offering of the securities made by this prospectus, and such future filings will become a part of this prospectus from the respective dates that such documents are filed with the SEC. Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document which is also incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may obtain any of the documents incorporated by reference in this prospectus from the SEC through the SEC&#x2019;s website at the address provided above. Documents incorporated by reference are also available from us, without charge. You may obtain documents incorporated by reference in this prospectus by requesting them in writing or by telephone at the following address or phone number:</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4370 La Jolla Village Drive, Suite 105</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, CA 92122</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(858) 225-7696</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attn: Chief Executive Officer</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You also may access these filings on our internet site at </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">https://aardvarktherapeutics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Information contained on or connected to our website is not a part of, and is not incorporated into, this prospectus or the registration statement of which this prospectus is a part or any prospectus supplement and the inclusion of our website address in this prospectus is an inactive textual reference. This prospectus is part of a registration statement we filed with the SEC. We have incorporated exhibits into the registration statement of which this prospectus is a part. You should read the exhibits carefully for provisions that may be important to you.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUBJECT TO COMPLETION, DATED MARCH 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROSPECTUS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img8190679_2.jpg" alt="img8190679_2.jpg" style="width:290px;height:62px;"></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Up to $150,000,000<br>Common Stock<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____________________</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into an Equity Distribution Agreement, dated March 23, 2026 (the Equity Distribution Agreement), with Piper Sandler &amp; Co. (Piper Sandler), relating to the sale of shares of our common stock, $0.00001 par value per share, offered by this prospectus. In accordance with the terms of the Equity Distribution Agreement, pursuant to this prospectus, we may offer and sell shares of our common stock having an aggregate offering price of up to $150,000,000 from time to time through or to Piper Sandler acting as sales agent.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#x201c;AARD.&#x201d; On March 20, 2026, the closing price of our common stock on the Nasdaq Global Select Market was $4.07 per share.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of our common stock, if any, under this prospectus may be made in sales deemed to be an &#x201c;at the market offering&#x201d; as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the Securities Act). Piper Sandler is not required to sell any specific number or dollar amount of securities but will act as a sales agent using commercially reasonable efforts, consistent with its normal trading and sales practices, on mutually agreed terms between Piper Sandler and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The compensation to Piper Sandler for sales of common stock sold pursuant to the Equity Distribution Agreement will be at a commission rate of 3.0% of the gross sales price per share sold under the Equity Distribution Agreement. In connection with the sale of common stock on our behalf, Piper Sandler will be deemed to be an &#x201c;underwriter&#x201d; within the meaning of the Securities Act and the compensation of Piper Sandler will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Piper Sandler with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended (the Exchange Act). See the section titled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Plan of Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; beginning on page 18 of this prospectus for additional information regarding the compensation to be paid to Piper Sandler.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an &#x201c;emerging growth company&#x201d; and a &#x201c;smaller reporting company,&#x201d; each as defined under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings with the Securities and Exchange Commission (the SEC). See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prospectus Summary &#x2013; Implications of Being an Emerging Growth Company and a Smaller Reporting Company</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____________________</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investing in our common stock involves a high degree of risk. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; beginning on page 12 of this prospectus and under similar headings in the documents incorporated by reference into this prospectus for a discussion of certain risks and uncertainties you should consider before investing in shares of our common stock.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus are truthful or complete. Any representation to the contrary is a criminal offense.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____________________</font></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Piper Sandler<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The date of this prospectus is </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">              </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, 2026.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1.13in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="margin-left:1.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:1.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</font></p><p style="margin-left:1.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:6.175000000000001in;box-sizing:content-box;"></td>
     <td style="width:0.32499999999999996in;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Page</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#about_this_prospectus1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ABOUT THIS PROSPECTUS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#special_note_regarding_forward_looking1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#prospectus_summary1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PROSPECTUS SUMMARY</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#the_offering1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">THE OFFERING</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#risk_factors1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RISK FACTORS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#market_industry_and_other_data1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MARKET, INDUSTRY AND OTHER DATA</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#use_of_proceeds1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">USE OF PROCEEDS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#dilution1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DILUTION</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#plan_of_distribution1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PLAN OF DISTRIBUTION</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#legal_matters1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LEGAL MATTERS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#experts1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">EXPERTS</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#where_you_can_find_additional_info1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#incorporation_of_certain_information1"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">i</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="about_this_prospectus1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ABOUT TH</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IS PROSPECTUS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus is part of a registration statement on Form S-3 that we filed with the SEC using a &#x201c;shelf&#x201d; registration process. Under this shelf registration process, we may offer and sell shares of our common stock and preferred stock, depositary shares, various series of debt securities and warrants or rights to purchase any of such securities, either individually or in combination with other securities or in units, from time to time in one or more offerings, up to a total aggregate offering amount of $400,000,000. Under this prospectus, we may offer and sell shares of our common stock from time to time in one or more offerings, up to a total aggregate offering amount of $150,000,000 through or to Piper Sandler, acting as sales agent. These sales, if any, will be made pursuant to the terms of the Equity Distribution Agreement, which is filed as an exhibit to the registration statement of which this prospectus is a part. The $150,000,000 of shares of our common stock that may be sold under this prospectus are included in the $400,000,000 of our securities that may be sold under the registration statement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We urge you to carefully read this prospectus, the documents incorporated by reference herein and therein and the additional information in the sections of this prospectus entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Where You Can Find Additional Information</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Incorporation of Certain Information by Reference</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; before buying any of the securities being offered under this prospectus. These documents contain information you should consider when making your investment decision. To the extent that any statement that we make in this prospectus is inconsistent with statements made in any documents incorporated by reference, the statements made in this prospectus will be deemed to modify or supersede those made in such documents incorporated by reference; however, if any statement in one of these documents is inconsistent with a statement in another document having a later date and that is incorporated by reference herein, the statement in the document having the later date modifies or supersedes the earlier statement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not, and Piper Sandler has not, authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and Piper Sandler is not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should not assume that the information contained or incorporated by reference in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus or on any date subsequent to the date of the document incorporated by reference, as applicable. Our business, financial condition, results of operations and prospects may have changed since those dates.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are offering to sell, and seeking offers to buy, the securities described in this prospectus only in jurisdictions where offers and sales are permitted. The distribution of this prospectus and the offering of the securities in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securities and the distribution of this prospectus outside the United States. This prospectus does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into this prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In this prospectus, unless otherwise indicated or required by the context, the terms &#x201c;Aardvark,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us&#x201d; and the &#x201c;Company&#x201d; refer to Aardvark Therapeutics, Inc. and its subsidiaries. General information about us can be found on our website at </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">https://aardvarktherapeutics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The information on our website is for informational purposes only and should not be relied on for investment purposes. The information on our website is not incorporated by reference into this prospectus and should not be considered part of this or any other report filed with the SEC.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="special_note_regarding_forward_looking1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> FORWARD-LOOKING STATEMENTS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This prospectus, including the documents incorporated by reference herein, contains forward-looking statements about us and our industry within the meaning of Section 21E of the Exchange Act and Section 27A of the Securities Act, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy, product candidates, planned preclinical studies and clinical trials, results of preclinical studies and clinical trials, research and development plans and costs, plans for manufacturing, regulatory approvals, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;expects,&#x201d; &#x201c;plans,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;could,&#x201d; &#x201c;intends,&#x201d; &#x201c;target,&#x201d; &#x201c;projects,&#x201d; &#x201c;contemplates,&#x201d; &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;predicts,&#x201d; &#x201c;potential&#x201d; or &#x201c;continue&#x201d; or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements contained in this prospectus and the documents incorporated by reference herein may include, but are not limited to, statements about:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation, timing, progress and results of our preclinical studies, clinical trials and research and development programs for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to demonstrate, and the timing of, preclinical proof-of-concept in vivo for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully complete our clinical trials;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to quickly leverage our initial product candidates and to progress additional candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence of certain diseases and conditions we intend to treat and the size of the market opportunity for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of the number of patients with certain diseases and conditions we intend to treat and the number of subjects that we intend to enroll in our clinical trials; </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the likelihood of our clinical trials demonstrating safety and efficacy of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the beneficial characteristics, including safety, efficacy and therapeutic effects, and potential advantages of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing or likelihood of regulatory filings and approval for our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to meet future regulatory standards with respect to our product candidates, if approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans relating to the further development and manufacturing of our product candidates, including additional indications that we may pursue;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to identify additional product candidates or technologies with significant commercial potential that are consistent with our commercial objectives;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rate and degree of market acceptance and therapeutic benefits of our product candidates, if approved, and any other product candidates we may develop;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the implementation of our strategic plans for our business, product candidates, research programs and technologies;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">anticipated developments related to our competitors and our industry;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our competitive position and ability to leverage the clinical, regulatory and manufacturing advancements to accelerate our clinical trials and regulatory approval of product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the success of competing therapies that are or may become available;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to identify and enter into future license agreements and collaborations;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expected potential benefits of strategic collaborations with third parties and our ability to attract collaborators with development, regulatory, manufacturing or commercialization expertise;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to efficiently and cost-effectively conduct our current and future clinical trials;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reliance on third parties to conduct clinical trials of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reliance on third parties for the manufacture of our product candidates;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans relating to sales strategy, manufacturing and commercializing our product candidates, if approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract and retain sales personnel, or to contract with a sales organization, if our product candidates are approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">anticipated regulatory and legal developments in the United States and foreign countries in which we may seek regulatory approval for our product candidates in the future;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract and retain key scientific and management personnel;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expected or anticipated financial performance;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain funding for our operations necessary to complete further development and commercialization of our product candidates, if approved;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain existing, and establish new, strategic collaborations, licensing, or other arrangements, including our ability to comply with our financial obligations pursuant to the terms of such agreements;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sufficiency of our existing capital resources to fund our future operating expenses and capital expenditure requirements;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the period during which we will qualify as an emerging growth company under the JOBS Act or a smaller reporting company; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of our expenses, capital requirements and needs for additional financing.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We caution you that the forward-looking statements highlighted above do not encompass all of the forward-looking statements made in this prospectus or in the documents incorporated by reference in this prospectus.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects.  There can be no assurance that future developments affecting us will be those that we have anticipated.  These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.  These risks and uncertainties include, but are not limited to, those factors described under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; in this prospectus, in our </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001774857/000119312526119770/ck0001774857-20251231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Report on Form 10-K for the year ended December 31, 2025</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as filed with the SEC on March 23, 2026, as updated by our subsequent annual, quarterly and other reports and documents that are incorporated by reference into this prospectus, and elsewhere in the documents incorporated by reference into this prospectus.  Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.  There may be additional risks that we consider immaterial or which are unknown.  It is not possible to predict or identify all such risks.  Readers are cautioned not to place undue reliance on forward-looking statements because of the risks and uncertainties related to them and to the risk factors.  We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this prospectus, except as may be required under applicable securities laws. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make or enter into.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, statements that &#x201c;we believe&#x201d; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of the statement is made, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="prospectus_summary1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROSPECTU</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">S SUMMARY</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">This summary contains basic information about us and this offering. This summary highlights selected information contained elsewhere in, or incorporated by reference into, this prospectus. This summary is not complete and may not contain all of the information that may be important to you and that you should consider before deciding whether or not to invest in our securities. For a more complete understanding of Aardvark and this offering, you should carefully read this prospectus, including the information incorporated by reference into this prospectus, in its entirety. Investing in our securities involves risks that are described in the section of this prospectus entitled &#x201c;Risk Factors,&#x201d; under the heading &#x201c;Item 1A. Risk Factors&#x201d; in our </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001774857/000119312526119770/ck0001774857-20251231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Annual Report on Form 10-K for the year ended December 31, 2025</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, as updated by our subsequent annual, quarterly and other reports and documents that are incorporated by reference into this prospectus, and in our other filings with the SEC.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients. We have focused our efforts on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Our initial compounds target TAS2Rs expressed in the gut lumen, which normally respond to the chemicals in food and participate in the gut-brain axis. Our research has shown that activating these receptors can induce the secretion of endogenous signaling molecules, including cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TAS2Rs are a family of 26 different nutrient-sensing G protein-coupled receptors (GPCRs) that are broadly expressed among vertebrates. TAS2Rs are present in the oral cavity to convey bitter taste and are highly expressed in many other tissues throughout the body where they are key in regulating metabolic and inflammatory pathways. CCK has long been recognized as a promising pharmaceutical target because its release is triggered with food and it helps suppress hunger, which is the feeling of discomfort that comes from a perception of not having eaten recently. We believe suppression of hunger could be complementary to the suppression of appetite reported from patients on GLP-1 receptor targeted treatments, which reduce the desirability of food. Previous approaches to directly agonize CCK receptors through exogenous molecules have been limited by safety concerns driven by systemic exposure, resulting in on-target, off-tissue toxicity, and in turn leading to adverse effects, such as pancreatitis. Our wholly-owned lead product candidate, ARD-101, is an oral, largely gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen. ARD-101, in contrast to previous approaches to directly agonize CCK receptors, elicits the endogenous release of CCK by leveraging the body&#x2019;s natural response to TAS2R agonism. Besides our product candidates, we are not aware of any approved or other clinical-stage candidates targeting certain TAS2Rs.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARD-101 has limited systemic absorption, which we believe reduces the potential for systemic toxicity and has contributed to ARD-101 being well-tolerated in our Phase 1 and 2 trials. We have completed a Phase 1 clinical trial of ARD-101 in healthy volunteers and a Phase 2 clinical trial in subjects with hyperphagia associated with Prader-Willi Syndrome (PWS). The Phase 2 clinical trial in hyperphagia associated with PWS evaluated two dosing regimens over 28 days followed by a 14-day withdrawal period. In Part 1 of the trial, 12 subjects completed the treatment period at a fixed dose of 200 mg delivered orally twice daily (BID). These 12 subjects that completed treatment had no significant treatment-related adverse events and, of these subjects, eight completed the Hyperphagia for Clinical Trial Questionnaire-9 (HQ-CT 9), with seven having complete post&#x2013;database lock datasets. In this subgroup of seven, the mean decline at day 28 was approximately 9 points. In Part 2 of the trial, four subjects were dosed under a revised protocol: 400 mg BID for seven days, followed by 600 mg BID for seven days and ending with 800 mg BID for 14 days. The four subjects that completed the trial per protocol had only grade 1 treatment-related adverse events and showed a decrease in HQ-CT 9 of approximately eight points at 28 days. In our completed Phase 2 clinical trial in subjects with hyperphagia associated with PWS, ARD-101 was shown to be well-tolerated and demonstrated clinical activity through a reduction in Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the second quarter of 2025, we initiated dosing for a Phase 3 clinical trial for hyperphagia associated with PWS, which we refer to as the HERO (</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">H</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unger </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limination or </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eduction </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bjective) trial. We previously reached alignment with the FDA on a protocol for a Phase 3 clinical trial, which we initiated in December 2024. In August 2025, we submitted a protocol amendment to remove the use of anti-psychotics and insulin-requiring type 2 diabetes as exclusion criteria for the clinical trial. In October 2025, we reached alignment with the FDA on a protocol</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amendment to lower the minimum age of eligibility to participate in the trial from 13 to 10 years of age. This change broadened the eligible trial population and expanded the potential addressable opportunity within PWS. In December 2025, we submitted an additional protocol amendment seeking to further lower the minimum age of eligibility to participate in the trial to 7 years of age. During the third quarter of 2025, we commenced enrollment for the HERO Open Label Extension (OLE) trial, which was available to patients completing the HERO trial and we initiated our first clinical sites in Australia.  In January 2026, we announced over 50% completion of the target enrollment of 90 patients in the HERO trial and within the first quarter of 2026, we initiated clinical sites in the UK, South Korea and Canada.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 27, 2026, we voluntarily paused enrollment and dosing in the HERO and OLE trials following reversible cardiac observations in a healthy volunteer study and are currently reviewing the data and collaborating with the FDA to determine next steps. As a result, aspects of the trial design, development timeline and future clinical plans may change. Following the voluntary pause, we are reviewing the trial designs and protocols in collaboration with the FDA and the previously agreed protocol elements may be revisited.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our second TAS2R program, ARD-201, was planned to be a fixed-dose combination of ARD-101 and a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of obesity and obesity-related conditions. We previously initiated a Phase 2 clinical trial, which we referred to as the POWER (Prevention Of WEight Regain) trial, in December 2025, to explore the efficacy of ARD-201 in the prevention of weight regain among patients who have successfully lost over 15% of body weight on GLP-1RA therapy.  In addition, we previously planned to initiate a second Phase 2 trial for ARD-201 in the first half of 2026, which we referred to as the STRENGTH (Sitagliptin and TAS2R for weight Reduction with Exercise, Nutrition, and GLP-1RA Trial and Hunger assessment) trial.  Because ARD-201 contains ARD-101 as a component of the planned combination therapy, we are assessing the potential implications of the voluntary pause of the HERO trial on the ARD-201 program. Following this assessment, we have voluntarily paused the STRENGTH and POWER clinical trials while we complete our ongoing evaluation of the safety observations identified in the healthy volunteer study of ARD-101 and continue discussions with the FDA regarding next steps for the ARD-101 program. We expect to provide further guidance in the second quarter of 2026.</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In preparation for these trials, we expanded our clinical management and regulatory capabilities, including hiring clinical, regulatory and quality personnel, and we expect to continue to need to expand our clinical management and regulatory capabilities and to rely on third parties to conduct our later stage or pivotal clinical trials in the future. However, the timing of additional staffing and operational expansion may be delayed as we evaluate next steps following the voluntary pause of the HERO trial and related clinical programs.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Pipeline</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing the below portfolio of wholly-owned novel and proprietary small-molecule programs that we believe can induce satiety in patients with hunger-associated indications, as outlined below. As discussed above, certain clinical programs, including the HERO trial for ARD-101 and the POWER and STRENGTH trials for ARD-201, are currently paused while we evaluate safety observations and continue discussions with the FDA regarding next steps.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Hunger Associated TAS2R Pipeline</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img8190679_3.gif" alt="img8190679_3.gif" style="width:613px;height:226px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implications of Being an Emerging Growth Company and a Smaller Reporting Company</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We qualify as an &#x201c;emerging growth company&#x201d; as that term is defined in the JOBS Act.  For as long as we continue to be an emerging growth company, we intend to take advantage of exemptions from various reporting requirements applicable to other public companies but not to &#x201c;emerging growth companies,&#x201d; including:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, as amended;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">permission to delay adopting new or revised accounting standards until such time as those standards apply to private companies;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced disclosure obligations regarding executive compensation in our periodic reports and Annual Reports on Form 10-K; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exemptions from the requirements of holding non-binding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the JOBS Act, we will remain an emerging growth company until the earliest of:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the last day of the fiscal year during which we have total annual gross revenues of $1.235 billion or more;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the last day of the fiscal year following the fifth anniversary of the Initial Public Offering, or December 31, 2030;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which we have issued, during the previous three-year period, more than $1.0 billion in non-convertible debt securities; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the date on which we are deemed to be a &#x201c;large accelerated filer&#x201d; under the Exchange Act (i.e., the first day of the fiscal year after we have (1) more than $700.0 million in outstanding common equity held by our non-affiliates, measured each year on the last day of our second fiscal quarter, (2) been public for at least 12 months, and (3) are not eligible to be deemed a &#x201c;smaller reporting company&#x201d; because we do not meet the revenue test of the definition of &#x201c;smaller reporting company&#x201d;, which includes an initial determination that our annual revenues are more than $100.0 million for the most recently completed fiscal year).</font></div></div></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a &#x201c;smaller reporting company,&#x201d; meaning that the market value of our common stock held by non-affiliates is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our common stock held by non-affiliates is less than $250.0 million or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our common stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have elected to take advantage of certain of the reduced disclosure obligations regarding executive compensation in this prospectus and may elect to take advantage of other reduced reporting requirements in future filings with the SEC.  As a result, the information that we provide to our stockholders may be different from the information you receive from other public reporting companies.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We were incorporated in Delaware on May 17, 2017. Our principal executive offices are located at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122 and our telephone number is (858) 225-7696. We have two wholly-owned subsidiaries, Artisan Therapeutics, Inc., incorporated in Delaware in October 2024, and Ardia Therapeutics, Inc, incorporated in Delaware in February 2026. Our corporate website address is </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">https://aardvarktherapeutics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Information contained on or connected to our website is not a part of, and is not incorporated into, this prospectus or the registration statement of which this prospectus is a part and the inclusion of our website address in this prospectus is an inactive textual reference.  We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC.  You may obtain any of the documents filed by us with the SEC at no cost from the SEC&#x2019;s website at </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">http://www.sec.gov.</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000;"><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="the_offering1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THE O</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FFERING</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
     <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
      <tr style="visibility:collapse;">
       <td style="width:2.8597222222222225in;box-sizing:content-box;"></td>
       <td style="width:3.640277777777778in;box-sizing:content-box;"></td>
      </tr>
      <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common stock offered by us</font></p></td>
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Up to an aggregate of $150,000,000 of shares of our common stock.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
      </tr>
      <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common stock to be outstanding immediately after this offering</font></p></td>
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Up to 58,670,389 shares (as more fully described in the notes following this table), assuming sales of 36,855,036 shares of our common stock in this offering at an assumed offering price of $4.07 per share, the last reported sale price</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">of our common stock on the Nasdaq Global Select Market on March 20, 2026. The actual number of shares of common stock issued will vary depending on the sales price under this offering.</font></p></td>
      </tr>
      <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Plan of Distribution</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;At the market offering&#x201d; as defined in Rule 415(a)(4) under the Securities Act that may be made from time to time through or to Piper Sandler acting as sales agent. See the section of this prospectus entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Plan of Distribution</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d; beginning on page 18 of this prospectus for additional detail.</font></p></td>
      </tr>
      <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Use of Proceeds</font></p></td>
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">We currently intend to use the net proceeds of this offering for general corporate purposes, which may include funding research and development, capital expenditures, working capital and general and administrative expenses.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">See the section of this prospectus entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d; beginning on page 15 of this prospectus for additional detail.</font></p></td>
      </tr>
      <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading symbol</font></p></td>
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#x201c;AARD.&#x201d;</font></p></td>
      </tr>
      <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Risk Factors</font></p></td>
       <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investing in our securities involves a high degree of risk. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d; beginning on page 12 of this prospectus and other information included or incorporated by reference in this prospectus for a discussion of factors you should carefully consider before investing in our securities.</font></p></td>
      </tr>
     </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares of our common stock that will be outstanding immediately after this offering is based on 21,815,353 shares of common stock outstanding as of December 31, 2025, but excludes:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3,038,413 shares of common stock issuable upon the exercise of stock options outstanding under the Aardvark Therapeutics, Inc. 2025 Equity Incentive Plan and the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan as of December 31, 2025, with a weighted-average exercise price of $9.08 per share;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up to 189,311 shares of common stock available for future issuance under the Aardvark Therapeutics, Inc. 2025 Equity Incentive Plan as of December 31, 2025, which contains provisions that may increase its share reserve each year, and pursuant to which 1,090,767 shares of common stock were added to the reserve on January 1, 2026;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up to 185,408 shares of common stock available for future issuance under the Aardvark Therapeutics, Inc. 2025 Employee Stock Purchase Plan as of December 31, 2025, which contains provisions that may increase its share reserve each year, and pursuant to which 218,153 shares of common stock were added to the reserve on January 1, 2026; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up to 660,017 shares of common stock available for future issuance under the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan as of December 31, 2025.</font></div></div></div></div></div>
  <div class="page-border" style="margin-left:0.0px;margin-right:0.0px;"><div class="page-border-spacing" style="padding-left:3.9215686274509802%;padding-right:3.9215686274509802%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="risk_factors1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK </font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FACTORS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing in our securities involves a high degree of risk.  Before deciding whether to invest in our securities, you should consider carefully the risks and uncertainties described below. You should also consider the risks, uncertainties and assumptions discussed under the section entitled &#x201c;Risk Factors&#x201d; contained in our most recent Annual Report on Form 10-K, which is on file with the SEC, and is incorporated herein by reference, and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could have material adverse effects on our future results.  If any of these risks actually occur, our business, financial condition, results of operations, cash flow and future growth prospects could be seriously harmed.  This could cause the market price of our securities to decline, resulting in a loss of all or part of your investment.  Please also carefully read the section below entitled &#x201c;Special Note Regarding Forward-Looking Statements.&#x201d;</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to this Offering</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will have broad discretion in the use of the net proceeds from this offering and may not use them effectively.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently intend to use the net proceeds of this offering for general corporate purposes, which may include funding research and development, capital expenditures, working capital and general and administrative expenses as further described in the section of this prospectus entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;. We will have broad discretion in the application of the net proceeds in the category of other working capital and general corporate purposes and investors will be relying on the judgment of our management regarding the application of the proceeds of this offering.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The precise amount and timing of the application of these proceeds will depend upon a number of factors, such as the timing and progress of our research and development efforts, our funding requirements and the availability and costs of other funds. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering. Depending on the outcome of our efforts and other unforeseen events, our plans and priorities may change and we may apply the net proceeds of this offering in different manners than we currently anticipate.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The failure by our management to apply these funds effectively could harm our business, financial condition and results of operations. Pending their use, we may invest the net proceeds from this offering in U.S. federal government or agency-issued obligations, FDIC-insured certificates of deposit, municipal bonds and money market accounts. These investments may not yield a favorable return to our stockholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">You may experience immediate and substantial dilution.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The shares of our common stock sold in this offering, if any, will be sold from time to time at various prices. If you purchase shares in this offering at a price that is higher than the net tangible book value per share of our common stock, you would suffer immediate, and potentially substantial, dilution.</font><font style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dilution or accretion with respect to net tangible book value per share represents the difference between the amount per share paid by purchasers of shares of common stock in this offering and the net tangible book value per share of our common stock immediately after this offering. The last reported sale price of our common stock on the Nasdaq Global Select Market on March 20, 2026 was $4.07 per share, which is less than our net tangible book value per share as of December 31, 2025. For a more detailed discussion regarding the foregoing and the accretion to new investors assuming that an aggregate of 36,855,036 shares of our common stock are sold at $4.07 for aggregate gross proceeds of approximately $150,000,000, please see the section of this prospectus entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dilution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;. The exercise of outstanding stock options may result in further dilution of your investment.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The shares of common stock will be sold in &#x201c;at the market&#x201d; offerings, and investors who buy shares at different times will likely pay different prices.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investors who purchase shares in this offering at different times will likely pay different prices, and so may experience different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and number of shares sold, and there is no minimum or maximum sales price. Investors may experience a decline in the value of their shares as a result of share sales made at prices lower than the prices they paid.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The actual number of shares we will issue under the Equity Distribution Agreement with Piper Sandler, at any one time or in total, is uncertain.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to certain limitations in the Equity Distribution Agreement with Piper Sandler and compliance with applicable law, we have the discretion to deliver issuance notices to Piper Sandler at any time throughout the term of the Equity Distribution Agreement. The number of shares that are sold by Piper Sandler after delivering an issuance notice will fluctuate based on the market price of the common stock during the sales period and limits we set with Piper Sandler. Because the price per share of each share sold will fluctuate based on the market price of our common stock during the sales period, it is not possible at this stage to predict the number of shares or the gross proceeds to be raised in connection with those sales, if any, that will be ultimately issued.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">You may experience future dilution as a result of future equity offerings.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions may be higher or lower than the price per share paid by investors in this offering.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Because there are no current plans to pay cash dividends on our common stock for the foreseeable future, you may not receive any return on investment unless you sell shares of our common stock for a price greater than that which you paid for it.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may retain future earnings, if any, for future operations, expansion and debt repayment and have no current plans to pay any cash dividends for the foreseeable future. Any decision to declare and pay dividends as a public company in the future will be made at the discretion of our board of directors and will depend on, among other things, our results of operations, financial condition, cash requirements, contractual restrictions and other factors that our board of directors may deem relevant. In addition, our ability to pay dividends may be limited by covenants of any existing and future outstanding indebtedness we may incur. As a result, you may not receive any return on an investment in our common stock unless you sell your shares of our common stock for a price greater than that which you paid for it.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sales of a significant number of shares of common stock in the public markets, or the perception that such sales could occur, could depress the market price of our common stock.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of a substantial number of shares in the public markets, or the perception that such sales could occur, could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. We have agreed, without the prior written consent of Piper Sandler, and subject to certain exceptions set forth in the Equity Distribution Agreement, not to sell or otherwise dispose of any common stock or securities convertible into or exchangeable for shares of common stock, warrants or any rights to purchase or acquire common stock during the period beginning on the date a placement notice is delivered to Piper Sandler pursuant to the Equity Distribution Agreement and ending on the date of settlement of sales pursuant to such placement notice. We have further agreed, subject to certain exceptions set forth in the Equity Distribution Agreement, not to sell or otherwise dispose of any common stock or securities convertible into or exchangeable for shares of common stock, warrants or any rights to purchase or acquire common stock in any other &#x201c;at the market offering&#x201d; or continuous equity transaction prior to the termination of the Equity Distribution Agreement with Piper Sandler. Therefore, it is possible that we could issue and sell additional shares of our common stock in the public markets. We cannot predict the effect that future sales of our common stock would have on the market price of our common stock.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="market_industry_and_other_data1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MARKET, INDUST</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RY AND OTHER DATA</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our general expectations about our product candidates, market position, market opportunity, market size, competitive position and the incidence of certain medical conditions, is based on or derived from publicly available information released by industry analysts and third-party sources, independent market research, industry and general publications and surveys, governmental agencies, our internal research and our industry experience. The content of these third-party sources, except to the extent specifically set forth in this prospectus, does not constitute a portion of this prospectus and is not incorporated herein. Our estimates of the potential market opportunities for our product candidates include a number of key assumptions based on our industry knowledge and industry publications, the latter of which may be based on small sample sizes and fail to accurately reflect such information, and you are cautioned not to give undue weight to such estimates. Although we are responsible for all of the disclosure contained in this prospectus and we believe that our internal assumptions are reasonable, no independent source has verified such assumptions.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Industry publications and third-party research often indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information and such information is inherently imprecise. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires. In addition, projections, assumptions and estimates of our future performance and the future performance of the industry in which we operate is necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and elsewhere in this prospectus, and involve a number of assumptions and limitations. These and other factors could cause results to differ materially from those expressed in the estimates made by independent third parties and by us.  You are cautioned not to give undue weight to any such information, projections and estimates.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="use_of_proceeds1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">USE OF P</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ROCEEDS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may issue and sell shares of our common stock having aggregate sales proceeds of up to $150,000,000 from time to time under this prospectus. Because there is no minimum offering amount required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. There can be no assurance that, in the future, we will sell any shares under or fully utilize the Equity Distribution Agreement with Piper Sandler as a source of financing. We currently intend to use the net proceeds of this offering for general corporate purposes, which may include funding research and development, capital expenditures, working capital and general and administrative expenses.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also use a portion of the net proceeds to in-license, acquire, or invest in complementary businesses, technology platforms, products, services, technologies or other assets. However, we do not have any agreements or commitments to enter into any material acquisitions or investments at this time.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts of and timing of our use of the net proceeds from the sale of securities under this prospectus will depend on a number of factors. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from the sale of securities under this prospectus. Accordingly, we will retain broad discretion over the use of such proceeds. Pending application of the net proceeds as described above, we intend to invest the net proceeds from the offering that are not used as described above in U.S. federal government or agency-issued obligations, FDIC-insured certificates of deposit, municipal bonds and money market accounts.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="dilution1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DILU</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TION</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you purchase our common stock in this offering, your interest will be diluted to the extent the public offering price per share of our common stock exceeds the net tangible book value per share of common stock immediately after this offering. Dilution or accretion with respect to net tangible book value per share represents the difference between the amount per share paid by purchasers of shares of common stock in this offering and the net tangible book value per share of our common stock immediately after this offering.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our net tangible book value as of December 31, 2025 was approximately $106.6 million, or $4.89 per share of common stock. Net tangible book value per share is determined by dividing the net of total tangible assets less total liabilities, by the aggregate number of shares of our common stock outstanding as of December 31, 2025.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After giving effect to the sale of our common stock pursuant to this prospectus in the aggregate amount of $150,000,000 at an assumed offering price of $4.07 per share, the last reported sale price of our common stock on the Nasdaq Global Select Market on March 20, 2026, and after deducting commissions and estimated aggregate offering expenses payable by us, our as adjusted net tangible book value as of December 31, 2025 would have been approximately $251.6 million, or $4.29 per share of common stock. This represents an immediate decrease in the net tangible book value of $0.60 per share to our existing stockholders and an immediate accretion in net tangible book value of $0.22 per share to new investors. While you will experience immediate accretion under the assumed public offering price of $4.07 per share, if you purchase shares at a price that is above our net tangible book value per share, you will experience immediate dilution.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table illustrates these changes in net tangible book value per share as a result of this offering:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:65.92%;box-sizing:content-box;"></td>
     <td style="width:1.12%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:13.12%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.6%;box-sizing:content-box;"></td>
     <td style="width:1.12%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:13.12%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed public offering price per share of common stock</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.07</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net tangible book value per share as of December 31, 2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.89</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Decrease in net tangible book value per share attributable to this offering</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.60</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">As adjusted net tangible book value per share after this offering</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.29</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accretion in net tangible book value per share to investors participating in this offering</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.22</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table above assumes for illustrative purposes that an aggregate of 36,855,036 shares of our common stock are sold pursuant to this prospectus at a price of $4.07 per share, the last reported sale price of our common stock on the Nasdaq Global Select Market on March 20, 2026, for aggregate net proceeds of approximately $145.0 million, after deducting commissions and estimated aggregate offering expenses payable by us. The as adjusted information is illustrative only and will adjust based on the actual price to the public, the actual number of shares sold and other terms of the offering determined at the time shares of our common stock are sold pursuant to this prospectus. The shares sold in this offering, if any, will be sold from time to time at various prices.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The above discussion and table are based on 21,815,353 shares of common stock outstanding as of December 31, 2025, but excludes:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3,038,413 shares of common stock issuable upon the exercise of stock options outstanding under the Aardvark Therapeutics, Inc. 2025 Equity Incentive Plan and the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan as of December 31, 2025, with a weighted-average exercise price of $9.08 per share;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up to 189,311 shares of common stock available for future issuance under the Aardvark Therapeutics, Inc. 2025 Equity Incentive Plan as of December 31, 2025, which contains provisions that may increase its share reserve each year, and pursuant to which 1,090,767 shares of common stock were added to the reserve on January 1, 2026;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up to 185,408 shares of common stock available for future issuance under the Aardvark Therapeutics, Inc. 2025 Employee Stock Purchase Plan as of December 31, 2025, which contains provisions that may </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increase its share reserve each year, and pursuant to which 218,153 shares of common stock were added to the reserve on January 1, 2026; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">up to 660,017 shares of common stock available for future issuance under the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan as of December 31, 2025.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent that options are exercised, new options or other equity awards are issued under our equity incentive plans, or we issue additional shares of common stock or other equity or convertible debt securities in the future, there may be dilution, or further dilution, to investors participating in this offering. Moreover, we may choose to raise additional capital because of market conditions or strategic considerations even if we believe that we have sufficient funds for our current or future operating plans. If we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="plan_of_distribution1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PLAN OF DI</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STRIBUTION</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into the Equity Distribution Agreement with Piper Sandler, as our sales agent, under which we may offer and sell shares of our common stock from time to time through Piper Sandler. Pursuant to this prospectus, we may offer and sell up to $150,000,000 of our shares of common stock. A copy of the Equity Distribution Agreement is attached as an exhibit to the registration statement of which this prospectus forms a part.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Piper Sandler will use commercially reasonable efforts to sell on our behalf all shares of our common stock requested to be sold by us, consistent with its normal trading and sales practices, under the terms and subject to the conditions set forth in the Equity Distribution Agreement. We may instruct Piper Sandler not to sell our common stock if the sales cannot be effected at or above the price designated by us in any instruction. We or Piper Sandler may suspend the offering of our common stock upon proper notice and subject to other conditions, as further described in the Equity Distribution Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon delivery of a placement notice, and subject to our instructions in that notice and the terms and conditions of the Equity Distribution Agreement generally, Piper Sandler may sell our common stock by any method permitted by law that is deemed to be an &#x201c;at the market offering&#x201d; as defined in Rule 415(a)(4) promulgated under the Securities Act, including sales made directly on or through the Nasdaq Global Select Market or on any other existing trading market for our common stock. Piper Sandler will provide written confirmation to us no later than the opening of trading on the Nasdaq Global Select Market on the day following each day in which our common stock is sold under the Equity Distribution Agreement. Each such confirmation will include the number of shares of our common stock sold on such day, the volume-weighted average price of the shares sold, the net proceeds to us and the compensation payable by us to Piper Sandler in connection with such sales.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will pay Piper Sandler commissions for its services in acting as sales agent in the sale of our common stock. Piper Sandler will be entitled to compensation in an amount equal to 3.0% of the gross sales price of all common stock sold through it as sales agent under the Equity Distribution Agreement. We have also agreed to reimburse Piper Sandler for the out-of-pocket reasonable fees and disbursements of its legal counsel, in an amount not to exceed $100,000 in connection with the establishment of this at the market offering program in addition to certain ongoing disbursements of its legal counsel. We estimate that the total expenses for this offering, excluding compensation payable to Piper Sandler under the terms of the Equity Distribution Agreement, will be approximately $0.5 million.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Settlement for sales of our common stock will occur on the first business day following the date on which any such sales are made, or on some other date that is agreed upon by us and Piper Sandler in connection with a particular transaction, in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will report at least quarterly the number of shares of our common stock sold through Piper Sandler, as sales agent, under the Equity Distribution Agreement, and the net proceeds to us in connection with such sales.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Piper Sandler and its affiliates have from time to time provided, and may in the future provide, various investment banking, commercial banking, fiduciary and advisory services for us for which they have received, and may in the future receive, customary fees and expenses. Piper Sandler and its affiliates may from time to time engage in other transactions with and perform services for us in the ordinary course of their business.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the sale of our common stock on our behalf, Piper Sandler will be deemed to be an underwriter within the meaning of the Securities Act, and the compensation paid by us to Piper Sandler will be deemed to be underwriting commissions or discounts. We have agreed to indemnify Piper Sandler against specified liabilities, including liabilities under the Securities Act, or to contribute to payments that Piper Sandler may be required to make because of such liabilities.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The offering of our common stock pursuant to the Equity Distribution Agreement will terminate upon termination of the Equity Distribution Agreement. The Equity Distribution Agreement may be terminated by Piper Sandler or us at any time upon specified prior written notice.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="legal_matters1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LEGAL M</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATTERS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The validity of the issuance of the common stock offered by this prospectus will be passed upon for us by Paul Hastings LLP, Palo Alto, California. Piper Sandler &amp; Co. is being represented in connection with this offering by Cooley LLP, New York, New York.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="experts1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXP</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ERTS</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements of Aardvark Therapeutics, Inc. as of December 31, 2025 and 2024 and for the years then ended, incorporated by reference in this Prospectus have been so incorporated in reliance on the report of BDO USA, P.C., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="where_you_can_find_additional_info1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHERE YOU CAN FIND ADDI</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TIONAL INFORMATION</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have filed with the SEC a registration statement on Form S-3 under the Securities Act with respect to the securities to be offered under this prospectus.  This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth or incorporated by reference in the registration statement of which this prospectus is a part and the exhibits to such registration statement.  For further information with respect to us and the securities offered by this prospectus, we refer you to the registration statement of which this prospectus is a part and the exhibits to such registration statement.  Statements contained in this prospectus as to the contents of any contract or any other document are not necessarily complete.  If a contract or document has been filed as an exhibit to the registration statement or an exhibit to the reports or other documents incorporated by reference into this prospectus, please see the copy of the contract or document that has been filed.  Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC.  The address of that website is </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">www.sec.gov</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may also request a copy of these filings, at no cost, by writing us at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122 or telephoning us at (858) 225-7696.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, file periodic reports, proxy statements and other information with the SEC.  These periodic reports, proxy statements and other information are available at the website of the SEC referred to above.  We also maintain a website at </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">https://aardvarktherapeutics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC.  Information contained on or connected to our website is not a part of, and is not incorporated into, this prospectus or the registration statement of which this prospectus is a part and the inclusion of our website address in this prospectus is an inactive textual reference.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="incorporation_of_certain_information1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INCORPORATION OF CERTA</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN INFORMATION BY REFERENCE</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC allows us to incorporate by reference the information and reports we file with it into this prospectus, which means that we can disclose important information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus, and information we file later with the SEC will automatically update and supersede this information. We are incorporating by reference the documents listed below as of their respective dates of filing, which we have already filed with the SEC. Any report or information within any of the documents referred below that is furnished, but not filed, shall not be incorporated by reference into this prospectus.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001774857/000119312526119770/ck0001774857-20251231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Report on Form 10-K for the fiscal year ended December 31, 2025</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, filed with the SEC on March 23, 2026;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our Current Reports on Form 8-K filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526009862/ck0001774857-20260112.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 12, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526043764/ck0001774857-20260210.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 10, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526047757/ck0001774857-20260209.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 12, 2026</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1774857/000119312526082787/ck0001774857-20260227.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 27, 2026</font></a><font style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the description of our common stock set forth in our Registration Statement on </font><a href="https://www.sec.gov/Archives/edgar/data/1774857/000119312525023571/d912100d8a12b.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Form 8-A</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(File No. 001-42513), filed with the SEC under Section 12(b) of the Exchange Act on February 10, 2025, including any amendments or reports filed for the purpose of updating such description, including the description of our common stock included as </font><a href="https://www.sec.gov/Archives/edgar/data/1774857/000095017025047835/ck0001774857-ex4_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.2</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 31, 2025.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also incorporate by reference any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including those made after the date of the initial filing of the registration statement of which this prospectus is a part and prior to effectiveness of such registration statement, until we file a post-effective amendment that indicates the termination of the offering of the securities made by this prospectus, and such future filings will become a part of this prospectus from the respective dates that such documents are filed with the SEC. Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document which is also incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may obtain any of the documents incorporated by reference in this prospectus from the SEC through the SEC&#x2019;s website at the address provided above. Documents incorporated by reference are also available from us, without charge. You may obtain documents incorporated by reference in this prospectus by requesting them in writing or by telephone at the following address or phone number:</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4370 La Jolla Village Drive, Suite 1050</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, CA 92122</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(858) 225-7696</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attn: Chief Executive Officer</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You also may access these filings on our internet site at </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">https://aardvarktherapeutics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Information contained on or connected to our website is not a part of, and is not incorporated into, this prospectus or the registration statement of which this prospectus is a part and the inclusion of our website address in this prospectus is an inactive textual reference. This prospectus is part of a registration statement we filed with the SEC. We have incorporated exhibits into the registration statement of which this prospectus is a part. You should read the exhibits carefully for provisions that may be important to you.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></font>&#160;</h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Up to $150,000,000</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img8190679_4.jpg" alt="img8190679_4.jpg" style="width:290px;height:62px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prospectus</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Piper Sandler</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II<br>INFORMATION NOT REQUIRED IN THE PROSPECTUS</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14.	Other Expenses of Issuance and Distribution</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth an estimate of the fees and expenses, other than the underwriting discounts and commissions, payable by the Registrant in connection with the issuance and distribution of the securities being registered.  All the amounts shown, except for the SEC registration fee and FINRA filing fee, are estimates.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:80.22%;box-sizing:content-box;"></td>
     <td style="width:1.48%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:16.3%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SEC registration fee</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,240</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounting fees and expenses</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal fees and expenses</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transfer agent and registrar fees and expenses</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trustee fees and expenses</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Blue sky fees and expenses (including legal fees)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">FINRA filing fee</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,500</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Printing and miscellaneous fees and expenses</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:73.333%;text-align:justify;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* These fees are calculated based on the type of securities offered and the number of issuances and accordingly, cannot be estimated at this time. The amount of securities and number of offerings are indeterminable and the expenses cannot be estimated at this time.  An estimate of the aggregate expenses in connection with the sale and distribution of securities being offered will be included in the applicable prospectus supplement.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15.	Indemnification of Directors and Officers</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Registration is incorporated under the laws of the state of Delaware.  Section 145 of the General Corporation Law of the State of Delaware, or the DGCL, authorizes a corporation&#x2019;s board of directors to grant, and authorizes a court to award, indemnity to officers, directors and other corporate agents.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Registrant&#x2019;s fourth amended and restated certificate of incorporation and amended and restated bylaws contain provisions that limit the liability of the Registrant&#x2019;s directors and officers for monetary damages to the fullest extent permitted by Delaware law. Consequently, the Registrant&#x2019;s directors and officers will not be personally liable to the Registrant or the Registrant&#x2019;s stockholders for monetary damages for any breach of fiduciary duties as directors or officers, except liability for the following:</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any breach of their duty of loyalty to the Registrant or the Registrant&#x2019;s stockholders;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">with respect to directors, unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL;</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">with respect to officers, derivative claims brought on behalf of the Registrant; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any transaction from which they derived an improper personal benefit.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors or officers of corporations, then the personal liability of the Registrant&#x2019;s directors and officers will be further limited to the greatest extent permitted by the DGCL.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Registrant&#x2019;s fourth amended and restated certificate of incorporation also provides that the Registrant will indemnify, to the fullest extent permitted by law, each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that he or she is or was, or has agreed to become, a director or officer of the Registrant, or is or was serving, or has agreed to serve, at the request of the Registrant, as a director, officer, incorporator, employee or agent of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity. In addition, the Registrant&#x2019;s fourth amended and restated certificate of incorporation provides that the Registrant must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, the Registrant has entered into, and expects to continue to enter into, indemnification agreements with each of its directors and executive officers that may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements require the Registrant, among other things, to indemnify its directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements also require the Registrant to advance all expenses incurred by the directors and executive officers in investigating or defending any such action, suit or proceeding, subject to certain exceptions. The Registrant believes that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The limitation of liability and indemnification provisions that are included in the Registrant&#x2019;s fourth amended and restated certificate of incorporation, amended and restated bylaws and in indemnification agreements that the Registrant enters into with its directors and executive officers may discourage stockholders from bringing a lawsuit against its directors and executive officers for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against the Registrant&#x2019;s directors and executive officers even though an action, if successful, might benefit the Registrant and other stockholders. Further, a stockholder&#x2019;s investment may be adversely affected to the extent that the Registrant pays the costs of settlement and damage awards against directors and executive officers as required by these indemnification provisions. Except as may be disclosed this Registration Statement or the documents incorporated by reference herein, the Registrant is not aware of any pending litigation or proceeding involving any person who is or was one of its directors, officers, employees or other agents or is or was serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, for which indemnification is sought, and the Registrant is not aware of any threatened litigation that may result in claims for indemnification.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Registrant&#x2019;s amended and restated bylaws provide that the Registrant may purchase and maintain insurance, at its expense, to protect itself and any person who is or was a director, officer, employee or agent of the Registrant or is or was serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Registrant would have the power to indemnify such person against such expense, liability or loss under the DGCL. The Registrant has obtained insurance under which, subject to the limitations of the insurance policies, coverage is provided to the Registrant&#x2019;s directors and executive officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or executive officer, including claims relating to public securities matters, and to the Registrant with respect to payments that may be made by the Registrant to these directors and executive officers pursuant to the Registrant&#x2019;s indemnification obligations or otherwise as a matter of law.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See also the undertakings set out in response to Item 17 herein.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16.	Exhibits</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:0.5340277777777778in;box-sizing:content-box;"></td>
     <td style="width:0.06666666666666667in;box-sizing:content-box;"></td>
     <td style="width:2.9847222222222225in;box-sizing:content-box;"></td>
     <td style="width:0.06597222222222222in;box-sizing:content-box;"></td>
     <td style="width:0.5305555555555556in;box-sizing:content-box;"></td>
     <td style="width:0.06597222222222222in;box-sizing:content-box;"></td>
     <td style="width:0.8618055555555555in;box-sizing:content-box;"></td>
     <td style="width:0.06597222222222222in;box-sizing:content-box;"></td>
     <td style="width:0.7291666666666666in;box-sizing:content-box;"></td>
     <td style="width:0.06597222222222222in;box-sizing:content-box;"></td>
     <td style="width:0.5291666666666667in;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="5" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit<br>No.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit Description</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing<br>Date/Period<br>End Date</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed<br>Herewith</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Underwriting Agreement</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="ck0001774857-ex1_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Equity Distribution Agreement dated as of March 23, 2026, by and between Aardvark Therapeutics, Inc. and Piper Sandler &amp; Co.</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1774857/000119312525021764/d882459dex41.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Common Stock Certificate</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">02/06/2025</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="ck0001774857-ex4_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Indenture</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Specimen Preferred Stock Certificate and Form of Certificate of Designation of Preferred Stock</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Debt Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Warrant Agreement (including form of Warrant Certificate)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Depositary Agreement and Form of Depositary Receipt</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Rights Agreement</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Unit Agreement</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="ck0001774857-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Opinion of Paul Hastings LLP</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="ck0001774857-ex23_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of BDO USA, P.C., Independent Registered Public Accounting Firm</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="ck0001774857-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Paul Hastings LLP (contained in Exhibit 5.1 to this Registration Statement)</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="#power_of_attorney"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Power of Attorney (contained on the signature page)</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.1&#134;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statement of Eligibility of Trustee on Form T-1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="ck0001774857-exfiling_fees.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Filing Fee Table</font></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</font></p></td>
    </tr>
   </table><p style="text-indent:-25.001%;padding-left:6.667%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:66.667%;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#134;	To be filed by amendment or as an exhibit to a Current Report on Form 8-K and incorporated herein by reference, if applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 17.	Undertakings</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Registrant hereby undertakes:</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To include any prospectus required by Section 10(a)(3) of the Securities Act;</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.  Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#x201c;Calculation of Registration Fee&#x201d; table in the effective registration statement; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided, however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> offering thereof.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(3)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(4)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">That, for the purpose of determining liability under the Securities Act to any purchaser:</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.  As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> offering thereof.  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:13.333%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(5)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">That, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of the securities, that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant;</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.0772958565543975%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">(iv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(6)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">That, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#x2019;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#x2019;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(7)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2) of the Trust Indenture Act.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNA</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TURES</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on March 23, 2026.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:58%;box-sizing:content-box;"></td>
     <td style="width:4%;box-sizing:content-box;"></td>
     <td style="width:38%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AARDVARK THERAPEUTICS, INC.</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Tien-Li Lee, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name: Tien-Li Lee, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title: Chief Executive Officer</font></p></td>
    </tr>
   </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="power_of_attorney"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">POWER OF</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ATTORNEY</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KNOW ALL PERSONS BY THESE PRESENTS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that each person whose signature appears below constitutes and appoints Tien-Li Lee, M.D. and Nelson Sun, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, with full power of each to act alone, with full powers of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments and any registration statement filed pursuant to Rule 462 under the Securities Act of 1933, as amended, in connection with said registration statement), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and generally to do all such things in their names and behalf in their capacities as officers and directors to enable Aardvark Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or any of them or their or his or her substitutes or resubstitutes, may lawfully do or cause to be done by virtue hereof.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:2.0298611111111113in;box-sizing:content-box;"></td>
     <td style="width:0.07013888888888889in;box-sizing:content-box;"></td>
     <td style="width:2.870138888888889in;box-sizing:content-box;"></td>
     <td style="width:0.07013888888888889in;box-sizing:content-box;"></td>
     <td style="width:1.9597222222222221in;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Signature</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Tien-Li Lee, M.D.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tien-Li Lee, M.D.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Nelson Sun</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Operating Officer</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nelson Sun</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Accounting and Financial Officer)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jeffrey Chi, Ph.D.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jeffrey Chi, Ph.D.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Roy D. Baynes, M.D., Ph.D.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Roy D. Baynes, M.D., Ph.D.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Susan E. Graf.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 23 2026</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Susan E. Graf</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Victor Tong, Jr.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Victor Tong, Jr.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>ck0001774857-ex1_2.htm
<DESCRIPTION>EX-1.2
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-03-23T16:54:03.1253+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-1.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 1.2</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EQUITY DISTRIBUTION AGREEMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PIPER SANDLER &amp; CO.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">350 North 5th Street, Suite 1000</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Minneapolis, Minnesota 55401</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ladies and Gentlemen:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	As further set forth in this agreement (this </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Agreement&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), Aardvark Therapeutics, Inc., a Delaware corporation (the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Company&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), proposes to issue and sell from time to time through Piper Sandler &amp; Co. (the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Agent&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), as sales agent, the Company&#x2019;s common stock, par value $0.00001 per share (the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Common Stock&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) (such shares of Common Stock to be sold pursuant to this Agreement, the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Shares&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) on the terms set forth herein.  Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	The Company hereby confirms its agreement with the Agent with respect to the sale of the Shares.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representations and Warranties of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company represents and warrants to, and agrees with, the Agent that as of the date of this Agreement, each Representation Date (as defined in Section 3(p) below), each date on which a Placement Notice (as defined in Section 2(a)(i) below) is given (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Notice Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), each date on which Shares are sold hereunder (each, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Applicable Time</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and each Settlement Date (as defined in Section 2(a)(vii) below) as follows:</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will file or has filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Securities Act&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), with the Securities and Exchange Commission (the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Commission&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) a registration statement on Form S-3, including a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Exchange Act&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). The Company has prepared, or will prepare, a prospectus included as part of such registration statement specifically relating to the Shares or a prospectus supplement to the base prospectus included as part of such registration statement specifically relating to the Shares (as applicable, the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Prospectus Supplement&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). The Company has furnished, or will furnish, to the Agent, for use by the Agent, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">relating to the Shares. The Company may file one or more additional registration statements from time to time that will contain a base prospectus and related prospectus or prospectus supplement, if applicable (which shall be a Prospectus Supplement), with respect to the Shares. Except where the context otherwise requires, such registration statement, as amended, when it becomes or became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b) of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant to Rule 415(a)(6) under the Securities Act by the Company to cover the Shares, is herein called the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Registration Statement.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">issuer free writing prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; as defined in Rule 433 of the Securities Act (</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Rule 433&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), relating to the Shares, if any, that (i) is required to be filed with the Commission by the Company or (ii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#x2019;s records pursuant to Rule 433(g), is herein called the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Prospectus.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#x201c;amend,&#x201d; &#x201c;amendment&#x201d; or &#x201c;supplement&#x201d; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to the Electronic Data Gathering Analysis and Retrieval System (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EDGAR&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Registration Statement and any Rule 462(b) Registration Statement have been, or will be, declared effective by the Commission under the Securities Act. The Company has complied, or will comply, to the Commission&#x2019;s satisfaction, with all requests of the Commission for additional or supplemental information.  No stop order suspending the effectiveness of the Registration Statement or any Rule 462(b) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, contemplated or threatened by the Commission. The Company meets the requirements for use of Form S-3 under the Securities Act. The sale of the Shares hereunder meets the requirements of General Instruction I.B.1 or I.B.6, as applicable, of Form S-3.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Prospectus when filed complied or will comply, and as amended or supplemented, if applicable, complied or will comply in all material respects with the Securities Act. Each of the Registration Statement, any Rule 462(b) Registration Statement, the Prospectus and any post-effective amendments or supplements thereto, at the time it became effective or its date, as applicable, and as of each Settlement Date (as defined in Section 2(a)(vii) below), complied in all material respects with the Securities Act, and as of each effective date and each Settlement Date, did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus, as amended or supplemented, as of its date, did not and, as of each of </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Settlement Date, will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the two immediately preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information relating to the Agent furnished to the Company in writing by the Agent expressly for use therein. There are no contracts or other documents required to be described in the Prospectus or to be filed as exhibits to the Registration Statement which have not been described or filed as required.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not an &#x201c;ineligible issuer&#x201d; in connection with the offering pursuant to Rules 164, 405 and 433 under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply, as of the date of such filing, in all material respects with the applicable requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. Except for the free writing prospectuses, if any, and electronic roadshows, if any, each furnished to the Representatives before first use, the Company has not prepared, used or referred to, and will not, without the prior consent of the Representatives, prepare, use or refer to, any free writing prospectus.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has been duly incorporated, is validly existing as a corporation in good standing under the laws of the state of Delaware, has the corporate power and authority to own or lease its property and to conduct its business as described in each of the Registration Statement and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect (as defined below) on the Company and its subsidiaries, taken as a whole. &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Adverse Effect</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean any material adverse change or effect, or any development that would reasonably be expected to result in a material adverse change or effect, on or affecting (i) the business, earnings, condition (financial or otherwise) or operations of the Company and its subsidiaries taken as a whole, or (ii) the ability of the Company to perform its obligations under this Agreement, including the issuance and sale of the Shares, or to consummate the transactions contemplated in the Prospectus.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each subsidiary of the Company has been duly incorporated, organized or formed, is validly existing as a corporation or other business entity in good standing under the laws of the jurisdiction of its incorporation, organization or formation (to the extent that such concepts are applicable in such jurisdiction), has the corporate or other business entity power and authority to own or lease its property and to conduct its business as described in each of the Registration Statement and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction (to the extent that such concepts are applicable in such jurisdiction) </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock or other equity interests of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable (to the extent that such concepts are applicable in such jurisdiction) and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Agreement has been duly authorized, executed and delivered by the Company.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(viii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The authorized capital stock of the Company conforms as to legal matters, in all material respects, to the description thereof contained in each of the Registration Statement and the Prospectus.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ix)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The shares of Common Stock outstanding prior to the issuance of the Shares have been duly authorized and are validly issued, fully paid and non&#x2011;assessable.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(x)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Shares have been duly authorized and, when issued, delivered and paid for in accordance with the terms of this Agreement, will be validly issued, fully paid and non&#x2011;assessable, and the issuance of the Shares will not be subject to any preemptive or similar rights that have not been validly waived.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to the stock options granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Stock Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), (i) each grant of a stock option was duly authorized no later than the date on which the grant of such stock option was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, and (ii) each such grant was made in accordance with the terms of the Company Stock Plans, and all applicable laws and regulatory rules or requirements, including all applicable federal securities laws.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement will not contravene (i) any provision of applicable law, (ii) the certificate of incorporation or by&#x2011;laws of the Company, (iii) any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries, taken as a whole, or (iv) any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any subsidiary, except in the case of clauses (i), (iii) and (iv), where such contravention would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, and no consent, approval, authorization or order of, or qualification with, any governmental body, agency or court is required for the performance by the Company of its obligations under this Agreement, except such as have already been obtained or waived or may be required by the securities or Blue Sky laws of the various states or foreign </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">jurisdictions or the rules and regulations of the Financial Industry Regulatory Authority, Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) in connection with the offer and sale of the Shares.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xiii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There has not occurred any material adverse change, or any development involving a prospective material adverse change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Prospectus.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xiv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the Company nor any of its subsidiaries is (i) in violation of its respective certificate of incorporation or bylaws; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument binding upon the Company or any of its subsidiaries, taken as a whole; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority applicable to the Company, any of its subsidiaries or their respective businesses and properties, except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no legal or governmental proceedings pending or, to the Company&#x2019;s knowledge, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject (i) other than proceedings accurately described in all material respects in each of the Registration Statement and the Prospectus and proceedings that would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by each of the Registration Statement and the Prospectus or (ii) that are required to be described in the Registration Statement or the Prospectus and are not so described; and there are no statutes, regulations, contracts or other documents to which the Company or any of its subsidiaries is subject or by which the Company or any of its subsidiaries is bound that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement that are not described in all material respects or filed as required.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xvi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each preliminary prospectus filed as part of the Registration Statement as originally filed or as part of any amendment thereto, or filed pursuant to Rule 424 under the Securities Act, complied when so filed in all material respects with the applicable requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xvii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not, and after giving effect to the offering and sale of the Shares and the application of the proceeds thereof as described in each of the Registration Statement and the Prospectus will not be, required to register as an &#x201c;investment company&#x201d; as such term is defined in the Investment Company Act of 1940, as amended.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xviii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xix)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no costs or liabilities associated with Environmental Laws (including, without limitation, any capital or operating expenditures required for clean&#x2011;up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties) which would, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xx)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to file a registration statement under the Securities Act with respect to any securities of the Company or to require the Company to include such securities with the Shares registered pursuant to the Registration Statement, except as otherwise have been validly waived or complied with in connection with the issuance and sale of the Shares contemplated hereby.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) None of the Company or any of its subsidiaries, or any director or, officer thereof, or, to the Company&#x2019;s knowledge, any affiliate, agent, employee or representative of the Company or of any of its subsidiaries or affiliates, while acting on behalf of the Company and its subsidiaries, has taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) in order to influence official action, or to any person in violation of any applicable anti-corruption laws; (ii) the Company and each of its subsidiaries and, to the Company&#x2019;s knowledge, its affiliates have conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein; and (iii) neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-corruption laws.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The operations of the Company and each of its subsidiaries are and have been conducted at all times in compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and each of its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental or regulatory agency (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-Money Laundering Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and no action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxiii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None of the Company, any of its subsidiaries, or any director, officer or employee thereof, or, to the Company&#x2019;s knowledge, any agent, affiliate or representative of the Company or any of its subsidiaries, is an individual or entity (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) that is, or is owned or controlled by one or more Persons that are:</font></div></div><div class="item-list-element-wrapper" style="text-indent:26.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:26.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.067%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(A)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the subject of any sanctions administered or enforced by the U.S. Department of the Treasury&#x2019;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, His Majesty&#x2019;s Treasury or other relevant sanctions authority (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sanctions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), or</font></div></div><div class="item-list-element-wrapper" style="text-indent:26.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:26.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.067%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(B)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, Crimea, Cuba, Iran, North Korea and the Donetsk People&#x2019;s Republic and Luhansk People&#x2019;s Republic located in Ukraine).</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxiv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person:</font></div></div><div class="item-list-element-wrapper" style="text-indent:26.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:26.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.067%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(A)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or</font></div></div><div class="item-list-element-wrapper" style="text-indent:26.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:26.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.067%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(B)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxvi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequent to the respective dates as of which information is given in each of the Registration Statement and the Prospectus, (i) the Company and its subsidiaries, taken as a whole, have not incurred any material liability or obligation, direct or contingent, nor entered into any material transaction other than in the ordinary course of business; (ii) the Company has not purchased any of its outstanding capital stock (other than from its employees or other service providers in connection with the termination of their service pursuant to the terms of the equity compensation plans or agreements described in the Registration Statement or the </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prospectus), nor declared, paid or otherwise made any dividend or distribution of any kind on its capital stock other than ordinary and customary dividends; and (iii) there has not been any material change in the capital stock, short&#x2011;term debt or long&#x2011;term debt of the Company and its subsidiaries, taken as a whole (other than the exercise, grant or forfeiture of any equity awards, in each case granted pursuant to any equity compensation plan described in the Registration Statement or the Prospectus).</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxvii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all tangible personal property owned by them which is material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxviii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, to the Company&#x2019;s knowledge, the Company and its subsidiaries own or have licenses or other rights to practice and use, or believe they can acquire or license on commercially reasonable terms, all technology, patents and patent applications, copyrights, trademarks, trademark registrations, service marks, service mark registrations, trade names, service names and know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures) and all other technology and intellectual property rights necessary for, or used in the conduct of the business of the Company and its subsidiaries as currently conducted or as described in the Prospectus (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), or to the development, manufacture, operation and sale of any products and services sold or proposed to be sold by the Company and its subsidiaries. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, to the Company&#x2019;s knowledge, the conduct of the Company&#x2019;s and its subsidiaries&#x2019; respective business as currently conducted and the proposed conduct of its business as described in the Prospectus (including the development and commercialization of the product candidates described in the Registration Statement and the Prospectus) has not and will not infringe or misappropriate any intellectual property rights of others. Except as set forth in the Registration Statement and the Prospectus, no third parties have any material rights to any of the Company Intellectual Property owned by the Company or any of its subsidiaries, and such intellectual property is owned by the Company or its subsidiary free and clear of all liens, security interests or encumbrances. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, to the Company&#x2019;s knowledge, the issued patents owned by the Company and its subsidiaries that are included within the Company Intellectual Property are valid, enforceable and subsisting, and the patent applications owned by the Company and its subsidiaries that are included within the Company Intellectual Property are subsisting and have not been abandoned. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, to the Company&#x2019;s knowledge, (i) no third party is infringing on any of the Company Intellectual Property owned by the Company and </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">its subsidiaries; (ii) except as set forth in the Registration Statement and the Prospectus, the Company and its subsidiaries are not obligated or under any liability to pay a royalty, grant a license, or provide other material consideration to any third party in connection with the Company Intellectual Property that is material to the conduct of the Company&#x2019;s and its subsidiaries&#x2019; respective business as currently conducted and the proposed conduct of its business as described in the Registration Statement and the Prospectus; (iii) no action, suit, claim or other proceeding of a third party is pending, or is threatened in a writing received by the Company, alleging that the Company or any of its subsidiaries is infringing, misappropriating, diluting or otherwise violating, or would, upon the commercialization of any product or service proposed in the Registration Statement and the Prospectus to be conducted, infringe, misappropriate, dilute or otherwise violate, any rights of others with respect to any of the Company&#x2019;s product candidates, processes or intellectual property, and the Company is unaware of any facts which could form a reasonable basis for any such action, suit, proceeding or claim;  (iv) no action, suit, claim or other proceeding of a third party is pending or is threatened in a writing received by the Company, challenging the validity, enforceability, scope, registration, ownership or use of any of the Company Intellectual Property owned by the Company and its subsidiaries, and the Company is unaware of any facts which could form a reasonable basis for any such action, suit, proceeding or claim; (v) no action, suit, claim or other proceeding is pending and served against the Company, or is threatened in a writing received by the Company, challenging the Company&#x2019;s rights in or to any Company Intellectual Property; (vi) the Company has not received written notice of any claim of infringement, misappropriation or conflict with any asserted rights of others with respect to any of the Company&#x2019;s current products, proposed products or processes as described in the Registration Statement and the Prospectus; (vii) no employee, consultant or independent contractor of the Company or any of its subsidiaries (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Personnel</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is in or has ever been in violation in any respect of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement nondisclosure agreement or any restrictive covenant to or with a former employer or counterparty to such agreements, where the basis of such violation relates to such Company Personnel&#x2019;s employment or independent contractor&#x2019;s engagement with the Company or any of its subsidiaries, actions undertaken while employed or engaged with the Company or any of its subsidiaries, or the ownership by the Company of any Company Intellectual Property; and (viii) the Company has taken reasonable measures to protect its confidential information and trade secrets and to maintain and safeguard any Company Intellectual Property of a confidential nature which is owned by the Company and its subsidiaries, including, where applicable, the execution of appropriate nondisclosure and confidentiality agreements. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, to the Company&#x2019;s knowledge, it and its subsidiaries have complied with the terms of each agreement pursuant to which intellectual property has been licensed to the Company or any of its subsidiaries, and all such agreements are in full force and effect. To the Company&#x2019;s knowledge, none of the Company Intellectual Property or technology (including information technology and outsourced arrangements) employed by the Company or any of its subsidiaries, has been obtained or is being used by the Company or any of its subsidiaries in violation of any contractual obligation binding on the Company or its subsidiaries or any of their respective officers, directors or employees or otherwise in violation of the rights of any persons. To the Company&#x2019;s knowledge, the duties of candor and good faith required by the United States</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patent and Trademark Office during the prosecution of the United States patents and patent applications included in the Company Intellectual Property have been complied with.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxix)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, (i) each Plan (as defined below) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to the Employee Retirement Income Security Act of 1974, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ERISA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and the Internal Revenue Code of 1986, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;); (ii) no non-exempt prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan; (iii) for each Plan, no failure to satisfy the minimum funding standards (within the meaning of Section 412 of the Code or Section 302 of ERISA), whether or not waived, has occurred or is reasonably expected to occur; (iv) no &#x201c;reportable event&#x201d; (within the meaning of Section 4043(c) of ERISA, other than those events as to which notice is waived) has occurred or is reasonably expected to occur; and (v) neither the Company nor any member of its &#x201c;Controlled Group&#x201d; (defined as any organization which is a member of a controlled group of corporations within the meaning of Section 414 of the Code) has incurred, nor is reasonably expected to incur, any liability under Title IV of ERISA (other than contributions to any Plan or any Multiemployer Plan or premiums to the PBGC, in the ordinary course and without default) in respect of a Plan or a Multiemployer Plan. For purposes of this paragraph, (x) the term &#x201c;Plan&#x201d; means an employee benefit plan, within the meaning of Section 3(3) of ERISA, subject to Title IV of ERISA, but excluding any Multiemployer Plan, for which the Company or any member of its &#x201c;Controlled Group&#x201d; has any liability and (y) the term &#x201c;Multiemployer Plan&#x201d; means a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA. </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxx)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No material labor dispute with the employees of the Company or any of its subsidiaries exists, or, to the knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers or contractors that, singly or in the aggregate, would reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as in the Company&#x2019;s reasonable judgment, are prudent and customary in the businesses in which they are engaged; neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied for; and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their respective businesses, and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, singly or in the aggregate, if the subject of an </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxiii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The financial statements included in each of the Registration Statement and the Prospectus, together with the related schedules and notes thereto, comply as to form in all material respects with the applicable accounting requirements of the Securities Act and present fairly in all material respects the consolidated financial position of the Company and its subsidiaries as of the dates shown and its results of operations and cash flows for the periods shown, and such financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. GAAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) applied on a consistent basis throughout the periods covered thereby except for any normal year-end adjustments and the exclusion of certain footnotes as permitted by the applicable rules of the Commission in the Company&#x2019;s quarterly financial statements. The other financial information included in each of the Registration Statement and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly in all material respects the information shown thereby. The statistical, industry-related and market-related data included in each of the Registration Statement and the Prospectus are based on or derived from sources which the Company reasonably and in good faith believes are reliable and accurate and such data is consistent with the sources from which they are derived, in each case in all material respects. To the knowledge of the Company, it does not require the consent of any third party for the use of any such data.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxiv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> BDO USA, P.C., which has expressed its opinion and certified certain of the financial statements of the Company filed with the Commission as part of the Registration Statement and included or incorporated by reference in each of the Registration Statement and the Prospectus, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise disclosed in the Registration Statement and the Prospectus, the Company and each of its subsidiaries maintain a system of internal accounting controls designed to provide reasonable assurance that (i) transactions are executed in accordance with management&#x2019;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#x2019;s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as otherwise disclosed in the Registration Statement and the Prospectus, since</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the end of the Company&#x2019;s most recent audited fiscal year, there has been (x) no material weakness in the Company&#x2019;s internal control over financial reporting (whether or not remediated) and (y) no change in the Company&#x2019;s internal control over financial reporting that has materially and adversely affected, or is reasonably likely to materially and adversely affect, the Company&#x2019;s internal control over financial reporting.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxvi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> To the extent required under applicable rules, the Company maintains disclosure controls and procedures that comply with the requirements of the Exchange </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Act; such disclosure controls and procedures have been designed to ensure that material information relating to the Company and its subsidiaries is made known to the Company&#x2019;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxvii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the date of this Agreement or have requested extensions thereof (except where the failure to file would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole) and have paid all taxes required to be paid thereon (except for cases in which the failure to file or pay would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, or, except as currently being contested in good faith and for which reserves required by U.S. GAAP have been created in the financial statements of the Company), and no tax deficiency has been determined adversely to the Company or any of its subsidiaries which, singly or in the aggregate, has had (nor does the Company nor any of its subsidiaries have any written notice or knowledge of any tax deficiency which could reasonably be expected to be determined adversely to the Company or its subsidiaries and which could reasonably be expected to have) a Material Adverse Effect on the Company and its subsidiaries, taken as a whole.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxviii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No stamp, issue, registration, documentary, transfer or other similar taxes and duties, including interest and penalties, are payable on or in connection with the issuance and sale of the Shares by the Company or the execution and delivery of this Agreement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xxxix)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> There is and has been no failure on the part of the Company, or to the knowledge of the Company, any of the Company&#x2019;s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sarbanes-Oxley Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and the rules and regulations promulgated in connection therewith, including Section 402 related to loans, to the extent compliance is required, and the Company is taking steps designed to ensure that it will be in compliance, at all times, with the other provisions of the Sarbanes-Oxley Act when they become applicable to the Company after the effectiveness of the Registration Statement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xl)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not taken, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xli)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act. </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xlii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preclinical tests and clinical trials, and other studies (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Studies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such Studies and with standard medical and scientific research procedures; each description of the results of such Studies is accurate and complete in all material respects and fairly presents the data derived from such Studies, and the Company has no knowledge of any other Studies the </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company has made all such filings and obtained all such approvals or authorizations as may be required by the Food and Drug Administration (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">FDA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of the U.S. Department of Health and Human Services or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory Agencies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), except where the failure to make such filing or obtain such approval would not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect on the Company and its subsidiaries, taken as a whole; and the Company has not received any written notice of, or written correspondence from, any Regulatory Agency requiring the termination, suspension or material modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus, nor is the Company aware of any reasonable grounds for such written notice or correspondence.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xliii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiaries and, to the Company&#x2019;s knowledge, their respective directors, officers, employees, contractors and agents are, and at all times have been, in material compliance with all applicable statutes, rules and regulations applicable to the Health Care Laws, as defined below. For purposes of this Agreement, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Health Care Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means: (i) the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.) and the regulations promulgated thereunder; (ii) all applicable federal, state, local and all applicable foreign health care related fraud and abuse laws, including, without limitation, the U.S. Anti-Kickback Statute (42 U.S.C. &#167;1320a-7b(b)), the U.S. False Statements Law (42 U.S.C. &#167;1320a-7b(a)), the Civil Monetary Penalties Law (42 U.S.C. &#167;1320a-7a), the U.S. Civil False Claims Act (31 U.S.C. &#167;3729 et seq.), all criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. &#167;&#167; 286 and 287, and the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">HIPAA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) (42 U.S.C. &#167;&#167; 1320d et seq.), the Physician Payments Sunshine Act (42 U.S.C. &#167;1320a-7h), the exclusions law (42 U.S.C. &#167;1320a-7), the statutes and regulations of applicable government funded or sponsored healthcare programs, and the regulations promulgated pursuant to such statutes, including but not limited to the coverage and payment provisions of Medicare (Title XVIII of the Social Security Act) and Medicaid (Title XIX of the Social Security Act); (iii) the Standards for Privacy of Individually Identifiable Health Information, the Security Standards and the Standards for Electronic Transactions and Code Sets promulgated under HIPAA, the Health Information Technology for Economic and Clinical Health Act (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">HITECH Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) (42 U.S.C. &#167;&#167; 17921 et seq.), and the regulations promulgated thereunder and any state or non-U.S. counterpart thereof or other law or regulation the purpose of which is to protect the privacy of individuals or prescribers; (iv) the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010; (v) licensure, quality, safety and accreditation requirements under applicable Regulatory Agencies that are applicable to the Company&#x2019;s operations; and (vi) any and all other applicable health care laws and regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, advertising, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company. Neither the Company nor its subsidiaries has received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in material violation of any applicable Health Care Laws, and, to the Company&#x2019;s knowledge, no such claim, action, suit, proceeding, </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hearing, enforcement, investigation, arbitration or other action is threatened. Neither the Company, its subsidiaries, nor any of their officers, directors, employees, contractors or agents, is a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority. Additionally, neither the Company including any of its employees, contractors, agents, officers or directors, nor its subsidiaries including any of the subsidiary&#x2019;s employees, officers or directors or, to the Company&#x2019;s knowledge, any of its agents or contractors, has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension or exclusion, or engaged in any conduct that would reasonably be expected to result in debarment, suspension or exclusion. The Company and its subsidiaries have filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by the Health Care Laws, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were timely, complete, accurate and not misleading on the date filed in all material respects (or were corrected or supplemented by a subsequent submission). The Company and its subsidiaries possess and are in material compliance with all licenses, certificates, approvals, clearances, exemptions, authorizations, permits and supplements or amendments thereto required by any such Health Care Laws. The Company and its subsidiaries have fulfilled and performed all of their respective obligations with respect to all licenses, sublicenses, certificates, permits and other authorizations and, to the Company&#x2019;s knowledge, no event has occurred which allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other impairment of the rights of the holder.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xliv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company (i) is and at all times has been in material compliance with all statutes, rules or regulations of the FDA and other comparable governmental entities applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under development, manufactured or distributed by the Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Applicable Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;); (ii) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or written notice from the FDA or any governmental entity alleging or asserting material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, exemptions, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Authorizations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;); (iii) possesses all material Authorizations and such Authorizations are valid and in full force and effect and the Company is not in material violation of any term of any such Authorizations; (iv) has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the FDA or any governmental entity or third party alleging that any product operation or activity is in material violation of any Applicable Laws or Authorizations and has no knowledge that the FDA or any governmental entity has threatened any such claim, litigation, arbitration, action, suit, investigation or proceeding; (v) has not received written notice that the FDA or any governmental entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any material Authorizations and has no knowledge that the FDA or any governmental entity has threatened such action; and (vi) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission).</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xlv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and each of its subsidiaries are, and at all prior times were, in material compliance with all data privacy and security laws and regulations, contractual obligations or industry standards regarding the collection, use, transfer, storage, processing (including by third parties), protection, disposal or disclosure of all sensitive, confidential, regulated data, personally identifiable information or any other information, personal information or personal data collected from or provided by third parties (collectively &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sensitive Data</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), including, without limitation, the European Union General Data Protection Regulation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GDPR</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) (EU 2016/679) and the California Consumer Privacy Act as modified by the California Privacy Rights Act (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CCPA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of 2018 (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Privacy and Security Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Personal Data</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means (i) a natural person&#x2019;s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&#x2019;s license number, passport number, credit card number, bank information or customer or account number; (ii) any information which would qualify as &#x201c;personally identifying information&#x201d; under the Federal Trade Commission Act, as amended; (iii) &#x201c;personal data&#x201d; as defined by GDPR or &#x201c;personal information&#x201d; as defined by the CCPA; and (iv) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data related to an identified person&#x2019;s health or sexual orientation, except any &#x201c;protected health information&#x201d; as defined by HIPAA that has been explicitly exempted by an applicable law. To ensure compliance with the Privacy and Security Obligations, the Company and its subsidiaries have in place, comply with and take appropriate steps to ensure compliance with their (x) policies and procedures relating to data privacy and security and the collection, storage, processing (including by third parties), use, disclosure, handling and analysis of Personal Data and (y) security policies (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Policies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Each of the Policies provides accurate and sufficient notice of the Company&#x2019;s then-current privacy practices relating to its subject matter and such Policies do not contain any material omissions of the Company&#x2019;s then-current privacy practices. The Company and its subsidiaries since inception have at all times made all disclosures to users or customers required by applicable laws, contracts, or regulatory rules or requirements. None of such disclosures made or contained in any of the Policies have been inaccurate, misleading, deceptive or in violation of any Privacy and Security Obligations or Policies in any material respect. The execution, delivery and performance of this Agreement or any other agreement referred to in this Agreement will not result in a breach of violation of any Privacy and Security Obligations or Policies. The Company further certifies that neither it nor any subsidiary: (A) has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy and Security Obligations, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (B) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy and Security Obligation; or (C) is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy and Security Obligation. </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xlvi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s, its subsidiaries&#x2019; and its third-party providers&#x2019; information technology assets and equipment, computers, technology systems and other systems, networks, hardware, software, websites, applications and databases (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IT Systems</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) are reasonably adequate for, and operate and perform in all material respects as required in </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company, its subsidiaries and its third-party providers have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures and safeguards to maintain and protect its confidential information and the integrity, continuous operation, redundancy and security of all IT Systems (including all Sensitive Data) and data used in connection with the operation of the Company or its subsidiaries. The Company, its subsidiaries and its third-party providers have used reasonable efforts to establish, and have established, commercially reasonable disaster recovery and security plans, procedures and facilities for the business, including, without limitation, for the information technology systems and data held or used by or for the Company or any of its subsidiaries. There have been no internal or external security breaches or attacks, violations, outages or unauthorized uses of or accesses to the Sensitive Data, or any other compromises of or relating to any such information technology system or data. The Company and its subsidiaries, and, to its knowledge, its third party providers have in the past and are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Sensitive Data and to the protection of such IT Systems and Sensitive Data from unauthorized use, access, misappropriation or modification.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xlvii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the Company nor any of its subsidiaries has any securities that are rated by a &#x201c;nationally recognized statistical rating organization,&#x201d; as such term is defined in Section 3(a)(62) of the Exchange Act.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xlviii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the Company nor any of its subsidiaries is a &#x201c;covered foreign person,&#x201d; as that term is defined in 31 C.F.R. &#167; 850.209. Neither the Company nor any of its subsidiaries currently engages, or has plans to engage, directly or indirectly, in a &#x201c;covered activity&#x201d;, as that term is defined in 31 C.F.R. &#167; 850.208 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covered Activity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The Company does not have any joint ventures that engages in or plans to engage in any Covered Activity. The Company also does not, directly or indirectly, hold a board seat on, have a voting or equity interest in, or have any contractual power to direct or cause the direction of the management or policies of any person or persons that engages or plans to engage in any Covered Activity.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(xlix)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not sold or issued any securities that would be integrated with the offering of the Shares contemplated by this Agreement pursuant to the Securities Act or the interpretations thereof by the Commission.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(l)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The shares of Common Stock are registered pursuant to Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC; the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Exchange, nor has the Company received any notification that the Commission or the Exchange is contemplating terminating such registration or listing.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(li)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any certificate signed by any officer of the Company and delivered to the Agent or the Agent&#x2019;s counsel in connection with the offering of the Shares shall be deemed a representation and warranty by the Company to the Agent as to the matters covered thereby.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(lii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not a party to any agreement with an agent or underwriter for any other &#x201c;at the market&#x201d; or continuous equity transaction.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Purchase, Sale and Delivery of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">At-the-Market Sales. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth, the Company agrees to issue and sell through the Agent as sales agent, and the Agent agrees to use its commercially reasonable efforts to sell for and on behalf of the Company, the Shares on the following terms and conditions; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that any obligation of the Agent to use such commercially reasonable efforts shall be subject to the continuing accuracy of the representations and warranties of the Company herein, the performance by the Company of its covenants and obligations hereunder and the continuing satisfaction of the additional conditions specified in Section 4 of this Agreement. The Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in selling Shares, and (ii) the Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Shares as required under this Section 2.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each time that the Company wishes to issue and sell the Shares hereunder (each, a </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Placement&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), it will notify the Agent by email notice (or other method mutually agreed to in writing by the parties) (a </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Placement Notice&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) containing the parameters in accordance with which it desires the Shares to be sold, which shall at a minimum include the number of Shares to be issued, the time period during which sales are requested to be made, any limitation on the number of Shares that may be sold in any one Trading Day (as defined below) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters necessary is attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Placement Notice shall originate from any of the individuals from the Company set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the Agent set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as such </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> may be amended from time to time. The Placement Notice shall be effective upon receipt by the Agent unless and until (i) in accordance with the notice requirements set forth in Section 2(a)(iii) of this Agreement, the Agent declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Shares subject to the Placement Notice or set forth in the Prospectus have been sold, (iii) the Company suspends or terminates the Placement Notice in accordance with the notice requirements set forth in Section 2(a)(iii) below, (iv) the Company issues a subsequent Placement Notice with parameters superseding those on the earlier dated Placement Notice, or (v) this Agreement has been terminated under the provisions of Section 7.  The amount of any commission or other compensation to be paid by the Company to the Agent in connection with the sale of the Shares shall be calculated in accordance with the terms set forth in Section 2(a)(v) below. It is expressly acknowledged and agreed that neither the Company nor the Agent will have any obligation whatsoever with respect to a Placement or any Shares unless and until the Company delivers a Placement Notice to the Agent and the Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein.  In the event of a conflict between the terms of this Agreement and the terms of the Placement Notice, the terms of the Placement Notice will control. For the purposes hereof, </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Trading Day&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> means any day on which the Company&#x2019;s Common Stock is able to be purchased and sold on the principal market on which the Common Stock is listed or quoted.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Shares are to be sold by the Agent on a daily basis or otherwise as shall be agreed to by the Company and the Agent on any day that is a Trading Day. The gross sales price of the Shares sold under this Section 2(a) shall be the market price for the Company&#x2019;s Common Stock sold by the Agent under this Section 2(a) at the time of such sale.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, the Company may instruct the Agent by telephone (confirmed promptly by email) not to sell the Shares if such sales cannot be effected at or above the price designated by the Company in any such instruction. Furthermore, the Company shall not authorize the issuance and sale of, and the Agent shall not be obligated to use its commercially reasonable efforts to sell, any Share at a price lower than the minimum price therefor designated from time to time by the Company&#x2019;s Board of Directors and notified to the Agent in writing. In addition, the Company or the Agent may, upon notice to the other party hereto by telephone (confirmed promptly by email), suspend the offering of the Shares, whereupon the Agent shall so suspend the offering of Shares until further notice is provided to the other party to the contrary; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that such suspension or termination shall not affect or impair the parties&#x2019; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice. Notwithstanding any other provision of this Agreement, during any period in which the Company is in possession of material non-public information, the Company and the Agent agree that (i) no sale of Shares will take place, (ii) the Company shall not request the sale of any Shares, and (iii) the Agent shall not be obligated to sell or offer to sell any Shares. </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to the terms of the Placement Notice, the Agent may sell the Shares by any method permitted by law deemed to be an &#x201c;at the market offering&#x201d; as defined in Rule 415(a)(4) under the Securities Act, including sales made directly on or through an Exchange and/or any other method permitted by law.  Subject to the terms of any Placement Notice, the Agent may also sell Shares in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices and/or any other method permitted by law, subject to the prior written consent of the Company.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The compensation to the Agent for sales of the Shares, as an agent of the Company, shall be 3.0% of the gross sales price of the Shares sold pursuant to this Section 2(a), payable in cash. The remaining proceeds, after further deduction for any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales, and reimbursement of expenses that the Agent may be entitled to pursuant to Section 3(g), shall constitute the net proceeds to the Company for such Shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agent will provide written confirmation to the Company (including by email correspondence to each of the individuals of the Company set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), no later than the opening of the Trading Day immediately following the Trading Day on which it has made sales of Shares hereunder, setting forth the number of Shares sold on such day, the volume-weighted average price of the Shares sold, and the Net Proceeds payable to the Company.  </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Shares sold pursuant to this Section 2(a) will be delivered by the Company to the Agent for the account of the Agent, against payment of the Net Proceeds therefor, by wire transfer of same-day funds payable to the order of the Company at the offices of Piper Sandler &amp; Co.,</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401, or such other location as may be mutually acceptable, at 9:00 a.m. Central Time on the first Trading Day following the date on which such Shares are sold, or at such other time and date as the Agent and the Company determine pursuant to Rule 15c6-1(a) under the Exchange Act, each such time and date of delivery being herein referred to as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Settlement Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d;  If the Agent so elects, delivery of the Shares may be made by credit through full fast transfer to an account or accounts at The Depository Trust Company designated by the Agent. On each Settlement Date, the Agent will deliver the Net Proceeds in same day funds to an account designated by the Company on, or prior to, such Settlement Date.  The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to timely deliver duly authorized Shares on a Settlement Date (other than due to the default of the Agent), the Company agrees that in addition to and in no way limiting the rights and obligations set forth in Section 5 hereto, it will (i) hold the Agent harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company, (ii) reimburse the Agent for any losses incurred by the Agent attributable, directly or indirectly, to such default and (iii) pay to the Agent any commission or other compensation to which the Agent would otherwise have been entitled absent such default.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Maximum Amount</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Under no circumstances shall the aggregate number or aggregate value of the Shares sold pursuant to this Agreement exceed: (i) the aggregate number and aggregate dollar amount of shares of Common Stock available for issuance and sale under the currently effective Registration Statement (including any limit set forth in General Instruction I.B.6 thereof, if applicable), (ii) the aggregate number of authorized but unissued shares of Common Stock that are available for issuance under the Company&#x2019;s certificate of incorporation or certificate of designation or (iii) the aggregate number or aggregate dollar amount of shares of Common Stock for which the Company has filed any Prospectus Supplement in connection with the Shares (the lesser of (i), (ii) and (iii), the </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Maximum Amount</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Association or Partnership</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Nothing herein contained shall constitute the Agent as an unincorporated association or partner with the Company.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Duration.  Under no circumstances shall any Shares be sold pursuant to this Agreement after the date which is three years after the Registration Statement is first declared effective by the Commission.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Market Transactions by Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company acknowledges and agrees that the Agent has informed the Company that the Agent may, to the extent permitted under the Securities Act, the Exchange Act and this Agreement, purchase and sell shares of Common Stock for its own account while this Agreement is in effect, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided, that</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (i) no sale for its own account shall take place while a Placement Notice is in effect (except to the extent the Agent may engage in sales of Shares purchased or deemed purchased from the Company as a &#x201c;riskless principal&#x201d; or in a similar capacity) and (ii) the Company shall not be deemed to have authorized or consented to any such purchases or sales by the Agent.  The Company consents to the Agent trading in the </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock for the account of any of its clients at the same time as sales of the Shares occur pursuant to this Agreement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covenants of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company covenants and agrees with the Agent as follows:</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amendments to Registration Statement and Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.   After the date of this Agreement and during any period in which a Prospectus relating to any Shares is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company agrees that it will: (i) notify the Agent promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference or amendments not related to the Shares, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus related to the Shares has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement (insofar as it relates to the transactions contemplated hereby) or Prospectus or for additional information; (ii) prepare and file with the Commission, promptly upon the Agent&#x2019;s reasonable request, any amendments or supplements to the Registration Statement or Prospectus that, in the Agent&#x2019;s reasonable opinion, may be necessary or advisable in connection with the sale of the Shares by the Agent (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided, however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the failure of the Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#x2019;s right to rely on the representations and warranties made by the Company in this Agreement); (iii) not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference, relating to the Shares or a security convertible into the Shares unless a copy thereof has been submitted to the Agent within a reasonable period of time before the filing and the Agent has not reasonably objected thereto (</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided, however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that (A) the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#x2019;s right to rely on the representations and warranties made by the Company in this Agreement), (B) the Company has no obligation to provide the Agent any advance copy of such filing or to provide the Agent an opportunity to object to such filing if the filing does not name the Agent or does not relate to a Placement or other transaction contemplated hereunder, and (C) the only remedy that the Agent shall have with respect to the failure by the Company to provide the Agent with such copy or the filing of such amendment or supplement despite the Agent&#x2019;s objection shall be to cease making sales under this Agreement; (iv) furnish to the Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (v) cause each amendment or supplement to the Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stop Order</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose, and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Continuing Amendments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  During any period in which a Prospectus relating to the Shares is required to be delivered by the Agent under the Securities Act with respect to any Placement or pending sale of the Shares, (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports (taking into account any extensions available under the Exchange Act) and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If during such period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Agent to suspend the offering of Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Qualification of the Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company shall take or cause to be taken all necessary action to qualify the Shares for sale under the securities laws of such jurisdictions as the Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Shares, except that the Company shall not be required in connection therewith to qualify as a foreign corporation or to execute a general consent to service of process in any state.  The Company shall promptly advise the Agent of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares for offer or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Copies of Registration Statement and Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will furnish to the Agent and counsel for the Agent copies of the Registration Statement (which will include three complete manually signed copies of the Registration Statement and all consents and exhibits filed therewith), the Prospectus and all amendments and supplements to such documents, in each case as soon as available and in such quantities as the Agent may from time to time reasonably request; provided, however, that the Company shall not be required to furnish any document to the extent such document is available on EDGAR.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Section 11(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will make generally available to its security holders as soon as practicable an earnings statement (which need not be audited) covering a 12&#x2011;month period that shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 promulgated thereunder.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay or cause to be paid (i) all expenses (including stock or transfer taxes and stamp or similar duties allocated to the respective transferees) incurred in connection with the registration, issue, sale and delivery of the Shares, (ii) all expenses and fees (including, without limitation, fees and expenses of the Company&#x2019;s accountants and counsel) in connection with the preparation, printing, filing, delivery, and shipping of the Registration Statement (including the financial statements therein and all amendments, schedules, and exhibits thereto), the Shares, the Prospectus and any amendment </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">thereof or supplement thereto, and the producing, word-processing, printing, delivery, and shipping of this Agreement and other underwriting documents or closing documents, including Blue Sky Memoranda (covering the states and other applicable jurisdictions) and including the cost to furnish copies of each thereof to the Agent, (iii) all filing fees, (iv) all reasonable and documented fees and disbursements of the Agent&#x2019;s counsel incurred in connection with the qualification of the Shares for offering and sale by the Agent or by dealers under the securities or blue sky laws of the states and other jurisdictions which the Agent shall designate, (v) the fees and expenses of any transfer agent or registrar, (vi) the filing fees and reasonable and documented fees and disbursements of the Agent&#x2019;s counsel (such counsel fees not to exceed $15,000) incident to any required review and approval by FINRA of the terms of the sale of the Shares, (vii) listing fees, if any, (viii) the cost and expenses of the Company relating to investor presentations or any &#x201c;roadshow&#x201d; undertaken in connection with marketing of the Shares, and (ix) all other costs and expenses incident to the performance of its obligations hereunder that are not otherwise specifically provided for herein.  In addition to (iv) and (vi) above, the Company shall reimburse the Agent for its reasonable and documented out-of-pocket expenses, including reasonable fees and disbursements of the Agent&#x2019;s counsel (A) in connection with this Agreement, the Registration Statement and the Prospectus in an amount not to exceed $100,000, (B) $25,000 in connection with each Representation Date (as defined below) involving the filing of a Form 10-K on which the Company is required to provide a certificate pursuant to Section 3(q) and a waiver does not apply and (C) $15,000 in connection with each other Representation Date on which the Company is required to provide a certificate pursuant to Section 3(q) and a waiver does not apply.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will apply the net proceeds from the sale of the Shares in the manner described in the Prospectus.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restrictions on Future Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. During the period beginning on the date a Placement Notice is delivered to the Agent by the Company and ending on the Settlement Date of the Shares to be sold pursuant to such Placement Notice or the earlier termination or suspension of such Placement Notice (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Company will not, offer for sale, sell, contract to sell, pledge, grant any option for the sale of, enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition of Common Stock (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company or any affiliate, or otherwise issue or dispose of, directly or indirectly (or publicly disclose the intention to make any such offer, sale, pledge, grant, issuance or other disposition), any Common Stock or any securities convertible into or exchangeable for, or any options or rights to purchase or acquire, Common Stock, or permit the registration under the Securities Act of any Common Stock, such securities, options or rights, and will not directly or indirectly enter into any other &#x201c;at the market&#x201d; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Shares (other than the Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Shares, warrants or any rights to purchase or acquire, Common Shares prior to the termination of this Agreement, except for: (i) the registration of the Shares and the sales through the Agent pursuant to this Agreement or the filing or registration of shares of Common Stock on a Form S-8, (ii) issuances or sales of shares through any dividend reinvestment and stock purchase plan of the Company, (iii) issuances, grants or sales of shares of restricted stock, restricted stock units, options or other equity awards granted pursuant to incentive or employee benefit or similar plans existing as of the date hereof, as such plans may be amended, or any successor plans thereto, and the Common Stock </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issuable upon the exercise of such options or vesting of such restricted stock units, (iv) issuances, grants or sales of shares of restricted stock, restricted stock units, options or other equity awards made pursuant to Nasdaq Listing Rule 5635(c)(4), (v) the issuance of shares pursuant to the exercise of warrants or the conversion of convertible securities, (vi) issuances or sales of Common Stock or any securities convertible into, or exercisable or exchangeable for, Common Stock, or the entrance into an agreement to issue Common Stock or any securities convertible into, or exercisable or exchangeable for, Common Stock, in connection with any merger, joint venture, strategic alliances, commercial or other collaborative transaction or the acquisition or license of the business, property, technology or other assets of another individual or entity or the assumption of an employee benefit plan in connection with a merger or acquisition; provided that the aggregate number of shares of Common Stock or any securities convertible into, or exercisable or exchangeable for, Common Stock that the Company may issue or agree to issue pursuant to this clause (vi) shall not exceed 10% of the total outstanding share capital of the Company immediately following the issuance of the Shares, or (vii) facilitating the establishment of a trading plan on behalf of a stockholder, officer or director of the Company pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Common Stock; provided that (A) such plan does not provide for the transfer of Common Stock during the Restricted Period and (B) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period; in the case of each of (ii), (iii), (iv), (v) and (vi), without giving the Agent at least three business days&#x2019; prior written notice specifying the nature of the proposed sale and the date of such proposed sale, so as to permit the Agent to suspend activity under this Agreement for such period of time as requested by the Company.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(j)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Stabilization or Manipulation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company has not taken and will not take, directly or indirectly, any action designed to, or which might reasonably be expected to cause or result in, or which constitutes: (i) the stabilization or manipulation of the price of the Common Stock or any other security of the Company to facilitate the sale or resale of the Shares, (ii) a violation of Regulation M.  The Company shall notify the Agent of any violation of Regulation M by the Company or any of its subsidiaries or any of their respective officers or directors promptly after the Company has received notice or obtained knowledge of any such violation.  The Company shall not invest in futures contracts, options on futures contracts or options on commodities, unless the Company is exempt from the registration requirements of the Commodity Exchange Act, as amended (the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Commodity Act&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), or otherwise complies with the Commodity Act. The Company will not engage in any activities bearing on the Commodity Act, unless such activities are exempt from the Commodity Act or otherwise comply with the Commodity Act.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(k)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Other Broker</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Except as contemplated by this Agreement, the Company will not incur any liability for any finder&#x2019;s or broker&#x2019;s fee or agent&#x2019;s commission in connection with the execution and delivery of this Agreement, or the consummation of the transactions contemplated hereby.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(l)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Timely Securities Act and Exchange Act Reports</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  During any prospectus delivery period with respect to the Shares, the Company will use its commercially reasonable efforts to file on a timely basis with the Commission such periodic and special reports as required by the Securities Act and the Exchange Act.  </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(m)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Controls. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiaries will use reasonable best efforts to maintain such controls and other procedures, including without limitation, those required by Sections 302 and 906 of the Sarbanes-Oxley Act and the applicable regulations thereunder, that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#x2019;s rules and forms, including without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#x2019;s management, including its principal executive officer and its principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure, to ensure that material information relating to Company, including its subsidiaries, is made known to them by others within those entities.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(n)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Permitted Free Writing Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company represents and agrees that, unless it obtains the prior written consent of the Agent, and the Agent severally represents and agrees that, unless it obtains the prior written consent of the Company, it has not made and will not make any offer relating to the Shares that would constitute an &#x201c;issuer free writing prospectus,&#x201d; as defined in Rule 433 under the Securities Act, or that would otherwise constitute a &#x201c;free writing prospectus,&#x201d; as defined in Rule 405 under the Securities Act, required to be filed with the Commission.  Any such free writing prospectus consented to by the Company and the Agent is hereinafter referred to as a </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Permitted Free Writing Prospectus.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  The Company represents that it has treated or agrees that it will treat each Permitted Free Writing Prospectus as an &#x201c;issuer free writing prospectus,&#x201d; as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely Commission filing where required, legending and record keeping.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(o)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representation Date and Opinions of Counsel</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Prior to the date of the first Placement Notice, and thereafter during the term of this Agreement, each time the Company (A) files an amendment to the Registration Statement or Prospectus (other than relating solely to the offering of securities other than the Shares), (B)  files an annual report on Form 10-K under the Exchange Act or files its quarterly reports on Form 10-Q under the Exchange Act; and (C) files a report on Form 8-K containing amended financial statements (other than an earnings release) under the Exchange Act, (each of the dates in (A), (B) and (C) are referred to herein as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representation Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Company shall cause:</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Paul Hastings LLP, counsel for the Company, to furnish to the Agent the opinion and negative assurance letter of such counsel, dated as of such date and addressed to the Agent, in form and substance reasonably satisfactory to the Agent; provided however, only a negative assurance letter of such counsel shall be required for each subsequent Representation Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">McNeill PLLC, intellectual property and patent counsel for the Company, or other counsel reasonably satisfactory to the Agent, to furnish to the Agent the opinion of such counsel, dated as of such date and addressed to the Agent, in form and substance reasonably satisfactory to the Agent; provided however, the opinion of such counsel shall only be required for the first Settlement Date.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Paul Hastings LLP, regulatory counsel for the Company, to furnish to the Agent the opinion of such counsel, dated as of such date and addressed to the Agent, in form and substance reasonably satisfactory to the Agent, which may be included in the opinion furnished pursuant to Section 3(o)(i). </font></div></div><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, the requirement to provide counsel opinions under this Section 3(o) shall be waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the date the Company delivers a Placement Notice to the Agent.  Notwithstanding the foregoing, if the Company subsequently decides to sell Shares following a Representation Date when the Company relied on such waiver and did not provide the Agent with opinions under this Section 3(o), then before the Agent sells any Shares pursuant to Section 2(a), the Company shall cause the opinions (including the opinion pursuant to Section 3(o) if not delivered on the date of the prior Form 10-K), comfort letter, certificates and documents that would be delivered on a Representation Date to be delivered.</font></h2><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(p)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representation Date and</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comfort Letter</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Prior to the date of the first Placement Notice and thereafter during the term of this Agreement, on each Representation Date to which a waiver does not apply, the Company shall cause BDO USA, P.C., or other independent accountants reasonably satisfactory to the Agent (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accountants</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), to deliver to the Agent a letter, dated as of such date and addressed to the Agent, confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating to the qualifications of accountants under Rule 2&#x2011;01 of Regulation S&#x2011;X of the Commission, and stating the conclusions and findings of said firm with respect to the financial information and other matters covered by its letter in form and substance reasonably satisfactory to the Agent of the same tenor as the first such letter received hereunder.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(q)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representation Date and Representation Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Prior to the date of the first Placement Notice and thereafter during the term of this Agreement, on each Representation Date to which a waiver does not apply, the Company shall furnish to the Agent a certificate (the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Representation Certificate&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), substantially in the form of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereto and dated as of such date, addressed to the Agent and signed by the Company&#x2019;s chief executive officer or chief financial officer.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(r)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disclosure of Shares Sold</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company shall disclose in its quarterly reports on Form 10-Q and in its annual report on Form 10-K the number of the Shares sold through the Agent under this Agreement, the net proceeds to the Company and the compensation paid by the Company with respect to sales of the Shares pursuant to this Agreement during the relevant quarter.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(s)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Continued Listing of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company shall use its commercially reasonable efforts to maintain the listing of the Common Stock on the Exchange.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(t)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Notice of Changes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. At any time during the term of this Agreement, as supplemented from time to time, the Company shall advise the Agent as soon as practicable after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect any opinion, certificate, letter and other document provided to the Agent pursuant to this Section 3.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(u)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Maximum Amount</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will not instruct the Agent to sell or otherwise attempt to sell Shares pursuant to this Agreement in excess of the Maximum Amount.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CFO Certificate. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If necessary and reasonably requested by the Agent during the term of this Agreement, on each Representation Date to which a waiver does not apply, the Company shall furnish to the Agent a certificate, dated the date of such Representation Date and addressed to the Agent, of its chief financial officer with respect to certain financial data contained in the Prospectus, providing &#x201c;management comfort&#x201d; with respect to such information, in form and substance reasonably satisfactory to the Agent.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Conditions of Agent&#x2019;s Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The obligations of the Agent hereunder are subject to (i) the accuracy, as of the date of this Agreement, each Representation Date, each Notice Date, each Applicable Time, and each Settlement Date (in each case, as if made at such date) of and compliance with all representations, warranties and agreements of the Company contained herein, (ii) the performance by the Company of its obligations hereunder and (iii) the following additional conditions:</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Continuing Amendments; No Stop Order</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If filing of the Prospectus, or any amendment or supplement thereto, or any Permitted Free Writing Prospectus, is required under the Securities Act, the Company shall have filed the Prospectus (or such amendment or supplement) or such Permitted Free Writing Prospectus with the Commission in the manner and within the time period so required (without reliance on Rule 424(b)(8) or Rule 164(b) under the Securities Act); the Registration Statement shall be effective; no stop order suspending the effectiveness of the Registration Statement or any part thereof, any registration statement filed pursuant to Rule 462(b) under the Securities Act, or any amendment thereof, nor suspending or preventing the use of the Prospectus shall have been issued; no proceedings for the issuance of such an order shall have been initiated or, to the knowledge of the Company, threatened; and any request of the Commission for additional information (to be included in the Registration Statement, the Prospectus or otherwise) shall have been complied with to the Agent&#x2019;s reasonable satisfaction. </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Absence of Certain Events</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. None of the following events shall have occurred and be continuing: (i) receipt by the Company or any of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not contain any untrue statement of a </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Material Misstatement or Omission</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Agent shall not have advised the Company that the Registration Statement or any Prospectus contains an untrue statement of fact which, in the Agent&#x2019;s reasonable opinion, is material, or omits to state a fact which, in the Agent&#x2019;s reasonable opinion, is material and is required to be stated therein or necessary to make the statements therein, in the light of the circumstances in which they were made (solely with respect to the Prospectus), not misleading.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Adverse Changes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Except as contemplated in the Prospectus, subsequent to the respective dates as of which information is given in the Prospectus, neither the Company nor any of its subsidiaries shall have incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions, or declared or paid any dividends or made any distribution of any kind with respect to its capital stock; and there shall not have been any material change in the capital stock (other than a change in the number of outstanding shares of Common Stock due to the issuance of shares of Common Stock upon the exercise or vesting of outstanding options or other equity awards or warrants), or any material change in the short&#x2011;term or long&#x2011;term debt of the Company, or any issuance of options, warrants, convertible securities or other rights to purchase the capital stock of the Company or any of its subsidiaries, or any development involving a prospective Material Adverse Effect (whether or not arising in the ordinary course of business), or any material loss by strike, fire, flood, earthquake, accident or other calamity, whether or not covered by insurance, incurred by the Company or any of its subsidiaries, the effect of which, in any such case described above, in the Agent&#x2019;s judgment, makes it impractical or inadvisable to offer or deliver the Shares on the terms and in the manner contemplated in the Prospectus.    </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compliance with Certain Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company shall have performed each of its obligations under Section 3(o) &#x2013; 3(q) and Section 3(v).</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Opinion of Agent Counsel.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  On each Representation Date to which a waiver does not apply, there shall have been furnished to the Agent the opinion and negative assurance letter of Cooley LLP, counsel for the Agent, dated as of such Representation Date and addressed to the Agent, in a form reasonably satisfactory to the Agent, and such counsel shall have received such papers and information as they reasonably request to enable them to pass upon such matters; provided however, the opinion of Cooley LLP shall only be required prior to the first Placement Notice, and thereafter, only a negative assurance letter of such counsel shall be required for each subsequent Representation Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representation Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  On or prior to the first Placement Notice, the Agent shall have received the Representation Certificate in form and substance reasonably satisfactory to the Agent and its counsel.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Objection by FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements contained herein. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Timely Filing of Prospectus and Prospectus Supplement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  All filings with the Commission required by Rule 424 under the Securities Act to have been filed by the Settlement Date, as the case may be, shall have been made within the applicable time period prescribed for such filing by Rule 424 under the Securities Act.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(j)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Documents and Certificates.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall have furnished to the Agent and the Agent&#x2019;s counsel such additional documents, certificates and evidence as they may have reasonably requested.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		All opinions, certificates, letters and other documents described in this Section 4 will be in compliance with the provisions hereof only if they are reasonably satisfactory in form and substance to the Agent and the Agent&#x2019;s counsel.  The Company will furnish the Agent with such conformed copies of such opinions, certificates, letters and other documents as the Agent shall reasonably request.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnification and Contribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company agrees to indemnify and hold harmless the Agent, its affiliates, directors, officers and employees, and each person, if any, who controls the Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any losses, claims, damages or liabilities, joint or several, to which the Agent may become subject, under the Securities Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Company, which consent shall not be unreasonably withheld), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon, in whole or in part:</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, including the Rule 430B Information (as defined below) and at any subsequent time pursuant to Rules 430A and 430B promulgated under the Securities Act, and any other information deemed to be part of the Registration Statement at the time of effectiveness, and at any subsequent time pursuant to the Securities Act or the Exchange Act, and the Prospectus, or any amendment or supplement thereto (including any documents filed under the Exchange Act and deemed to be incorporated by reference into the Prospectus), any Permitted Free Writing Prospectus, or any roadshow as defined in Rule 433(h) under the Securities Act (a </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;road show&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), or an omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made (solely with respect to the Prospectus), not misleading, </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any inaccuracy in the representations and warranties of the Company contained herein;</font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any investigation or proceeding by any governmental authority, commenced or threatened with respect to the Company (whether or not the Agent is a target of or party to such investigation or proceeding); </font></div></div><div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any failure of the Company to perform its respective obligations hereunder or under the law;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and will periodically reimburse the Agent for any legal or other documented expenses reasonably incurred by it in connection with investigating or defending against such loss, claim, damage, liability or action; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided, however,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that the Company shall not be liable in any such case of (i) through (iv) to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Prospectus, or any such amendment or supplement, in reliance upon and in conformity with written information furnished to the Company by the Agent specifically for use in the preparation thereof.  &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 430B Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; as used herein, means information with respect to the Shares and the offering thereof permitted to be omitted from the Registration Statement when it becomes effective pursuant to Rule 430B under the Securities Act.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to its other obligations under this Section 5(a), the Company agrees that, as an interim measure during the pendency of any claim, action, investigation, inquiry or other proceeding arising out of or based upon any statement or omission, or any alleged statement or omission, described in this Section 5(a), it will reimburse the Agent on a monthly basis for all reasonable and documented legal fees or other expenses incurred in connection with investigating or defending any such claim, action, investigation, inquiry or other proceeding, notwithstanding the absence of a judicial determination as to the propriety and enforceability of the Company&#x2019;s obligation to reimburse the Agent for such expenses and the possibility that such payments might later be held to have been improper by a court of competent jurisdiction.  Any such interim reimbursement payments which are not made to the Agent within 30 days of a request for reimbursement shall bear interest at the WSJ Prime Rate (as published from time to time by the Wall Street Journal).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agent&#x2019;s Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Agent will indemnify and hold harmless the Company, its directors, its officers who sign the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any losses, claims, damages or liabilities to which the Company or any such director, officer or controlling person may become subject, under the Securities Act or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of the Agent), but only insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus, any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in conformity with written information furnished to the Company by the Agent specifically for use in the preparation thereof, it being understood and agreed that the only information furnished by the Agent for use in the Registration Statement or the Prospectus consists of the statements set forth in the seventh paragraph under the caption &#x201c;Plan of Distribution&#x201d; in the Prospectus, and will reimburse the Company and each such director, officer or controlling person for any legal or other expenses reasonably incurred by the Company or such director, officer or controlling person in connection with investigating or defending against any such loss, claim, damage, liability or action.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Notice and Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party except to the extent such indemnifying party has been materially prejudiced by such failure.  In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of the indemnifying party&#x2019;s election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable and documented costs of investigation; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if, in the sole judgment of the Agent, it is advisable for the Agent to be represented by separate counsel, the Agent shall have the right to employ a single counsel to represent the Agent, in which event the reasonable and documented fees and expenses of such separate counsel shall be borne by the indemnifying party or parties and reimbursed to the Agent as incurred (in accordance with the provisions of the second paragraph in subsection (a) above).</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		The indemnifying party under this Section 5 shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or judgment.  Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable and documented fees and expenses of counsel as contemplated by this Section 5, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into, and (iii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement.  No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent (a) includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such action, suit or proceeding and (b) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contribution; Limitations on Liability; Non-Exclusive Remedy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the indemnification provided for in this Section 5 is unavailable or insufficient to hold harmless an indemnified party under subsection (a) or (b) above, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a) or (b) above, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other from the offering of the Shares, or (ii) if the allocation provided by clause (i) above is not permitted </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company on the one hand and the Agent on the other in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.  The relative benefits received by the Company on the one hand and the Agent on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total commissions received by the Agent (before deducting expenses) from the sale of the Shares.  The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission.  The Company and the Agent agree that it would not be just and equitable if contributions pursuant to this subsection (d) were to be determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in this subsection (d).  The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities referred to in this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending against any action or claim which is the subject of this subsection (d).  Notwithstanding the provisions of this subsection (d), the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement.  No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Representations and Agreements to Survive Delivery</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  All representations, warranties, and agreements of the Company herein or in certificates delivered pursuant hereto, including but not limited to the agreements of the Agent and the Company contained in Section 5 hereof, shall remain operative and in full force and effect as of their respective dates regardless of any investigation made by or on behalf of the Agent or any controlling person thereof, or the Company or any of its officers, directors, or controlling persons, and shall survive delivery of, and payment for, the Shares to and by the Agent hereunder.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Termination of this Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall have the right, by giving five (5) days&#x2019; written notice as hereinafter specified, to terminate the provisions of this Agreement relating to the solicitation of offers to purchase the Shares in its sole discretion at any time. Any such termination shall be without liability of any party to any other party except that (i) with respect to any pending sale, through the Agent for the Company, the obligations of the Company, including in respect of compensation of the Agent, shall remain in full force and effect notwithstanding the termination and (ii) the provisions of Section 3(g), Section 5 and Section 6 of this Agreement shall remain in full force and effect notwithstanding such termination. </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agent shall have the right, by giving written notice as hereinafter specified, to terminate the provisions of this Agreement relating to the solicitation of offers to purchase the Shares in its sole discretion at any time. Any such termination shall be without </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">liability of any party to any other party except that the provisions of Section 3(g), Section 5 and Section 6 of this Agreement shall remain in full force and effect notwithstanding such termination.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless earlier terminated pursuant to this Section 7, this Agreement shall automatically terminate upon the earlier to occur of the issuance and sale of all of the Shares through the Agent on the terms and subject to the conditions set forth herein, except that the provisions of Section 3(g), Section 5 and Section 6 of this Agreement shall remain in full force and effect notwithstanding such termination.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Agreement shall remain in full force and effect unless terminated pursuant to Sections 7(a), (b) or (c) above or otherwise by mutual agreement of the parties; provided that any such termination by mutual agreement shall in all cases be deemed to provide that Section 3(g), Section 5 and Section 6 shall remain in full force and effect. </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any termination of this Agreement shall be effective on the date specified in such notice of termination; provided that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of the Shares, such sale shall settle in accordance with the provisions of Section 2(a)(vii) of this Agreement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Default by the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the Company shall fail at any Settlement Date to sell and deliver the number of Shares which it is obligated to sell hereunder, then this Agreement shall terminate without any liability on the part of the Agent or, except as provided in Section 3(g) hereof, any non&#x2011;defaulting party.  No action taken pursuant to this Section shall relieve the Company from liability, if any, in respect of such default, and the Company shall (A) hold the Agent harmless against any loss, claim or damage arising from or as a result of such default by the Company and (B) pay the Agent any commission to which it would otherwise be entitled absent such default.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">9.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Notices.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Except as otherwise provided herein, all communications under this Agreement shall be in writing and, if to the Agent, shall be delivered via overnight delivery services to (i) Piper Sandler &amp; Co.,</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401, Attention: Equity Capital Markets, with a copy to Piper Sandler General Counsel at</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401 and LegalCapMarkets@psc.com, with a copy to Cooley LLP, 55 Hudson Yards, New York, NY 10001, Attention: Daniel Goldberg, email: Dgoldberg@cooley.com; (ii) the Company at Aardvark Therapeutics, Inc., 4370 La Jolla Village Dr, Suite 1050, San Diego, CA 92122, Attention: Chief Executive Officer, with a copy to Paul Hastings, LLP, 1117 South California Avenue, Palo Alto, CA 94304, Attention: Jeff Hartlin, email: jeffhartlin@paulhastings.com, and Samantha Eldredge, email: samanthaeldredge@paulhastings.com; or in each case to such other address as the person to be notified may have requested in writing.  Any party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">10.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Persons Entitled to Benefit of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns and the controlling persons, officers and directors referred to in Section 5.  Nothing in this Agreement </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy or claim under or in respect of this Agreement or any provision herein contained.  The term &#x201c;successors and assigns&#x201d; as herein used shall not include any purchaser, as such purchaser, of any of the Shares from the Agent.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">11.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Absence of Fiduciary Relationship</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company, having been advised by counsel, acknowledges and agrees that: (a) the Agent has been retained solely to act as a sales agent in connection with the sale of the Shares and that no fiduciary, advisory or agency relationship between the Company (including any of the Company&#x2019;s affiliates (including directors), equity holders, creditors, employees or agents, hereafter, </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Company Representatives&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), on the one hand, and the Agent on the other, has been created or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Agent has advised or is advising the Company on other matters and irrespective of the use of the defined term &#x201c;Agent;&#x201d; (b) neither the Agent nor any of its affiliates (including directors), equity holders, creditors, employees or agents (hereafter, </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#x201c;Agent Representatives&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) shall have any duty or obligation to the Company or any Company Representative except as set forth in this Agreement; (c) the price and other terms of any Placement executed pursuant to this Agreement, as well as the terms of this Agreement, are deemed acceptable to the Company and its counsel, following discussions and arms-length negotiations with the Agent; (d) the Company is capable of evaluating and understanding, and in fact has evaluated, understands and accepts the terms, risks and conditions of any Placement Notice to be executed pursuant to this Agreement, and any other transactions contemplated by this Agreement; (e) the Company has been advised that the Agent and the Agent Representatives are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that the Agent and the Agent Representatives have no obligation to disclose any such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship, or otherwise; (f) the Company has been advised that the Agent is acting, in respect of any Placement and the transactions contemplated by this Agreement, solely for the benefit of the Agent, and not on behalf of the Company; and (g) the Company and the Company Representatives waive, to the fullest extent permitted by law, any claims that they may have against the Agent or any of the Agent Representatives for breach of fiduciary duty or alleged breach of fiduciary duty in respect of any Placement or any of the transactions contemplated by this Agreement and agree that the Agent and the Agent Representatives shall have no liability (whether direct or indirect, in contract, tort or otherwise) to the Company or any of the Company Representatives in respect of any person asserting any claim of breach of any fiduciary duty on behalf of or in right of the Company or any of the Company Representatives.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">12.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recognition of the U.S. Special Resolution Regimes</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that the Agent is a Covered Entity that becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from the Agent of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that the Agent that is a Covered Entity or a BHC Act Affiliate of the Agent becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As used in this section:</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BHC Act Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning assigned to the term &#x201c;affiliate&#x201d; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k);</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covered Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any of the following: (i) a &#x201c;covered entity&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#x201c;covered bank&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii) a &#x201c;covered FSI&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b);</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Default Right</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Special Resolution Regime</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">13.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Governing Law and Waiver of Jury Trial</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement and any transaction contemplated by this Agreement and any claim, controversy or dispute arising under or related thereto shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflict of laws that would results in the application of any other law than the laws of the State of New York.  EACH OF </font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company AND THE AGENT (on its own behalf and on behalf of ITS RESPECTIVE STOCKHOLDERS AND affiliates) hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">14.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Submission to Jurisdiction, Etc.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Each party hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts sitting in the Borough of Manhattan, City of New York, in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.  The parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any lawsuit, action or other proceeding in such courts, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such lawsuit, action or other proceeding brought in any such court has been brought in an inconvenient forum.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">15.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile or electronic mail (including, without limitation, </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;pdf,&#x201d; &#x201c;tif,&#x201d; or &#x201c;jpg&#x201d;) and any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com, and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">16.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Construction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The section and exhibit headings herein are for convenience only and shall not affect the construction hereof. References herein to any law, statute, ordinance, code, regulation, rule or other requirement of any governmental authority shall be deemed to refer to such law, statute, ordinance, code, regulation, rule or other requirement of any governmental authority as amended, reenacted, supplemented or superseded in whole or in part and in effect from time to time and also to all rules and regulations promulgated thereunder. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.  This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit.  </font></div></div><h1 style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></font>&#160;</h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Signature Pages Follow]</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		Please sign and return to the Company the enclosed duplicates of this letter whereupon this letter will become a binding agreement between the Company and the Agent in accordance with its terms.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Very truly yours,</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AARDVARK THERAPEUTICS, INC.</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Tien-Li Lee, M.D.				</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	Name: Tien-Li Lee, M.D.</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	Title: Chief Executive Officer</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Confirmed as of the date first</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">above mentioned.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PIPER SANDLER &amp; CO.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Connor Leahey				</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	Name: Connor Leahey</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	Title: Director</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE 1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM OF PLACEMENT NOTICE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Facsimile and No Voicemail</font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:14.2%;box-sizing:content-box;"></td>
     <td style="width:85.8%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:28.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">From:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p></td>
    </tr>
    <tr style="height:169.2pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">To:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">                                      </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Piper Sandler &amp; Co.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Attention:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Neil A. Riley</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Connor Leahey</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Connor N. Anderson</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:42.5pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subject:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[&#x25cf;], 2026</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity Distribution Agreement &#x2013; Placement Notice</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gentlemen:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between Aardvark Therapeutics, Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and Piper Sandler &amp; Co. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) dated 23, 2026 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Company hereby requests that Agent sell [up to [&#x25cf;] shares of the Company&#x2019;s common stock, par value $0.00001 per share, at a minimum market price of $[&#x25cf;] per share.  Sales should begin on the date of this Placement Notice and shall continue until [&#x25cf;]] /[all shares are sold].</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE 2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICE PARTIES</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tien-Li Lee, M.D.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nelson Sun</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Piper Sandler &amp; Co.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neil A. Riley</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leahey, Connor</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Connor N. Anderson</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[***]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SCHEDULE 3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM OF REPRESENTATION CERTIFICATE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO SECTION 3(q) OF THE AGREEMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Attached</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">]</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ck0001774857-ex4_2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-03-23T16:54:03.1501+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-4.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.2</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:5.05pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDENTURE</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dated as of [            ]</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[            ]</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:14pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trustee</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:5.05pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:0.493%;font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS</font></p><p style="font-size:10pt;margin-top:1.15pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page</font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:13.68%;box-sizing:content-box;"></td>
     <td style="width:83.66%;box-sizing:content-box;"></td>
     <td style="width:2.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE I.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;DEFINITIONS AND INCORPORATION BY REFERENCE</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 1.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Definitions</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 1.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Definitions</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 1.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Incorporation by Reference of Trust Indenture Act</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 1.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rules of Construction</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE II.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;THE SECURITIES</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuable in Series.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Establishment of Terms of Series of Securities.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Execution and Authentication</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registrar and Paying Agent</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paying Agent to Hold Money in Trust</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securityholder Lists</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.7</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transfer and Exchange</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.8</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mutilated, Destroyed, Lost and Stolen Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.9</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.10</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Treasury Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.11</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Temporary Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.12</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancellation</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.13</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Defaulted Interest</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.14</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Global Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 2.15</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CUSIP Numbers</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE III.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;REDEMPTION</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 3.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notice to Trustee</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 3.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selection of Securities to be Redeemed</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 3.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notice of Redemption</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 3.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effect of Notice of Redemption</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 3.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deposit of Redemption Price</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 3.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities Redeemed in Part</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE IV.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;COVENANTS</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 4.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of Principal and Interest</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 4.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SEC Reports</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 4.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compliance Certificate.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 4.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stay, Extension and Usury Laws</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 4.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate Existence</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE V.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;SUCCESSORS</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 5.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">When Company May Merge, Etc</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 5.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Successor Corporation Substituted</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE VI.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;DEFAULTS AND REMEDIES</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Events of Default</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acceleration of Maturity; Rescission and Annulment</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collection of Indebtedness and Suits for Enforcement by Trustee</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trustee May File Proofs of Claim</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trustee May Enforce Claims Without Possession of Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Application of Money Collected</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.7</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Limitation on Suits</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.8</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unconditional Right of Holders to Receive Principal and Interest</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.9</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restoration of Rights and Remedies</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.10</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rights and Remedies Cumulative</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.11</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delay or Omission Not Waiver</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.12</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Control by Holders</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.13</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Waiver of Past Defaults</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 6.14</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Undertaking for Costs</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="margin-left:0.493%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:center;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS<br>(continued)</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:13.68%;box-sizing:content-box;"></td>
     <td style="width:83.66%;box-sizing:content-box;"></td>
     <td style="width:2.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE VII.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Duties of Trustee</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rights of Trustee</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Individual Rights of Trustee</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trustee&#x2019;s Disclaimer</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notice of Defaults</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reports by Trustee to Holders</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.7</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation and Indemnity</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.8</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Replacement of Trustee</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.9</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Successor Trustee by Merger, etc</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.10</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Eligibility; Disqualification</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 7.11</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferential Collection of Claims Against Company</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE VIII.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;SATISFACTION AND DISCHARGE; DEFEASANCE</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 8.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Satisfaction and Discharge of Indenture</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 8.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Application of Trust Funds; Indemnification</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 8.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal Defeasance of Securities of any Series</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 8.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Covenant Defeasance</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 8.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repayment to Company</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 8.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reinstatement</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE IX.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;AMENDMENTS AND WAIVERS</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Without Consent of Holders</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">With Consent of Holders</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Limitations</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compliance with Trust Indenture Act</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revocation and Effect of Consents</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notation on or Exchange of Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 9.7</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trustee Protected</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE X.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;MISCELLANEOUS</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trust Indenture Act Controls</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notices</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Communication by Holders with Other Holders</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.4</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate and Opinion as to Conditions Precedent</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.5</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statements Required in Certificate or Opinion</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.6</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rules by Trustee and Agents</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.7</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal Holidays</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.8</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No Recourse Against Others</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.9</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Counterparts</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.10</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Governing Laws</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.11</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No Adverse Interpretation of Other Agreements</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.12</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Successors</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.13</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Severability</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.14</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Table of Contents, Headings, Etc</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.15</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities in a Foreign Currency or in Euros</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.16</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Judgment Currency</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.17</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Force Majeure</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 10.18</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.A. Patriot Act</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ARTICLE XI.</font><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;SINKING FUNDS</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 11.1</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Applicability of Article</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 11.2</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Satisfaction of Sinking Fund Payments with Securities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</font></p></td>
    </tr>
    <tr style="height:0.7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10.1pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="margin-left:1.867%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Section 11.3</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Redemption of Securities for Sinking Fund</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ii</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section3"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reconciliation and tie between Trust Indenture Act of 1939 and</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indenture, dated as of [            ]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:10.12%;box-sizing:content-box;"></td>
     <td style="width:2.78%;box-sizing:content-box;"></td>
     <td style="width:67.6%;box-sizing:content-box;"></td>
     <td style="width:2.5%;box-sizing:content-box;"></td>
     <td style="width:17%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 310(a)(1)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.10</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(2)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.10</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(3)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(4)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(5)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.10</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.10</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 311(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.11</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.11</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 312(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 313(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.6</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)(1)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.6</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(2)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.6</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)(1)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.6</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(d)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.6</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 314(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)(1)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)(2)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)(3)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(d)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(e)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(f)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Not Applicable</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 315(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(c)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(d)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(e)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.14</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 316(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.10</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(1)(A)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.12</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(1)(B)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.13</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 317(a)(1)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(a)(2)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.4</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(b)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#167; 318(a)</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note: This reconciliation and tie shall not, for any purpose, be deemed to be part of the Indenture.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iii</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indenture dated as of [            ] between Aardvark Therapeutics, Inc., a Delaware corporation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and [            ] (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p><p style="text-indent:9.173%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders of the Securities issued under this Indenture.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE I.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>DEFINITIONS AND INCORPORATION BY REFERENCE</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Amounts</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any additional amounts which are required hereby or by any Security, under circumstances specified herein or therein, to be paid by the Company in respect of certain taxes imposed on Holders specified herein or therein and which are owing to such Holders.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; of any specified person means any other person directly or indirectly controlling or controlled by or under common control with such specified person. For the purposes of this definition, &#x201c;control&#x201d; (including, with correlative meanings, the terms &#x201c;controlled by&#x201d; and &#x201c;under common control with&#x201d;), as used with respect to any person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such person, whether through the ownership of voting securities or by agreement or otherwise.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any Registrar, Paying Agent or Service Agent.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Board of Directors of the Company or any duly authorized committee thereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board Resolution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been adopted by the Board of Directors or pursuant to authorization by the Board of Directors and to be in full force and effect on the date of the certificate and delivered to the Trustee.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, unless otherwise provided by Board Resolution, Officers&#x2019; Certificate or supplemental indenture hereto for a particular Series, any day except a Saturday, Sunday or a legal holiday in The City of New York, New York (or in connection with any payment, the place of payment) on which banking institutions are authorized or required by law, regulation or executive order to close.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Capital Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the party named as such above until a successor replaces it and thereafter means the successor.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Order</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a written order signed in the name of the Company by two Officers, at least one of whom must be the Company&#x2019;s principal executive officer, principal financial officer or principal accounting officer.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Request</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a written request signed in the name of the Company by its Chief Executive Officer, the President or an Executive Vice President, and by its Treasurer, an Assistant Treasurer, its Secretary or an Assistant Secretary, and delivered to the Trustee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">continuing</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, with respect to any Default or Event of Default, that such Default or Event of Default has not been cured or waived.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Corporate Trust Office</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the office of the Trustee at which at any particular time its corporate trust business shall be principally administered.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Default</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any event which is, or after notice or passage of time or both would be, an Event of Default.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depositary</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, with respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global Securities, the person designated as Depositary for such Series by the Company, which Depositary shall be a clearing agency registered under the Exchange Act; and if at any time there is more than one such person, &#x201c;Depositary&#x201d; as used with respect to the Securities of any Series shall mean the Depositary with respect to the Securities of such Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Discount Security</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any Security that provides for an amount less than the stated principal amount thereof to be due and payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.2.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dollars</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">$</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the currency of The United States of America.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Euro</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the single currency of participating member states of the economic and monetary union as contemplated in the Treaty on European Union.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities Exchange Act of 1934, as amended.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Currency</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any currency or currency unit issued by a government other than the government of The United States of America.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Government Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, with respect to Securities of any Series that are denominated in a Foreign Currency, (i) direct obligations of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged or (ii) obligations of a person controlled or supervised by or acting as an agency or instrumentality of such government the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i) or (ii), are not callable or redeemable at the option of the issuer thereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GAAP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means accounting principles generally accepted in the United States of America set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect from time to time.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Global Security</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Global Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a Security or Securities, as the case may be, in the form established pursuant to Section 2.2 evidencing all or part of a Series of Securities, issued to the Depositary for such Series or its nominee, and registered in the name of such Depositary or nominee.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Securityholder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a person in whose name a Security is registered.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indenture</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means this Indenture as amended or supplemented from time to time and shall include the form and terms of particular Series of Securities established as contemplated hereunder.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">interest</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; with respect to any Discount Security which by its terms bears interest only after Maturity, means interest payable after Maturity.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Maturity</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; when used with respect to any Security, means the date on which the principal of such Security becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption or otherwise.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Chief Executive Officer, the President, any Executive Vice President, the Treasurer, the Secretary, any Assistant Treasurer or any Assistant Secretary of the Company.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Officers&#x2019; Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a certificate signed by two Officers, one of whom must be the Company&#x2019;s principal executive officer, principal financial officer or principal accounting officer.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Opinion of Counsel</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a written opinion of legal counsel who is acceptable to the Trustee. The counsel may be an employee of or counsel to the Company.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">person</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any individual, corporation, partnership, joint venture, association, limited liability company, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">principal</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; of a Security means the principal of the Security plus, when appropriate, the premium, if any, on, and any Additional Amounts in respect of, the Security.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Responsible Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any officer of the Trustee in its Corporate Trust Office and also means, with respect to a particular corporate trust matter, any other officer to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with a particular subject.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities and Exchange Commission.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the debentures, notes or other debt instruments of the Company of any Series authenticated and delivered under this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means each series of debentures, notes or other debt instruments of the Company created pursuant to Sections 2.1 and 2.2 hereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stated Maturity</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; when used with respect to any Security, means the date specified in such Security as the fixed date on which the principal of such Security or interest is due and payable.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; of any specified person means any corporation, association or other business entity of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such person or one or more of the other Subsidiaries of that person or a combination thereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TIA</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Trust Indenture Act of 1939 (15 U.S. Code &#167;&#167; 77aaa-77bbbb) as in effect on the date of this Indenture; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that in the event the Trust Indenture Act of 1939 is amended after such date, &#x201c;TIA&#x201d; means, to the extent required by any such amendment, the Trust Indenture Act as so amended.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the person named as the &#x201c;Trustee&#x201d; in the first paragraph of this instrument until a successor Trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#x201c;Trustee&#x201d; shall mean or include each person who is then a Trustee hereunder, and if at any time there is more than one such person, &#x201c;Trustee&#x201d; as used with respect to the Securities of any Series shall mean the Trustee with respect to Securities of that Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Government Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means securities which are (i) direct obligations of The United States of America for the payment of which its full faith and credit is pledged or (ii) obligations of a person controlled or supervised by and acting as an agency or instrumentality of The United States of America the payment of which is unconditionally guaranteed as a full faith and credit obligation by The United States of America, and which in the case of (i) and (ii) are not callable or redeemable at the option of the issuer thereof, and shall also include a depository receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depository receipt; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the U.S. Government Obligation evidenced by such depository receipt.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p>
   <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:11.882%;box-sizing:content-box;"></td>
     <td style="width:61.972%;box-sizing:content-box;"></td>
     <td style="width:11.882%;box-sizing:content-box;"></td>
     <td style="width:14.263%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TERM</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DEFINED IN</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SECTION</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Bankruptcy Law</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Custodian</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Event of Default</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Journal</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Judgment Currency</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Holiday</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">mandatory sinking fund payment</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Market Exchange Rate</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">New York Banking Day</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">optional sinking fund payment</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.1</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Paying Agent</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Registrar</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Required Currency</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Service Agent</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">successor person</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.1</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Incorporation by Reference of Trust Indenture Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the SEC.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">indenture securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">indenture security holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a Securityholder.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">indenture to be qualified</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">indenture trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">institutional trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Trustee.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">obligor</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; on the indenture securities means the Company and any successor obligor upon the Securities.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under the TIA and not otherwise defined herein are used herein as so defined.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rules of Construction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless the context otherwise requires:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) a term has the meaning assigned to it;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">or</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; is not exclusive;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) words in the singular include the plural, and in the plural include the singular; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) provisions apply to successive events and transactions.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section5"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE II.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>THE SECURITIES</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issuable in Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth or determined in the manner provided in a Board Resolution, supplemental indenture or Officers&#x2019; Certificate detailing the adoption of the terms thereof pursuant to authority granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time, the Board Resolution, Officers&#x2019; Certificate or supplemental indenture detailing the adoption of the terms thereof pursuant to authority granted under a Board Resolution may provide for the method by which specified terms (such as interest rate, maturity date, record date or date from which interest shall accrue) are to be determined. Securities may differ between Series in respect of any matters, provided that all Series of Securities shall be equally and ratably entitled to the benefits of this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Establishment of Terms of Series of Securities.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At or prior to the issuance of any Securities within a Series, the following shall be established (as to the Series generally, in the case of Subsection 2.2.1 and either as to such Securities within the Series or as to the Series generally in the case of Subsections 2.2.2 through 2.2.24) by or pursuant to a Board Resolution, and set forth or determined in the manner provided in a Board Resolution, supplemental indenture or Officers&#x2019; Certificate:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.1	the title of the Series (which shall distinguish the Securities of that particular Series from the Securities of any other Series) and ranking (including the terms of any subordination provisions) of the Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.2	the price or prices (expressed as a percentage of the principal amount thereof) at which the Securities of the Series will be issued;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.3	any limit upon the aggregate principal amount of the Securities of the Series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series pursuant to Section 2.7, 2.8, 2.11, 3.6 or 9.6);</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.4	the date or dates on which the principal of the Securities of the Series is payable;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.5	the rate or rates (which may be fixed or variable) per annum or, if applicable, the method used to determine such rate or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall bear interest, if any, the date or dates from which such interest, if any, shall accrue, the date or dates on which such interest, if any, shall commence and be payable and any regular record date for the interest payable on any interest payment date;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.6	the place or places where the principal of and interest, if any, on the Securities of the Series shall be payable, where the Securities of such Series may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Company in respect of the Securities of such Series and this Indenture may be served, and the method of such payment, if by wire transfer, mail or other means;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.7	if applicable, the period or periods within which, the price or prices at which and the terms and conditions upon which the Securities of the Series may be redeemed, in whole or in part, at the option of the Company;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.8	the obligation, if any, of the Company to redeem or purchase the Securities of the Series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the period or periods within which, the price or prices at which and the terms and conditions upon which Securities of the Series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.9	the dates, if any, on which and the price or prices at which the Securities of the Series will be repurchased by the Company at the option of the Holders thereof and other detailed terms and provisions of such repurchase obligations;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.10	if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities of the Series shall be issuable;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.11	the forms of the Securities of the Series and whether the Securities will be issuable as Global Securities;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.12	if other than the principal amount thereof, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.2;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.13	the currency of denomination of the Securities of the Series, which may be Dollars or any Foreign Currency, including, but not limited to, the Euro, and if such currency of denomination is a composite currency other than the Euro, the agency or organization, if any, responsible for overseeing such composite currency;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.14	the designation of the currency, currencies or currency units in which payment of the principal of and interest, if any, on the Securities of the Series will be made;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.15	if payments of principal of or interest, if any, on the Securities of the Series are to be made in one or more currencies or currency units other than that or those in which such Securities are denominated, the manner in which the exchange rate with respect to such payments will be determined;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.16	the manner in which the amounts of payment of principal of or interest, if any, on the Securities of the Series will be determined, if such amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.17	the provisions, if any, relating to any security provided for the Securities of the Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.18	any addition to, deletion of or change in the Events of Default which applies to any Securities of the Series and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.2;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.19	any addition to, deletion of or change in the covenants set forth in Articles IV or V hereof which applies to Securities of the Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.20	any other terms of the Securities of the Series (which may supplement, modify or delete any provision of this Indenture insofar as it applies to such Series);</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.21	any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to Securities of such Series if other than those appointed herein;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.22	the provisions, if any, relating to conversion or exchange of any Securities of such Series, including if applicable, the conversion or exchange price, the conversion or exchange period, provisions as to whether conversion or exchange will be mandatory, at the option of the Holders thereof or at the option of the Company, the events requiring an adjustment of the conversion price or exchange price and provisions affecting conversion or exchange if such Series of Securities are redeemed; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.2.23	whether the Securities of such Series will be senior debt securities or subordinated debt securities and, if applicable, a description of the subordination terms thereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Securities of any one Series need not be issued at the same time and may be issued from time to time, consistent with the terms of this Indenture, if so provided by or pursuant to the Board Resolution, supplemental indenture hereto or Officers&#x2019; Certificate referred to above.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Execution and Authentication</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An Officer shall sign the Securities for the Company by manual, facsimile or electronic signature.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an Officer whose signature is on a Security no longer holds that office at the time the Security is authenticated, the Security shall nevertheless be valid.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Security shall not be valid until authenticated by the manual signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee shall at any time, and from time to time, authenticate Securities for original issue in the principal amount provided in the Board Resolution, supplemental indenture hereto or Officers&#x2019; Certificate, upon receipt by the Trustee of a Company Order. Such Company Order may authorize authentication and delivery pursuant to oral or electronic instructions from the Company or its duly authorized agent or agents, which oral instructions shall be promptly confirmed in writing. Each</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Security shall be dated the date of its authentication unless otherwise provided by a Board Resolution, a supplemental indenture hereto or an Officers&#x2019; Certificate.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate principal amount of Securities of any Series outstanding at any time may not exceed any limit upon the maximum principal amount for such Series set forth in the Board Resolution, supplemental indenture hereto or Officers&#x2019; Certificate delivered pursuant to Section 2.2, except as provided in Section 2.8.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the issuance of Securities of any Series, the Trustee shall have received and (subject to Section 7.2) shall be fully protected in relying on: (a) the Board Resolution, supplemental indenture hereto or Officers&#x2019; Certificate establishing the form of the Securities of that Series or of Securities within that Series and the terms of the Securities of that Series or of Securities within that Series, (b) an Officers&#x2019; Certificate complying with Section 10.4, and (c) an Opinion of Counsel complying with Section 10.4.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee shall have the right to decline to authenticate and deliver any Securities of such Series: (a) if the Trustee, being advised by counsel, determines that such action may not be taken lawfully; or (b) if the Trustee in good faith by its board of directors or trustees, executive committee or a trust committee of directors and/or executive vice presidents shall determine that such action would expose the Trustee to personal liability to Holders of any then outstanding Series of Securities.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate of the Company.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrar and Paying Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall maintain, with respect to each Series of Securities, at the place or places specified with respect to such Series pursuant to Section 2.2, an office or agency where Securities of such Series may be presented or surrendered for payment (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Paying Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), where Securities of such Series may be surrendered for registration of transfer or exchange (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Registrar</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and where notices and demands to or upon the Company in respect of the Securities of such Series and this Indenture may be served (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Service Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The Registrar shall keep a register with respect to each Series of Securities and to their transfer and exchange. The Company will give prompt written notice to the Trustee of the name and address, and any change in the name or address, of each Registrar, Paying Agent or Service Agent. If at any time the Company shall fail to maintain any such required Registrar, Paying Agent or Service Agent or shall fail to furnish the Trustee with the name and address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may also from time to time designate one or more co-registrars, additional paying agents or additional service agents and may from time to time rescind such designations; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that no such designation or rescission shall in any manner relieve the Company of its obligations to maintain a Registrar, Paying Agent and Service Agent in each place so specified pursuant to Section 2.2 for Securities of any Series for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the name or address of any such co-registrar, additional paying agent or additional service agent. The term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Registrar</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; includes any co-registrar; the term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Paying Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; includes any additional paying agent; and the term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Service Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; includes any additional service agent.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company hereby appoints the Trustee the initial Registrar, Paying Agent and Service Agent for each Series unless another Registrar, Paying Agent or Service Agent, as the case may be, is appointed prior to the time Securities of that Series are first issued.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Paying Agent to Hold Money in Trust</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust, for the benefit of Securityholders of any Series of Securities, or the Trustee, all money held by the Paying Agent for the payment of principal of or interest on the Series of Securities, and will notify the Trustee of any default by</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary of the Company) shall have no further liability for the money. If the Company or a Subsidiary of the Company acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of Securityholders of any Series of Securities all money held by it as Paying Agent. Upon any bankruptcy, reorganization or similar proceeding with respect to the Company, the Trustee shall serve as Paying Agent for the Securities.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securityholder Lists</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders of each Series of Securities and shall otherwise comply with TIA &#167; 312(a). If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least ten days before each interest payment date and at such other times as the Trustee may request in writing a list, in such form and as of such date as the Trustee may reasonably require, of the names and addresses of Securityholders of each Series of Securities.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer and Exchange</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Where Securities of a Series are presented to the Registrar or a co-registrar with a request to register a transfer or to exchange them for an equal principal amount of Securities of the same Series, the Registrar shall register the transfer or make the exchange if its requirements for such transactions are met. To permit registrations of transfers and exchanges, the Trustee shall authenticate Securities at the Registrar&#x2019;s request. No service charge shall be made for any registration of transfer or exchange (except as otherwise expressly permitted herein), but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer tax or similar governmental charge payable upon exchanges pursuant to Sections 2.11, 3.6 or 9.6).</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the Company nor the Registrar shall be required (a) to issue, register the transfer of, or exchange Securities of any Series for the period beginning at the opening of business fifteen days immediately preceding the mailing of a notice of redemption of Securities of that Series selected for redemption and ending at the close of business on the day of such mailing, or (b) to register the transfer of or exchange Securities of any Series selected, called or being called for redemption as a whole or the portion being redeemed of any such Securities selected, called or being called for redemption in part.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mutilated, Destroyed, Lost and Stolen Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any mutilated Security is surrendered to the Trustee, the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a new Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If there shall be delivered to the Company and the Trustee (i) evidence to their satisfaction of the destruction, loss or theft of any Security and (ii) such security or indemnity as may be required by them to save each of them and any agent of either of them harmless, then, in the absence of notice to the Company or the Trustee that such Security has been acquired by a bona fide purchaser, the Company shall execute and upon its request the Trustee shall authenticate and make available for delivery, in lieu of any such destroyed, lost or stolen Security, a new Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In case any such mutilated, destroyed, lost or stolen Security has become or is about to become due and payable, the Company in its discretion may, instead of issuing a new Security, pay such Security.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the issuance of any new Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Every new Security of any Series issued pursuant to this Section in lieu of any destroyed, lost or stolen Security shall constitute an original additional contractual obligation of the Company, whether or not the destroyed, lost or</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of that Series duly issued hereunder.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Securities outstanding at any time are all the Securities authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation, those reductions in the interest on a Global Security effected by the Trustee in accordance with the provisions hereof and those described in this Section as not outstanding.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a Security is replaced pursuant to Section 2.8, it ceases to be outstanding until the Trustee receives proof satisfactory to it that the replaced Security is held by a bona fide purchaser.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Paying Agent (other than the Company, a Subsidiary of the Company or an Affiliate of the Company) holds on the Maturity of Securities of a Series money sufficient to pay such Securities payable on that date, then on and after that date such Securities of the Series cease to be outstanding and interest on them ceases to accrue.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining whether the Holders of the requisite principal amount of outstanding Securities have given any request, demand, authorization, direction, notice, consent or waiver hereunder, the principal amount of a Discount Security that shall be deemed to be outstanding for such purposes shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration of the Maturity thereof pursuant to Section 6.2.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Treasury Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining whether the Holders of the required principal amount of Securities of a Series have concurred in any request, demand, authorization, direction, notice, consent or waiver, Securities of a Series owned by the Company or any Affiliate of the Company shall be disregarded, except that for the purposes of determining whether the Trustee shall be protected in relying on any such request, demand, authorization, direction, notice, consent or waiver only Securities of a Series that the Trustee knows are so owned shall be so disregarded.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Temporary Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Until definitive Securities are ready for delivery, the Company may prepare and the Trustee shall authenticate temporary Securities upon a Company Order. Temporary Securities shall be substantially in the form of definitive Securities but may have variations that the Company considers appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and the Trustee upon request shall authenticate definitive Securities of the same Series and date of maturity in exchange for temporary Securities. Until so exchanged, temporary securities shall have the same rights under this Indenture as the definitive Securities.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cancellation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee shall cancel all Securities surrendered for transfer, exchange, payment, replacement or cancellation and shall destroy such canceled Securities (subject to the record retention requirement of the Exchange Act) and deliver a certificate of such destruction to the Company, unless the Company otherwise directs. The Company may not issue new Securities to replace Securities that it has paid or delivered to the Trustee for cancellation.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.13	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Defaulted Interest</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company defaults in a payment of interest on a Series of Securities, it shall pay the defaulted interest, plus, to the extent permitted by law, any interest payable on the defaulted interest, to the persons who are Securityholders of the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series on a subsequent special record date. The Company shall fix the record date and payment date. At least 10 days before the record date, the Company shall mail to the Trustee and to each Securityholder of the Series a notice that states the record date, the payment date and the amount of interest to be paid. The Company may pay defaulted interest in any other lawful manner.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.14	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Global Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.14.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Terms of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. A Board Resolution, a supplemental indenture hereto or an Officers&#x2019; Certificate shall establish whether the Securities of a Series shall be issued in whole or in part in the form of one or more Global Securities and the Depositary for such Global Security or Securities.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.14.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer and Exchange</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Notwithstanding any provisions to the contrary contained in Section 2.7 of this Indenture and in addition thereto, any Global Security shall be exchangeable pursuant to Section 2.7 of this Indenture for Securities registered in the names of Holders other than the Depositary for such Security or its nominee only if (i) such Depositary notifies the Company that it is unwilling or unable to continue as Depositary for such Global Security or if at any time such Depositary ceases to be a clearing agency registered under the Exchange Act, and, in either case, the Company fails to appoint a successor Depositary registered as a clearing agency under the Exchange Act within 90 days of such event or (ii) the Company executes and delivers to the Trustee an Officers&#x2019; Certificate to the effect that such Global Security shall be so exchangeable. Any Global Security that is exchangeable pursuant to the preceding sentence shall be exchangeable for Securities registered in such names as the Depositary shall direct in writing in an aggregate principal amount equal to the principal amount of the Global Security with like tenor and terms.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as provided in this Section 2.14.2, a Global Security may not be transferred except as a whole by the Depositary with respect to such Global Security to a nominee of such Depositary, by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such a successor Depositary.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.14.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legend</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Any Global Security issued hereunder shall bear a legend in substantially the following form:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;This Security is a Global Security within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depositary or a nominee of the Depositary. This Security is exchangeable for Securities registered in the name of a person other than the Depositary or its nominee only in the limited circumstances described in the Indenture, and may not be transferred except as a whole by the Depositary to a nominee of the Depositary, by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such a successor Depositary.&#x201d;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.14.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acts of Holders</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Depositary, as a Holder, may appoint agents and otherwise authorize participants to give or take any request, demand, authorization, direction, notice, consent, waiver or other action which a Holder is entitled to give or take under this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.14.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Notwithstanding the other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.2, payment of the principal of and interest, if any, on any Global Security shall be made to the Holder thereof.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.14.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consents, Declaration and Directions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Except as provided in Section 2.14.5, the Company, the Trustee and any Agent shall treat a person as the Holder of such principal amount of outstanding Securities of such Series represented by a Global Security as shall be specified in a written statement of the Depositary with respect to such Global Security, for purposes of obtaining any consents, declarations, waivers or directions required to be given by the Holders pursuant to this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2.15	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CUSIP Numbers</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company in issuing the Securities may use &#x201c;CUSIP&#x201d; numbers (if then generally in use), and, if so, the Trustee shall use &#x201c;CUSIP&#x201d; numbers in notices of redemption as a convenience to Holders; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any notice of a redemption and that reliance may be placed only on the other elements of identification printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section6"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE III.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>REDEMPTION</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice to Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may, with respect to any Series of Securities, reserve the right to redeem and pay the Series of Securities or may covenant to redeem and pay the Series of Securities or any part thereof prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities. If a Series of Securities is redeemable and the Company wants or is obligated to redeem prior to the Stated Maturity thereof all or part of the Series of Securities pursuant to the terms of such Securities, it shall notify the Trustee of the redemption date and the principal amount of Series of Securities to be redeemed. The Company shall give the notice at least 30 days before the redemption date (or such shorter notice as may be acceptable to the Trustee).</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selection of Securities to be Redeemed</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise indicated for a particular Series by a Board Resolution, a supplemental indenture hereto or an Officers&#x2019; Certificate, if less than all the Securities of a Series are to be redeemed, the Trustee shall select the Securities of the Series to be redeemed on a </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro rata</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> basis (or, in the case of Global Securities based on a method that most nearly approximates a </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro rata</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> selection as the Trustee deems fair and appropriate) unless otherwise required by law or applicable stock exchange or depositary requirements. The Trustee shall make the selection from Securities of the Series outstanding not previously called for redemption. The Trustee may select for redemption portions of the principal of Securities of the Series that have denominations larger than $1,000. Securities of the Series and portions of them it selects shall be in amounts of $1,000 or whole multiples of $1,000 or, with respect to Securities of any Series issuable in other denominations pursuant to Section 2.2.10, the minimum principal denomination for each Series and integral multiples thereof. Provisions of this Indenture that apply to Securities of a Series called for redemption also apply to portions of Securities of that Series called for redemption.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Redemption</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise indicated for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers&#x2019; Certificate, at least 15 days but not more than 60 days before a redemption date, the Company shall mail a notice of redemption by first-class mail to each Holder whose Securities are to be redeemed.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The notice shall identify the Securities of the Series to be redeemed and shall state:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) the redemption date;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) the redemption price;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) the name and address of the Paying Agent;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) if any Securities are being redeemed in part, the portion of the principal amount of such Securities to be redeemed and that, after the redemption date and upon surrender of such Security, a new Security or Securities in principal amount equal to the unredeemed portion of the original Security shall be issued in the name of the Holder thereof upon cancellation of the original Security;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) that Securities of the Series called for redemption must be surrendered to the Paying Agent to collect the redemption price;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) that interest on Securities of the Series called for redemption ceases to accrue on and after the redemption date;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) the CUSIP number, if any; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) any other information as may be required by the terms of the particular Series or the Securities of a Series being redeemed.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the Company&#x2019;s request, the Trustee shall give the notice of redemption in the Company&#x2019;s name and at its expense.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effect of Notice of Redemption</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once notice of redemption is mailed or published as provided in Section 3.3, Securities of a Series called for redemption become due and payable on the redemption date and at the redemption price. Unless otherwise set forth in the Board Resolution, supplemental indenture or Officers&#x2019; Certificate for the applicable Series of Securities, a notice of redemption pertaining to such Series may not be conditional. Upon surrender to the Paying Agent, such Securities shall be paid at the redemption price plus accrued interest to the redemption date.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deposit of Redemption Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On or before 10:00 a.m., New York City time, on the redemption date, the Company shall deposit with the Paying Agent money sufficient to pay the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Redeemed in Part</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon surrender of a Security that is redeemed in part, the Trustee shall authenticate for the Holder a new Security of the same Series and the same maturity equal in principal amount to the unredeemed portion of the Security surrendered.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section7"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE IV.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>COVENANTS</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payment of Principal and Interest</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company covenants and agrees for the benefit of the Holders of each Series of Securities that it will duly and punctually pay the principal of and interest, if any, on the Securities of that Series in accordance with the terms of such Securities and this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC Reports</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall, so long as any Securities are outstanding, deliver to the Trustee within 15 days after it files them with the SEC (unless already publicly available through the SEC&#x2019;s EDGAR Filing System) copies of the annual reports and of the information, documents, and other reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe) which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act. The Company also shall comply with the other provisions of TIA &#167; 314(a). All such reports, information or documents referred to in this Section 4.2 that the Company files with the SEC via the SEC&#x2019;s EDGAR system shall be deemed to be filed with the Trustee and transmitted to Holders at the time such reports, information or documents are filed via the EDGAR system (or any successor system).</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Certificate.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall deliver to the Trustee, within 120 days after the end of each fiscal year of the Company, an Officers&#x2019; Certificate stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his/her knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge).</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will, so long as any of the Securities are outstanding, deliver to the Trustee, promptly upon becoming aware of any Default or Event of Default, an Officers&#x2019; Certificate specifying such Default or Event of Default and what action the Company is taking or proposes to take with respect thereto.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stay, Extension and Usury Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture or the Securities; and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law has been enacted.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Existence</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:12.507%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to Article V, the Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence and rights (charter and statutory); </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the Company shall not be required to preserve any such right if the Board of Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company and its Subsidiaries taken as a whole and that the loss thereof is not adverse in any material respect to the Holders.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section8"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE V.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>SUCCESSORS</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 5.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When Company May Merge, Etc</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall not consolidate with or merge with or into, or convey, transfer or lease all or substantially all of its properties and assets to, any person (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">successor person</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) unless:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) the Company is the surviving corporation or the successor person (if other than the Company) is a corporation organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes the Company&#x2019;s obligations on the Securities and under this Indenture; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall deliver to the Trustee prior to the consummation of the proposed transaction an Officers&#x2019; Certificate to the foregoing effect and an Opinion of Counsel stating that the proposed transaction and any supplemental indenture hereto complies with this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the above, any Subsidiary of the Company may consolidate with, merge into or transfer all or part of its properties to the Company. Neither an Officers&#x2019; Certificate nor an Opinion of Counsel shall be required to be delivered in connection therewith.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 5.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successor Corporation Substituted</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon any consolidation or merger, or any sale, lease, conveyance or other disposition of all or substantially all of the assets of the Company in accordance with Section 5.1, the successor corporation formed by such consolidation or into or with which the Company is merged or to which such sale, lease, conveyance or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor person has been named as the Company herein; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the predecessor Company in the case of a sale, conveyance or other disposition (other than a lease) shall be released from all obligations and covenants under this Indenture and the Securities.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section9"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE VI.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>DEFAULTS AND REMEDIES</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Events of Default</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Event of Default</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; wherever used herein with respect to Securities of any Series, means any one of the following events, unless in the establishing Board Resolution, supplemental indenture hereto or Officers&#x2019; Certificate, it is provided that such Series shall not have the benefit of said Event of Default:</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) default in the payment of any interest on any Security of that Series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of such payment is deposited by the Company with the Trustee or with a Paying Agent prior to the expiration of such period of 30 days); or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) default in the payment of principal of any Security of that Series at its Maturity; or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) default in the performance or breach of any covenant or warranty of the Company in this Indenture or any Security (other than a covenant or warranty that has been included in this Indenture solely for the benefit of Series of Securities other than that Series), which default continues uncured for a period of 60 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the outstanding Securities of that Series a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a &#x201c;Notice of Default&#x201d; hereunder; or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) the Company pursuant to or within the meaning of any Bankruptcy Law:</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) commences a voluntary case,</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) consents to the entry of an order for relief against it in an involuntary case,</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(iii) consents to the appointment of a Custodian of it or for all or substantially all of its property,</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(iv) makes a general assignment for the benefit of its creditors, or</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(v) generally is unable to pay its debts as the same become due; or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) is for relief against the Company in an involuntary case,</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) appoints a Custodian of the Company or for all or substantially all of its property, or</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(iii) orders the liquidation of the Company,</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and the order or decree remains unstayed and in effect for 60 days; or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) any other Event of Default provided with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto or an Officers&#x2019; Certificate, in accordance with Section 2.2.18.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bankruptcy Law</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means title 11, U.S. Code or any similar Federal or State law for the relief of debtors. The term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Custodian</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acceleration of Maturity; Rescission and Annulment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an Event of Default with respect to Securities of any Series at the time outstanding occurs and is continuing (other than an Event of Default referred to in Section 6.1(d) or (e)) then in every such case the Trustee or the Holders of not less than 25% in principal amount of the outstanding Securities of that Series may declare the principal amount (or, if any Securities of that Series are Discount Securities, such portion of the principal amount as may be specified in the terms of such Securities) of and accrued and unpaid interest, if any, on all of the Securities of that Series to be due and payable immediately, by a notice in writing to the Company (and to the Trustee if given by Holders), and upon any such declaration such principal amount (or specified amount) and accrued and unpaid interest, if any, shall become immediately due and payable. If an Event of Default specified in Section 6.1(d) or (e) shall occur, the principal amount (or specified amount) of and accrued and unpaid interest, if any, on all outstanding Securities shall </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ipso facto</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At any time after such a declaration of acceleration with respect to any Series has been made and before a judgment or decree for payment of the money due has been obtained by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the outstanding Securities of that Series may rescind and annul such declaration and its consequences if all Events of Default with respect to Securities of that Series, other than the non-payment of the principal and interest, if any, of Securities of that Series which have become due solely by such declaration of acceleration, have been cured or waived as provided in Section 6.13.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No such rescission shall affect any subsequent Default or impair any right consequent thereon.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Collection of Indebtedness and Suits for Enforcement by Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company covenants that if:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) default is made in the payment of any interest on any Security when such interest becomes due and payable and such default continues for a period of 30 days, or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) default is made in the payment of principal of any Security at the Maturity thereof, or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) default is made in the deposit of any sinking fund payment when and as due by the terms of a Security,</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">then,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the Company will, upon demand of the Trustee, pay to it, for the benefit of the Holders of such Securities, the whole amount then due and payable on such Securities for principal and interest and, to the extent that payment of such interest shall be legally enforceable, interest on any overdue principal and any overdue interest at the rate or rates prescribed therefor in such Securities, and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company fails to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company or any other obligor upon such Securities and collect the moneys adjudged or deemed to be payable in the manner provided by law out of the property of the Company or any other obligor upon such Securities, wherever situated.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an Event of Default with respect to any Securities of any Series occurs and is continuing, the Trustee may in its discretion proceed to protect and enforce its rights and the rights of the Holders of Securities of such Series by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein, or to enforce any other proper remedy.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trustee May File Proofs of Claim</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Company or any other obligor upon the Securities or the property of the Company or of such other obligor or their creditors, the Trustee (irrespective of whether the principal of the Securities shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of overdue principal or interest) shall be entitled and empowered, by intervention in such proceeding or otherwise,</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) to file and prove a claim for the whole amount of principal and interest owing and unpaid in respect of the Securities and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders allowed in such judicial proceeding, and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) to collect and receive any moneys or other property payable or deliverable on any such claims and to distribute the same,</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.7.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nothing contained in this Indenture shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trustee May Enforce Claims Without Possession of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All rights of action and claims under this Indenture or the Securities may be prosecuted and enforced by the Trustee without the possession of any of the Securities or the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Securities in respect of which such judgment has been recovered.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Application of Money Collected</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any money or property collected by the Trustee pursuant to this Article shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such money or property on account of principal or interest, upon presentation of the Securities and the notation thereon of the payment if only partially paid and upon surrender thereof if fully paid:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First: To the payment of all amounts due the Trustee under Section 7.7; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Second: To the payment of the amounts then due and unpaid for principal of and interest on the Securities in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for principal and interest, respectively; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third: To the Company.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitation on Suits</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Holder of any Security of any Series shall have any right to institute any proceeding, judicial or otherwise, with respect to this Indenture, or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) such Holder has previously given written notice to the Trustee of a continuing Event of Default with respect to the Securities of that Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) the Holders of not less than 25% in principal amount of the outstanding Securities of that Series shall have made written request to the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee hereunder;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) such Holder or Holders have offered to the Trustee reasonable indemnity against the costs, expenses and liabilities to be incurred in compliance with such request;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) the Trustee for 60 days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) no direction inconsistent with such written request has been given to the Trustee during such 60-day period by the Holders of a majority in principal amount of the outstanding Securities of that Series;</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">it being understood and intended that no one or more of such Holders shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to affect, disturb or prejudice the rights of any other of such Holders, or to obtain or to seek to obtain priority or preference over any other of such Holders or to enforce any right under this Indenture, except in the manner herein provided and for the equal and ratable benefit of all such Holders.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unconditional Right of Holders to Receive Principal and Interest</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding any other provision in this Indenture, the Holder of any Security shall have the right, which is absolute and unconditional, to receive payment of the principal of and interest, if any, on such Security on the Stated Maturity or Stated Maturities expressed in such Security (or, in the case of redemption, on the redemption date) and to institute suit for the enforcement of any such payment, and such rights shall not be impaired without the consent of such Holder.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restoration of Rights and Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination in such proceeding, the Company, the Trustee and the Holders shall be restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding had been instituted.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights and Remedies Cumulative</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities in Section 2.8, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not, to the extent permitted by law, prevent the concurrent assertion or employment of any other appropriate right or remedy.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delay or Omission Not Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No delay or omission of the Trustee or of any Holder of any Securities to exercise any right or remedy accruing upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article or by law to the Trustee or to the Holders may be exercised from time to time, and as often as may be deemed expedient, by the Trustee or by the Holders, as the case may be.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Control by Holders</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holders of a majority in principal amount of the outstanding Securities of any Series shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Securities of such Series; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) such direction shall not be in conflict with any rule of law or with this Indenture,</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction, and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) subject to the provisions of Section 7.1, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer of the Trustee, determine that the proceeding so directed would involve the Trustee in personal liability.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.13	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Waiver of Past Defaults</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holders of not less than a majority in principal amount of the outstanding Securities of any Series may on behalf of the Holders of all the Securities of such Series, by written notice to the Trustee and the Company, waive any past Default hereunder with respect to such Series and its consequences, except a Default in the payment of the principal of or interest on any Security of such Series (provided, however, that the Holders of a majority in principal amount of the outstanding Securities of any Series may rescind an acceleration and its consequences, including any related payment default that resulted from such acceleration). Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 6.14	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Undertaking for Costs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All parties to this Indenture agree, and each Holder of any Security by his acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken, suffered or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys&#x2019; fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company, to any suit instituted by the Trustee, to any suit instituted by any Holder, or group of Holders, holding in the aggregate more than 10% in principal amount of the outstanding Securities of any Series, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or interest on any Security on or after the Stated Maturity or Stated Maturities expressed in such Security (or, in the case of redemption, on the redemption date).</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section10"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE VII.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TRUSTEE</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Duties of Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent person would exercise or use under the circumstances in the conduct of such person&#x2019;s own affairs.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) Except during the continuance of an Event of Default:</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) The Trustee need perform only those duties that are specifically set forth in this Indenture and no others.</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) In the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon Officers&#x2019; Certificates or Opinions of Counsel furnished to the Trustee and conforming to the requirements of this Indenture; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in the case of any such Officers&#x2019; Certificates or Opinions of Counsel which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall examine such Officers&#x2019; Certificates and Opinions of Counsel to determine whether or not they conform to the requirements of this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that:</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) This paragraph does not limit the effect of paragraph (b) of this Section.</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) The Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts.</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(iii) The Trustee shall not be liable with respect to any action taken, suffered or omitted to be taken by it with respect to Securities of any Series in good faith in accordance with the direction of the Holders of a majority in principal amount of the outstanding Securities of such Series relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture with respect to the Securities of such Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Every provision of this Indenture that in any way relates to the Trustee is subject to paragraph (a), (b) and (c) of this Section.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) The Trustee may refuse to perform any duty or exercise any right or power unless it receives indemnity satisfactory to it against any loss, liability or expense.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) No provision of this Indenture shall require the Trustee to risk its own funds or otherwise incur any financial liability in the performance of any of its duties, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk is not reasonably assured to it.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) The Paying Agent, the Registrar and any authenticating agent shall be entitled to the protections, immunities and standard of care as are set forth in paragraphs (a), (b) and (c) of this Section with respect to the Trustee.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights of Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) The Trustee may rely on and shall be protected in acting or refraining from acting upon any document (whether in its original, electronic or facsimile form) believed by it to be genuine and to have been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated in the document.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) Before the Trustee acts or refrains from acting, it may require an Officers&#x2019; Certificate or an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers&#x2019; Certificate or Opinion of Counsel.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care. No Depositary shall be deemed an agent of the Trustee and the Trustee shall not be responsible for any act or omission by any Depositary.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within its rights or powers, provided that the Trustee&#x2019;s conduct does not constitute willful misconduct, negligence or bad faith.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) The Trustee may consult with counsel and the advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder without willful misconduct or negligence and in good faith and in reliance thereon.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders of Securities unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) The Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities generally or the Securities of a particular Series and this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual Rights of Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or an Affiliate of the Company with the same rights it would have if it were not Trustee. Any Agent may do the same with like rights. The Trustee is also subject to Sections 7.10 and 7.11.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trustee&#x2019;s Disclaimer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be accountable for the Company&#x2019;s use of the proceeds from the Securities, and it shall not be responsible for any statement in the Securities other than its authentication.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Defaults</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a Default or Event of Default occurs and is continuing with respect to the Securities of any Series and if it is known to a Responsible Officer of the Trustee, the Trustee shall mail to each Securityholder of the Securities of that Series notice of a Default or Event of Default within 90 days after it occurs or, if later, after a Responsible Officer of the Trustee has knowledge of such Default or Event of Default. Except in the case of a Default or Event of Default in payment of principal of or interest on any Security of any Series, the Trustee may withhold the notice if and so long as its corporate trust committee or a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of Securityholders of that Series.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reports by Trustee to Holders</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Within 60 days after May 15 in each year, the Trustee shall transmit by mail to all Securityholders, as their names and addresses appear on the register kept by the Registrar, a brief report dated as of such May 15, in accordance with, and to the extent required under, TIA &#167; 313.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A copy of each report at the time of its mailing to Securityholders of any Series shall be filed with the SEC and each stock exchange on which the Securities of that Series are listed. The Company shall promptly notify the Trustee when Securities of any Series are listed on any stock exchange.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation and Indemnity</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall pay to the Trustee from time to time compensation for its services as the Company and the Trustee shall from time to time agree upon in writing. The Trustee&#x2019;s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request for all reasonable out of pocket expenses incurred by it. Such expenses shall include the reasonable compensation and expenses of the Trustee&#x2019;s agents and counsel.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall indemnify each of the Trustee and any predecessor Trustee (including the cost of defending itself) against any loss, liability or expense, including taxes (other than taxes based upon, measured by or determined by the income of the Trustee) incurred by it except as set forth in the next paragraph in the performance of its duties under this Indenture as Trustee or Agent. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have one separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. This indemnification shall apply to officers, directors, employees, shareholders and agents of the Trustee.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company need not reimburse any expense or indemnify against any loss or liability incurred by the Trustee or by any officer, director, employee, shareholder or agent of the Trustee through willful misconduct, negligence or bad faith.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To secure the Company&#x2019;s payment obligations in this Section, the Trustee shall have a lien prior to the Securities of any Series on all money or property held or collected by the Trustee, except that held in trust to pay principal of and interest on particular Securities of that Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Trustee incurs expenses or renders services after an Event of Default specified in Section 6.1(d) or (e) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions of this Section shall survive the termination of this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Replacement of Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee&#x2019;s acceptance of appointment as provided in this Section.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee may resign with respect to the Securities of one or more Series by so notifying the Company at least 30 days prior to the date of the proposed resignation. The Holders of a majority in principal amount of the Securities of any Series may remove the Trustee with respect to that Series by so notifying the Trustee and the Company. The Company may remove the Trustee with respect to Securities of one or more Series if:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) the Trustee fails to comply with Section 7.10;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) a Custodian or public officer takes charge of the Trustee or its property; or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) the Trustee becomes incapable of acting.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor Trustee. Within one year after the successor Trustee takes office, the Holders of a</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">majority in principal amount of the then outstanding Securities may appoint a successor Trustee to replace the successor Trustee appointed by the Company.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a successor Trustee with respect to the Securities of any one or more Series does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of at least a majority in principal amount of the Securities of the applicable Series may petition any court of competent jurisdiction for the appointment of a successor Trustee.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Immediately after that, the retiring Trustee shall transfer all property held by it as Trustee to the successor Trustee subject to the lien provided for in Section 7.7, the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee with respect to each Series of Securities for which it is acting as Trustee under this Indenture. A successor Trustee shall mail a notice of its succession to each Securityholder of each such Series. Notwithstanding replacement of the Trustee pursuant to this Section 7.8, the Company&#x2019;s obligations under Section 7.7 hereof shall continue for the benefit of the retiring Trustee with respect to expenses and liabilities incurred by it prior to such replacement.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successor Trustee by Merger, etc</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee, subject to Section 7.10.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eligibility; Disqualification</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Indenture shall always have a Trustee who satisfies the requirements of TIA &#167; 310(a)(1), (2) and (5). The Trustee shall always have a combined capital and surplus of at least $100,000,000 as set forth in its most recent published annual report of condition. The Trustee shall comply with TIA &#167; 310(b).</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 7.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferential Collection of Claims Against Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee is subject to TIA &#167; 311(a), excluding any creditor relationship listed in TIA &#167; 311(b). A Trustee who has resigned or been removed shall be subject to TIA &#167; 311(a) to the extent indicated.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section11"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE VIII.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>SATISFACTION AND DISCHARGE; DEFEASANCE</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Satisfaction and Discharge of Indenture</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Indenture shall upon Company Order cease to be of further effect (except as hereinafter provided in this Section 8.1), and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) either:</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) all Securities theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and that have been replaced or paid) have been delivered to the Trustee for cancellation; or</font></p><p style="text-indent:20%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) all such Securities not theretofore delivered to the Trustee for cancellation</font></p><p style="text-indent:26.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) have become due and payable, or</font></p><p style="text-indent:26.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) will become due and payable at their Stated Maturity within one year, or</font></p><p style="text-indent:26.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(3) have been called for redemption or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company, or</font></p><p style="text-indent:26.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(4) are deemed paid and discharged pursuant to Section 8.3, as applicable;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and the Company, in the case of (1), (2) or (3) above, has irrevocably deposited or caused to be deposited with the Trustee as trust funds in trust an amount sufficient for the purpose of paying and discharging the entire indebtedness on such Securities not theretofore delivered to the Trustee for cancellation, for principal and interest to the date of such deposit (in the case of Securities which have become due and payable on or prior to the date of such deposit) or to the Stated Maturity or redemption date, as the case may be;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) the Company has paid or caused to be paid all other sums payable hereunder by the Company; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) the Company has delivered to the Trustee an Officers&#x2019; Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under Section 7.7, and, if money shall have been deposited with the Trustee pursuant to clause (a) of this Section, the provisions of Sections 2.4, 2.7, 2.8, 8.2 and 8.5 shall survive.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Application of Trust Funds; Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) Subject to the provisions of Section 8.5, all money deposited with the Trustee pursuant to Section 8.1, all money and U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.3 or 8.4 and all money received by the Trustee in respect of U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.3 or 8.4, shall be held in trust and applied by it, in accordance with the provisions of the Securities and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the persons entitled thereto, of the principal and interest for whose payment such money has been deposited with or received by the Trustee or to make mandatory sinking fund payments or analogous payments as contemplated by Sections 8.3 or 8.4.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) The Company shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on or assessed against U.S. Government Obligations or Foreign Government Obligations deposited pursuant to Sections 8.3 or 8.4 or the interest and principal received in respect of such obligations other than any payable by or on behalf of Holders.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) The Trustee shall deliver or pay to the Company from time to time upon Company Request any U.S. Government Obligations or Foreign Government Obligations or money held by it as provided in Sections 8.3 or 8.4 which, in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written certification thereof delivered to the Trustee, are then in excess of the amount thereof which then would have been required to be deposited for the purpose for which such U.S. Government Obligations or Foreign Government Obligations or money were deposited or received. This provision shall not authorize the sale by the Trustee of any U.S. Government Obligations or Foreign Government Obligations held under this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Defeasance of Securities of any Series</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless this Section 8.3 is otherwise specified, pursuant to Section 2.2.20, to be inapplicable to Securities of any Series, the Company shall be deemed to have paid and discharged the entire indebtedness on all the outstanding Securities of any Series on the 91st day after the date of the deposit referred to in subparagraph (d) hereof, and the provisions of this Indenture, as it relates to such outstanding Securities of such Series, shall no longer be in effect (and the Trustee, at the expense of the Company, shall, at Company Request, execute proper instruments acknowledging the same), except as to:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rights of Holders of Securities of such Series to receive, from the trust funds described in subparagraph (d) hereof, (i) payment of the principal of and each installment of principal of and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) interest on the outstanding Securities of such Series on the Stated Maturity of such principal or installment of principal or interest and (ii) the benefit of any mandatory sinking fund payments applicable to the Securities of such Series on the day on which such payments are due and payable in accordance with the terms of this Indenture and the Securities of such Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) the provisions of Sections 2.4, 2.7, 2.8, 8.2, 8.3 and 8.5; and</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) the rights, powers, trust and immunities of the Trustee hereunder;</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that, the following conditions shall have been satisfied:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) the Company shall have deposited or caused to be irrevocably deposited (except as provided in Section 8.2(c)) with the Trustee as trust funds in trust for the purpose of making the following payments, specifically pledged as security for and dedicated solely to the benefit of the Holders of such Securities (i) in the case of Securities of such Series denominated in Dollars, cash in Dollars and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment of interest and principal in respect thereof in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge each installment of principal of and interest, if any, on and any mandatory sinking fund payments in respect of all the Securities of such Series on the dates such installments of interest or principal and such sinking fund payments are due;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) such deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) no Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit or during the period ending on the 91st day after such date;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) the Company shall have delivered to the Trustee an Officers&#x2019; Certificate and an Opinion of Counsel to the effect that (i) the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (ii) since the date of execution of this Indenture, there has been a change in the applicable Federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the Securities of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such deposit, defeasance and discharge and will be subject to Federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) the Company shall have delivered to the Trustee an Officers&#x2019; Certificate stating that the deposit was not made by the Company with the intent of preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating, hindering, delaying or defrauding any other creditors of the Company; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) the Company shall have delivered to the Trustee an Officers&#x2019; Certificate and an Opinion of Counsel, each stating that all conditions precedent provided for relating to the defeasance contemplated by this Section have been complied with.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Covenant Defeasance</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless this Section 8.4 is otherwise specified pursuant to Section 2.2.20 to be inapplicable to Securities of any Series, the Company may omit to comply with respect to the Securities of any Series with any term, provision or condition set forth under Sections 4.2, 4.3, 4.4, 4.5, and 5.1 as well as any additional covenants specified in a supplemental indenture for such Series of Securities or a Board Resolution or an Officers&#x2019; Certificate delivered pursuant to Section 2.2.20 (and the failure to comply with any such covenants shall not constitute a Default or Event of Default with respect to such Series under Section 6.1) and the occurrence of any event specified in a supplemental indenture for such Series of Securities or a Board Resolution or an Officers&#x2019; Certificate delivered pursuant to Section 2.2.18 and designated as an Event of Default shall not constitute a Default or Event of Default hereunder, with respect to the Securities of such Series, provided that the following conditions shall have been satisfied:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) With reference to this Section 8.4, the Company has deposited or caused to be irrevocably deposited (except as provided in Section 8.2(c)) with the Trustee as trust funds in trust for the purpose of making the following payments specifically pledged as security for, and dedicated solely to, the benefit of the Holders of such Securities (i) in the case of Securities of such Series denominated in Dollars, cash in Dollars and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign Currency (other than a composite currency), money and/or Foreign</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Obligations, which through the payment of interest and principal in respect thereof in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge each installment of principal of and interest, if any, on and any mandatory sinking fund payments in respect of the Securities of such Series on the dates such installments of interest or principal and such sinking fund payments are due;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) Such deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) No Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) The Company shall have delivered to the Trustee an Opinion of Counsel to the effect that Holders of the Securities of such Series will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such deposit and covenant defeasance had not occurred;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) The Company shall have delivered to the Trustee an Officers&#x2019; Certificate stating the deposit was not made by the Company with the intent of preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating, hindering, delaying or defrauding any other creditors of the Company; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) The Company shall have delivered to the Trustee an Officers&#x2019; Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the covenant defeasance contemplated by this Section have been complied with.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Repayment to Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee and the Paying Agent shall pay to the Company upon request any money held by them for the payment of principal and interest that remains unclaimed for two years. After that, Securityholders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned property law designates another person.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reinstatement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Trustee or the Paying Agent is unable to apply any money deposited with respect to Securities of any Series in accordance with Section 8.1 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the obligations of the Company under this Indenture with respect to the Securities of such Series and under the Securities of such Series shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.1 until such time as the Trustee or the Paying Agent is permitted to apply all such money in accordance with Section 8.1; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if the Company has made any payment of principal of or interest on or any Additional Amounts with respect to any Securities because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money held by the Trustee or Paying Agent.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section12"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE IX.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>AMENDMENTS AND WAIVERS</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Without Consent of Holders</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and the Trustee may amend or supplement this Indenture or the Securities of one or more Series without the consent of any Securityholder:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) to cure any ambiguity, defect or inconsistency;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) to comply with Article V;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) to provide for uncertificated Securities in addition to or in place of certificated Securities;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) to add guarantees with respect to Securities of any Series or secure Securities of any Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) to surrender any of the Company&#x2019;s rights or powers under this Indenture;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) to add covenants or events of default for the benefit of the holders of Securities of any Series;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) to comply with the applicable procedures of the applicable depositary;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) to make any change that does not adversely affect the rights of any Securityholder;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) to provide for the issuance of and establish the form and terms and conditions of Securities of any Series as permitted by this Indenture;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(j) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more Series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee; or</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(k) to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With Consent of Holders</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and the Trustee may enter into a supplemental indenture with the written consent of the Holders of at least a majority in principal amount of the outstanding Securities of each Series affected by such supplemental indenture (including consents obtained in connection with a tender offer or exchange offer for the Securities of such Series), for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights of the Securityholders of each such Series. Except as provided in Section 6.13, the Holders of at least a majority in principal amount of the outstanding Securities of any Series by notice to the Trustee (including consents obtained in connection with a tender offer or exchange offer for the Securities of such Series) may waive compliance by the Company with any provision of this Indenture or the Securities with respect to such Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It shall not be necessary for the consent of the Holders of Securities under this Section 9.2 to approve the particular form of any proposed supplemental indenture or waiver, but it shall be sufficient if such consent approves the substance thereof. After a supplemental indenture or waiver under this section becomes effective, the Company shall mail to the Holders of Securities affected thereby, a notice briefly describing the supplemental indenture or waiver. Any failure by the Company to mail or publish such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture or waiver.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Without the consent of each Securityholder affected, an amendment or waiver may not:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) reduce the principal amount of Securities whose Holders must consent to an amendment, supplement or waiver;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) reduce the rate of or extend the time for payment of interest (including default interest) on any Security;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) reduce the principal or change the Stated Maturity of any Security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) reduce the principal amount of Discount Securities payable upon acceleration of the maturity thereof;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(e) waive a Default or Event of Default in the payment of the principal of or interest, if any, on any Security (except a rescission of acceleration of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series and a waiver of the payment default that resulted from such acceleration);</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(f) make the principal of or interest, if any, on any Security payable in any currency other than that stated in the Security;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(g) make any change in Sections 6.8, 6.13 or 9.3 (this sentence); or</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(h) waive a redemption payment with respect to any Security, provided that such redemption is made at the Company&#x2019;s option.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with Trust Indenture Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Every amendment to this Indenture or the Securities of one or more Series shall be set forth in a supplemental indenture hereto that complies with the TIA as then in effect.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revocation and Effect of Consents</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Until an amendment is set forth in a supplemental indenture or a waiver becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder&#x2019;s Security, even if notation of the consent is not made on any Security. However, any such Holder or subsequent Holder may revoke the consent as to his Security or portion of a Security if the Trustee receives the notice of revocation before the date of the supplemental indenture or the date the waiver becomes effective.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any amendment or waiver once effective shall bind every Securityholder of each Series affected by such amendment or waiver unless it is of the type described in any of clauses (a) through (h) of Section 9.3. In that case, the amendment or waiver shall bind each Holder of a Security who has consented to it and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder&#x2019;s Security.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the second immediately preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only those persons, shall be entitled to give such consent or to revoke any consent previously given or take any such action, whether or not such Persons continue to be Holders after such record date. No such consent shall be valid or effective for more than 120 days after such record date.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notation on or Exchange of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company or the Trustee may place an appropriate notation about an amendment or waiver on any Security of any Series thereafter authenticated. The Company in exchange for Securities of that Series may issue and the Trustee shall authenticate upon request new Securities of that Series that reflect the amendment or waiver.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 9.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trustee Protected</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In executing, or accepting the additional trusts created by, any supplemental indenture permitted by this Article or the modifications thereby of the trusts created by this Indenture, the Trustee shall be entitled to receive, and (subject to Section 7.1) shall be fully protected in relying upon, an Opinion of Counsel stating that the execution of such supplemental indenture is authorized or permitted by this Indenture. The Trustee shall sign all supplemental indentures, except that the Trustee need not sign any supplemental indenture that adversely affects its rights.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section13"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE X.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>MISCELLANEOUS</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trust Indenture Act Controls</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any provision of this Indenture limits, qualifies, or conflicts with another provision which is required or deemed to be included in this Indenture by the TIA, such required or deemed provision shall control.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any notice or communication by the Company or the Trustee to the other, or by a Holder to the Company or the Trustee, is duly given if in writing and delivered in person or mailed by first-class mail (registered or certified, return receipt requested), facsimile transmission, email or overnight air courier guaranteeing next day delivery, to the others&#x2019; address:</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:31.62%;box-sizing:content-box;"></td>
     <td style="width:2.78%;box-sizing:content-box;"></td>
     <td style="width:31.78%;box-sizing:content-box;"></td>
     <td style="width:2.78%;box-sizing:content-box;"></td>
     <td style="width:31.04%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">if to the Company:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:180.7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4370 La Jolla Village Drive, Suite 1050</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">San Diego, CA 92122</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Telephone: (858) 225-7696</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Attention: Chief Executive Officer</font></p><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">With a copy (which shall not constitute notice) to:</font></p><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paul Hastings LLP</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1117 S. California Avenue</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Palo Alto, CA 94304</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Telephone: (650) 320-1804</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Attention: Jeffrey T. Hartlin, Esq.</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:27.92%;box-sizing:content-box;"></td>
     <td style="width:2.78%;box-sizing:content-box;"></td>
     <td style="width:9.64%;box-sizing:content-box;"></td>
     <td style="width:3.5%;box-sizing:content-box;"></td>
     <td style="width:25.3%;box-sizing:content-box;"></td>
     <td style="width:2.78%;box-sizing:content-box;"></td>
     <td style="width:28.08%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">if to the Trustee:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:23.75pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Attention:</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any notice or communication to a Securityholder shall be sent electronically or mailed by first-class mail to his, her or its address shown on the register kept by the Registrar, in accordance with the procedures of the Depositary. Failure to send a notice or communication to a Securityholder of any Series or any defect in it shall not affect its sufficiency with respect to other Securityholders of that or any other Series.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a notice or communication is sent or published in the manner provided above, within the time prescribed, it is duly given, whether or not the Securityholder receives it.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company sends a notice or communication to Securityholders, it shall send a copy to the Trustee and each Agent at the same time.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding any other provision of this Indenture or any Security, where this Indenture or any Security provides for notice of any event (including any notice of redemption) to a Holder of a Global Security (whether by mail or otherwise), such notice shall be sufficiently given to the Depositary for such Security (or its designee) pursuant to the customary procedures of such Depositary.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Communication by Holders with Other Holders</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securityholders of any Series may communicate pursuant to TIA &#167; 312(b) with other Securityholders of that Series or any other Series with respect to their rights under this Indenture or the Securities of that Series or all Series. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA &#167; 312(c).</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.4	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certificate and Opinion as to Conditions Precedent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) an Officers&#x2019; Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent have been complied with.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.5	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statements Required in Certificate or Opinion</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to TIA &#167; 314(a)(4)) shall comply with the provisions of TIA &#167; 314(e) and shall include:</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a) a statement that the person making such certificate or opinion has read such covenant or condition;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c) a statement that, in the opinion of such person, he has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) a statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.6	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rules by Trustee and Agents</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Trustee may make reasonable rules for action by or a meeting of Securityholders of one or more Series. Any Agent may make reasonable rules and set reasonable requirements for its functions.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.7	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Holidays</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided by Board Resolution, Officers&#x2019; Certificate or supplemental indenture hereto for a particular Series, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Holiday</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; is any day that is not a Business Day. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.8	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Recourse Against Others</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A director, officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. Each Securityholder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.9	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Indenture may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. The exchange of copies of this Indenture and of signature pages by facsimile or electronic format (e.g., &#x201c;.pdf&#x201d; or &#x201c;.tif&#x201d;) transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or electronic format (e.g., &#x201c;.pdf&#x201d; or &#x201c;.tif&#x201d;) shall be deemed to be their original signatures for all purposes.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided herein or in any other Securities, the words &#x201c;execute&#x201d;, &#x201c;execution&#x201d;, &#x201c;signed&#x201d;, and &#x201c;signature&#x201d; and words of similar import used in or related to any document to be signed in connection with this Indenture, any Securities or any of the transactions contemplated hereby (including amendments, waivers, consents and other modifications) shall be deemed to include electronic signatures and the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature in ink or the use of a paper-based recordkeeping system, as applicable, to the fullest extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, and any other similar state laws based on the Uniform Electronic Transactions Act, provided that, notwithstanding anything herein to the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contrary, the Trustee is not under any obligation to agree to accept electronic signatures in any form or in any format unless expressly agreed to by such Trustee pursuant to procedures approved by such Trustee.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.10	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governing Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THIS INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN SUCH STATE, WITHOUT REGARD TO THE CONFLICT OF LAWS PROVISIONS THEREOF.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.11	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Adverse Interpretation of Other Agreements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Indenture may not be used to interpret another indenture, loan or debt agreement of the Company or a Subsidiary of the Company. Any such indenture, loan or debt agreement may not be used to interpret this Indenture.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.12	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All agreements of the Company in this Indenture and the Securities shall bind its successor. All agreements of the Trustee in this Indenture shall bind its successor.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.13	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.14	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents, Headings, Etc</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cross Reference Table and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.15	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities in a Foreign Currency or in Euros</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an Officers&#x2019; Certificate delivered pursuant to Section 2.2 of this Indenture with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage in aggregate principal amount of Securities of all Series or all Series affected by a particular action at the time outstanding and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars (including Euros), then the principal amount of Securities of such Series which shall be deemed to be outstanding for the purpose of taking such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For purposes of this Section 10.15, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Market Exchange Rate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the noon Dollar buying rate in New York City for cable transfers of that currency as published by the Federal Reserve Bank of New York; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in the case of Euros, Market Exchange Rate shall mean the rate of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal of the European Union (such publication or any successor publication, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Journal</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). If such Market Exchange Rate is not available for any reason with respect to such currency, the Trustee shall use, in its sole discretion and without liability on its part, such quotation of the Federal Reserve Bank of New York or, in the case of Euros, the rate of exchange as published in the Journal, as of the most recent available date, or quotations or, in the case of Euros, rates of exchange from one or more major banks in New York City or in the country of issue of the currency in question or, in the case of Euros, in Luxembourg or such other quotations or, in the case of Euros, rates of exchange as the Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this paragraph shall apply in determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection with any action taken by Holders of Securities pursuant to the terms of this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All decisions and determinations of the Trustee regarding the Market Exchange Rate or any alternative determination provided for in the preceding paragraph shall be in its sole discretion and shall, in the absence of manifest error, to the extent permitted by law, be conclusive for all purposes and irrevocably binding upon the Company and all Holders.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.16	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Judgment Currency</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is necessary to convert the sum due in respect of the principal of or interest or other amount on the Securities of any Series (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Required Currency</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) into a currency in which a judgment will be rendered (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Judgment Currency</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the day on which final unappealable judgment is entered, unless such day is not a New York Banking Day, then the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the New York Banking Day preceding the day on which final unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any tender, any recovery pursuant to any judgment (whether or not entered in accordance with subsection (a)), in any currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable, and (iii) shall not be affected by judgment being obtained for any other sum due under this Indenture. For purposes of the foregoing, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">New York Banking Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any day except a Saturday, Sunday or a legal holiday in The City of New York on which banking institutions are authorized or required by law, regulation or executive order to close.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.17	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Force Majeure</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, it being understood that the Trustee shall use reasonable best efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10.18	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S.A. Patriot Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act.</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="section14"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ARTICLE XI.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>SINKING FUNDS</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 11.1	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Applicability of Article</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions of this Article shall be applicable to any sinking fund for the retirement of the Securities of a Series, except as otherwise permitted or required by any form of Security of such Series issued pursuant to this Indenture.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The minimum amount of any sinking fund payment provided for by the terms of the Securities of any Series is herein referred to as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">mandatory sinking fund payment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and any other amount provided for by the terms of Securities of such Series is herein referred to as an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">optional sinking fund payment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d; If provided for by the terms of Securities of any Series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 11.2. Each sinking fund payment shall be applied to the redemption of Securities of any Series as provided for by the terms of the Securities of such Series.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 11.2	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Satisfaction of Sinking Fund Payments with Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may, in satisfaction of all or any part of any sinking fund payment with respect to the Securities of any Series to be made pursuant to the terms of such Securities (1) deliver outstanding Securities of such Series to which such sinking fund payment is applicable (other than any of such Securities previously called for mandatory sinking fund</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">redemption) and (2) apply as credit Securities of such Series to which such sinking fund payment is applicable and which have been repurchased by the Company or redeemed either at the election of the Company pursuant to the terms of such Series of Securities (except pursuant to any mandatory sinking fund) or through the application of permitted optional sinking fund payments or other optional redemptions pursuant to the terms of such Securities, provided that such Securities have not been previously so credited. Such Securities shall be received by the Trustee, together with an Officers&#x2019; Certificate with respect thereto, not later than 15 days prior to the date on which the Trustee begins the process of selecting Securities for redemption, and shall be credited for such purpose by the Trustee at the price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. If as a result of the delivery or credit of Securities in lieu of cash payments pursuant to this Section 11.2, the principal amount of Securities of such Series to be redeemed in order to exhaust the aforesaid cash payment shall be less than $100,000, the Trustee need not call Securities of such Series for redemption, except upon receipt of a Company Order that such action be taken, and such cash payment shall be held by the Trustee or a Paying Agent and applied to the next succeeding sinking fund payment, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the Trustee or such Paying Agent shall from time to time upon receipt of a Company Order pay over and deliver to the Company any cash payment so being held by the Trustee or such Paying Agent upon delivery by the Company to the Trustee of Securities of that Series purchased by the Company having an unpaid principal amount equal to the cash payment required to be released to the Company.</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 11.3	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Redemption of Securities for Sinking Fund</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not less than 45 days (unless otherwise indicated in the Board Resolution, supplemental indenture hereto or Officers&#x2019; Certificate in respect of a particular Series of Securities) prior to each sinking fund payment date for any Series of Securities, the Company will deliver to the Trustee an Officers&#x2019; Certificate specifying the amount of the next ensuing mandatory sinking fund payment for that Series pursuant to the terms of that Series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting of Securities of that Series pursuant to Section 11.2, and the optional amount, if any, to be added in cash to the next ensuing mandatory sinking fund payment, and the Company shall thereupon be obligated to pay the amount therein specified. Not less than 30 days (unless otherwise indicated in the Board Resolution, Officers&#x2019; Certificate or supplemental indenture in respect of a particular Series of Securities) before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.2 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.3. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.4, 3.5 and 3.6.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.19in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="section15"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of the day and year first above written.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:48.58%;box-sizing:content-box;"></td>
     <td style="width:3.32%;box-sizing:content-box;"></td>
     <td style="width:2.58%;box-sizing:content-box;"></td>
     <td style="width:45.52%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Its:</font></p></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="3" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">[NAME OF TRUSTEE], as Trustee</font></p></td>
    </tr>
    <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:8pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Its:</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ck0001774857-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-03-23T16:54:02.8486+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-5.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 5.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img82710889_0.jpg" alt="img82710889_0.jpg" style="width:183px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4370 La Jolla Village Drive, STE 1050</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">San Diego, CA 92122</font></p><p style="text-indent:-7.224%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.046%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Re:	Registration Statement on Form S-3</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Ladies and Gentlemen:</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">We have acted as counsel to Aardvark Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), in connection with the preparation and filing on the date hereof with the U.S. Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) of a registration statement on Form S-3 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;).  You have provided us with a draft of the Registration Statement in the form in which it will be filed, which includes (i) a base prospectus (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), which provides that it will be supplemented in the future by one or more supplements to the Prospectus, free writing prospectuses or term sheets (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Prospectus Supplement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), and (ii) a sales agreement prospectus (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Sales Agreement Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), which relates to the issuance and sale of up to $150,000,000 of shares of Common Stock (as defined below) (such shares, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">ATM Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) that may be issued and sold from time to time pursuant to that certain Equity Distribution Agreement, dated as of March 23, 2026, by and between the Company and Piper Sandler &amp; Co. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Sales Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Registration Statement and the Prospectus relate to the proposed issuance and sale from time to time, pursuant to Rule 415 of the rules and regulations promulgated under the Act, of up to $400,000,000 of (i) shares of the Company&#x2019;s common stock, par value $0.00001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), (ii) shares of the Company&#x2019;s preferred stock, par value $0.00001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), (iii) one or more series of debt securities (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) to be issued pursuant to indentures to be entered into between the Company, as issuer, and a trustee (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Trustee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), the form of which is filed as Exhibit 4.2 to the Registration Statement (each, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Indenture</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), (iv)  warrants to purchase Common Stock, Preferred Stock or Debt Securities (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), which may be issued under warrant agreements (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), to be dated on or about the date of the first issuance of the applicable Warrants thereunder, by and between the Company and a warrant agent to be selected by the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), (v) rights to purchase shares of Common Stock or Preferred Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), (vi) units consisting of any combination of Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants and/or Rights (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), which may be issued under unit agreements by and between the Company and a unit agent to be selected by the Company (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Unit Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), and (vii)  depositary shares representing shares of Preferred Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Depositary Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;). The Sales Agreement Prospectus relates to the proposed issuance and sale from time to time, pursuant to Rule 415 of the rules and regulations promulgated under the Act, of the ATM Shares. The Common Stock, Preferred Stock, Debt Securities, Warrants, Rights, Units, Depositary Shares and the ATM Shares are collectively referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This opinion letter is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, the Prospectus, the Sales Agreement Prospectus or any Prospectus Supplement, other than as expressly stated herein with respect to the issuance of the Securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">As such counsel and for purposes of our opinions set forth herein, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of such documents, resolutions,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Paul Hastings LLP  I  1117 S. California Avenue I  Palo Alto, California 94304</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">T: + 1.650.320.1800  I  www.paulhastings.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img82710889_1.jpg" alt="img82710889_1.jpg" style="width:177px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">certificates and other instruments of the Company and corporate records furnished to us by the Company, and have reviewed certificates of public officials, statutes, records and such other instruments and documents, and have made such investigations of law as we have deemed necessary or appropriate as a basis for the opinions set forth in this opinion letter.  In such examination and in rendering the opinions expressed below, we have assumed, without independent investigation or verification: (i) the genuineness of all signatures on all agreements, instruments, corporate records, certificates and other documents submitted to us, (ii) the legal competency, capacity and authority of all persons or entities (other than the Company) executing all agreements, instruments, corporate records, certificates and other documents submitted to us, (iii) the authenticity and completeness of all agreements, instruments, corporate records, certificates and other documents submitted to us as originals, (iv) that all agreements, instruments, corporate records, certificates and other documents submitted to us as certified, electronic, facsimile, conformed, photostatic or other copies conform to the originals thereof, and that such originals are authentic and complete, (v) the due authorization, execution and delivery of all agreements, instruments, corporate records, certificates and other documents by all parties thereto (other than the Company), (vi) that no documents submitted to us have been amended or terminated orally or in writing, except as has been disclosed to us in writing, (vii) that the statements contained in the certificates and comparable documents of public officials, officers and representatives of the Company and other persons on which we have relied for the purposes of this opinion letter are true and correct on and as of the date hereof, (viii) that there has not been and there will not be any change in the good standing status of the Company from that which was reported in the certificate of good standing regarding the Company obtained from the Secretary of State of the State of Delaware and the Secretary of State of the State of California, and (ix) that each of the officers and directors of the Company has properly exercised his or her fiduciary duties.  As to all questions of fact material to this opinion letter and as to the materiality of any fact or other matter referred to herein, we have relied (without independent investigation or verification) upon representations and certificates or comparable documents of officers and representatives of the Company. Our knowledge of the Company and its legal and other affairs is limited by the scope of our engagement, which scope includes the delivery of this opinion letter. We do not represent the Company with respect to all legal matters or issues.  The Company may employ other independent counsel and, to our knowledge, handles certain legal matters and issues without the assistance of independent counsel.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With your consent, we have assumed that (i) each of the Debt Securities, the Indentures and any related supplemental indenture, term sheet or certificate establishing the terms thereof, the Warrants and any related Warrant Agreement, the Rights and any related rights agreement, the Units and any related Unit Agreement, the Depositary Shares, any related deposit agreement and any depositary receipt issued pursuant thereto, and any purchase, underwriting, sales agreement or similar agreement (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Documents</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) will be governed by the internal laws of the State of New York and that the choice of law is legally enforceable, (ii) the Warrants, Warrant Agreements, Rights, rights agreements, Units, Unit Agreements, Depositary Shares, deposit agreements and depositary receipts will contain all provisions required under the laws of the State of Delaware in respect of contracts for the sale of securities issued by a Delaware corporation, (iii) each of the Documents will be duly authorized, executed and delivered by the parties thereto other than the Company, and (iv)  each of the Documents will constitute valid and binding obligations of the parties thereto other than the Company, enforceable against such parties in accordance with their respective terms.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">We also have assumed that none of (i) the execution, delivery and performance of any of the Documents, (ii) the terms of any of the Securities to be established after the date hereof, (iii) the issuance or delivery of such Securities, or (iv) the compliance by the Company with the terms of such Securities will (a) violate any applicable law, rule or regulation to which the Company is then subject or the Company&#x2019;s Fourth Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware, as amended or restated from time to time (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Certificate of Incorporation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) or its Amended and Restated Bylaws then in effect, (b) result in a breach of or default under any instrument or agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img82710889_1.jpg" alt="img82710889_1.jpg" style="width:177px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">then binding upon the Company or any of its properties, or (c) violate, or cause the Company not to comply with, any consent, approval, license, authorization, restriction or requirement imposed by, or any filing, recording or registration with, any court or governmental body having jurisdiction over the Company.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Other than with respect to the ATM Shares, we have further assumed that (i) an appropriate Prospectus Supplement relating to the Securities offered thereby will have been prepared and filed with the Commission in compliance with the Act and will comply with all applicable laws at the time the Securities are offered and issued as contemplated by the Registration Statement, the Prospectus and such Prospectus Supplement, (ii) the terms of the Securities will conform to the descriptions thereof in the Registration Statement, the Prospectus, and any Prospectus Supplement, as applicable, and the corporate action of the Company authorizing the issuance and sale of such Securities, (iii) all Securities will be issued and sold in compliance with the applicable provisions of the Act, the Trust Indenture Act of 1939, as amended, if applicable, and the securities or blue sky laws of various states and in the manner stated in the Registration Statement, the Prospectus and any Prospectus Supplement, as applicable, (iv) the Indentures and the Trustee will have been qualified pursuant to the Trust Indenture Act of 1939, as amended, at the time the Securities are offered or issued (or such later time as may be permitted pursuant to the rules, regulations, interpretations or positions of the Commission) as contemplated by the Registration Statement, and (v) the number of shares of Common Stock or Preferred Stock, as the case may be, offered pursuant to the Registration Statement, the Prospectus and any Prospectus Supplement, as applicable, or, in the case of Preferred Stock, Debt Securities, Warrants, Rights, Units and Depositary Shares, as applicable, represented by, comprising or issuable upon exchange, exercise or conversion of such Securities, does not exceed, at the time of issuance of such Securities, the authorized but unissued shares of Common Stock or Preferred Stock, as the case may be.  We have also assumed that the Registration Statement and any amendments thereto will have become effective under the Act (and such effectiveness shall not have been terminated or rescinded) and comply with all applicable laws at the time the Securities are offered and issued as contemplated by the Registration Statement, the Prospectus, the Sales Agreement Prospectus and any Prospectus Supplement, as applicable.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Based upon the foregoing, and in reliance thereon, and subject to the assumptions, limitations, qualifications and exceptions set forth herein, it is our opinion that, as of the date hereof:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any shares of Common Stock to be offered by the Company pursuant to the Registration Statement (including any shares of Common Stock duly issued upon the exchange, exercise or conversion of Securities that are exchangeable or exercisable for, or convertible into, Common Stock), when (i) the issuance of such shares of Common Stock has been duly authorized by all necessary corporate action of the Company, and (ii) such shares of Common Stock have been duly issued and delivered against payment of the consideration therefor (not less than the par value of the Common Stock) as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, such shares of Common Stock will be validly issued, fully paid and nonassessable. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any shares of Preferred Stock to be offered by the Company pursuant to the Registration Statement (including any shares of Preferred Stock duly issued upon the exchange, exercise or conversion of Securities that are exchangeable or exercisable for, or convertible into, Preferred Stock), when (i) a series of Preferred Stock has been duly established in accordance with the terms of the Certificate of Incorporation and applicable law and authorized by all necessary corporate action of the Company, (ii) the relative rights, preferences and limitations of such series of Preferred Stock have been designated by all necessary corporate action of the Company and set forth in a Certificate of Designation or amendment to the Certificate of Incorporation properly filed with the Secretary of State of the State of Delaware, (iii) the issuance of such shares of Preferred Stock has been duly authorized by all necessary corporate action of the Company, (iv) such shares of Preferred Stock have been duly issued and delivered </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img82710889_1.jpg" alt="img82710889_1.jpg" style="width:177px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">against payment of the consideration therefor (not less than the par value of the Preferred Stock) as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (v) if such shares of Preferred Stock are convertible into shares of Common Stock, such shares of Common Stock have been duly authorized and reserved for issuance by all necessary corporate action of the Company, such shares of Preferred Stock will be validly issued, fully paid and nonassessable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any series of Debt Securities (including any Debt Securities duly issued upon conversion, exchange or exercise of any other Debt Securities, Preferred Stock or Warrants) to be offered by the Company pursuant to the Registration Statement, when (i) the applicable Indenture has been duly authorized, executed and delivered by the Company and the Trustee and has been qualified under the Trust Indenture Act of 1939, as amended, (ii) the specific terms of a particular series of Debt Securities have been duly established in accordance with such Indenture and applicable law, (iii) such Debt Securities have been duly authorized by all necessary corporate action of the Company, duly authenticated by the Trustee and duly executed, issued and delivered against payment of the consideration therefor in accordance with such Indenture and any applicable purchase, underwriting, sales or similar agreement and as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (iv) if such Debt Securities are convertible into shares of Common Stock or Preferred Stock, such shares of Common Stock or Preferred Stock have been duly authorized and reserved for issuance by all necessary corporate action of the Company and in accordance with the applicable Indenture, such Debt Securities will constitute binding obligations of the Company, enforceable against the Company in accordance with their terms. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any Warrants to be offered by the Company pursuant to the Registration Statement, when (i) a Warrant Agreement has been duly authorized, executed and delivered by the Company and the Warrant Agent named therein, (ii) the specific terms of the particular issuance of Warrants have been duly established in accordance with such Warrant Agreement and applicable law and authorized by all necessary corporate action of the Company, (iii) the Warrants have been duly executed, countersigned, issued and delivered against payment therefor in accordance with such Warrant Agreement and as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (iv) as applicable, (a) the shares of Common Stock or Preferred Stock issuable upon exercise of the Warrants have been duly authorized and reserved for issuance upon exercise of the Warrants, or (b) the Debt Securities issuable upon exercise of such Warrants have been duly authorized, executed and authenticated in accordance with the provisions of the applicable Indenture and reserved for delivery upon exercise of the Warrants, in each case by all necessary corporate action of the Company and in accordance with the terms of the Warrants and the Warrant Agreement, such Warrants will constitute binding obligations of the Company, enforceable against the Company in accordance with their terms. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to Rights to be offered by the Company pursuant to the Registration Statement, when (i) a rights agreement has been duly authorized, executed and delivered by the Company and the subscription agent named therein, (ii) the specific terms of the particular issuance of Rights have been duly established in accordance with such rights agreement and applicable law and authorized by all necessary corporate action of the Company, (iii) the Rights have been duly executed, countersigned, issued and delivered against payment therefor in accordance with such rights agreement and as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (iv) the shares of Common Stock or Preferred Stock relating to such Rights, as applicable, have been duly authorized and reserved for issuance by all necessary corporate action of the Company and in accordance with the terms of the Rights and the rights agreement, such Rights will constitute binding obligations of the Company, enforceable against the Company in accordance with their terms. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img82710889_1.jpg" alt="img82710889_1.jpg" style="width:177px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any Units to be offered by the Company pursuant to the Registration Statement, when (i) the applicable Unit Agreement has been duly authorized, executed and delivered by all necessary corporate action of the Company and the counterparty named therein, (ii) the specific terms of the particular issuance of Units have been duly established in accordance with such Unit Agreement and applicable law and authorized by all necessary corporate action of the Company, (iii) the Units have been duly executed, countersigned, issued and delivered against payment of the consideration therefor in accordance with such Unit Agreement and as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (iv) as applicable, (a) the shares of Common Stock or Preferred Stock (A) comprising the Units, (B) represented by the Depositary Shares comprising the Units, (C) underlying the Warrants comprising the Units and/or (D) relating to the Rights comprising the Units have been duly authorized and reserved for issuance and/or (b) the Debt Securities or Warrants issuable upon exercise of such Units have been duly authorized, executed and authenticated in accordance with the provisions of the applicable Indenture or Warrant Agreement and reserved for delivery upon exercise of the Units, and/or (c) the Depositary Shares comprising such Units have been duly executed, authenticated, countersigned, issued and delivered in accordance with the applicable deposit agreement, and/or (d) the Warrants comprising such Units have been duly executed, countersigned, issued and delivered in accordance with the applicable Warrant Agreement, and/or (e) the Rights comprising such Units have been duly executed, countersigned, issued and delivered in accordance with the applicable rights agreement, in each case by all necessary corporate action of the Company and in accordance with the terms of the Units and the Unit Agreement, such Units will constitute binding obligations of the Company, enforceable against the Company in accordance with their terms.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any Depositary Shares to be offered pursuant to the Registration Statement, when (i) a deposit agreement has been duly authorized, executed and delivered by the Company and the depositary named therein, (ii) the specific terms of the particular issuance of Depositary Shares have been duly established in accordance with such deposit agreement and applicable law and authorized by all necessary corporate action of the Company, (iii) the Preferred Stock represented by such Depositary Shares has been duly authorized for issuance by all necessary corporate action of the Company, (iv) the Depositary Shares have been duly executed, authenticated, countersigned, issued and delivered against payment therefor, and the depositary has issued depositary receipts in connection therewith, all in accordance with such deposit agreement and as contemplated by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (v) the shares of Preferred Stock represented by such Depositary Shares have been validly issued and deposited with the depositary in accordance with the deposit agreement, such Depositary Shares will constitute binding obligations of the Company, enforceable against the Company in accordance with their terms. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">8.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">With respect to any ATM Shares to be offered by the Company pursuant to the Sales Agreement Prospectus, when the ATM Shares have been duly issued and delivered against payment of the consideration therefor (not less than the par value of the ATM Shares) as contemplated by the Sales Agreement and the Sales Agreement Prospectus, such ATM Shares will be validly issued, fully paid and nonassessable.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Our opinions are subject to (i) the effect of any bankruptcy, insolvency, reorganization, moratorium or similar laws and principles affecting creditors&#x2019; rights generally (including, without limitation, fraudulent transfer or fraudulent conveyance laws), and (ii) the effect of general principles of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) and the availability of equitable remedies (including, without limitation, specific performance and equitable relief), regardless of whether considered in a proceeding in equity or at law.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img82710889_1.jpg" alt="img82710889_1.jpg" style="width:177px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Without limiting any of the other limitations, exceptions and qualifications stated elsewhere herein, we express no opinion as to any provision (i) that could be construed as a penalty or forfeiture, (ii) indemnifying a party against liability for its own wrongful or negligent acts or otherwise in cases where indemnification or contribution could be considered contrary to public policy (including, without limitation, under federal and state securities laws and regulations as interpreted by applicable governmental authorities), (iii) exculpating another party from liability or waiving defenses or other rights, (iv) to the effect that terms of a document may not be waived or modified except in writing, (v) regarding the recovery of attorneys&#x2019; fees for a person who is not the prevailing party in a final proceeding, (vi) imposing a payment obligation with respect to the Company&#x2019;s obligations, or (vii) whereby a party purports to ratify acts in advance of the occurrence of such acts.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">We express no opinion with respect to the validity or enforceability of (i) any provision allowing any party to exercise any remedial rights without notice to the Company, (ii) any waiver of demand by the Company or any waiver of any rights or any defense that as a matter of law or public policy cannot be waived, (iii) any provision purporting to establish evidentiary standards, (iv) any provision that purports to establish the subject matter jurisdiction of the United States District Court to adjudicate any controversy, (v) any provision that purports to entitle any person or entity to specific performance of any provision of such document, (vi) any provision that requires a person or entity to cause another person or entity to take or to refrain from taking action under circumstances in which such person or entity does not control such other person or entity, (vii) any provision insofar as it purports to effect a choice of governing law or choice of forum for the adjudication of disputes, (viii) any provision to the extent that it requires that a claim with respect to a security denominated in other than U.S. dollars (or a judgment in respect of such a claim) be converted into U.S. dollars at a rate of exchange at a particular date, to the extent applicable law otherwise provides, or (ix) the effectiveness of service of process by mail in any suit, action or proceeding of any nature. Further, we express no opinion as to the acceptance by a federal court located in the State of New York of jurisdiction of a dispute arising under any Document or the Sales Agreement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">We express no opinion as to the validity or enforceability of any provision that (i) waives (a) vague or broadly stated rights, (b) future rights, (c) the benefits of statutory, regulatory or constitutional rights, unless and to the extent that the statute, regulation or constitution expressly allows waiver, (d) unknown future defenses, or (e) rights to damages, (ii) states that rights or remedies are not exclusive, that every right or remedy is cumulative and may be exercised in addition to any other right or remedy, that the election of some particular remedy does not preclude recourse to one or more others or that the failure to exercise or delay in exercising rights or remedies will not operate as a waiver of any such right or remedy, (iii) grants set-off rights, (iv) imposes penalties, forfeitures, late payment charges or an increase in interest rate upon delinquency in payment or the occurrence of a default, (v) appoints one party as an attorney-in-fact for an adverse party or (vi) states that time is of the essence.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Without limiting any of the other limitations, exceptions and qualifications stated elsewhere herein, we express no opinion with regard to the applicability or effect of the laws of any jurisdiction other than, with respect to any shares of Common Stock and Preferred Stock, the General Corporation Law of the State of Delaware and, with respect to the Documents and the Sales Agreement, the internal laws of the State of New York, in each case as in effect on the date hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This opinion letter deals only with the specified legal issues expressly addressed herein, and you should not infer any opinion that is not explicitly stated herein from any matter addressed in this opinion letter.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This opinion letter is rendered solely in connection with the Registration Statement. This opinion letter is rendered as of the date hereof, and we assume no obligation to advise you or any other person with regard to any change after the date hereof in the circumstances or the law that may bear on the matters</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.31in;z-index:2;min-height:0.31in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img82710889_1.jpg" alt="img82710889_1.jpg" style="width:177px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aardvark Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">set forth herein even if the change may affect the legal analysis or a legal conclusion or other matters in this opinion letter. We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the reference to our firm in the Prospectus and the Sales Agreement Prospectus under the heading &#x201c;Legal Matters&#x201d;. In giving such consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the Commission promulgated thereunder.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Very truly yours,</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Paul Hastings LLP</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ck0001774857-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-03-23T16:54:02.7774+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:73.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 23, 2026, relating to the consolidated financial statements of Aardvark Therapeutics, Inc. (the Company) appearing in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also consent to the reference to us under the caption &#x201c;Experts&#x201d; in the Prospectus.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ BDO USA, P.C.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, California</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 23, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">&#xfeff;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>ck0001774857-exfiling_fees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025q4">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-442">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-443">S-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-444">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-445">0001774857</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-446">Aardvark Therapeutics, Inc.</ix:nonNumeric>
          <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric>
          <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-450">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-451">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-452">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-453">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-454">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_6" id="ixv-455">0.0001381</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_7" id="ixv-456">0.0001381</ix:nonFraction>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025q4/ffd-2025q4.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_2">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_3">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_4">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_5">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_6">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_7">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_8">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001774857</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2026-03-23</xbrli:startDate>
              <xbrli:endDate>2026-03-23</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-544">S-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-545">Aardvark Therapeutics, Inc.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 1: Newly Registered and Carry Forward Securities</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-546">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-547">Common Stock, $0.00001 par value per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-548">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-549">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-550">Preferred Stock, $0.00001 par value per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-551">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_3" id="ixv-552">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_3" id="ixv-553">Depositary Shares</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_3" format="ixt:booleantrue" id="ixv-554">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_4" id="ixv-555">Debt</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_4" id="ixv-556">Debt Securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_4" format="ixt:booleantrue" id="ixv-557">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_5" id="ixv-558">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_5" id="ixv-559">Warrants</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_5" format="ixt:booleantrue" id="ixv-560">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_6" id="ixv-561">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_6" id="ixv-562">Rights</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_6" format="ixt:booleantrue" id="ixv-563">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_7" id="ixv-564">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_7" id="ixv-565">Units</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_7" format="ixt:booleantrue" id="ixv-566">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_8" format="ixt:booleanfalse" id="ixv-567">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_8" id="ixv-568">Unallocated (Universal) Shelf</ix:nonNumeric>
          </td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_8" format="ixt:booleantrue" id="ixv-569">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-570">400,000,000.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-571">0.0001381</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_8" id="ixv-572">55,240.00</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-573">400,000,000.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-574">55,240.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-575">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-576">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-577">55,240.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_8" id="ixv-578">
(1) There are being registered hereunder such indeterminate amount of common stock, preferred stock, depositary shares, debt securities, warrants to purchase common stock, preferred stock or debt securities, rights to purchase common stock, preferred stock, units and other securities and units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $400,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $400,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The Registrant will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities the Registrant is registering under this registration statement. The securities registered also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

The proposed maximum aggregate offering price per unit will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to pursuant to Item 16(b) of Form S-3 under the Securities Act.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 2: Fee Offset Claims and Sources</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center;  border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 10%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 8%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 16%;">
				Registrant or Filer Name
			</th>
          <th style="width: 6%;">
				Form or Filing Type
			</th>
          <th style="width: 7%;">
				File Number
			</th>
          <th style="width: 6%;">
				Initial Filing Date
			</th>
          <th style="width: 6%;">
				Filing Date
			</th>
          <th style="width: 6%;">
				Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Security Type Associated with Fee Offset Claimed
			</th>
          <th style="width: 8%;">
				Security Title Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Unsold Securities Associated with Fee Offset Claimed
			</th>
          <th style="width: 9%;">
				Unsold Aggregate Offering Amount Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Fee Paid with Fee Offset Source
			</th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rules 457(b) and 0-11(a)(2)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>

	</td>
          <td style="text-align: left;">

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>

	</td>
          <td style="text-align: left;">

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rule 457(p)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>

	</td>
          <td style="text-align: left;">

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>

	</td>
          <td style="text-align: left;">

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td>

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 3: Combined Prospectuses</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 4%">
            <!-- Note column -->
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 25%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title</b>
            </p>
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 18%">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 6%">
            <p style="margin: 0pt; text-align: center;">
              <b>Form Type</b>
            </p>
          </th>
          <th style="width: 10%">
            <p style="margin: 0pt; text-align: center;">
              <b>File Number</b>
            </p>
          </th>
          <th style="width: 8%">
            <p style="margin: 0pt; text-align: center;">
              <b>Initial Effective Date</b>
            </p>
          </th>
        </tr>
        <tr style="background-color:#E7E7E2;">
          <td style="text-align: center;">

	</td>
          <td>

	</td>
          <td>

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img8190679_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img8190679_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "0 IX# 2(  A$! Q$!_\0
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MHHHN@"BBBBZ ****8!111D'H:5T 444472 **,CUHHYD $@=2*0X..,UXO\
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M]I+8>:'>1%R%^>1ASST&:^[()#(I;MGCZ4J^'J8:7+-:E4,13Q$>:(^BBD+
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M*<DZ4OD?3.X[MM+2=QD<^M+7SZV/>5PI&8*0,$Y/;M2Y ZFDR=PP/K0,\O\
MVA?VMOA!^S8+:/XA:E.;FZ7?#9640DE*9QNP2!C/O70_"7XR>!/C=X0B\;>
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M?B;+#*A62.2ZNB&'H<YI+ 5D[^W7WC>-HM?P7]QX5^T!X<T;PC\:_$_A?P[
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M%;:__P %7[N!;B#7?B<4<94_:+G_  KUYY9BHM.5:U_,\J./PTE[M*Y^K/\
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MMKW*%55Z,9KJ>36INC5<'T$<[5)KZ(_X)D_M62?LN_M&6-UKEZR>']=06&L
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M5\O_ &!Y/ZU\W_M.ZG8ZU^T-XQU'3KE)8)?$%RT4B-D,-_7Z5]'_ /!$;/\
MPU?(1C_D$2#^=?8XK3+7YH^2PR3QZ79G[!8. 0:_(;_@N7//+^U?86\C[DB\
M/0E%8$@9>3-?KR2P   K\A_^"YEK=0?M6Z?<RP'9/X=B\MNQVR/G^=>#E#3Q
MMGV9[N;+_8G\CQK_ ()P:99:K^V+X.M-0MHYHQJ ?;)&#DCIU%?NW%%%%&$
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M/9'Q,YSFW.6S'5>\*>%M8\<>*;#PAH5JT]WJ5[';6\:#)W.P'X^M9S2%<#<
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M5Y KVZ>0XZ<4[Q3?2ZN?GM?Q/X<HRE:-248_:C3DX_>?H#17A'[(W[;G@_\
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M=Z;N7H2.:\Y>9]8V]EN8?Q%\6MX-\"ZSXK$08Z9ILUR%(X.Q"V/TK\B?B_\
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MR:":\D8DS,NX%LMS7ZBC[P%7Q%'_ &BG9W]U:KKH<GA#.<\JQ7-'EM6G[O\
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M)W1]41;&WYV]S7-_&"PN-3^%^NV%FI:672Y54 <D[374U'+;Q30M!(F492K
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M#+\LK5756(2AV>_H=4^)N,<'A8X/^S)3JI6]I&2]GZ]SB?@%::Y^U=^W4OQ
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MA_P6>_:CU7X/_!.V^%/A*>6"_P#%1*7,\8'%LH^9>>F[H?8FOR-C#@!<@A0
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img8190679_1.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img8190679_1.gif
M1TE&.#EA>! 6!O<  /___P  ,P  9@  F0  S   _P S   S,P S9@ SF0 S
MS  S_P!F  !F,P!F9@!FF0!FS !F_P"9  "9,P"99@"9F0"9S "9_P#,  #,
M,P#,9@#,F0#,S #,_P#_  #_,P#_9@#_F0#_S #__S,  #, ,S, 9C, F3,
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MS)F9_YG, )G,,YG,9IG,F9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P
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MIQ?Y9?4 ($RABNQWN O+'_71#WW,0QW_RX93 2#%L<P4E>L,*N8:,@N(BB4
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M/?FQ)4^R7NWZ]2Z\XKL?/OSE7POQ__ORQS\^_N(33)K]_>=_?_W^Y[]ST0^
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M. VY*+$3(NQLC%K>>9'V0.9S[8& #.@KSXLVC X B.>%'$37RS8V+I!;N_K
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MKUC<KO4^1.M>[^T6KO9V+P#4KO=N[_0:+_F.K_DF+_K>7? "P/#N4_J6;[[
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M,4N<)N9A2P] ':(8*/(A'8!5*;:A"[)K)8#K+]#7B=0WQVE\V&V<V(7=6O^
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MX^X=_/?NX\.3%X_^O'KS[,N[3]\>_OOU\^/3EX__OG[[_.O[S]\?@/_M-V"
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M$WE\3G'>$HKGNJ? 4.5J>^L GS_PH0X!:B-@J#-+PP2R, =R4(1?^=X((?C
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M\[9'IKZ0,($5<1FV@,3#A7VQ@NHIQQ&S9S.7W"-0JM*BZ[RH$"B&KR+<&,?
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MRUN&(WNT.9N\C_FRU=N]TQN^G=FSW]N\Z7N][?MB9_(1T+FU<=N_M_J_^QO
M!US "YRU#SRV;YO $7RV<SN>J80FO$C"PV+"(YS"+]S"(QP^XQ/#(Z/"/;S#
M/US$0YS$,QS$37S$4;S$3YS%4[S%5]S%8QS&9US%:_S%;5S&.?^W'_+SQGL\
MQWV<QH$<QX/\QXN<R(]\R)-<R)?<R)6\R9=<'^ SR)Z<RH,\K8$[ZKH[NIL;
MNKM<NK?<NKU;S,%<R[V<R[_<S,.<S+=[S<><6A/[%O$XX>+[OND\8M&[ONU<
MSPVVO?>\SO,<T,%WOEOZK3;L*1Y9LNM!B:Y9CV0@-,LE&PX@- WLF09SF&1B
M,?5A)=2!,?EA)=:A,"_]/T'[&M= P0T\P1U\P5,]P!G\U%U=U5&]P5N=U5>]
M W3  G*  W(@U]>YUWE=UW%=UX'=UX>]UX5]UX_]UY7=V(-]V9V]V8L]V:%]
MVJ6=V)']VI_=VIF]VK&=V[,]VKV=VL'_O=NU7=RW?=R_7=W3G=W1W=W/'=[-
M7=[#?=[+G=[OW=[SG=SW?=W?O=[YO=WC'=\!WM\'OM\%7M\/_M\5WN #?N$=
MON$+/N$A?N(EGN 1_N(?WN(9ON(QGN,S/N(]GN)!OMKKI# E J __,J-&DO*
M',U?_LQC7LW3W.5EON9G'N9QWN;9G.9Y/N=O7LOA7*6S(8*<-]#QV\_OO,^/
M/NF;_J83ENFC_L^G'ID'W;$+G2-BDV6R 1S\$A[*@1QDH!S,82[O81R*Y3\Q
MLQ[4P4L^!!WH03CK81P89!O P53\0=$5PS41H1S:7HC, 1\T\QW$'NP='>_)
M 3@0738C!=09_S. N'XEHIPPMRP;T$$QS8'PR:&B,GW3._W3+S_S-Y_4A[$5
M9MW67[W691WU35_U8QW6:9WU7__T7=^>0U[C17[C1_[C=U_W>S_W?Q_W@__V
MA]_VB[_CB?_XC9_DEY_W@1_YF=_WA5_YFU_ZD]_ZH=_YIS_ZGY_ZN7_[M3_[
MK[_[P;_Z<P 1\$$?2C,?8%50_2'E.WSEVUI,@-[G=][-?[[^=5[_Z?_^[;_-
M_Q\@_/6;U4_@+'\&"PY$.%#AP80&&1*,"'%AQ8<-*6:TN!'C1(X?/3J4./(B
M28TA3X(LV5&E2)0L4YJ<V9*FS)HX;^J,R1.FSY4_7P(=*K2H/P!(D?\>39IT
M*5, 3IE&;8IT7+:K6+,]!9 5*[VM4,%.52H6+$B):%&F/:NV+=NW'M?&=3L7
MKMR[=/':S<MWK]^Z@/4&[COXK^##_?*URJ>/7^''APE'-BRY,N7+D"UGQCQY
ML^?.H#5'5LS8<6C.HE.C7OU9=6O6IU_+CDW;=6W8MG/;Y4=:'^[?LR6'Z_HX
MW_"NXU"F0_[X.%9]@<MUY;<67-=Y=J5GA2>77%=Y@?EU99%V>59RNN.^ZRH(
M+;>L[C &R$HO8K^N,O!JRYH?I;ZNZM0E7E;KL+4?5OT!=UMPEY6UU5AA/>C@
M4Q!6.*%4:P#!@0X=  $$AQJ"^&&'&W8X8HC_)H)8HH<JBMABBB2Z&".,*+(X
MHXTUGKBBCC+F^"*.._[((XU!WC@DD#T6Z:.10G*H@P4Y<) #E!M2.6643T9Y
M995:4IFEE%Y:&6:76(I9)IE<@GFFFFEN^:6;9K8Y)IMOS@DGFG6N>2>=<>8I
MIYYV!@KHH'\6ZN>A?2:*IZ)\+NIHHY#N*:F@AC(Z*:&(/GIII9I2FFFDGEH:
M:J>8BEHJJ9R">JJJJ6[ZJ:NFMCHJJZ_."BNJM:X*:Q>(W(,//OHT!MU($18K
MU8542:@LA<B2M>RQSR;+;+3.3FLMM-=*B^VVVG9;+;??>FNLN!922)1+Z-K4
MT[GJ!I5N3NL:U2Z[__"Z.Z^\]=*[D[WYXKNOOO&^^Z^_ =\K<,']'LSOP H#
MO##"#!LL<<(31TSQQ19G#/'&#W?L\,<$>QPRR V/;'+)*%?,,<DJBYPRQBN?
MW#+++64;[LWC.FM55UH]Q7,V7U&;\] 0*IC>@D@?K;313#/H=-*P);988T\O
M77734%^M==9<6]WU7KV9YO786).]M=E?GUWVVFJWG?9=O$W-]MNB.7>5UN8]
M]Q@_!V;%C3KU\#/2>EDADM;.6%%G5SU=<:>1W=D<P,T!WG@SN3>24VXYY9F_
M0U'>5^E#=A==X7-/5Z*?Y1U6Z\SR35;C[-5W-@EZ]%]6 :XU(.L&\D?WW/^J
M-4NT\.7:/+P_)QZI?)-,-K_D\TI&G^3T1%*/9/787Z_]\LY+GSWWT%O_H:RZ
MVFI^^>B3KWZNZ\?*_OONQX^K_+32?VO]\^>/__[W]W]^^_KS7_K@%\#_$9!_
M!K1? @LX0 4VD($ 1. #U02$>MSC'OE@3#YF(3B+^&,6U2H>N(8G-!&2BW@H
M+&$*C6="G+60A"Q<X0C'XK*9R0QF-<0AS3260Q[N,&8O\^$-A1A$(-JPB#TT
MH@Z'J$0B'O&)2T3B#Y-(Q2E:D8E5Q.(5I:C%+G+QBU!T8A3#V,0RNBN&*E06
MXK*RE9\%#8UP9 KPYN@VM-F1CK^KHX*D5AH]^C'_CX"\XQ\%&4BCA6V0>"2D
M(A/)2$0ZLI"//%K<&--(2*(%<GA#W6.VT95M&"XB_##'S[(Q#[EH)RM7*(EQ
M?N:XLX@2.?DX"^&PH@W%/01TV4B=V]3QLW#XA70\ T=D9E<[B=P.*[G3R.ZN
M4J"Y$-.2BZR+#$^8QC@^8GO,"]_WLND];'9/?-P$YS>W.4YO:M.<W01?.E_T
MI0,*,(+O=.<")0C/><;3@?6<X#TA*$]]VO.?_@QH/@?:3X+BLZ (/:A"^;E0
M>B:4H1#E'R+J@0A\9) ?C1';!X_BE(Y.TX4?A>$,0_K"DI+TI-4<:4J]E44P
MCO&E8HRI&;=(QI;6E*8P_YVI%V^ZTYS:U*<XE>E/A1I4G;J4J#U%ZE&-RM.E
M#I6I0$TJ5)5JL#A2<UIKQ$H;>?9&E5H5*96,)C3#2M9(EO4N?*3:6,W*UK6Z
M5:QPI<PAWWK6N+;5KG2]:UWW&I=)^D:O@,VK8/%*6+X.UK#!6RE(%3LT?I13
MG>(\)V2_-Y7M579$6P'".#F:%,WB"(1-F06*$E$L?Y0!1T#01[*2%TYR2K:U
MZ.Q10_?IT-D"U* 1I:UN;_O0VN:6M[85:&]W*]S@XM:WR"7N<94[7.#^MKC/
M;9\\>O6K5@@K):5%Z5=%>E6O>K>[X%WL=DW*6/+:[*GH+6IZI;I>IZKWO>R%
MK_][XTO?^=JWJ?B-ZGWUFU^J\O>__@WP5 ?<WOX26+X&=MEX4YC5JVRU*UT-
M+W?!&MC"5ABQ&+YP7-(JM@P?5L,?#K&%\3+7$9O8PR<&<8I%;%B_HOC%*H8Q
MBV-,XQE/1KO?%:\^7+O.Q\)VLI:=IHU4F(@2<99:CV@1:)=2!NKUHUADX'%D
M>_Q:']_(N<G%,G.-VUSH9MG+6XYNEY>KY3*#V<QD/K.:T\SF,;N9RW 6LZG(
M8$$,,L8W'3P(5)8L8?/F>,* ]G.?<3SH\A+Z9@4&\('KFV $*SK1 H;THO<;
M:4=7FM&/MO2D&XWI2U-ZTYGN-*@]S>E/MW?!:6QPSYC_XL9##TW&*XXUK&<]
M&P[76-:WIK6-QU9B7>-ZU[X.=JYK[.)A ]O8OTZVL(_].U<+6BFGI;*TITQM
M*9OHLD+"=@>J&>4C \"S(R*M5()0HT>,A8.@E8IHIVWMV+8;R"-ZLYSG_>4V
MQ[G>\L;WO<.L;WKS^]]HSC? URSP@._;X/Y&.*2Z4(]ZY,.B&Q2<1OD<0F=;
MW- 81[7&__SL0#](TY(..<A'+FJ1EYSDID9YJ5<>ZI2?_.4NCSG+2=WRF8_Z
MYB:7><LW3DU5/Y@^%W_*LI6-[*%[V-;,)@PYR#$.%HR#Z4Z'.L^X$?6F/]WJ
MY$CF7WAY%6TT$VGW2,<!?G: _W)@IS7U2,=[NG( <JRCPX%1!];G7G49I*,=
M[OBDT5O3ZZ+[/>E[!_S?T59LP;^U'NOP!L^TP8UR@,?PN:%'5SP7>*)#GI%!
M_RXBX/WCSENYRJ!GM[M'S_G/B[[TH:\VDOK-^H';.^$$/WCL8?_ZUBO<]06?
MO>UUCWO9U[[WM,_]^G1 #]-5-Z/8]6C&.9[Y0O-<O,Q?OO/!E7.;5[_FV*>Y
M]G&N\NQS'^;6[_[VKS]^\7]?Y^4'O_?)?_[PZSGZ:/2YS[C:? I??O"5S[_;
MD&YYU[3C.T]C-Y-S'I5Q2E?1#GTQ=EDA#QP!#UV!#GOQ.EFA2Y=$'(>Q#CQ#
M@?T'-O]3 W?W]X$;B'\B"(*&47@A^#OHT!7M\!=KAQ7P,()\(7E907DPJ'\D
MR"#U!T/@YGFI]VX\>'H_J'JH!X2F)X1!Z(/E)"6_=WM,R'M-N(1.&(50.(7"
M5X6^9X7!=X5:F(5<N'M4*"HZ0%UV%BP$T0\+L6<5)WW0-WULN(9NZ'%J"(?/
MQWYT:'YUJ'[IAW[MMWYVV(=XN(=YZ'YZ>(>#Z(>%^(>$*(B"^'PD)'^L1G]Q
M6#0U.(DW6(FVP7\V2!?_MX#!(8%7P0TC<1^PTQF>V!7A\ X%83:,DQ7?$!B8
M)!C]4(K9$ Z6R!9]5XN4>(*ZF(FZ9H*\Z#3]8!T_ P[P8$O_G9%5\;$6B( <
M((%+V: -[H 2^=""S"07^< SY! 3]Z!XDZ<</X. <-$/"H@5!V",$<%U65%*
M9^&,OG06,L@SWT =&M$*G+0=@,&-6#$.=;&,7;%!N/@U.6@A9$"$/4AZ1V@C
MXB9AB- AZ09#_. A)_((4A%M24(&TA)EUU,M.UB$2%B00PA.7]B%P.>%6$B2
M6VB2(OF$)3F2+*F2)]F24KB2+IF2$S0/]^!PP!)Q_3!Q;]AQ/AF00!F)02D5
MAJB(?(B(17F4A[B41AF(2MF4@!B5B?B45.F45BF527F5A,B(Y>*(2=%J0KD5
MO_B/NYB+AH&)9@D8FX@5CV<9XQ@Z_XXA<1RTD[. #UWA#5>#"*O3%>4@&;'8
M%=J #X8!.17U< ]G.L"4%?>0EB36@8Q9EF0YEI Y8K[XF'14#WN9%>7P%F^9
M#8)S$)FI#8"!2]"!%VNT#6O! ET1@]W8C)JD%V_I#82QEE=1#W&!2X6AFEB!
MFG;QEN P%[(X2L)Y%5T0F5<SE$SA6!YYD!_9D462D$BQD,_3D/Y ;CN""$_Q
MD" BD4U!D2D2!$\Q"SK0D  0!"^BD<YIA!QID)_WDC.)DO )DR$9G^\IGS(9
MD^Z)GS0YG_:9G_Q9GP9$9Z;S<!C%#XY!+,K'E<C9AG((?P[*H"TTE5J9E5B)
ME!;*E%59H?\8.J$7"I42JJ$>2J$?.J(B6J)>I*!J]#,_YQ4Y*)DN6F/]< \5
M98:6&1AH:9P209O9T)9_48]8@0^;<8U9X0UGX8#?T1>0HPYL@0_SD17AX('"
M88%TX:-780XUBA"W.)DO&AKYT"N?28*MT!5?IZ57JA:5B:.5,4ML^1?"B!7I
M8*.S4SIT09J#<9IRD8+G$1C'A!4T*!%T*A@8F!6_B1=JF@V\>9M2^A:Z>16'
M>A>^61<RT!7@L!?UP WC\*5D"I!A:3/BN9[-R9[+V3S0"0#2J234:9TZP)U.
M@9$1.9$H8I$F-9 <@IZ@2I"VJI[0LY_W^9_Z29^]VI^ZZI^[.JS_PEJLP7JL
MOLJKRBI/7D!=.4F&""HM/[FI#]J3"VJMU*H4)KJA(*I?Z'@WW-I>JX@5Q1FB
M'9JA!N$K!TJB4C6NQ-FM$Z$/WZJ"Z+JMYBH1_'!!Y\JAX6JO];JOQ%*MC:BB
M\P=A+5IC1CI*\E 9;7H5YG@6=MD5Z'$6K^@6\\ SVY"*O[&H6<$"\& WHMD9
M5)H-BRD7[IH-K2@7#:8-XR /#1L -G:CF3JS Z$/]? .7; .[O .B*"!6ZJ+
M6?JSF1BH!+(7K[0=LQ:F15NF6WJF-+LU^D /\- .Z] .\D /?Q4;LX.*&E8/
M\* .5_ .]."/T=0/^" /[S"U/.NS(G@/__/@#CG[#O,02T_;;-EZ,VO G'KK
MJ7L[JAAIJN/F(]S)%!@YN%"1(4'@467@/:354=LV84G&MY(;JJ&'K,":K,1J
MN0#ZJYN[K,:*N9][N:+;N9D+NEQ801>40?H02W+)412'HK KL-,:NQ#Z4>S:
MKT:AH^UQKR8QKP KKEU1KJ'6L$3ZN_[*KP9VLEW0K<N4#1#X+W8CF\<+K]1[
MN[S[K[B;O4U%NSI#L(]HL'<+ "BFH^IX$/)PI'S1L)[)%R>;#;$4%Q7[%[/S
M#7.S1B'+%Q&+%> X&$=[%3&!%W8#LRLFLT++M 8,>4%[P&6)CX;*&<U;3 (Q
MKUCA#5:+#_5P=O\2,;+:4!^@U+]7X0YOH;2\H\!CZ;0%O%;"Z4LDO,)H^F+7
MVF23>ZOI.<.UBJLR7,,T_*DZ'$ZFV\.CR[E [+F:&\2E^\-"[,.D&[I)/,1'
M["H359CY8*!TZ1!IR+T-6KOA.[NRVRS6"R\ZFA4'H$N3IKLI\XX3_((.@0^9
M>15]&442?!7J(#@&40^0DPUM+!/U$*?A8)L.X0YQJ@Y<),$'4+X[V0YQ2IPN
M<3K(40\)T0^&W!7I0!3$RRYY;(I\;!!^#" J\<;90,'3=<%PAZ==\0U8^Q#\
MD+ _L\$.T0_S,+*>"12SLYG>^#/H8)L,@0_4>!6(P!.*+*CW8!'\4*C_V?"F
M,>&,@PQ*C\PSRUM#_)#+VP >#J$/HHP5T8@3S:NDT#ND]E+)3GK) Y')N+/)
MH^3)$S4/<(<PG$S.%]P1O9R/C-P0CARGD>P1#:L-PX(2.@K-&M&D5S&Q>*S'
MWCP+X(Q,)\' !Q 3J.RF,(&;U3N]78R\"6/%2^&52 &65HQAB7D57"L7.MH.
M@Z&^PZF9D!&_C\' VL 1@A#2'VP8]IL9)UO-@T&:E1' ,9O +<S"==M_-IW3
M^C?*J&&*:S&OF+H7_" /P1G2MCR/8GK"=6O".,W44/W44LT0U]JIE'O#.QS#
M-KS5.;RW5\W5M<K$1;S$2$S$2FS68GW634S6_T8\UFA=UFL]05T@#_ P#_(P
M#_-0#_30< ^WNG-YA@FZQ5E\K5>,K=S[T#%1QSQ3#RU'QO=RF@!#FD#DNP+3
MSME@I0ZQQBK],R#,0VN,#^ZBO">A:IN=%<(;$I-<%)I=VO"Q$?.:M38QS;FT
M+P(8+PP\J2\1R\6L23T!V1IA@*RM@A2QQOF@+LI;1OWP#B"-U-8,(/D2O4&Q
MVL&=#9VM$*^-4T)=+Z0=W*>M$&_ISP(1O._"S]G@SYD]W9S=$=^:L0_!P*W@
M#\VKL:"3'-A[O1!]WT8ET57AO5\)B1<-6/.J=85!M,S$%NK[L!XAP:Z8J( Q
MC6SWOT?3TI/!CUBQF?^!D57R2!DT/< ['=4W_>&QUN%3_6N6G0W<X1?GVX]U
MD=V#4:@P+1>+71<B7. C'GA.#>(>SM,C7@^<,SGWH.-Z0=BMH-5=3>0X?.19
M_=5%KN1(GDUJ[=9Q'>50/N5/7N5I?>5P3>58WM96_F5>  _P\ YT3=>", _T
M, \3E;IW5H: C<7Z/=AP_N;GY=#;ZM@)TYEZIQ.R2 ]$-*_=K1$4_HD=T0\C
MF^<\0:-2U)F":10$G@U_S@_D3;)7E-HN0>A=8>@P@>@5<=W^(MOW#!2U'12W
M#<N:N=L3N"^^#1)Q&M"53A.*#B^-OLPDD]!_SA&+W=RX\]S:3!267C@'H^G_
MKHTZV#T=]0+I7?'+7M0/L_.6Z, OY&W>"5'HOT[)PFD.*-'H\&&\VJZ]]:U?
M;T[17.'?@BUT;>4.^%$;P-VG_I"9 0#A(-&^HA,1P#UUWV!W[U":8K5&W# ;
M]5 .A_R,Y<#8P6$W!U#3CFF)_.#*C KD- O=E2?B.$Z)^.#OU9[4OT3LF<$/
M[L# M(0.I9E5>2X1]%KC(WCC#+\0HO@S[7[R)"\1E!YK9IP-Z@[5A'T43)[D
MT_:Z(S3D0% &KHK57FVK%EDM^O (3Q85HH7S8,UY4M[E7+[E;!WU;_WT6>[T
M4M_T4#_U5W\H.B#F8"[F\A#V9TX/]."LJPNM$9%=_X8][FSOYFV_]FV(V+>K
MHYC^,?J0#O^>#> @"$9%F_KH#_1 VC( VA^3#^F@\(;:#FS;1'<_2N! #P7!
MP+4N$OB #I&^F^NP0063#ZL-#^MB^(B_#8K_$^:>%4.M$XV^KD!A@* 8% V+
MVR=!C3(0$SKZZ2_1OQEK+V&7]W]C,HT_C'SO#]0HZTS4#^O0F8R*#I\).7S.
M$M><,/H0#H?\#O\"^J,D^HLO$*6?.#BU_0X+,Y5_^8R:^1FSI[%C,6]I[?EB
M_3^#_0_#P)K_$^2=_72^[?;=T$;Q[?Q=T>+N]DF1XP#1;Y8_?P()&BPX,.%!
MA0@=-H3(4.)"B@\G6JP8,?_C18T8/78$R5'D1I(?1YHL.;!?OE;Y]/$+F?)D
M3)0U(6;#B;,<PG$YLP7H)S,AOP ^<W(+QX*;4:-=1*9CFNT .77FPD7=I@\D
MU*@XMX6[BC7D-I_C0)9CJLU;N70RO$5M1]$<BW#CPI8-1V[<N'HT_<X$+!0A
M2Y<P ]L\_%>P8L2+$S]V'+GQ9,:5(5.^;%FR9LR;,P/F1UA?9]*<30?6I\UG
MN87DC"IVS92;C'3EEC)==S;J6G1NX9;D:O1 N:H]F0;@E_);VG#HTJ5[RQ3>
M1K(YS7)\AY5<NG7DJOO4UL]ANKIYF>;=&P[?17=1FZLC=R!MR'[??6YC,>YV
MUW?_GOV7_JPD  8D$ !_"B3P0 0-7)#!!15$4,%9=.@ "" H!((##"^L4,,*
M.<QP0PP]M'!$$3L\,<0/35P1Q5D&5+ ,,F0L(Y%''@P"B#(*/%!%,APT\,-$
M$$R$PQ]YM)"#?!($@ P/?X20GPZ@++",$G<L<$(46U3QR@<'? 0(+DD$D4P6
M2]P2S2[+3-',--GL, <-+9 S!SKGK/-.'>ZT4\X]\_233ST%#110/#GH\]!$
M_T1T4$,9791011UMM-!*)[4TTD<EA91232_M-%-/1Q6U5$Q/#1553E?=M%50
M67W5U4]G)55566M--5=8:355UUM[W1778(']U=98C^75_]AD?456V&*97798
M99UMEMAJI[4VVF>EA9;:6>%Y1QYXQ)U'GG(1H:>>>O"Y)Q]\^'D)IJ , A)"
M'ANTE\DO]XT07W_YO1=@??L5&,9_"48XX(0'5KAAAA\V\*%Y(9J8H8H3NEB@
MC&?9N..,/);X8Y%#)IGBD4TNV>*354X9XY5=;EGCEV6.F>.9;:X99)1W9IEG
MF'VF&6B<A=:Y9Z-_/CKHI(=>NFBDGU8::J:E=CIJJZ>^NFJLM]:ZZYN]SOEK
ML<,FF^BQS2Z[Z;/53IOJM=UN.^NWY8Z;Z[GMKAMLM/?.-U^#"P8R8..,6C J
M>@YV^.^%!P3PO],<#[!QR1^?//]RRB^W7*256GH)<\@WT\<H<$("QZB@2$+'
M*'EDPJ>IB=#R:>.+9# JH^!PTFJDP7\2R;[K,HI-MG+@R4>RN[+QYO/*_1/-
M,.4]7SYZZ*?/_/GJI;^>>NNWQWZCT#CO/GSH^3$JG(^6\REWDG;WZ0!SB*\L
M>*.X&;YXF\PQRGF3\/<I(MASTD?F?/>7>I2#!=Y035=RTA>.E"XGWOA(ZGSB
MC7"  QS?J. %,_@-^?@$'@Y1AU'H@1)Z&*4_XLM>"@N".(@%KH5^<Z&:W+2F
M,\%)AFW"X9AP^"('!2&':L(2C*Q$HH$4*$= L-<LU!2A' 4!)D\<(H6H!*,.
M#"E*%BK_$R*L9$,0(9%):T($D;A80S*^J8PT-&,:0W2M;F7+6V]T8QRQ-<<V
MTI%;=]Q6'MF(QSWJ45M]!.0?!0E'._J1D'5$)!\'*<=$&I*1BCPD)!_IR$(&
M,I*4;*0E)UDM'< #7.(2ER#F,4IUW:,>[M)'/F;!CWXXSQ\\A&$L6:BXQ+F0
MEB^<I2UU*4O \7)QN\RE+VLI3!CE[6YZ8QO?X*9,NC$3;\Y$YC*3.4UI5K.9
MU+RF-9^)S6UJ,YK9!&<WP_E-<9:3G.<\9CJ-N4YHJK.=[.0F.N'I37?&LY[T
MG.<X[ZE/>/Z2F+?\&_MP4CBF'*Z7P6P0"KFG/84VE*$/5:%#_P&SN<) =*'^
MR(=P$K,?G*AR(O<H'^M<1Q&0^B0<0H&'4=!A.Z.H#R.["T#ORJ(1=Z@C'3:]
MPDSFYY'C)4^B%\4HY_1GT9\6E:A'C2A2@6K4I#;5>M]S"5.7ZI?6^80;C.D@
M !_BCG2@PZ;K, GY?!)3BM3T.>C(:4IV"I&2YB0<?DFI3\P1D1+Z1!TST8<&
MP1$.CRYD@!.9AU'B\I';98.!&7$@3B ($GD8Y7>D081C26C"J3I5<@@]:&8C
ME*0?CE&-,P1M9\\86AV6]H:F]2P:54O:T[8VM:Q]K6@_*]O5GBB3BZPD;F][
M24WFEK>ZE:1O-PE<3 9WM\/];7*1N_]<X3;WN,XU;G2+.]W>/M>ZTJTN=HG[
M*G>(ZY/R "\]YB%>1-R#7?EPB5;$0Z]7*NZ?P-3L,#'KS_G*-[ZXO"] X4O?
M".73G/O\KW_E^4X"VU/  !ZP@0N,SP7SL\$!?G""&:Q@"D_8P@ZN,(8O#.$,
M<WC#$M9PB#TL8A"/V,0E1O%"^+MBP46%H"*L+WX1)%4:*[7&EK5QCC-'T<[A
MN'KU,$IX.L,/^V0#'Q[)C@)Q @X@^\0I*?F?DKF!B)D4UJ4:@:E,K1,3=Q2Y
M*P%PAU_T492HO$/'GVO>F6]<63:OV<UJAK./VQP1J(XFSG/V1UMQ A3/](,I
MZWG(.Q*HY&S_<..$7/8R5L(\T7(,6H'>J$=CZ)%5);O#)'_=R#VBHT!MS*,?
MCLY&<C:2FJZLSGL"[4H[;")H0H=#'QP]M)S??) 8Z_>]OD0$:D=+6]CN6M>S
M_75M@]UK8+O6U\8N=FR'S>L?(@JZU-UNM)7[[.Q">]K7M39SL5UM;DM;V]J]
M-KB_G6UJ>[O<X2;WMLVM;G0CJPOA&M>XS"4/=-6#'NS"!SY:$2^FU:O6^[4O
MBV4<<((/W."V_O>M:XU@AA_8X1%N.,0?WN$43_S#$:<XQB]N<1)KO.,</[''
M0P[RBDO<Y!DGN<A+CO*32U/@"-\7JE_L$X.^'. $FC6>=9YSGM\9_WL\'JJL
M?4X34HMN'>.%1SH2ZQ-+#UWH3]^YY](,]9Y3W>E1MWK6L;YUS-2YZER_^M?%
M'G:R:]W-"4<[X,B0[&,K&]G"?CNQX>YVNK?=[FS'^]SOOMITB_O<X^YVN]?M
M=W8#?O!]1WS@#2]XQB_>\7^'?.$C3WC*)_[PG'S')^,M"'/-P][J0@0^T+O*
M5BJDO?Z&N<T5GM^;I[[@KC]XZV6_^I>KW/8IQWW+/Z[[D?-^Y1OW_>V#GWN6
M%Q_XQM\]\GNO_-\G__C/=W[TEP_]Z6-8]9B5.8(,E_9?CMWL90?[]\4O$Z"#
MW_OA1__YOS[U])O?_>-7__O;GW6ORS_^\/^W?_[QO__Y"X;[KY^]!#FBO9.[
M F2V94/ N#M !4S NLL[ T1 1I&\":P\Q9L\RVN\"[1 "L3 Q^/ #:S RQ/!
M#/S $?3 $"1!%#S!+O N> NE\9H'1*B'>VB7]&HE\2BBTX,0V@- 'HP]'X2]
M( Q U@/"(5P<X6,^)*2^YJN^)F3")U1"Z8-"XEO"*'1"*YS"X=/")*1"*<3"
M+^S"*R2^Z\NL["N0[2/"7+J__EO#-M2_C2@__G-#.7S#.60>H:K#/*3#/61#
M/>Q#T! -.Q1$/QQ$/BS$/ZR(__M!M$,$"&3 1W1 O7O !8Q$1ZQ$2B3 #0D1
M%=1 $^S$%.S 3SS_P5 L05 $05+DQ%(<Q5-D14]415&$Q1)\-^^2-_"J-WHH
MKWS;-WCIMQU41"$LPF#\12/LP6$4QH(!PRVLPC#,0BY41B]DQF1TQFE<QF<4
M0VMLQFJD1FC$1FG4QF_DQFU</C+D+S,D$#0DQUHZQ'4DQ'9LJCA$1'8T1'>,
M1XU@/WFLQWG4QWSDQUFKOWWT"/;!P<2P#Z"@1WPTB!#J'X"\G'[@J'(X2*(R
MQHD$''V8Q ;,1(R\2$C,2([<R$L<-E04R58T15=,Q9,<29-,R9)DR55429)T
MR9:,192$R9FDI"[0/'+IO,^KA]!#+WCA!U?*P8$YQG1<Q#1$2J,$1HI4_TI;
M\L9P!,=K%,=LA,JJE,JHI,JKM,JLY,JGU,JO[,IH%,MN',NI],J*:4I>,L<!
M0<=B!!R$C$B&E,O*@D>XG$N[[$>ENL>XS,N[Y$N\G,-_[,N*$$C**$B'R"BC
MZ"N,8 K[&0B%5*S"4B!X^(OV(#2<T(9(VPJCB++T88C;^08)NDQY, G(Q E$
M2#2FF*N3N(++9#K!J =0ZXIRH+3!B@C[((>82 ?95* G0TBF=$NE5**/[$B0
M]$A)1$Y++,[E_*R5C,GGM,F:?,7II,F7M$Z9I$[GC,[KA,[LE,[JQ$X\:D%0
M@@=1(J\9K,%4(CV$T,&C3$O@=,_@E,_XI,^ES/^OL\3/LL3*_"3+_C1+_=Q*
M_OQ/_]Q/  5+ 2U0 @U0 PW+ GO/F',Q[2LH^&2<O[10O\10R*G+"QU,P.30
MSMC+#/50$?W0$GTZP11$5'--!3)(P HIA^@"U;$(T\P&OY"?;)@'B(BKG% '
MFJ#1>W@(*_,+(3T)VO$)3XL(&J4)%@ /R$FRG*"RBF@LGT 'E-"S;+!-B<#-
MR[',!?I+"B7&^M2E7$M.3"3.,RU3C4S3XRQ [?1.[MS.\'13\.Q..HW3.IW3
M//U./873-Y73/444'8 W3P*O\!HO7#0O?-"'EU O%?/%I)Q/^WS028W4,)74
M2OTG!%U0!3U0!M743N7_U 8=T%%-4%+=5%,%5505U5)EU5-MU7'$U']92P!H
M2S&%H1'M4!/-U<?84!+UU5T%UI\*T6#555PUUF*U#!0EQ,*LC,,,B2?%B>D@
M,YQ AY!0TIF8TIQ8M(00S8ZZ'")-"7#U"$$PH1E]C9.(,FW("$?KM&<UBBAU
MB'8HUYBXTBSU*Y_(S8N85IP8(9#H4IPXK'4$TZ*,U2]!A"YBSC4USH5-6.5,
MMDWDTS_M4SOU4SP%U(F-6(O%V(N5V([56(^]TY"M(YQT07@HEW-)EYX4O7?A
M-[1\5$N%68*UU8&E64B=663TU)P-U4]=55?UV51]U9X%VI\5VJ+EV:/5655%
M_]J=[:>")9A9K=5+;:%C_56JW=5>)=:J15:M#8QAM=JOW=JL%5O$4-:[9%:"
M'"N;H-%L."F96-L5S89U. E$X,U6VQAQW4RX-8ITL-9S+8ETS8A7T]N]'0EY
M'=R<L%>#V%*.X*C!K=:JK5E*O=F%X0<?0E.'5=B&-=/D] +Q*A?/E0?0%=U1
M"EW2'=W/-=W41=W5+5W6/=W6A=W7E5W2I<79=5W5C5W<M=W<O=W>Y=W?W=W@
MU=WA]5WA+5[B!5[D-=[D/=[F9=[G7=[H5=[I=5[9%9=PH5[HS5[IK=[M]=[N
M!5_M#5_N%=_R)=_S_5[S35_T[5T75-_Q7=_4)2]ZH/_?\J)!]%)/5A)*]XI<
MI_7?R?U?J17@F)VEI57:I U: TY@!"9:!6Y@!A[:"#9:")Y@IK7@ ]Y"R0VH
M"#W#";59_0);KAW;N,3:$!YA$<9'KPU;$V;A%=:_LCWAI3)2S!Q(M_5;=L1;
M%(Z(?$B@=/@('AZI%KZ>_@7@(I9:?K"2R]U<S&7B% $",DB$1<T'>$DE*IYB
M*;;B+,;B+:YB+K[B+@;C+Q9C+0YC,AYC+S9C,[9?EBUC-';C-H;C,X[C-'YC
M.;9C.I[C.L;C.];C/L[C/^9C0-[C0?;C0#9D0A;D0D;D,<ZW>T $18;D1);D
M0XYD2I[D1<;D2L[D2];D3N;_Y$^VY%#>Y)ZLP4T694_^8JU@5-*3%T<U8@+^
M8%C68%D.8%JN3P>68%RN8 SFY06^8%_NY0?^96$.YERF8%U&YJ2=906!6@^>
M92&.86B^L1)V81VV9F!5X6N6YFJ.YKB$X6W69FX&YVZ^""(>8)D]YU^<A7Q8
M S) 6"5N0!VQ$?:"I1RLYP/107N&$7TV$'Y^)7R^YW[>9X >:('N9X(^:(/^
M9X7VYX9&Z(76P58*RH#.YX=V:(:V:']XTOZPYWY(Z(K&Z) &Z?8*BHL>:8I&
MZ8(^Z8*&"95.Z8]^:8B.:9.>Z8P6Z9J^:9?6:9C>Z2<-LYV6::#N:'@)BIR&
M:8\._VJ>5NJD9FJ:%FI1B^G_X0>AMNF57FJGOFJ;;NFL-NJFKFJ<MFJO[FJL
M%NNP)NN+U@I6*FNP9FNJ5FBB?&5TMN5TCF6YMFMS;KUD'F9CWNM=!N:_)F;
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MY_R+XO7+WWS0[_S?)/9$9_N[1WW3E^SNGFUH5W"?D %L!WCVL78 RO:<V'8
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M>F=&N66:<;:YYIMUSIGGG_]W_NFHB_3IV6B@?=ZY+JSJ:6I?@<CA!JM[6CH
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M$ CIQHN0"<^"0B6K;1OFX23(* !A\K8>4/!*4KI.4@ASLB3C#9G002:^\29
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M=7K5DGK#]WO"5X9#\WIGJ(; 1X;%5GMK:(9L"(=M.'N])X=W&(=Y2(=[6#)
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MMSKU5(#UBWN0T_80A 1!Q_;@AGS(CWY@6/_YB"8#D<UP: 7^\"AD*4&YV+P
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MB/' \"PHA8WHGW[4J/[KG_8\-0Y6'XY7C_7W\/>\&&W#".=<?X]MN(RGEP&
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MS7 **'<0?2@V)VK1BF)4FQFEJ$99E#SR<-0[S?S@=?J14/'Y QUP64Y>LA$
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M<F)9G9D;LF$\PN,\#ET]4(L@C!T^WF,^RL,^AI$^DAT_^F- #B1 XN,_]F-
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M%-51$0>)[:A3=(<@U,1O%.EV1"9T"%E%+&95O%A%M*M%:"D8@FFVMJFV$NS
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M6;"+!<D#:B!ER6I,/]P#/>"#-/7#\]8#\^9G/LP#/ES_;;PXG#QXUFT0U#M
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MYVJ\R_N[5[>[]V=0Q7>J6YE6EU#4UAW VQ1H"SRO0_QM.3R'#GS8BC97K<7
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MRQ,\J1,]K7,\O7,]S;,]SU,]TU,\Y9,\X7,^XQ,_[U,_Z_,]^Y,^V?,_W3-
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MZW-(\5F&'!!T'X>*.!1 _BLGS\(,&0>B/_/USR'_JU4.W?_W1=.%46W 1).
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MI1Y/:H<_9B$Q</ADE-W$RSD%=%#_DAS10I9$)&=LTD/.^%$FD10C9[BA3H,
MRT+NU A</S+4B[1/0/!@R5P-5->=N%*+.:EG0&5RQ"0NDX-GJ:<#*W)9#UVU
M(8LE*K]V5U*?L%2.$=$;5'$"R,O,(R>BXQ A<6E(.GTS/QF#(D@Z"Y5\>$BE
M)S&C^9J*U36.\W9>O>=7T0)33&YF@-+MUC I4J\5H?"8"GQ(/5+D3HJT;T51
MS4B8*D(]#S&I*OH4+WEA4J05H0, E)'HB<C%C17AS1_[8MR#FCC=[XVR%$9I
M4V>8-(YC@2Z3E3GD/&HTCI/(HT;F"&V-]-$/W_&CP[/X,%4STE?N95<Z]<7,
M??.KR12F_VBBM<W&.SA2,W-\PT/#$XC*+I.\*TX1<F75QHXK\ZZW"994*"F>
M ]M16*ED$8X5#"]$QKNB\GK$<PPVD,*,4N('_94D@17)>3&37HNL%\+U$= M
M 9"XZ"8MS!'%C/PNL^8VJQ:)$XGQC#?RR?=QI L"DNE74ER9%;^XE0*ZK4UB
M&2LQIZC,$3FS,X7<H")KZ\1N7A]W4_1=A\1WRO,-,H<]#&(1;^2Q'!)T5!JF
ME-2B><[9J#,F?[PID!QJ16M"RU(Y9 [)&4BG0=XL3]GSZ8MT61L9GO2H0]QA
M?WQ81?1-D:'UJQ*_=<8;[ECHF%+$CP^36A\A%DR#OHCI IN&U?\-B:"%,CP1
MG/'CV\Q6L(%N(N\',=C!-Q&PA;CQCH5E=L.E;K:I _,.#)?[X'S1]$.ZBYE.
M0P16W19XJ2\#0.LU*,L<VG+H.G0 )O=$8OEP=L!])^RG]&,>.%,UPMW,\N_$
M:\B@!2OA+&:948L<W -7B=@0-21Z-0C!@"$TAO![:)G "M:RKGA*COWEYP92
M)+?&3*Z;XNHX1SC/ HK21X0^[18C)<:*IB? X9USJ^,9(WIVG7U5>!F1+63.
M5+30:45I+\;.>B?N)CN(;0VD;S!Y*F"GR9@K ^F+2-HB+V_05<EJ]HCC7. J
M4=9E(KL2)7_(XT:I965D8.[.KWPDIJS_^'6A2.#/AS2/J/>&ML&;R"%J'23+
MA+)%QL:94#DD[I6!'4(\FDB0LMZB77R]2DYJ(?CQ<W])[1IGP.&/?F:CPOZ@
MQ_(!H'DBF][ =0<*/#$#Y?9BIK(/;_TWV7T21F>#C05Q/B5[CGC@N\_W)NGR
M^Z[/&N)7QOCP0#YGS3=11)BO'#3&&8M4?>]U85X$ (.7#3[V.+565O9D?JC$
M>!DT1CB1#T\%?,D'$](D>_LE?EG'$AM8$+Q'>$%Q3MK0='!"3K!G/AQX$3?6
M&;;G3;5R69S72)[''W F5+J3/#5X=^%';0PQ7@8"@'QF)QRQ/1P2=EIA?_,W
M$/G'&1E(6^0$_TL42!&Q%Q*TAQDQ"$8Z!  0"  2>(/@PSN_51FJIWP>:"#"
MATVH)V,;@82O9!6:U6KF$U<%88,TR&;BE(*<44[*Q()A<51;HQ &9"'(A4TE
M)X;(X3-E^#F^U88H15 =P83XIW\M<0\!XG[@-TGNQQF4!Q?CUG+T%Q<;U8F5
M05@!:$*J." D,5?=1U<Y<0^AITJ%9SJ-"#A[87GPIXBCB!0BM4$"<H9W=HL^
MB!$A.! C>'XS88&KJ$<J<421V&AD(710=%_#QHO7"!]S^(5AR(7-6!F[>!+5
MY#Y@XW.7XQ>4>!!/B!E1B#A[F(<V>!/RAX)8!&16F"(M:([0-8R0>/\ _N81
MZ>B$EFA94\@PIH@9X7B'_#<1_L<91+AJ*\(R-E093S 0U(-7U*=XM9-]:+84
MOQB-0042^! .G7B(*Q%X+R&(V9"/!_&"EK&%MG@Q7@A%$2A<^I*&'/*)\?-K
M/,&,T:@-[6@1RJ6%O9B-1@D@'4(^%5)Z1]ENV^44Q79L>T(2QG5# 361E6%E
M!E$D1=<0N.>&4F4A"R25P)81]28W&K>3&3<O^&$A)+ B<.0D!U*4+7-@5",T
M7:F#0!ACA&429YD-3980^L9^7"236<%T=!D8?[DL:6EVA_27S(53VS4+%G(9
MHP)TVU<9"P@1.5B8EN$P"J8E<),1C*8-LP3_ .- #JD9#C*@33!EB"_Q9#41
ME34RE1\A.WAY&649?S5"C[3V=!11E81SE:%F=@N14%HBBCAHCWI95+N6G'?V
MF'O#$7T62@31D!P2#JG((2%G$8OY+8UYDHE&A?X4G"F"012!E>U$<QRE$*'9
M(:.IG&/XE$5!FYUAF^PI+TB!G9>AG21E(-WIF>VICR)D=TJ'G$F9@@U($51V
M@"*A1BNR4 W!#Q2'EX4CH/K9E/]1;$F!;NW7&6QB/!17,1@A ZM9#M#G$/[
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M&WR.(@Q"/!Q"(\Q#/MS#/@3$/Q1$/:2S_5,J)?0_0D/!1<1 $FQ$$_2J%DM
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M("S":NIE'IEFAEIML>K]SFK^QNK_WNK^%G"2Q8R%',MF4T1X[F=W]N8+'.>
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M0_,%1S,U3[,U9_ U2[.GG6<'IV=&2&VJ'2[ACO/S(J[@*M76DC,\>JU"M"W
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M17K#-_3W?Q^ ?P-X?Q,K_W)_G5%B,ETO>(]Y]5: M6"(]57,PKU)JB=VLEF
M<E^ HEP\65R;,H//M>/)LB_#<HF_,HJ3^"^ON(FS>(K7,B^[N(JW.(V_>"ZC
M7I?:WG.FW&@U<V3_.&03SV8/N6=S=F8?N9$G.9$C^9*3)S>'=IZ>XWI>]%5C
M=)5?N3A[2SI3]#HWC3N[B^(J!#>82S] :AYGBYDS1#T@##\XJZ_, ]"@@T[Q
M-JZ(K<<4DI7#'T-G.5;GN4+SN9]3.:"#BD5+--6"+D/00\3\D5)'BPR4-'_?
M"DJC]Z>L=+#,Q$]0][3 ='D_RZ2'RTQ("G5WBSQX3#K@K@^G2GT3M:3D-ZR4
M.O]-/(&A__F[6"<EB[B/.7A!0#A>2#A("@9:8X7YAA9:(,(:&#M;?S(F;L6M
M<W4I O9@1[M@3SNT4SMA7[NT5[NV8[NU,UPPWT.?+<PQANEC^WB0FWO3-KFZ
M%_FZ,SF[[XD^S ,\O(,\-.R[NSN^*_F]WPEHEUJ>CC8(CW";_X3MHE -Q_;^
M'  ZN' /NZ45><,['.;7Z0,\'/PVM) _I /H8B8WM$,,X;,^]V<):UV[,C=4
MM'8[;Q B_\0[G% [6%$Y"(48D1$Y,'Q( &L7@0-3\ /MIFL^&!&=\P0_E.YT
M'[AREZK)&[V ]271_P\W8.MI2_=M*WW2Y]!R4WV&E7K_&95#P]Y$/O1\IB<0
M#*]1.Q20=J.W4'2W5#RZHQSH1^C#-^#E2%/1>3_0\6J$28,$/)CY0GS#OE:$
M? /U1ZPZ >$W5.@TA.*#J;A#&74QUK\8-/9=B#N[V^@Z /!Z7O@Z -R%Y6]^
M7@0[ &@X$ A0!C([KE.^9<VXC<=XC:N^Z\/XB;_^C:]^[,.^C-M^Z^,^[=_^
M=>A <_X98T_7N9<[\?]XN]_(QLNVPW.1-WB:URZ$BVHP(IB1OD-?4L2M]%,_
MS]W]&&5HOEOC%FO$.!P_^>^[1_DX.?*/-YO4E,_Z0, VQ:B#2]7P2=S#6*W+
MHLK#.Z2#[W+1&<LM0&03J"T;_SY\_/+IPU?OW3IO @="7.</0+]9_OQ9I*@Q
MX\6*%SMNO+@.8L22 [>%_(A1XTI_^;9!) B.GD>+]+Z=/-!/)4=U!$V>),BM
M)<>B((^RM(ETJ5*13EWVZY<P'S^>27LR?9H5JM&F7,%B%?N5I$QY86WB.[F-
MG]:H7RW*%'@/[BQ^[K0!%7HR&SE^72_VV\M7;\G"]:*.DRNU[M-P.J\V?KMU
M+&7)7BUG_ICP(+_)GS&#=AN:]&C3@%&CU5PZ=671K2_>RU8XVS9U^I3B4S=;
M*+[3JE\#9QU2'V^!$X.['J[\-W/8JYM?C@[]>52$^JI67RY=^_3DW%7W6W>
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M4AM;.(=)SF'62Z$QT^9"VYDUA/(3HN*,*$4Q>E&-6I2C%>78*V\)(]?=#6\
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MPR%!!B(%0B+;$"(TK".,C2#&H1^^;#;<05[L1Q]#4!SAL@/C<AOELF.LD6Y
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M^J$=3+/_<O,SO0?-M $<P*)*Z^][4E,\JX<U^5?ADFD;UN%_P_/95O( +I:
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M<?S&B2=1H8K(/:B!D7S)A[S)A?S)=SS*TR>%I;P\.\<;,N< F1S*MUS;JO0
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M0.K[LWYHTS-/1F?Z-$__\_6_3QU]X>WO'O_Z]P_ _PD0/_XC8  -., "*O"
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MNJCF)'>M!):56G?ZH&8R)1+E4)B1:JF0^JDD!Y6A2JJ.ZJFF6JJ@BJJK6I(
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M$2Y#',2 [,JM',10/,6S[,127,NT+,NWK,NYS,NV[+>PC!<&>Y_NJ[ 5?,$
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MP/^$!^M=G)CQX<*(#2L^VD7>N\OSX,F#1V^>9T3U\-W3EX^?OG[\_/&;Y0^
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MB:I2VF!,'Y$'WN#B;*A2]16DOOT1+0Z.SBH8H,%>'C&'W.A7R[4-QN41QP6
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M_W :W_$9[W$=]_$<AY7_+G !+_]RUBG6M2[6WGCGRL4-E_F1JU9DW7 B+P:
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MWKI]\_XM/#CQW<:!'Q^>O#CRYLJ=,W\N/3KUY=:A7Y^>O3KV[MH1^ZT[#NO
MA@TY?JP7."_"P^UGO8\/P/U\^/7ET\]O7S_^_?[[ WB?@/P-^%^! 1*8H($*
M(KB@@PU">*"$#$[X8(414ICA+/GH TU3%X*H(886BA@BB2>.F**)*I;8(HHK
MPN@BBR\JR&'_/OSP$R.-.\[8HXX^ROBCD$$2R>.01A8))))+*MED?1QZZ&22
M1TK)))573IFEE5I6V2666X+I)9<2#E9F>&8*=J:::;*Y'IINKAD3/NB09]4X
M_* %D6%PMOFFGW'^V2>@@PI:*)^''M94H(<N&B@\6@TT#D*-$LIHI90:BFE*
M<,V2Z:6?>AJJI:)J6BJHC'K'W7>KJMKJ=J^F"BNKLKH:JZVSWEHKKKOJVBNM
MO^8*+*_"^AJLL<,>6RRRRRK;++'&G3H2.76:EU!5VJAGJC^,Q<?M?=ZZ!RY\
MXF[+'[GGFION?^BNJVZW[GX+;[CRCDMON>WB^VZ^\>X[;[_U_GNO_[X#\TOP
MO/W8J*B][!H,<,,"%QRQOP\S++'#%D,\,<85:]SQQ1YG_+'((9/,\<@FE[PP
MO1SB@^/&*@>,LLPP4TSSRS';#/+,./-<<\\W^QPTT$/KG//)1J?,3\(I_UQT
MTT<_S;303D\-==52$VUUUEA3O?7.5W_M-=)A=UVV?::2&JW::;,]JMMHO[T3
M1!+%W3;<=Z]=M]YXVXW74HKFS??>@1/>M^&#]\WIX8(S7CCBCS>^N%[)/DNY
MY<Q6COGESFZ>.>>:@_ZYZ)Z3WKGIH9>.^NFCKYXZZZK#7EK@XZ%77K6U6Y6M
MVF*&^27OO_L>_)C#]ZXEE!\2#WSRPA??O/_RSC/_?(,)Y[B\]=!?+WWTVV?/
M/?;?:V]\AWAZ'S[XY:/?O?KGKV^^^^D;&3GDCLM?/_WW&Z[G1/C/+[G__0/0
M?O]+E%/X)\  &C"!_SL@612'P 4J\($29& $[=*Z"\;.=1K$X.LZN,$,<O"#
M'@PA"4%HPA&>4(0J+"$*6[C"605N6KBK%@"NI;NT<4UK9LLA#\FFPQ_V<&Q"
MC)H/@TA$(2),'S=Z#-B&V,0C0O&)4A1;%*DXQ1T6T60L<QD6G6C%+W:QBF&\
M(A"SZ,4Q@K&,9U2C&-6H-"7BR8QM-"(9Z9A&.Z(QCVRLHQSYN$8\[O&.?100
M!2%HR E6,)&'7,C_W/:W2$4B\I&2C*0$_U; 21:2DIG<)"3-Y$!.8K*3H@PE
M*<7"PA>Z\)2J3.$J4\G*5[HREJB<92MI"4M;RK*6NKPE=F9'K=M!*G?S>U_[
MX$=,]B'SF,\[GD&*Z<QD&C.:SU0F_*@G36A.\YK4S"8WL>G-;6YH?. <IS;+
MV4URGM.<WU3GI$:I27>"\IVES),^]A3/>\(SG_.,( 'QN<]_RC.@_G3()_4I
M4(,.-*'TVV4N>>G0AD(4EQ)EZ$0?6M&(4C2C%M4H1C?J45?%\)?FL>$P!ZE'
M0*+4I($\J4I3^L>6HBN)2X3I2VLZ1YK>U*9^S"E/W[/%ZJTTJ"[MJ2!U_UI4
MHK+4J$E%JE!I^L8;#76G4CWJ5)=:U:8J%:M,C2I5N[K#@P)4H6%%*/X:"=:S
MBA6M9#VD)=/JUK6J=:R"*JA<XVK7M];53QR]*%_WZM>/]A6P?^TH80-;V,$:
M-K&(7>RP?#E#8 (%6\-D)V73:=EU7K9*S*PL9CN+3L]RUGS6S&QH2TO:TX(6
MM9\=T?%6:]K4PM:UJGVM;->)U[O"];:ZE5L]'8G;O.8VN,"-2C^%^]OC[G:X
M.:$K<HV;W.8JUQ^,/:Q@JTO=ZRK6NMG%[G2WZ]WN@E>[X?552!\[TJ#<<'!<
MM:I7M7K5];JWO?!UJ4P5ME6<OA>_\M4O>_L;7_^/_72_69TO?_]K8 (/N, (
MOF]-GQK'!$.8P1+.;X0I/&$!7]B_*(4NAY_KX;6:]</1=2Z)2]G6$G<8Q2(^
M*'-7[&(5PYA4X_VN>&O,71O3^,8ZSC&/9^QC'/]XQY1S;#!IB#O):HNV2IXM
MDV-;S?$UT\E-KBV5E]S9T4HYRU6>LI6WK&7OM;;+8N8RF;]<9B]3\\4C7G.*
M2:F_-L-9S7'FYRP QV8YXSG&<6NQGO-\YSX#*L@]!C*AA5SH01LZT8A>M* ;
M?6A'>["\10;F3])+J05;.-,8UK2&%>SII22,B9L>=:<K3.H#?SK#X6P94#%]
M:E>76M6P1K6I8\UIK#K_>-:Z3O6M=UUK6LN:UZ]6\)S_;.QBRS/$@#ZVGY']
MIA,S>]G.EO:?^!SM:T\;VV6"-*,?[6U%<SO<W^XVN,<M[G*CV[M$!HJ1@XGD
MW8W9S/)&<[Q9"^5ZX_O,^9YWA;!,;WT#G-\!_S=LPSSP?1,\X0A?N+Z;[7!J
M0_PE;WZXMB.>;:X4M^(:OSC%ESNWC7<\Y-0^-[E+3O*3FSOEZ4;YRE5N<I>3
M7-+LIG1Z2OIK7P?[YL*V];!!#4=1\SSHP.[USH?>\S8&6.@X)[K.FY[SIS,=
MZO'*==&7?O2H8_WJ6E=ZU8DM<I!;W,_*!CO9.1[VAD#;[&7_NMFMK?:WL]W%
M_RQ_><OK3O>[SSWO,-^[W?7>]UNNFRB0K7F2#VYX@2.^MIL]O,(9S_""P['5
MCV]\XB=O><?72)R7KSSF.>]YRE<Y[F=?>XPG/GJXGU[.&4<]Z5L_;;>+WO6Q
M%ZC?\<YWV_\]][C??>U[?WO?ZQX\=I/AI,];:9M+G>M.S[KRDZ_&^@+=Z,UG
MOO2K;_7I6RSIUN_Z\K>^_>YC/_S?ISKXO^_\ZYN?^NA?/_>CQOKWSU[$8X=_
MZNO/YK3'W_[T'ROL]9]_V5<0\/'>[Q%@\!7@ !I@ B+@ @K@C 6>[9Q79%G:
MIW *7##%W%A@!4+$!49$!F+@!FJ@/G!@G8'@!XI@"/^.H =V8 FNX F:8 JR
M( FZ8 O"X S*8 WB( KJX ON( WVX W^H H"(0\2H0\6X1 :81(BX1(>3Q#&
MH!!"X1-*H0U&(15.80X>815BH1)JH1-:X1=NX1)V819>H1>&X1AR81F2(1@F
MC B"H1G"X1J>H1JFX1O*81S6X1S:81[BH1C2H1_N(2#JX2#V(1H*8B'^H2$J
M(@N^D8<@8B N(B0FXB1*8B42XAUB(A]FXB%N8B1>HB:"(B>&HB<^XB>*XBEV
MX?ZIXO]!E^D!X"NNHD&M'BO2HO_=3__!8BWF8N @(0?ZH@K^(@L&XPP.8S$"
MXS$*(S(2HS(:8S(ZXS(^8S/_0N,T2F,U,N,U1B,V4J,V6F,V>N,V?F,W@N,X
MBF,Y<N,YAB,ZDJ,ZFF,ZNN,ZOF,[PN,\RF,]LN,]QB,^TJ,^VF,^^N,^_F,_
M N1 "F1!\N-!!B0ZYLCPB=1YH-?\;%'"1"0<3>2-5.0;M8Q$ZD-&4N1&.MA%
M@J1':B1'6J1(=B1)8N1'FF1)HF1(MN1*IN1(JN1+TN1,VJ1,XN1)WJ1.YB1+
M[J1/]F1,\N10 B51"F51(N51*J5+_N12PB13!B54&J54)B55.F5-1N53:B56
M3N56-J55@J579B575J58=B597N57FF59HF58MN5:IN58JN5;TN5<VJ5<XN59
MWJ5>_^8E6^ZE7_9E7/+E8 (F80IF82+F82JF6_[E8L(E8P8F9!JF9"8F93IF
M74;F8S[E4C3@ 7;FC362 GXF WY;4S0%:8JF9WHFIZAF:KHF UIF;&HF9D[F
M;#:F;-)F9=IF9N;F9=[F;M9F;^+F;PHG<.IF<2(G<2HG;RYG<#;G<3ZG;S+G
M=#HG=4*G=4IG=6KG=6YG=G+G=WJG4^K# V9#NTG@9'4>Z&V>>HJ/AT09>W[>
M>LKG]?C;?,9G>MHG?"J>YN%G?][G?^IG?@J)+L;B+DJ2*Q9H@A*H_,RB+1JH
M@B82+D+H@R[HI8SFA;8F:FHHAKXFAVYHAGKH*<F<X!D?X?_M3ONI'XIZ'_N5
M7[E GXJ*'XN>'XRF7]9HGXRF:(O2*(ZNZ(YR'_G-J(X*:9 2:8X6:8_:RX0J
M:87ZS_PQZ9(ZZ./@7Y0^:96JB81:*852Z9F$*(AZ:8=^Z8>"Z9B*:9EVJ:*1
MIWF:* X)J'\&J)L^R;W!Z9P":)N>2'W2Z9O6:9[:*>\8W)X"JIX*:I\*:)9"
MJ9:&"H(:ZJ)N*7&1(*,BZJ%:"I8VJJ1"JBF%Z9F:::9R*IEJZJ=VZJ9ZJG:,
M* 0ZY/%IBX\.J9&R*I+FU(NNJJNV:HRJJJK=:*W.:HW2:JSNZI&6&I#F*H_V
M:K#BJJP:Z[ 24J5>ZK+R%MTP:Z3_/NM\7&"T4JNR @"E0JNU9JM<@.JH>JNH
M@FNWAFNHBFNYCEN:#AY'3*"G#"J?NNM_+EZ@$NJ[MFLXW8CDT>N\RFN^\FLX
M18F^UFO  NS %E.U;JNE)H6B:BO"'NQ@-&C#+JS!$M3',6S%2NQ,F.NW9NRX
M:BRY>FS'@BS'+F"IEB?-J2OR$2NOZNK*"BNMP:JOLFRQ(NO,5M^MJFS+XJS,
MQNS-ZFS2+$W/ BW/"BW,YNS07HW%1FS2%HJ3*BW20BQQ36O37JS47BO%3NW3
M6NS&:NW'BNS6AJS7=BW7@JWP00[M%)]#GF?A[>O:"JQ_QFO;LBW! BJ>QFV_
MPNW=ZNN?_^*MW<KMWM9M[URMTSJMPF)MX,[>PPJNX6XIMB8NU3;LV(IMY'ZM
MY(;MY%INY6)N+9%LNZ'JB1KML>XLT09MN[QLRHKNY])LT?Z+S9YNZYKNZX*N
MZC(=L,;NZ,)NZMIN[:+NR#1NX3JN5#"M[PJOX$[I\"HN #+N\?8NW$'NY39O
MYE+N\TIO]%*O[J%K!*ZI>O7M]O+M^KPM]_ZMWWH9W8HO^)9O]\J;WIKO^J+O
M^8;O\BKO_Q$N_/[NDR)N_-9O_25O_AHOE4ZO\U8O] +P  MP ?\ON&ZNR0I3
MJNZN[.JNZR)IZ3[P[88N!3LP@'EDJ^4N[C;P!E?P! L8[7(P!/^/L 5[\ 5_
M,,C0;_\*;_"N\ NS8O'",/\B[/ZR\ ROW0'K< #O, 'WL 'S<!"/SO6B;?9>
M&ON^;_L^F7LBL?LZ\361;Q-+L1)3<?.H;Q4_,19/<7SB[PU_W?QV,0Y?W/W2
M<!CGF0V+L1GGU@^SL1 #L0^[<1O#\1QK4 *7Z,DR, FG\!ZC<!\;A@27, @'
M\B#SL;BPK@EW<"+KL1\GL@@7LB(C\B*?\"0/6!J7L=*ZL!I[L9[)L"9;\I^A
ML2>+\D+%<2G3L1R_<2JC\BJ;LFT0L;6XV[K&318G<2U_UO=J<2[;,IA%WA;3
M\B_[,O-<\2[K,C 7\\*-\B9K'!A?LC+_)R@9.W,RIU@H-_,G<QPKGW(K8[,J
M:W,W9_,W6X<=GZH1?PHC2S(D"[++AAHEGW,[1_)5'7(ZF_,[RS,[([(CSW,]
MHS,AYS,_>UTU+\IAT(,77 %!=\$5Z, 5'+1!([1"%[1#)_1"0[1#,W1$/_1!
M6W1%%[0@),)X'F\F W1(NUXGB[0U/QPU1W-)>]@VL[0W<S,XMS1,NW3MO7(-
MQ3)Z$G-.&S,RX;).!_,Q%TD4 [5/#_5.S\@P&_5/$_52*YP:]P,BN -#2S5%
M4[5$6_5%8_547[569W55=_564[4@X$.GK# SI_19OQTTF[1*0QQ*KS5:NU5,
MO_1<RW5=S_1=_\NTW8DS+'<N#MFS/KLS8#<1(#]R8/OS/M=L!@OV8A^V81<V
M/<\+/O]U8T/V8S.V96O86P/ /7!U1D_T57LV1GMU:#<T:(_V:9MV:F,U:6>T
M(-C'MH(T7+,UMI&T;-OVZUGM;&NVP]EU7M,U7O^V;_=V<&MH31^9+/])4A>U
M4O>T<C.U4MO;O4+W="_W4",U=3]W=6<W:#UK/P@"5X.W5X<W6)/W5YOW>)^W
M>*MW>8-W%R""01BH6>^V;C^76DOS?=]B;M\V?N?5</LW</^W< /X@ MXI#&D
M>8TS'GNN8_<S9CLX@A%V@TOX9#^X2L4S95_VA".VAN><9&\XA7-X9?^'N#PO
M+SYT-FJO-HIKM&JO>(JS^&>[>(RW^(S#.(V+]D*_PVOO7VS/]WX;5VWW>)"_
ME5OSMY#S(H$3=X G.9(K>9,SN7(8]TVKK7-3^18W-W97N2X+]79G.9=C>8%<
MMW9W^9A_>8DLZ"P( GNO=WJK>9NS^9NC=YRON9R[.5<C MEMH&\5^9X[CGW3
M]Y^#LGX;N8_?F9,7^)(?NJ$C^J(K.G+LM4WWM7J!^*1_>")'.*4S.*97]H57
M>*5GNJ>+N%/]+*AGN*:7.JFGKJ0.=(VS^HW+>*N7]JN[NHW'.JVSMHK#^JV_
M^*SG>A>T0CL!NT,$^[ +>[$3^[$;>[(C^['_\X,([L^R*WNT0_NT2WNU4_NU
M6WNV8_NV:WNW<_NW>WNX@_NXBWNY0SM<D ^YJ[NYL_NZ\SG8$3F@#SKM/7FB
MUSNCWWNCY_N^#['=F.W,8:^"LZF8EWE.7SG!(_Q2;SF9)SS#UW*8>WG#%[S#
M1XCH^0-!TSF<S_G&USG':WS'@_S'BSQZS\ 5S( YE/S)ISS*FSS+JWS+KWS,
MP_S,OWS-N_S-R[S-YSS.TSS/ZWS/[WS0 _W0_WS1^_S1"[W1)SW2$SW3*WW3
M+WW40_W4/WW5._W52[W59SW64SW7:WW7;WW8@SW8UP.W@$NQ$WHLQGO:O_O>
MZ+N]PSV^Q_W;RWW=__?2@9\M7Y,SNYHZAOM]I^/,I:,ZX(?ZX'/ZB/\]XA/^
MJ3.8AW_ZXQ<^Y#.^^L7B/.QZK><ZKO/ZYF,^Y^NZK'=^Z'^^K6N^Z)>^18O]
MUZN^U[-^ZK?^V*^^Z\L^[+]^[-/^[-M^[M?^[N,^[]_^[^M^[PL_T:=#LS<[
M"?)#8[03VY_=VL][V^L5O]N]]--]]5/_]1-PE*<MO$E\]__MP<>GN]5)9(W_
M1W##BO!#,&T#OO+(/&P#^1_9-JQ#\D>(/!Q ^7/$-L!#AOP[_D/*-@!$NGH
M^LWR1] @PH,%%R9DJ!#B0XD.*3:T&+$BQHL%\^G+QX^?1I$3-V8D.=)DRO^2
M*U&R//E294N9,%W&I#G39LZ:.W'RO/E39T^A0'T&)8JP(S1^19D.-?JTZ5&I
M3_FYVZ8M6U:L6K-F.^"N']!T7+/E@^HTZEF:_K)MS58N;5RT<Z?*K4OW[$$
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M2!,7"R RFK %L<7ET!O&>Q+/&!<5=Q)81A4X:[2,_,B3K)V%.9R4S,J2/,L
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M_X5TWWW:H[W?PWW? _[?MT34/_U(G_@O,5 V? /%^X.ZWZ&2^/_ZPH,<KP.
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M?36E.1&V2UNV8YL[0WNU:1O$39P63UO$0WRV49RU:=NU6WS$:7S&;3S%69S
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MQ.V/?X?;%]__]\?F.LBK#?)P-4D%@-G #8!R,ORP#787#OJ0,.YP9NK +^4
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M,L*I2\&$G6VX!_8:APZKGF_XPL1QJ,>,D2=HG7M8AU",EF\"P/59/A<$@':
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M5^F"=?\!%VT0EY-]69.-V<,*49H=49L%T9L549S=V26L0GBX29]=O,4CK9%
M(B],+1R=41Y56J:-"AMMVAV%VJ5-6JK%BC-5/0HRE'F02ZK4P#=ECBWMTE%Z
M.#B]VCH4R^X0V^KRUFQ(A]3H5)PRV[*=6S>5V[J-2]TK1#K%2U8CT,7QAP\$
MCW$JP<H!59W;G/_\Q\$Y5!R;FUJ4H=W;ALYY!]B1!\%IO[C%'(8<!_"1FU 5
MT,(!3= ]/GV($41IG'P 4K0,3];UVP%]W?UYJ0>$W=:E7?$B%.!YD,8IW?+
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M@ $2N)^! !XX8((%YF0111@Y&"%!CV%UT$&!U50/A!5QN"&$ G4$XBPBD@A
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M&35/,VK)T"/-+Q21IU3(0R_1EOXZK"=VTOIF0R0),*J&;"9V<TP$63%QH'/
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M+7LX+G\X*V>B(L=JAX/X*CVR.4D;5K0O)7M%M6JBL#:QB(_19FO# 6P#-Y
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M)LM/Q,@#MH@\2-BAG^F-I!Z)0M3+QSRYI0@_X-TV,).0R,,BTN:=9*!4P$/
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M#M_ #=Z@E J12_0TH]DP,%MQ&#@* %,5EV)A5$8I&5J3%A7:$OJ "/10#_1
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M"R52I([G[+'H_,[N',^]5;'M+++UC++WS+'P;,_IO"(@N\_XW,_Y7,[R'-
MK<\:Y,P*S<&-\;+9\!@TV9$M,96U^Z':,FT^*ZUBX<(,H3$GV<9%.\G=I&@Y
MO!5W^[0_# #&F@W@\!F:J+=* <M8F\09$5-16TG"VY:@P0_$\KAJ05%J"Y?N
MA#8Z[,6A9+=9FQ<X#=-*D4E]6Y: *[I($=* RM0+-9>+ZQE+;;W9X-2C*]6/
M?,Q5;=5>:JF.W+G_]@M47+W)BPS6@/PRFI33L+MI9P4WB52:LIL@0)K3O 0
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M*$U\PQ.B>(QS \D+.3O=V_-2C&^CZ@MYND/\SG2^#^3L:5=(X3O^<8:$O?$
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M4F*#1GXY/')URA?@\@1.=@?A[X1;>QY.*/4[S(1/RU>$^V3D?V3IX\0X K-
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M_?6/SSX;U5UC7>CQP3<<?(<)RIQ4MZ7'D"LE#!TCX_^=[2*7D<EEI'+M$T@
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M/_G1SWWUMS_^[W<_^ZV$>M6/=OB^[S___R]\ ?A[ NA_! B  XB !9B !ZB
M#<B #VB $?AZD6=\^V=Z%XB!&:B!&\B!'>B!'PB"(2B"(TB")>AY^?=QZ.:
M$KB""\B"$.B",=B",_\(@S3X@C<H@S6H@SAH@SG(@SOH@WE2? NF%_#G??5'
M?_=G?_-WA$J8A$PH?T88A4LHA4C8A%!HA5/XA%7HA%?(A5C8A5KHA51(AEM8
MAF-HAFF(AFLHAFV8A6\8AJZ$@B/T@W48A#V(AT"8AW:XAW>HAW_(AX#HAX%(
MB(-HB'V(B(((1A1(A,<G+_W@#P0!B9(8B0 PB998B9>HB9G(B93HB9CXB9L8
MBIT(BJ4HBJ9(BJ>HBJG(BJ/HBJCXBJL8BZT(B[4HB[9(B[>HB[G(B[/(#_H
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M?WOROQ_?_-Q++>K\\,MO'WWXWY>???K=KS_^^^>W?W_\,Y_P_\N]28 1(B
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M)PW?SJ!'P&<U7W,V;W,WQV<RV.?=7@A_[NTYOW,[]PZ"/O,\YVVZG5L^]_-
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MO^X]^W?QX<ES'V^^/'CTZ]6W/^\^_7OY\>FSGV^_/GS\^_7WO^\_O_\$#)!
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M05$U4^R7?Y!DO=5-.?VK3KI'K6]T$,EF0P6@Y%7ZSR24SB!J!:R$C@!GA!P
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MYZ'^K0P[ZJ:>&_TP#Y"KL@Z,8<OQD@%5EQ*AD1G3T:&1LLJ\' ^F,>['&^M
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MAIP'?."5#8,&?N"'64@0J3*6<$0Q<?S(D/3(D7S D@3)%I.RE'RRB>G #_1
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M!^7T3N5,QMI,!SV !WF !SU8JN/<&NKDBFYK&F+KG:N83*/)!U:\0'>0!W=
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M[-5[_TK66A56:L567>HU&LG5:U76;[76:KU5;PW7;"U7<!U7<?TE37V*O&Q
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M;YF47![3<<0TF.1$I$K.J8 <PSPGE,!!#A7<CAR:C-@SDS(.2?9#6K<C03C
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M(O!-<_[R+OTA+_QK+@<3,?'R+U:!+-/R(9X@+(?BZI;B'FJ.M+@!49PF[ #
MZ+(!Z1:3,!53-)?"OD9B-%&S+X(N&\HN-4/3-:%B+Z/&+U^S'RQ+5Q*S,9;R
M(1@L-VNS)XCR*(4S:8H2*8WC.),#.9%C.3FI.*UD-+QP,DPL.:ES.9>C.J\3
M"#J&.*]F.JU3.:_S.['_$T?(<T;,\T;.4T;0<SW5LSUMQ#UCY#WE,S[ILT;J
M$T;L,S_Q<S_+DSWG4S_[$SX!-#W_DS\)]#X#M$ 3%$$/=$#]DT$?U$$%5$*
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M[)6O>^D+W_GBM[[Y_[VO?OO+W_^6=[SF#?!["6Q? ^\7P?Y5,( '[& !0[C
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M+5=T/5</7==T95=UA==WE=>?8LO.<\M,%2P?I5%]W5&N6=%]_5& %5C<^\N
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M_^DS'_,T9W.A1G,W7W,X5_,Y;W.=UJ"B7D[N?DM-;>L^9^L_-VNQ+M6H3NM
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MO6MA!SO7Q1ZVL5F:#V,3N]G,?C:RHWW_[&D[.TVLP]FU=79J;&];VS;S]LO
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MDB=!JB,[$J1Z!N1ZFN>9^)][QF=YSF=[TF?\]:-\UJ=^LB=_YF=_Q@D+!JB
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M_=7;<<']5MQRR3U7W637=39==N%U%]UY_]OMEMYX[:TW7'SWE5=?<_D%V-^
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M]$T_]4=_]4N?]5'?]:ORH!M9?ML156O]]C\][_H\]_O!'5!F'B:D'S@^B$A
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MA"EDX0I-Z,(8PG"&+:3A"VN(PQOJD('E*Y^WTJ0--H$L3A<IHA&/B!  )<I
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M=5LOGFH6XILR3";T7 2AOB2Y00EJ\I2C?.4E9_G)U]C&-YZ\Y26WHYI4S,M
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MQ]E #Z*4P>MPM=^B1;!YEP;2=-S@#=[P#2H0T=\ T1)-T1)]T<,$1M#P#N1
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M=-/IAX.@@@^W\*A\%OH,D^1B#9*F]#SX0(MKEF*;O[1G*=R Z$%M"AGAY$-
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M/-<JPLDS0GVB!T20!WJ8!T1((:<HDKW["7K0DEF8BBI\D:G@$7IP"GXXDI^
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MD_=OQJ]RHK=YLW=G(RA,RW=ZQS=]S[=[US=^WW=[BU2 HN> "FB!!KA_O^>
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M^!BT>V0J'&[28SLRI0Y,3B2725%!TS+&CV1RBI^W7.6'&J>5;9#*C_S@EUE
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M\"@_\"9?\AT?\HG'#0O5\B=/G-/L(O @WM\M&?W@63L/(CE"K&BB&?3 (O2
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MI&I9G?4XNK24J43-QE.!Z@^I.B2M)J4@Y$!25H:I(W2'<6GK'/*ZH&*N:M\
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MES?#(^[PB4.<WA*_.,4S;G%])]SC#_]XQ4.^\9%W'.0G%SG*2:YRDZ=\XET
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MKLE;+X]2+!-3J?9KS\ B*LJ"J7N8O.F$G-&AK7=41KOZ*N@<B)D T*;*3FZ
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MH<T&MB4*M_W9?$ 'LMV&=L#5I.&'J?59?[#:GP6:?F@'%2@Q=%"<">6\CZ%
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MW=S/#YUG Q[ZO+GYO-XG-_^:H3G?FUG?GWG?_;W? 1[?_UW@ Y[?'U6 J'F
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MW'^?/?C;AT_^^.9[7S[ZYXNO?OOLOY\^_.O'3__\]B,?>NB"RJ?->WG2QY(
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M]P[O.__O]@Q6/H:-]-^TY2S3PBW8$H#5,H#;(H ):( *2(#2LH />" O BP
MZ("TDFWK05L(UQ[D,"K]L%O?<"!@Q![C("K^L&_AD"GNMEPUTESL@0Z8_T(/
M\@$./B)N_(8I^<<-JY)_VH!N%J(/\:$F7 (@2A0?Y(" $'B$_<%?2<B$!=B
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M3$B&[$>'C,AQM,9@K#L^M#;C0ACM,[(B2S(?^TB.)#*15+(C TF/#$F2[$@
M0#R4-,D@2\F1=,F2;$F:/$F;?$F95$D0J[S$R<F8K$F<!,J9O,FA#$JBU$FD
M_,FC5$JC;$H8$\JDA$FI],FIA$JF+$JLC$JJW$JKK,JE],K_#(,_]QM+L3PA
M?D!"?M@1?-"'M5S+?$#"3>NT2+N,C+R;GB 'JRC+]?N=><A"<B *FW"'NX2)
MV9 ,O9R)/;1+GN"&XUN8IS%$Z]L=?&B,)\B):>N)>N"3>CB8=&B)M&$D:N,,
M[/ 'P>2)KL&TJ^&)+[NA4OC#S%RAMVF,SC"81GP_)RO-;,!+LF08[MO+P]Q-
MVPQ.X!S.PXQ+XO1-Y!3.WUS.Y-Q-!V1 !%Q Z7S.Z8Q.ZKQ.Z\Q.Z-S.ZN1.
M[/1.[>Q.\?S.\0Q/Z@2_R_2)"1P*@[M!]^3!]]Q!A )!<I-/'+3/^+S/5&HW
M%<Q/_X1/ ,7/ -5/W\@W AW0_Q10_P4]T 6--YU[4 B-T*)@C=;H#'60T$B1
M&IXH!:3HOJ)HPYI;!<_8AKK,!G XBCJ4CT(4"KD$ !$EC-.,"7,@#.N+S0KM
MB51L"0\5E$[,T?CHFVR8!_F@T!L5"GS T$NBI(.K121M4B=]4BBUN9F+4BJM
M4BN]TD#I.K;;4KGCTJSC.C!]NR\54RWM4C,=T[A#T[934R\M4S8]4S>-TS!-
M4SDETSE=TSJETSMMTSV%TSY]4T#-4SS]TSRENX'!2+P3/]ACO45UO=A[5$:%
MU*!AR4:M5$FUU$C-5$?55)7A24S=5%#]5%&]5%+EU%(-50 HO5$U559%U59=
M55>-55B=5?_<:4[F5$Y;73_66)J'>8>R28V'Z8=\*(4*W!-^H =ZN(=9T#AH
MJ(=YR ?K>Z%>>M;=60>C$5(1.LO&'(A[H(=Z\% 3\H=N!<P<>@?0W 9!5)BZ
M49MMF$( Z(EQ,*'-5)O7H(EP*)ML.-*.(IMQB(G/-!IW321_J =ZT-??2<UL
M^#)Q3=81ZAMMX%#8A)N G=&E\0;=.=9D[;3B@89[F(?&E-9\F(=ZR-'DFE:^
M0#G$R</CQ%6675F7O=67/1X:DLN6A5F;S=6:Q=F8G0GR[%GS_%GP#-KR%%J?
M)5J@'5JD+=JD/5JE;5JF?5JCC=J52+\(5$]K>Z1F=*H$95"NW=K_]Z1/KT50
ML6W0L56.% Q;LDW;KBU;M)4W VU;N&5;N57;N*5;/=E&O*7(K,7&:-1&O<W;
MI")2G@@^H##7T6@)QN")Q^R)6.2'2.R,<HB)>97$=XI-<%W)]"0,<^"3Q1T,
MS[C0@F@-;7B)R6V'F1@1MSD-$CA2G$C<;/!5S]"#G^('SM#8H@!2Q04 VCV-
M;1@JP?6&F#"-SHA1P\7,F+!1IB&JTD64=O ,;=#0;%B'F.A$Z.6,"V4*T:TI
MY&U1?R6,C='=Q^6,S8TDW.0,R.")>GT)S_6,UVB/R95>H.C<TP!=9F32;*3&
MOL7?O?5;OMU?_05<_@W@_[7&*;U? \[?_P/VWP0&X 'N7P9>X+^-X*-:2(EL
M2 J^8 O.8(C$X W6X(*LX X.X0_FX!'V8((\884TX106811^R!)FX15^81EN
M81">X1BF81+&815V81V&X<:2X*6RR)ZX._9<OZ[DRJ]$XJ;,RJO4RB-^XIND
MU"5VXB2&XBEN8BP&2R;68JWT5"[.8B7>XC"FXBO^8C,>8S"V8C$&RJ>L8C<N
M8S0^8S4FXS5^XSJ&XSE.8SMFKIO-63_>V1*BRR'>$R"ES9:H6A-=AU*0AXVI
M.VY !*9HWJE)&$G.!GBX"74PFM1XB17-&X@%@#UD77]87)Y8!Z+@!WGPB<B%
M"6OE"6RMB?<ES/]^H%!M( %YZ"AZX :CX0:&Z>3/R!YX6!IT*!Y)-IKKY1V#
MX=69@%<7*DVCR<Q19B3C2IST!(>9^%?5M*!-X[ZF<8E8I@E^$ V>.(!2> I]
MV RC:5\ 0-C/ +Y^@%V>V%R&T="'O2'D#=C-7!K=U(DZ?,U^P%V#E0F?((%Y
M( A\^)JE,8R6F-QL0(=.XP=T$(K5!(![Z G3K8FG61I3UMU4[HE53K7>_.,^
M!N21+FF=M3CC-&F1/FF67FF71CFGE=J87EJ9AEJ:ONF9SFF;UNF:[FF<WFF@
M]FF>_NGO5;_,+9CU9-SVG-NUM5NGUD"P9>JZ;6JJ%CC^G&JLEFJM?NK_K)[!
MZZCJK09KK@[KKD8G+#UKM(8/P4W8V="-><!=V4!<CT:*3@96H.B'MZDV +C,
M%M6'GI!G?CX:=OK,=FV)Q6W$HN!5H(#>3XZ)BBYEH+"&QX7?HBC>WHT)UP5L
MH%@:)951PFALHQ#B:/6'G@@'^A#G>%[)T: 'H>A,OQ8*NP8 Y&V-V'[LZ 6*
MV)1=HU"!GM!M .C$CP8*H4 4(!72^%AK/7"'=G '=#CJ? V8GH"^NT9MH"#2
M>IU0B\9L;O &$MC1F"B%W@:*;XZ)PSX*ZAX4^TUK]5YO]L;0 FYO^(YO^5Y2
M0JUO.[UO/<7O0=5O/N5O/_7O0+7O_![P_2;P__XV\/]&\  '<$$]\ )_< >/
M\ 2'\ F7\ 6/%4,E+D15F[Q#/EI]U5/]<%D-\="38A _\1%'<1%?<='S8A4G
M\1>/\12?<1:7\<%351BG\1RO<1VW\1W_<1\7&94FZ98F<IO85;L!S8J-UA75
M!I+][JGIU]PQ5X.1!QU-YLITB9VHY9I@;8,YS9MP!TV6B8S.ALMUB3*/3 !H
MY2!MF'R^;9J YZYQF(@NF.N.0#!DF,1U\A%Z3*.Q<MT1F*7Y6&;.(80>XCHW
MF"/M9&W@AT-'ZFN^&WPM&.D>6+R!7W_P\MST'7E(9YI V(G^=*,9S9APV$\N
MGKQ.\K+I3)J8!Z/IU_\]*=YY8 E7YPE8SPG6Y@F%SAU_R(=[*(5Z$//<?0G;
MOF@TQYLS)W-DO[24+?(A?W9GC_:7]J&9-7)KA_9IE_9K-YZA[O:@)FIP]W:A
M_G9Q#W=R/_=Q3W=S5_=R;_<]@D!)3^KC4N"6*FM[)VM\!XZH'FM^%VM_U[:S
MS?=_%_A[[_?W?%N"3WB#5_B!7_BXH'>(?V $GOB(!V(S7&O>-7;,[HEH9>4B
MS>Z6F(>>L'( P,U8K.0BU>W%_1LJC.N88.R<6-Z8J/-L &V8L.W(90G7#77#
MYOBC0GDX5RG4YHF:(&V>,&TW-/KH%@HIS_52ME'?;HGM55Z+?@G<O.2C &__
MR#YD'(48U_71->\)XP:JV?8,;D"4Q*S0>@6$GG"'=Q)Y](4)?1#BSJ@"\>X)
MRNYYGO#NEYC1O:]?#6E@ 89@![9XPA]\BI?XBB]\QE_%]UY\Q(=\P9_\PZ?\
MQ#?\RV]\D\KA&^Y\'O;\&NYA&_Y\T@]]T.?\TD=]TT_]'5Y]UU=]V&_]V/?A
MUY=]VZ?]V1_]VL?]V]?]B=3\FJ+[;"!BI3;B/=9C/#Y^.5;^.&Y^*S9Q.HY^
MY+]CZI?^Y4]^["])%\_CZZ_^Z;=^YV=^[@__[ =_-JZ\\4]_\5__\O]^]^]^
M\V=_[Y=C;-_V;&<_029Z%XK )V\)("T'@-"7CQ\T_X$$#4+S!P" 0G/:LFGK
MUR\;Q78*%_IS!S$;NH$%/2+4UX]A.8K9^&%<2'(C2H8 UCW,-L\EQGHFUZ5<
M=Y,FSW<FT:D<9Q*:RHL R%'41C0E4P#WDB;E:53CQFSC>)H<9W1KT:X.38+5
M5D^E-ZA@LXTT2L*L0JY-_=FDB),A/)/JW@*8%[.=2W(Q]4D]:A*P43U)2W7%
MNY#;V;8 U(4E<5%ANYCF#H+,[$^A3XKI @.@9]+=Q70FO='KFL]D.9I/*VXM
M^;!E[,&*0>,6B=(M;MZ^$_<&_OOV\.#$A2,_KMPX\^+.DS>'_GSY].C4I6._
MCK$?OUDCM5L/7WU\=O'ER?^#1V\^_?GV[-^OCU^]G[^1].W7!W!??_[]_OL#
MB)^ _ WX7X$!$IB@@0HBN*"##4)XH(0,3OA@A1%2F*&%&F*XH8<=@GBAB!R.
M^&&)(9*8HHDJHKBBBRW">**,+,[X8HTQTIBCC3KBN*.//0)YHY \#OECD4$2
MF:212B*YI)/YJ:<>.&=!I))*5&9SCY5;<MFEEU_RIQ!]8FX6IIECGEDFFFNJ
MV2:9;Z8))YMRNAFGG7/>62>>>^K9)YU_Y@DHGX+Z&:BA@QY:**)L\J//1_4I
M&BFADR9*Z:*25IKII99BNJFFG8+*J:B?CCJGH_J(Y*FJH9+:ZJJELOJJJ['2
M"JO_K;/>*JNNM>+:*WVH?N0KK[OF.JRQQ2(K;++$*MLLL\\>ZVRT>()9K;77
M8INMMMMRVZVWWX*;;5E@&74M4A0!QN5KV7"SK3^,9?.$4-E\PR4^IV5;$D4M
M;6F.2?P"8!A%B&VY[EP+Q94-"5^&8])8"YV;3;I;ZBNQM>V<Q<W$*E%EDC8
M^V-2.-Q"@V4V(ZLTC\E ;0FO2=]9:[!*_)Q6+L<FZ:'2$T-U&?%2*NE$T4S8
MCFM2N4&;M V_ZRZ,;<D4-<UE9]GP!<#3\7:YBDE56)GPP0M5#+!*_NX;+D;\
M]&.-V6NSW;;;;\,=M]QSTUUWVO35G;?>>_/=M]]_ V[E_V9S0OIFX6$>/F;B
MFRT^N)N-0TZXY(]/;GCEB%^N>.:,;^ZXY92#_KGHF(=.^NB:EX[ZZ9RGSOKJ
MGIL>N^JRNTX[[+/C7GONM^O>.^^_1]XZ\)T'_WKQMA^_>_*^+S^\\,U#3[ST
MST]O?/7(7Z]\]LQO[[SUU(/_O?C8AT_^^-J7C_[YW*?/>M\-4\EE51MI*5][
M8KJ4EG[Y\X^___O_3W\"[!\ "SC  !+P@ 9,( ,1Z, %/E"!$FP@!"LXP0A2
M\((6S" ',>C!#3X051Y14P=!:$(-HK"$*?S@"D^HPA>R$(8NC"$-9VC#%N(P
M@0C!6PYKV,,;RO"'0@PB$7U81/\@&C&)2%SB$)781"8>\2,$.>(3JTC%*SH1
MBU#,(A>WZ$4K=A&,7]2B&%,(GRBYQWYG3",:U^A&-3*D+#')1GCFI13AZ"0F
M,]F*:+3ACL3HPV,0V4U7U#''>G!E'MO(QCLP(IN3O,5?LTE)92HB%9L\9"X*
MX4?'Q-(5?2Q2+D;9&43R 9QSW?$XE30+.- Q#L;,41LD^(Y1LH*>B,WQ'EOY
MQOP>8DJ>K*4JW#B -[[A#7!PPYC$_ 8^&(+);&CR)7/DQU;D416^*,0OZ I,
M.?["$XQ!Y&#%@5=,'+,0R,RO3   )T2&1A-,_O$B[-S&SS@S1]( 0!]SU,=6
MZA(3<KC_QB06*<HC:4-0EKP1&MR!8QL9RL:'OK&A$H6H0R-*T8E:E#C<R4]&
M*^I1C'[THB+M*$A+.M*0@N=)1UHIDUBJTI;"]*4R;1)-75K3F-YTIC;=*4YY
MJM.> O6G0LTI47U:U* >=:A&72I2F:K4IJ;(I+<A92SE1R5==LEF31%<5KL$
MK65-*ZQ@':NTR/K5L@JK48\Z*UO%BM:VFM6M<'VK7$-UJGQ(I*YQW2M=^3K7
MO^JUKX(%K%]I!2R!##:PA$UL81O+V,<N-K**G>RHM,H3KG+)LIKM:F8YNZ7-
M=C:TG_4L9D<KVM*B%CBIW:IJ6\O:UUYV(46CR&1(*YAMEK8>_W.DR&PMR=6.
MR42SZTH*"7:;#7P"(&Q:)1LD57*UI%TD80-=B#7Z48]0GF:WVEA%5R)&&(K9
M9K4,Z<>\3 86>&0V9!1!&6@_*YJSU&M+*CO+56SF,O.>I7[2+9<U\;N3A9 R
M&_54B<^V%,BS: .V"KDO6K@$W&TJY![&[2TTMU07__K6'_W%<-0 X#7PEBTQ
MS*6F;17L#[2I3<$ECJV*3^M:%L.XO>*5\8MIW&+3XGC&*[9QC'?L8Q??6,=
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MUE>0YUW]T\G__,U__=T?1E"]_>?__>E?U7V]_O/__MF?UO5?_?<?(/P!Z =
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MK/:XW;U_!Q]>_'CRY<V?1Y]>_?I^U@BNAQ]?_GSZ]>W?QR^^X$5__/U7[ _
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M+Q_1O<;@2:]T2A=_BC#S\D=S-1<AQ5^3<!@(]/:&IOB&"L)?GX"&"@('B$C
M->&&FY"'"@((>?X ]/,WL""X; H56C-(T&'!@P;7+53H3B+&AQDC:NS(\2/$
MD!M%>B0)TI\^:/_Z\O4[67(DS)<R7=(T:3-F39PW9^[,R5,GT)]"?1+M:31H
M4:1'ARY-RE0I5*;Z4JY\:M4IUJ9:HV;ENO7JUZY@O9(=:U8LVK!JRZ:-.1
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M..ZA39V4 S*EL(GL%M(0G=RC,M:49C;Q:1"JM#"?_GRF/M<9T('^4Z %)2A
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M/_F?OP3!&PK9+ O9K\E8.N_/O_S7?Z6_I4'?/Z3K/__]\[_][S]   #@3^#
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M%W3DB[[IJ[[KR[[MRRV_)WR[%[^]UWFY-[_!5[_RF[_T"[_[B[_]"\#VZ[_
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M[5A'.J25<(%GW.$;W]7QC#)6C',\Y <G^<A-KO&2H_SD6AKWC%1KE*(:#:F
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M_R+BOXGZMW_^_;___^L_ !Q  2Q _CO  $1  E1  TQ !US !VQ ")Q ":Q
M!KS ",1 "M1 "\S "(0M+Y(',)*'>?BU%K(0Q<B022JV/>(^%WQ!&(Q!&9Q!
M&JQ!&[Q!',Q!%Y0D2M)!'_Q!( Q"(1S_0B(L0B,\PH$X.R6$ER4T/B9\0B>,
MPF]IPBF$0FY)ON13@:B@PNNRPBZ4PB_DNVSPNRWTPFWAPC,TPS($PS1DPS5D
M*(?ZPBITPZAXPJ,#'S6L0SI$PS6<0S^40T!LPS\4Q#%YLFRH@CX,Q$0D1$9<
M1$?4PT%\Q%^"0TG,0SZ$Q$ \/'=HQ*A ON_!1$Z\1%&T1%+<PU*,1%"L1"GT
MAQ23"1$+Q5-4Q%2<Q5$T15M$Q5K$Q5B$Q5N4Q5STQ5U415WLQ39$PKIX/JW
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MS1;;;;W5%MQNP^66W&_%Q=9$_:@UMUQ]6-6O'7";G,E;?,BAT,EV[J$J&V[
M?6?>F;@AYYUQ\<%''6\2Y6:=>PP.]]U$)::WW7,KOIC=C!^V^-MZ[IFG'GH0
M 9F>CT,>.6231299991+)MGEEEF&>>:3:UXY99ISMGEGG%_F^6>?9>XY9IV#
M+AKHH8^^&6FAC58:ZJ>E3GIJIZF^VNJLF]Z:Z:Z)]GKIK\4.F^RHL>9Z[(_G
M@4>>=^!A&YYYYJ&G%'H\IA5;:/@QSKB!VG,6P&<';';9P T''/'"$X^6<,:A
M;1SRQR4??'+!+3]<\<S_':><\\L7C[SSP_NQ1D3/-0?=],U31QUSU5MG_?/*
M7Y<]]M!K7YWVTW-W_?;9;=?]]_\4I,A%XH>W52+DB8_0^.295Y[+YZ4O'OKF
MEZ<^0NB*C1Y[%^?2#QSNCW^GPFVJ/S_"7"M4ZOR LT$Q0F)G\LOZZ.O9AIS9
MT.]^(/E7*L=Y*=)'HMPA/@ @!DG<8]X]2$ .?@3P0"N:B5ZNIR#_98-^Z+M?
M_@S8*/T\JH+.4]],\,2_@#WI>!!2&(\@B*^5C -[WYM)7?B'P)E@#SL\FMY
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M>+\;7O..][SE1>]ZU=M>\KXWO?!EKWS=&U_[SO>^]<7O?O7;7_K^-[\ YJ^
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M_, +W,!],:(2+$+25Z-NI**49PXEM&)1\DDDY \O"9]\MZ7=ET$L^QYI^4&
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MYCD+[*_#)GMLL^L1&^VRU3X[;;?7?KMMN.>6NVZV[XX;;[KUMCMOO_?^NV_
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MICW;/9T+Q]LD+[YB6XEPU:?GBI7]>_=AX<^7WX_^??OX]^OO?S;^?_4%F-^
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M;_FB[_F*K_JV+_N6HBJR8K#)*7;$XC !:Z[F;Z_B[_Y66;KYHOX.ZNX8JN]
MK2OVQ;%E1Z/*!YQ":N]0H[.MXZE*3S3BCC>"X^Z(X^[(;V+M3SM\1W&V1:7J
M[P+!(ZO^*@GS+PKW+PNOL O;:KJ]< K/< NKL W3_[ ,5Y!9[C!9%H2)GE=$
M/B3&S"M8P@ZW"=OJ@(.,&(0[9 =@E67Q8L?Q#L0'8\<3!!-,@-83\_ L)2-V
M9*KL7*JW(=L4'Y,\>.-WF /PVE+69L<WC(,W</$N-3'^T=+28L<:*T0J664M
MC:JT@<,J$%,4EQ59DJ,!RC$LT?%?[= =.^\L0? 8UQ59SNOL&/(W(C(F9[(F
M;W(/,69D.F9E@G)FBG)GDK(GA_(GIS(JK_(HJW(KLW(INW(LP_(IO[(MS_(M
MUS(N[[(N]S)G^K)G_K(P!S,QF_(P&[-A@N;JS*Q-%6F!(NB!/K,T)V@T4S-O
M">TTZ]9M?I]4[29V)&U/-?^R=P@G7LG(5)$#66V#<OH5U=;'>5ZM3LW#6Z&#
M=3J64&UG_C!5\\JL:HV66\E(?+QS-CM7>UKS0!^T02=T-2\T-#<T0OLG?SZT
M0ROT1#.T1%\T16.T1?_G]58O]G8TT?@#-Y"69F7'QMRI86T#G2K$!WO',2;O
M;4YQ0>C#=2@6G+6T,4+$SMR#ZM@T2-_9ZV*'.YA,.Y T94F6-IQND=8#68&#
M.M1#L<"I=X QF!TG=N##1W]T/Q@6N'U9\P+O0K16Z*X#3<V#S8PT4B/UUN9A
M\7J'4C<H66.'68\'/QPG":A?5H>:/O3T2TM$7&?#7%?$5X,7^AUU22\Q]%K9
MQ]3_-7#BM4<_=O;^=%Y'MAVN;_J^[V5GMF5OMOMJ=F=S-F:#MF>']F>7-FF?
M]I6^*:DEQ+"M-+XJQ0W7, ['=@ZSVI\"<*L*<.\0</ 8\*(J\/&(K39$:C5*
M<':@*O"PW_=IJG9@<.]T:O$HLE O3S]\AS>8ZG'3MNZLJG;/MG?+-GC7=G=K
MSZV.MWA_]WF'MWFOM\#QZVO_Z\O"]WN?ZWPC:V%CAS=@M0\W,LWF1!7G=,#6
M*Z_!@WN3Q'\[XT!@*WW[ZX*/JQ=G QA7Q2HM&#] +82?4AGZ7X$;A3X "1_[
M1 %6I[UF1SALN'PSN(G;:2/G\5;LL4T,9S:4PE3X,6NA_\H\9%8:H_A#S -N
MZOATP+B,GWB U[>[ OE#K'B^0G)=43B36T^#"_E14/*0^SB1Q_>37WF*9SG
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MR<K#IE;)2@^NRHFQMU*4\C$;$ZWIIT:L1&RJ1R&SJB="%+/BAH3EPH*-2:S
MX@K&*V>L$$JLY''PRR&] 4T=L:XJD<5LM,%GPF^PTN8I*TETDRQ]A/2&*WR"
M\ZK,U)SDBL[>["0+3JP:!("WK+)L"D2LSDQ*G]FR(H'2K-()Z]%LDFQJ2R:[
M3&K)*YWL1TAN'IS2JT2= @W5IJ#I,\X_LW(QK'=Z6S.K=YH:)RNR."R(*WI
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M,0ZSHIHVQZSFB(K^*1MV"@"649KDS&#R+QL X)^T88_NZQN@8AKWQZNRX8X
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M(+Z95K,.Q%=O)DBO7<MB-7O5*=1Y'\^Z34OV[<:.\_)=E$NT7\>/(4>6A L
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M)$);2>-@$EE1#^/P2>$P#_"IGVY!#MRE#D-!H6X$$0+1BOJ)$CGK#0#@#M_
M7>0PLG&4J&P4H$&1LYV:#AJ+#QJ!#^.@L21!#J60'2'K(_- %A]+$OP0LFX4
M/2VK#2]+%'6;A20P#GYK$U_KH%BAN(FD#7E[$H#+#?Z #^102=L #FV;$??P
M3FX$#O-0D=H@H6@QLQ7:%*N;H?5"L2?!N8%[$)BKN;,[$IX+NAHANCZB#>"
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MAT1D7O1Z*+WE56][V?O>\[HWOO!=[WSM6U_\RC>_]-5O?_G[W_OZ-\  WN^
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M7WWYX9.?OOFD2];89.[#_UC\[<M?/_WWOV]__OC/O[___0-0?P'DGP +2/_
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img8190679_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img8190679_2.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "0 IX# 2(  A$! Q$!_\0
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MHHHN@"BBBBZ ****8!111D'H:5T 444472 **,CUHHYD $@=2*0X..,UXO\
MMT_M#>,_V8/@5=?%GP=X;M=4FM+F-)K>[<JH1C@GBOA1?^"]_P 8P./@SHW_
M (&O_A77A\!B,52YX'%B,?0PU3DF?JF50=?YTO3BO%_V%OVDO$'[5'P-M?BI
MXDT&WT^YGNGB-O:N64!>^37M![5S3A.E4<)=#IISC4@I1ZA102!U-&0>AI&@
M4444 %%%% !1110 4444 %%%(SA!D@T 0:C?VVF6LE]=R!(HHR\CG^$#DG\L
MU^(?_!37]J63]IS]I:_U#2;EFT+0/^)?I46<HPC8EI<>K-GGTK]$O^"L_P"U
M?;_ 3]G^Y\(>'=76+Q#XFC-M:A2-T<!R)']LC('UK\9%=Y"9'))8DEFZD^IK
MZ')L(FO:R^1\_F^*M:G$2-6$85SD@?,0.IIU%%?1[JY\]JW<#TK[#_X(W_M4
MQ_!GXZ_\*J\2ZDD&B^*R(@T[X6.Y7/ED9Z9SC\17QX>E.T^\O]-OH=2L+EX;
MB"1)(94QF.1>0RGJ#D5CB:$<30E!F^'K.A7C-/8_I'C>*104;((R*?7@O_!.
MO]IFQ_:>_9PT?Q?-=!M7L8EL=<B9@7%RB#=(?0-P?SKWJOA*E.5*HX/H?;4J
MBJTU-=0HHHJ+W- HHHH **1F"]:!(I&<T!<6BD5@PR*6@ ZTW<BC=NQ[GBEW
M#UKY?_X*0_MR^)?V*_"N@ZKX/\-:=J=[K-_+%Y.H"0HJ*N<@(ZFKI49UY^SA
MN8UJL*,.>6Q]0;U_OBC>/[ZU^5'_  _K^/\ W^#GA?\ []77_P >I?\ A_3^
MT#_T1OPO_P!^KK_X]7=_9..[(XO[5PG=GZK;Q_?6DWJ.2XK\JO\ A_5^T!_T
M1KPO_P!^KK_X]2-_P7K^/ZC+?!SPN!W)BN>/_(U']D8[L@_M7!]V?JMYB'HX
MI001D$'Z5^66@_\ !?;XLIJ<,GB3X,Z!-99S,MBTR28]07D8?I7W=^R#^V1\
M,?VO? W_  E/@:1K>Z@ &HZ7.1YMNY]?4>]85LOQ>'7-..G<WHX_"XAV@]3V
M"D9@O)8#ZTH()(':OFW_ (*/_MK^(/V+O >B^)_"F@V.IWVJZLML;6_W[1%M
M8LWRL#G.*PITJE:?)#<WK5H4*?/+8^D"ZCJZCZT;U/21:_*F/_@O3^T 4R?@
MYX7/TCN3S_W]I3_P7J_:!'!^#7AC_OS=?_'J[O[(QMMD</\ :F$[L_5;>/[Z
MT;Q_?6ORI_X?U?M _P#1&O"__?JZ_P#CU-/_  7N^/HX;X/>%@<=#%=?_'J7
M]DXU*]D/^U,)W9^K!8 X+#\J4$'D'KTK\K-'_P""^GQA^VH?$'P;\/2VF0)5
MLWG5SDXX+28K[I_8Y_;7^&O[8_@V3Q%X-CDLKZS8+J.E7$@,D1/<$'D5E7P&
M*PRO..AM0QV&Q#Y8/4]I8A1D]*:9HE?8\B@^AXIT@)0@#)KY+_X*1?MU_%?]
MB>X\-W_A'P;HVJ6>MF=)#J(F+1NFTC&R11T)[5A2HU,14Y(6N;U:U.C'FGL?
M68D0]'%()48X#CIW%?E9;?\ !>_XW_:(_MWPC\+B#>/.*+<9"YYQ^^/.,UM?
M$?\ X+T^+;3Q&\/PI^$VF2Z6B*/M&LF5I)'[D;)!@<'%=O\ 9&/ZHX/[6P7=
MGZ=%TR"T@H\R(D .N3TYK\IQ_P %\_CM@[OA'X4&.IV7/_QZNW_9R_X+1_%K
MXR_&?0/AOXB^&_AVTL]7OE@DN;5+C>F>XS,1^E3/*<="/,UHBH9K@I244]6?
MI$C;AG/Z4$IG!(SZ5' 4";E3&>N*^;/VX_\ @I)\.?V.)HO#<FE2:WXAN8?,
MBTV"4*(E[,Y]*Y*5&K7GR16IV5*U.C3YI/0^E]RCC<!1O']]:_*F;_@OA\<?
M/<6?PA\+B/<=OF?:&('N1*!^E'_#^K]H C(^#GA<CVBNO_CU=G]DXWL<7]JX
M.^Y^JV\?WUKG?BJ^_P"&GB J<C^Q;D<#_IF:_,L?\%Z/V@C_ ,T:\+_]^KK_
M ./5>T7_ (+F^+?$>GZAX>^*OPAT^*SO;*6W6YT<RAXRR$ D2NP/-7#*<;S)
MV1,LTP;BU=GP+K[J-=O1_P!/LG;_ &C7Z(?\$ CC6O&Y_P"G"#_T):_.K5;H
M7NJW%_"&"RW#/C/8D_XU^BG_  0$.-9\;G_IPM__ $):]_,_^1=(\7+/]\B?
MIGN7.,T@<%OO#!Z<US'Q@U+XAZ)\.M7USX8:?8W6MVEH\ME:WZL8YV49V'8R
MGD=.1SBOS6US_@NO^T7X=U:YT/6O@MX8@N[2<Q31.ET-KC@@@S>M?*4,%5Q;
M]P^EQ&+I8;XS]4=P]: 03UZU\(_L'?\ !5_QA^U+\;XOA/\ $+PAHND17=M*
M]I+8>:'>1%R%^>1ASST&:^[()#(I;MGCZ4J^'J8:7+-:E4,13Q$>:(^BBD+
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M*<DZ4OD?3.X[MM+2=QD<^M+7SZV/>5PI&8*0,$Y/;M2Y ZFDR=PP/K0,\O\
MVA?VMOA!^S8+:/XA:E.;FZ7?#9640DE*9QNP2!C/O70_"7XR>!/C=X0B\;>
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M?B;+#*A62.2ZNB&'H<YI+ 5D[^W7WC>-HM?P7]QX5^T!X<T;PC\:_$_A?P[
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M%;:__P %7[N!;B#7?B<4<94_:+G_  KUYY9BHM.5:U_,\J./PTE[M*Y^K/\
MPQ-^R7_T07PS_P""]:KW_P"Q%^R3<VLEK-\!/#BJZ$,5L0#CZ]J_+,:I_P %
M9",_\)#\3Q[?:;G_  J&YNO^"K%]:R6UWK'Q+>-U*NOGW//XU'U"LE?V^WF-
MXNE)65$\4_:2\+^'_!GQT\5>&?"L2I866LSI9QQM\J*K\ 5],_\ !#SQ3JFD
M_M53^'[:X9;74-&F\^'/#,N"&/OUKX^\4V7B+3?$-Y9^,!<+J4=UF^^UY\T2
ME_FSGG-?5W_!%+'_  V);\?\PFX_E7MX^-\"];V1Y.$J)X]65C]DZ_.__@OV
M!_P@_@)@>?[4NQT[;$K]$*_._P#X+]_\B-X"_P"PI=_^BTKYC+/]]B?0YE_N
MC/S$CC::184ZN<5^HW[,?_!&?]G_ ,7?!3P_XT^)6N:O>:GK.EP7L_V>54CC
M:1 Q5?ESWK\O;#_D(6Y/:93^M?T&?LRQD?L]>"@Q_P"99LO_ $2M>UG=>M0I
MQY':YX^4T:=:H^97L?.O_#D?]D+=N$FM_3[6O/\ X[4GAC_@C1^SUX#\<Z5X
M_P# _BK7K&]TF]2XA4S1LCE3G!!6OL AL\$8I1GO7S_US%-6<SWE@\->ZCL0
MI&8(@A.[CECU)%?A/_P4?\8:KXU_;#\8WFH3NQMM0-K$"WW$0]!^M?NW.=J%
ML= :_ []NHG_ (:U\=$#_F.S?^A5ZN0P4L3)OL>=G<FL/&*[G5_\$Q_@SX(^
M./[5VE>%?B%I27VFPPR7#6<H^23!X5AZ<C]:_72/]B3]DZ- @^ /AL@#K]@%
M?EM_P1G7_C,NQ!_Z!DH_5:_9S:3SGC%99O4G'%63:T'E%*,J#DTGJ>7#]B;]
MDO&#\ O#7_@ *Y#XY_L(?LJZS\*M>AC^"VB6LL>ESR075G;".2-E0E2&'TKZ
M!V"N>^*JC_A6WB #_H#W/_HMJ\VE7J\Z]YGI3HT^1^ZC^=K4[9+'5)[2+.V&
M=U&?0?\ ZJ_13_@@'SK7C@8Z64"GZ[EK\[]?R=?OCZ7<@_4U^B'_  0"R=:\
M<G_IT@/_ (^!_2OK,S_Y%TCYC++?7(GZ9. RE2,@CI7XY_\ !9#]F=?@[\?Q
M\4- T_9I7B]#*P1#MBN5^\/09ZU^QC D8'K7@_\ P45_9NMOVDOV9M=\.062
MOJ^GVS7NC.H^;SHP6V@_[0R*^:RW$?5L0F]$SZ#,,/\ 6*#MNC\2?A7\2/$'
MPC^(&D_$3PQ<M%>:7=I-&RD_-SRO'J,C\:_?G]GCXMZ-\<OA!H7Q0T*YCDAU
M;3HY9!&V1'+C#K^#9%?STZC87=AJ$UA>1M%-;R.C*3\P(.TGZ[@WY>]?I#_P
M0U_:B2!M1_9D\17HW2R-?Z$7<G/&98QZ=-WXFO>SK"NI252*U2O\CQLHK^RJ
MNG(_2O/.,4R5PI P3TSCTS_2A)=Z;]O7I7G'[6/QYT#]G+X)ZS\3M=N0OV6W
M\NTC+8\R=@=BCUS@_E7RM.+K248]=#Z6I.-.+D^A^=O_  6>_:7U#XL_&&P_
M9F\#3&>WT:91=Q0D-YUZXP$P#R0"/QK[A_X)V_LQVG[,W[.6D^&[BT5-6U(&
M]UB4\EI')95S[*0,5^=W_!+[X'ZU^U7^US/\9/&L;W-GHUR=2O;B4;_-N2V8
MU)/^<"OV*B")$H10% P !P!7KYA4CAZ4<-#IOZGE8&#Q%66(E\B.:%9HFAD4
M$."K\\8Q7DB_L*?LE+JEUK5U\$=#GO;R=Y[N>YM][22,2S,<^I)->H^*/$%C
MX5\/WOB359 EM8VSS3.>@55+$_I7XV_M6_\ !57]I+XI?$;44^&OCV^\-Z!:
MWDD6FV^D7;0O)&K$!W=,$D@ X]ZY,#A<3B;JC*QTXW%8:A;VJN?J</V*/V3"
M.?@+X:_\ %H_X8F_9+_Z(+X9_P#!>M?D!\.OV@_^"BGQ9,H^'?Q.\?ZN(,>?
M)8ZA<2+']2N0#[5U7]K?\%9/^@[\3O\ P(N?\*[Y9;B(.TJ]GZG&L=1DKJEH
M?JHW[$W[)FWCX"^&OPL%KY$_X+!?LO\ [/WPU_9RM_&W@+X?:3HFJ0:K%'$]
MA"(FE5G56!'\6 37S,VK?\%8RI!UOXF'CHT]R17GW[0&G_MLZCX:BU;]HR;Q
ME<Z3:RKY+Z]+,T4<AX ^;@<D?I6V$P56&(3=:_E<PQ6*I3H-*E8\;=GCQ)&/
MF4_+S7[Q?\$\?%>H>,_V-? 6M:G*SS#0TA=W/+["5!_("OP=;+ 'L:_<W_@E
M^"?V'O H_P"H:?\ T-JVSZ,?81?9F>2RE[=KI8]\NP/LTG&05.X>V*_GB^/"
M"/XX>,D P!XGO@!_V\/7]#UW_P >LG^X?Y5_/%\?CCXZ>,QCKXHOO_1[US9!
M_%F;Y[_#B>H_\$[/V0]#_;#^-DW@CQ/KT]AINGV)N[UK;'F2*&P$7((&3U-?
MH1!_P1&_9%$0$DFMD_\ 7VO_ ,37R_\ \$'P&_:.\1+CG_A'?_:E?K,OW>.Y
MK+,\7B*6+Y82LK&F6X6A4H<THW/C:Y_X(A_LDS0-'!>:[$6Z.ETI(_-:]G_9
M!_8W\'?L=^&-5\'^!O$%_?6.I7PN -0V;HSMQ@%0,U[&H(&#2UY4\5B*D.2;
MNCTZ>%HTI\T59GS=_P %7@1^Q3XF!_O0_P#H1K\0QTZ5^WG_  5?_P"3*O$W
M^]#_ .A&OQ#SM4L>V:^BR+_=V?/9S_O!^SG_  1LPG[&6G'=DG49\$?6NH_;
M0_X*)_!O]D;19[.ZU*#5_$[)_HN@VTP+*>QE(/[L?K[5^<'PN_X*8^-/@1^R
MA;_ /X4:4+;5;AI_M.LRGF!).GE#U]_6OF;Q3JWB?Q)KTVO^+]1NKK4+U_.G
MN[QR\DA89!8MRV.WI4T\J=;%SG4VO]YJ\S5+"1C2WL?1.M>+?VQ_^"IWQ<30
M+%;JXLA/O%G"66PTF)FV[I" >@[\D^E?HK^Q9_P3(^#W[+FGVNOZ]9V^O^*0
MH:34[B'Y;=_2)2.![U^;'_!.7]LK4_V0_C-'<ZI(9?#.N&.VURW/.P;O]>/<
M?RK]L_!?BO0?'7AVR\7>&+^.ZL=0MEFMIXFRKH1P:Y\UJ8K#I4X+EB;Y7&C7
M3G/61J1Q[,#T&.G6GTT!\Y/\Z=7@ZH]Q;!1113&%%%% !113)G9 "H!.>] &
M=XR\3:5X-\,WOBG7+I8+.PMGGN97( 5%4DY_*OP9_;._:*US]IKX_:S\0+^^
M9[-;IH-(C!.R*W5B%P.V1R:_0C_@M;^U[)\.?AS:?L\>$KH#4_$T+R:PZ2#-
MO: @!3Z%\D_1?>ORAB&X[RV2<'.W&:^ER3"<E+VTMWL?-9QB5*:IQ?J/1!&N
MU>E!SGBEII+%B!@8/4^E>[)7L>*G8FTVRO=8U"+2],M6FN+B41011@EG<G &
M/J17Z3?%_P#X)<:;X:_X)WV-GINB0MXYT.$ZOJ%W%"#++(PW/#GDE0#QUZ5X
M_P#\$<?V34^,_P :'^,/BO3BVB>%2)+0R+\DUV<A!SP=N<G\*_7NXL+>\M)+
M&YC#12(4=&&01C&,5X&:9@Z>(C&#VW/:R[ 1K4'*?78_FYD$L,C02PE)%;!C
M;@YZ8_/BEKZ2_P""I7[*TO[-'[2-[<Z-IWEZ!XE=M0T<KT4EP9$SV*MV]&KY
MMKW*%55Z,9KJ>36INC5<'T$<[5)KZ(_X)D_M62?LN_M&6-UKEZR>']=06&L
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M5\O_ &!Y/ZU\W_M.ZG8ZU^T-XQU'3KE)8)?$%RT4B-D,-_7Z5]'_ /!$;/\
MPU?(1C_D$2#^=?8XK3+7YH^2PR3QZ79G[!8. 0:_(;_@N7//+^U?86\C[DB\
M/0E%8$@9>3-?KR2P   K\A_^"YEK=0?M6Z?<RP'9/X=B\MNQVR/G^=>#E#3Q
MMGV9[N;+_8G\CQK_ ()P:99:K^V+X.M-0MHYHQJ ?;)&#DCIU%?NW%%%%&$
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M/9'Q,YSFW.6S'5>\*>%M8\<>*;#PAH5JT]WJ5[';6\:#)W.P'X^M9S2%<#<
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M5Y KVZ>0XZ<4[Q3?2ZN?GM?Q/X<HRE:-248_:C3DX_>?H#17A'[(W[;G@_\
M:?M9M*2Q;3-;M$W7=@TNX$9^\A[C^5>Y[F/(;J*\O$X>MA*KIU59H^SRO-L!
MG.#CBL)/FA+K_F244S<1R3VKY5\=?MZ:UX!_:[E^">O:=9PZ!#(B3ZE)*0T:
MF'<2?QJL+A:V,DU25[*YAG.?9;D%&%7&SY8SDH7\W?\ R/JVBOBOXE?\%*/B
M/XP\27/A#]F#X:S:JMO(4_M62)I=Y'7;&!T],FN-O/\ @H/^V/\ ">[CO/BW
M\-HOLS,-T4MFT&1_O8//MFO1IY%CIPN[)]KJY\KBO$WAO#5&DIRIQWFH/D7_
M &]U/T&HKRG]ES]JKP#^T[X6.L^&)VM[^ #^T-+F;,ENW]1GO7J<9!.0QZ]*
M\NM1J4)N$U9H^VR_,<%FF$AB<+-3A-7374?13)&P,Y.<\8->4_M,_M7?#G]F
MWPRNI^*+MY]0G!^P:5;R 33D'&>> H[DU-&E7Q%54Z4;MAF&88/*\)+$XJ:A
M"*O=NQZS17Y_M^W[^V?\5))-4^$GPK$6FH^$*6#3D_\  S@&MGX;_P#!4+Q_
MX-\3Q^#_ -I/X?R6:N<27T*&)XN0,E<8*CGI7K3R+&PBVK-KHG=GP]#Q0X9K
MU4GSQ@[+GE!J-WYGW/167X6\4:)XRT"V\3>'=32ZLKV$2V]Q$V0ZGN*T=^1P
M>U>/*+B[,_0J=2%2"E%W3U7H/HKR[]K/XT:W\!_@OJ?Q&T#3H[J[LR@CAG8A
M&!.#TKGOV*/VDO%'[1_PXO/%OB?3;>TGMKXP(EJY*E< Y.:Z%A*SPOM[:7L>
M-4XBRREG4<KE+]ZX\UO(]RHJ-7\S.UNE>(?MO_M(^)_V;/AY9^*?"VF07D]S
M?"%DN'( &.M9T*-3$5HTH;O0Z\VS3"Y+E]3&XEVA!79[G17F?[*WQ>UKXZ_!
M+2_B/K]E':W5\9/,AA8E1AB!C\*]$E,J)YB[B3P!GI2JTY4JCIO=.QM@L92Q
M^%IXBCK&:37HRKXOU^U\+>'+SQ%>L!%90/,^3V4$UY#^QQ^U#J?[2UOXDOKW
M0X;*'2-3^SVGE3%C*F#\QXXKQW]O7]J7XRV>F:_\+_"?POO+72("(;_Q%+N*
MO&<9*8' YQG->"?L;_M"?'SX,^&]6L?A-\-/[<BN[P27<P1F$;\@#.#U%?08
M7))5<MJ56US.UKL_*<X\1J6"XTH8**G[**ES)0=V_+ND?J7$V1BG5\S_ ++'
M[37[1OQ:^(G_  C?Q0^%1T;3A9O(+L1D#>,8&<"OI://)/\ .O#Q.&J82I[.
M;5UVU/TS)\VP^=8-8F@I*+_F3B]/)ZGC/[<7P"\4_M#_  ?F\%^$-2C@O$N(
MYTCF;"2A2<H?3ZUG?L,?L\^,/V=OAB_A[QKJ4,EW<7+2&"V?<D0)Z UO?MF_
M'37_ -GGX,7?Q%\-:;!=W4-U#"L-PQ"D22!?ZU3_ &+?C]XC_:-^%'_"<^)-
M,ALYUOI(O+MVR"HZ&NSGQ:RAIV]GS?.Y\W*EP[+CE7;>+5.]KZ<NBV^9[+""
M$Y)ZGK3JC4OM&21QTJ&65K<;WEPJ@LV37EZO8^X=HZ=/\BU17R=^TI_P4X\)
M_"O79? _PPT+_A(=5@9DGE:4B&*0'&W*\L<CH*\A'[=O[>%]%_PE%C\/$73F
M^<*NDL0!Z<G=7KTLDQ\X1E-<M^Y\!F'B5PU@L2Z%-RK2C\7LXN7+ZV/T/HKY
MH_8E_;$^*?[1&M:CX<\=_#V+3FTZ%7>]B9E#$G[NQ@"*^E'D^7('2O/Q>'J8
M*KR53ZK)LYPF>X!8O"I\K_F33^YCZ*X3X]?'KP7^SYX$F\<^-+S$8;R[:V1A
MOGE(R$7/?BOD.\_X**?M5?%N^F;X'_"$QV:\1L;=IW_$@;<_2NG"99BL93]I
M%6CW>B/*SWC/).'\3'#8B3E5:NH13E*WHC[WHK\_F_;Z_;9^%]Q'>_$SX2^?
M:E@'2339(6;VW#(%?7G[,?QJO/C[\,[?XBWGA6;2#<L56VEG$F['!8' XSG\
MJ>+RO$X.FJDFFO)ID9#QIE.?XF6&HQG"K'5QG%Q:7?4]%I';8I8]A2$8&"N<
M=Z;N7H2.:\Y>9]8V]EN8?Q%\6MX-\"ZSXK$08Z9ILUR%(X.Q"V/TK\B?B_\
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MR:":\D8DS,NX%LMS7ZBC[P%7Q%'_ &BG9W]U:KKH<GA#.<\JQ7-'EM6G[O\
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M)W1]41;&WYV]S7-_&"PN-3^%^NV%FI:672Y54 <D[374U'+;Q30M!(F492K
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M#+\LK5756(2AV>_H=4^)N,<'A8X/^S)3JI6]I&2]GZ]SB?@%::Y^U=^W4OQ
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MA_P6>_:CU7X/_!.V^%/A*>6"_P#%1*7,\8'%LH^9>>F[H?8FOR-C#@!<@A0
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img8190679_3.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img8190679_3.gif
M1TE&.#EA>! 6!O<  /___P  ,P  9@  F0  S   _P S   S,P S9@ SF0 S
MS  S_P!F  !F,P!F9@!FF0!FS !F_P"9  "9,P"99@"9F0"9S "9_P#,  #,
M,P#,9@#,F0#,S #,_P#_  #_,P#_9@#_F0#_S #__S,  #, ,S, 9C, F3,
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MS)F9_YG, )G,,YG,9IG,F9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P
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MIQ?Y9?4 ($RABNQWN O+'_71#WW,0QW_RX93 2#%L<P4E>L,*N8:,@N(BB4
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M/?FQ)4^R7NWZ]2Z\XKL?/OSE7POQ__ORQS\^_N(33)K]_>=_?_W^Y[]ST0^
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M. VY*+$3(NQLC%K>>9'V0.9S[8& #.@KSXLVC X B.>%'$37RS8V+I!;N_K
MYC:(Q;,1\WSHI=<%*7B0&2["@C ]&^7@-)K!3%VTL[WM;F\[IN/^Z+E?FNZ6
MOKO<ZZYWO-N]M%Y#7UY0FQ= 'ZOOAM_[]"9]>+XC7G^M$ W_\L[XR4O_'M.*
M;SSF*;_XRIOD[9[_?-=VOG8 B'X@HC[(7B@^\[$;9/4.Y[;3#W+KF(]8:@@Q
M;[99_Y#2-Z3V[ZBYP@6RZY 3Q.?$'XCQ!V+M<1-D]?HXR*Z?#X!90%WZ!&F%
M7F10$"9GX]P$R7K,;QW[@\2LQ,@'\D&2KY"LY47[" $9Q@&P:XH[I.!Y.>Y$
M]V+^J>OE[ [AMO\91.W%W^GAD[/=6H<AUS4=GT"87#:\&/#]VT"(7T*47^Y9
MG[?E!0;JG%_\WD'XUU[0FT"HGT$$AP8*1-%-F\TXQ*VIG$-PG_=57+H5Q/)E
M@SPPG,/QWPJ"WIJI'0_^(! &H?-P7N81H>85_^'F)2$2+N$1-J$1^EW7 !Y?
M^)F[J!83/J$2<L;E.6$68J&S,%H7AN$5BB&X;*$7<N$8IN%P"2$;MB'S^(,^
MS,,\W ,#"DL_U$/O!!G(Y!Q"\$,7T4--X9X;(A$)N<=#^,,]R ,B;"!#]$H]
MR ,]T-_RZ ,BR$,]W$IQZ0,+(4(^C!Y!W"$]_$>RQ.$<UN'MY4,]P$I-K5A"
M]$,E5I!$^*$@5) GP@LE0B(.240^\,X],"(*ZH72E1<>SD,G-N(NAJ(O3E<B
M+B*R:*(RX4,M#B*\^* T5J,U7B-"G*$VDN$VJF$WHB$X?J,X<F,]_=T]4>'Z
M6&$XDJ,W0H49LN,ZMO]C4X"A/,:C/8ZC8;QC/>+C/<+CN& C0 9D-0JB0!:D
M0;X=1K#B02XD0_8@KD1C0T:D1"(1/U:D/U[D/F)D/V8D1V[DY/'97@A>-A">
ML6BD1:JA/GKD2:KD2- C2W;D2O)C2L:D2=8D3!K%1.:D3GX30>ZD3_XDLB2D
M*0(E41:E15"C42:E4HJ33;ZD4]+D34;E4S8E5$XEMX!D^J CNW4-57;EWLVD
M5UJE$[ID599E6%J>846,64KE6HIE32PE7,:E0_2D7-:E7 JE7>9E72*E7O9E
M4K8E8)ZE8++E8+IE809FI6%EX&EE:G$E83[FW8$E9")FG)'E85[F9*J39!K_
M9F9VYCKZ)6@F)5V&)FE&)%Z6)FI*)%^F)FL:)&6^)F9RIFS"IF?2YFRJDV).
M(4'\F3K:IF]J9EK&YF_NEF76IG >)\-LYG#>IG'Z5FL^YT&.)G1.9QN>)G5>
MIQNN)G9NYP\NIW<B)W.&YW<VIWB"IU/DIDB29+&8)WL"5'"2YWC.5G&6)WRV
M)_4HIWW&IWXF#'?V9Q!*IW\&J*99IX 6Z*9IIX$F:''M9WTV*'T^*(-":'XV
M)7HRYN#UYH0Z:.*]IX1J*&G-9X2&:(8J!7YZJ(EVZ  IJ(JJ&8"NJ(MV$X&^
MJ(QZ$X+.J(V^X8B*Z(GJ*(KRJ(_FZ+E4Z&Y68=<0_TQ:&BEM(.ED**D^,*F3
M/EZ3)BF4'NF42JFM6&F4+FF5:NF5<FF61FF7@NF7/FF8DNF8;JF84FF9HJF9
MJNF9KBF<OJF<NBF=8FF=>NF=IJF=[BF>\JF>]BF@_JF@MJF?$FJ@&NJ@LJFB
MQFF>(JJC+NJ<%BJD-NJD2BJC6FJD'FJE:NJE<FJF)FJG@NJG/FJHDNJH;JJH
M4FJIHJJIJNJIKBJLOJJLNBJM8FJM>NJMIJJM[BJN\JJN]BJP_JJPMJJO$FNP
M&NNPLJJRQFJN(JNS+NNH7M,"Y@J83:NU5BNV6E.V4JNV=BNW?NNU>FNX@NNV
MCJNYEBNZBFNZDJNZMBN[OO_KN;IKO,+KNLZKO=8KOLIKOM*KOO8KO_[KO?IK
MP +LO@ZLP18LP@ILPA*LPC8LPS[LP3ILQ$+LPDZLQ58LQDILQE*LQG8LQW[L
MQ7ILR(+LQHZLR98LRHILRI*LRK8LR[[LR;ILS,+LMB8KLQ8KM#9KSN+LS1[K
MSOILS]KLK/+LT )MT0JMS@;MLRKMSR(MT2;MT2YMU#:MU$*MU3XMUAKMU6IM
MUCHMUWZMUX9MU7;MV(+MHTHBLDAA>F+HC@+I0W'HC[:MOX"HV_9HW3I%B=JM
MW.JM_-RHWR91B_ZMX!)+C ZNX19+C1ZNXA)(W/)MXS[NW4;NWD)N2@CI0/"F
M8SK_KN0"3-Y2KN8Z!MU.[N9&:.>.KNF*KE LKNH22^"NKNLFRP*^KNQ61.+.
MKNTFA.?F[NE^+N_J+NKRKN4*!.:VS^_ZKEJ4;O'N[D%!:>0IK_,Z*/+V[O-*
MKUC<KO4^1.M>[^T6KO9V+P#4KO=N[_0:+_F.K_DF+_K>7? "P/#N4_J6;[[
M[?E2;[2$+OW"+XI&+_[N[W&&K_\.1/;^K^IRKP#/+O@6\.KR[_O.KP+?+P,_
ML!&M;_L&V@)7\&O)KP4W\/)"7@9#\(/JKP=KL& BL/<&, D/+@&?L.H>L H;
MK@AW, P[< R_L S+E@03*?'6, V[! C/\.C:[PZ'\.+U_[ ."[&'MK#UFC 2
MVV@*+_'@LK 3WV@0^S 5%W$53[$5 \P-IV/F8G'C$K$7FR<0&W$6KR08DW$8
MC^'LSH(^M$(?"8(77($.7$$7R#$=VW$=SW$>W[$>V[$7M(,7" (G[DJ"*G$4
MNV@3'_*-0K$BOV@:ES$:1_(52S(D)\46;V4./S*/GO$D[^@8=W(E.R4GA[(F
MUR1WMH([]+$J\S$K[[$KXS$LK_(KRW(LMW(MS[(MT_(<,V-<&G(C)V@B__*+
M,K(P*V@I@_(QDS(E)_-R7G)C9O(R;^XH,_-9?K(R(S,93G,T8S,2ZN4L" (N
MA_,MC[,NY[(YBW,YH_,YD_,ZI__S.B1"1/IR,0=H,,^S@A*S/0LH-7/S-??S
M/OOS]#KSA7;Q-M>P-O.S;UKS/R^TPQPT0"/T10*E/Y!!.U>T.E\T.V-T.F<T
M1V^T1UOT.'L!8!P727-723_621M82J^T2;<T2F\3KN2*2ZOT3+/T2]\T3>.T
M3><T3^^T3]<T4.MT4/?T4/^T4!\U42.U42<U4R^U4Q<U %S3<"@U5%.U53=U
M56/UD>7SL. S5_<G0T.T6#\T68=U> KT2+)M64^O0YMU12IT0;MU][1U7->U
M<RXD/L3Q1VLT2.]U1_<U8/.U8/_U8-/R#%S!#)C#82?V8BLV8CLV8S]V8T^V
M9%=V9%__-F1G-F5C]F9KMF5[-F=_=F>/MFB7=FB?-FBG-FFC]FJKMFF[-FN_
M=FO/MFS7=FS?-FSG-FWC]F[KMFW[-F__=F\/MW#_MA?L!C:11&/Q]%<'AE<W
M-W;*]5A+]UI/MUU_I#F>EH6F-4%;]][2-8 DW*>Q!S=(A?WEQ3>@!3^8X'CC
MFCSTA!3VQP$T;TI03'M#W0?A'5Q[=W4?&GA;Y3R(=WMI ST,10B%V=S5(-+1
M=TBDPSB$ SF, WA@\S7.0N(0-H;[M88'=H9S^(87MH=S> X4=W"7.'"?.'&;
M>(JC.(FSN(JW^(K'.(S/^(O7N(O?N(S;>([C.(WS>&Q#4ZTT_VFW;L1RIS1T
M.\1S'_ET4C>37W>3\_>3'P9:JR>Q.'G=_C?T<%]>O'=<"%LX9 0(HO=4L'?#
M%04_I(Q)B%M>; -1B)T-NH1]-]!27-33$"?S0KF5NQ:6D^.9[\5Q8(5?:,Q*
M'#@\8,QT> .7%P4B$!EUC,,]'$4_K -(:0,\!(6AD\-(]/F&(<U%A8-/"%PV
M=('FLN$\@+BI=_BI?SBJK[JJMWJ(B_..QWJ/R[J.S[JMUSJN^[BNT_JNWWJO
MYSJO![NO"WNM7T$? 0\^2(:*%16P0*22"T22/WMK1CFUYWE_5SN>!\B4JS6V
MR^:>TXN6VR!:]$/4E/=+V!\W5$6A3_]Z.CC&R,D,4,2YV96#.92##)B#.40X
MF9L''>KWG5^[M4O>M]\C/CB'5X2YG)-$".F#3R!\-H291VAZ7J@,3\2Y-L $
MJ"/-3+2#.[1#.ZQ#)[+$I=\$HQ\ 4)3=N*U$P>\%.>SGYT6ZJZ?ZJ[/ZS,<\
MS<L\SG=X#OPZSQ-[SP\[T -[T/^\T!<]T1^]SR?]T"M]C5^!%_6B: S';AR/
MD4O[]SZDU:]HMV]]P'=]M@.\MF=WGPTI%T/SU\?GP,]+N"<Z5.3???MY$2U&
M")6#45Q4-BB05LA[3H#Z 5#>?H,]X#=:VH?A%?B%.EP%J,-#2RR\3W!;LJG$
MZB7\:B!".T3__EZ0 $Z,/$Z4_%'(^W"@_)]++]N!\\V7OLV??LVG?LZC_NJO
M,],C_=+'OM&_/NW+/NS/ONW7/N[O_NWO.CW,2JW4BGEU1)%;?;1G?6ER_=E[
M?> SO_)+N=B'Y'93^; XOWT._K:L?5/H@WBK4%0T3<^4A,^E##JL@SS<8#J<
M-]+5 TL GH37^[W7.SK@N[W3__RC@P5IA-XK1>V9&Z3]/4#XZS?+GT""!@L.
M3'A0(4*'#2$RE+B0XL.)%BM&S'A1(T:/'4%R%+F1Y,>1)DN&3'E2)4J7+6&R
ME+F2YLN9-OWQR]=*G[Z8-7_B%!J4Z,VB&65D4[I4Z;=RZ=25 \>4_VFYD^FH
M,AW7#EZ7=-RR9KL7$BQ5;>;@U4,TKUU9IN8TO@L[;AT]>O/6)<TJ<AM3<B'7
M997Q[ETZ1"D/A&T%U&ACQH^'.HZ<$$!ERY<Q9]:\F7-GSHFN=+FB(_3HTJ1%
MHS:=^G1KUJ]7QU8]N_0LS%[:>>GB15"KS/Z\A&ZGN5[P+N]L8\ZG.A%F1*OQ
M:5ZG.KGEX#HRN]/M9=WVW+M'^\.L?;<[1/PRSW(M>SUMV.[9OV_?>H:Y&5?J
MW\^/WSY__?WW"Q#  ?\KT+\#!30P000)9%#!!A>,$,()'ZS0P0LEM#!##"GD
M4,,.-PP1Q!$_+-'#$T4T,4442611Q197C/\1Q@;I40N??/+A1Q]^^#G(G^3$
M\TS((8DLTL@CD4Q2R269O*Q'?H)L4LHIJ:S2RBNQS%+++;GT;+(OCP)3LC#)
M'--,R,I$\TPQU6R3S3?3A'/-..F<TTXWZ\3S3CGU[)///_,$=,] "1W44#\+
M1?1006GJ$K-QPLHLK'H<M2Q11C&]5--%-U744T9UXLDG3DG]M--,2T75U%0#
MW2F?'5F-==595:WUU%MEM3771$/M"5=:?]45V%V)';:F?+1A2AYAF0V6S$J;
M%&0^^:B-SUKXL%VONB+Y(6U; )ZCMA_,!&%M6W]TH.>R1-:Y3#U$;CO-R'E2
MBY)(>K*M-M]KI^7_5SX97PS8Q8$!)GA&@0M.^&"#$5Y8X88A9ECBAR=VV.*(
M*<X8P'D0N0<??'CB<99^$ (@2GNA35GEE;=\$F6688Y9YIEIKKG+9HO%V5B=
M>78V9Y]W!KKGGXD.NNBAC4X:Z:6%;OIHIY562&5(LY(T*TJAA9KII[F.NFL^
M>QW5Z[&W)EOKLW-V%5:SOT:;[;?+CMMML'?RM>V[X9Y;;Z[=06<<%M:91Q^\
MY=[59LW4T[???1E?O-]OKW.\"W<TF\>X=GS#3!_WVM4,M-0HU^RYV3)KAW&4
MIRO-B\R6D]S?UQM7'+8<*L;XXMIQU]CVW7._7??>>?]=>-^)#[YXX)&__T^0
M>NZY!\>>1NY'ZA\/K][ZE5V^7OOMN>_>>R8+SYOPO<4O/_SSR4=__/7-3]]]
M]M5O'_[W'YLZ4LPF39G^^/G?W_^9PO8_^0VP?_-;E-IZ1$ !%E"!!FS@ Q$2
M0 <RD((+M. $+PB4Z_5#=K!S7>P\V$$0CO"#)12A"4.80A*>D(7X2=[QAF<\
M&;YPAC&DX0UMF$,8[K"&/,3AQ>11CWKDXT;YF 4_^I' @@#I>TUTHF:R]T0I
M3I&*5>12!3&810AF$(M;U&(7P<A%,7YQC%XT8Q@)8K^JX>]J^B/C&\]81F%)
ML'SZH,HVH"1'G_4C64L9!QS16! $ E*/A#1D'/\/2<= +C(? ="*0]1!%7>X
M)!]408=+ZD$5<*B*CTQA@=&PPI3!(9*4@*K>/%:H0A2FDI6K=&4+6PG+5ZI2
MEB?480]Q^<-<WE*7O>3E+WT(S%T&DYB\6]['B*@CD9%L()4YF16A&;,H1I.:
MU;1F-1=9R%)J,YN'[.8VO<E-<8:3G. TYV342!6K405KE1KG.=_Y38PH4FOX
MH$H[(LF4._4#'XC0AZ"<=ZE\^%-8_"1H4::RE -LJA]4,0?A!@G/<LHSGA65
M%3TGNC]Z4(4>)D$'5>8A$GB$12G@$$DGE^(-Q^1C+$DSZ#^+$LJEC!(A^K@'
M$H624*4<0*(*M!D]:DG_2Z'&<C3M1!(JKV"DT;4F<Y8)E[6^I1YL929U027J
M56>IFF%NU9?%["I7A?E5L8:5K%XM*U@A!(^.?:PGT&-F&E]V3;E2:9ISM>M=
M\3HSBF:4KSW=JU\M"MB^_I6P@2WL8#623J:LDRE&[9)A(8M8!V(T:HB@2CHB
M8@ZJX$,F^5P*-TB&$3O>TR)R80H>2U(.36+$LTOI:$?F095Q8*0O2R&'2%3;
M6)$$ABGJ$(E.L[%04C7T+1!MQ:N4&%G!+O>PS/T)99N[M=@R!1XW(0=58'H0
MS2[EDP*Q[%*T\9!PG-8C\J"*-Z3'$=XNQ1T=Z:-29+"1UF8#M"09+5/:81&9
M_R[E,!C9J"=+ ER>1O=L- -.5A%LU:S> S-(E4]FC+.:X<2+-$VMS%-G,Z[+
MA,XR^G@/5;&J8!$/E3YF-3%:43S6$ZLXQ6=E\8M='.,)=8%YSGN53Y X/<O$
M-:\]QDQ=?1QD(0]Y2026K'./;&0D+UG)35:NDY/\Y,2FC&KJ9",[W<AD*4>Y
M:]#%529)&N:LC(4CUP6O2^Y!6H@D9BG?L(D[V#F1^;)$+TH)KT9JJY3;KN0>
MN15S-L:!#Y,(F*$.-2YRN:SE1$/9G%Y>M,_\K)2B5#D;VQB(6[(!CXY0Y3 ?
MU2=)@/OG,*_C(N_-1GP?8F8[HUG-$MEO-FC:$4H'(/_ 3!GPEJ-&,Q*/.,1#
M9?!E',R>S"1"$(AP+ !:P1X+@ZLU&BY2XD8#X@3OFMI8O<**9=QB;&];V]V&
M,;>_[>UL Z\=0D1$$8^81!\QT9E$QBN0W1UO><^;T?7&M;T?G6]%[QO?_+[W
MOP^EV*4P=BG'WM+_/*N-=80I'2P8!SG^1@Z(.WSB3UD'/ 3]$W50&N(3)X<Y
MU &/>>##9_= !S=,K8UOD*,+>71,/]P1#E-G0QLLT'2=\*$.;G27?(Z>U727
M$@[(?(.C%@$S4[JP$7X0O=4+0=9E27+TI:R#M52A,U/N/)$\9V//#S$O4[AA
MQ(U(/1LFW0BELR%V01%W*0__-5]$^RU/>,C &S,_ #GF(49^4&7A^@ZDS^/>
M*5735S),W\M*T+Z4]);DOU4)R3SZR V2EYHIJ(X(V;.1=(LL/2OYC<BK8WV1
M69<$[?D(/*MFME1>3[O7C/NU98)-&PB[AM28D>H5EATN9U<F'_K2QX^Q8Z1D
MMY[UQ8>-N,$];N4GG_G(=WZXH;]\KG:!'FL%V8YZ]%;Q\'C>581W]\$??KN>
MGB83?_C?SN_PK!P@_>V'^!7*]^I$DUWS (>@._JXC?XJE_X$-'Q8WL'^LJD+
MEB( ZH'\$%  $T7@E(+@E,+@M(1^QBNEV$S/<HHJM,\CYBL;D&@B)G I9*(>
M'*GR__IDI)@B'5;B_V"-([[+ME0BU$(K(BCM&]H!2OSA [.!UL('\)[,TPHN
M ?TN3N!. ;7HOI8"!6&BSI0B ))K?/:.*?K.WQ*I;L0&"(T&TS K"/?$!Q_0
M"BDJ]:K-^,)P]<AP#,V0^,JPUYY/^J*O^=IP#=V0#>4P#NFP1.;!+JPO9 ;G
MK=JM#\6OB;[O#P5Q$*7("X^B':A"$,Q(_O:M_W2%T+10"A_#$?7F"9="'6 "
M![W!$".1$R51R1@P&QPP&R P2]+G_[B!(MA.*6;+)6 0)?K!&U9+(W P&QI#
M%@LP6,ANDSJ"[":I)5[-Y6H"!W6PYZ@PLM!AYD@*'CZ1"/]I90@[\7],3;@@
M0[8R8@.S89(^@@"9PALX*R->[1M PA*5(@H]<0>/,1J[QK1 L!E%(AE%+=/<
MT=]F9OC$$ W/\![U,0WW,1_)L [?,"#G$ X)4B !<B -,GBN !X84N3D81XX
MID9L!$?23<?\D!"W)Q Q<B,Y\G#0"/.HHAR$!1&90A%QHA\P+1N^H0,KXM6R
M(>_.Q"6YH1XZ(M*4@LQ4$1?]:/$0 NCLS/3(I)*H(AQ84">7HOXDPB@!C06S
M0NTB A))(A9EBR<5PB=I#B@9 AN1<B.X4"E80!@- O+" AR<\B#P80270A[<
MBP3U*RNTX1<E A]2DNHLHA]4D 7_,G @K#(;%N,AC% IB#(C$$$I,\]-X*P;
M\Z$CMJO-/H(<LP$364(385$IQX$J"<(JM0$K$T(K$84S38(RF9(JRI(=E0(Y
M-@('\8@C,(T<,$(JM<(R_0$S-=,?0,\B;%(I-E$C@"LPS]$9=2841[$4L41O
M*E I8$5ZGD3=A#*E3B+4G.=&/N9&2%,I]F\D:K$QMHX:O2L>VTLF5# S:\*>
M\,LE%E/2A((8!X@'U7$>>_,BH)$]_P?3 N H5C$;>"XKJ8(E4>(>MBX>'Y C
M'-,<?5. U!,^U[,]#31H: 9?^A$?';1!(90?)=0?^04A+?0@,;0@+U1#,S0A
M/70&WD$>_QI2'DA4'A#!+JK/8ZYOF0S"#[FO(V5&(V%T1FFT4M#HZ<(,"66%
M))?")&/B_[13)7B4.MN$$4W",;MN($+-/_DN3'!0&_)R(BCQ():428]R(Z#2
M(JK42K-!0.=+/T.B*T.O(B@M%3^3*<)A+9?"\EP-NTYB],2+2\."ZAKB2:.4
M(J943>XA)?V3)@&4*B S)20S)+;42KTT/PEEOJJP(PJ52;=2(*X ZQ;OZY;"
M!D%B-;543K-"0&>![.J!(,2S*0X"!Y=%((H3+A,4084%.*^LL;)L:/KS&U]B
M.7>*43'P2-%2*5 0(ZXS)1"A/[-!T.0D'_JS,L6D/\MR(4)5*?^X03+0$QU%
M94 /5%K=Y#U556L&C^;HH27H8>:R\!H1]20H52G,X2,$X6K^% JIE8$*]%I/
M@A_.S5U3-5#*,QM>BXQJ!MH>=$*IXTAF(77@Y3(P+$(I%#X"=DBDA5\)EC0V
M]$,[M&$A]F$EED,I%GG@(40;<AX>TD0E\MQP1)F4B'I,ID:]1T9)]F115DKD
M%2.&-!M\=";6BQ7O5"#&E;[2Q"4SCB.4,!O@8B+J%1QF=B!$\(_PY-7*(23^
MLC ?8F>!]B3H@1O( 4PE KCF<R1^-F@[-0"(]B&^-";$]$W!;B6,,DTI;TTW
M O3 M@ WHEZ_@25^E1S&5"",%FFSXE'_?\(JV;0B3+"QQA%0,Y&\5.)J36)H
M.:)K!T51DU"3N!5JI;8B;O,'80)3-4)P0X)P$8.DYL$BEE4TI[5SWX95+R-_
MLL9SV[,>Y&$=Y*$=@B@&CZQ=Y>@50Z)F<Q L(Z(6FU#I0DT;:'<6;%<F^"%W
M=]=/&BE'[\U:U_6"\H$>WN$XWH$>^A)H\*$KU&$=W($F5U:;7+=8:I$IW@$R
M#G,LE0P'FW5>@Y#LMA6##D?U"K8?(4<V!&'8KN!@=ZP5Z*$Y,*,?4&,>,,,?
M$*$[?N\RT"4TU.4R>N\*O.!_.\Q;6*<5.,LYANH=,B-AUU=A1:-B(]:")]9A
M,7B#-;B#!:0+_Q@28T54$""28VJ,B"@RQ];M(E-6>TRVA6$XAKWD>+NF'^Z!
M'MP!'E"W'A:55>CW'=;A.(;H3&P8A]TAY$;N=O]$'Q!!AT..'A+33NZ!+;I@
M'=Z!8[!V(_JA'O"I'9IW)HK8'8Y8Y/!!B6E83_A)'KJ@':CWW&#3)9C8B>$!
MBG'E'E)W':PXI+RF'MPA'838C"<BC,<XB<EIBMNABJ\8$;*X; 09B<N8=,\8
M%*GL?D*WC4:7?#'9"K.WE&!W)K9.I4XS/V^B96>K=D6Y)DB93]*,*2[)("ZK
M>(]K;:X7DFE9$C=96'#0I%9Y*:PB)79V+%B *7@QD&=.&V R(?JA*_^SH7MI
MRR\*EZ308?(*XAZ*\S])0GS=-BO H3K[83JS04<I AMYMCKW=,Q:LYB/62"2
M.2N8^?.@^1X8 A'X5%@CHF5/;3;E8>:8\"+N8>;"X5,7 O\ M2:,\CY]JGH^
M9X(IM'T;1WZ9S5SBI>7(!:(O(\)HPPM"*C.Z!8$K0Q"PRJ$!H!\BAX(5FF$S
M^((]^*15FH-1NJ633QU$E"%+5![N @]K3!]N+'HL<F1EN'M>N*>!NJ=G.9,C
MN:AK>:B1VJB)^JA5 G0M0W3=B:FE>M]NF8LZF2944"2V-QZU@1Q,TR2V6M2T
MH1R^.B+V,BS:02+V5E=%XI47S7BG.JGCNHS_JEI6>M4@3$T<)>+_4C,A3&V8
MM1@>5%#4#A#/G!E<F:)Q$6+PM,$ZP6XDLE53TSJ<K<Z7L<XD^D&PN;2PVU24
MTG8)*P*XPDM,(EM.N[,D_A*<T6=[/'IA77M">4,03,=UO, =!.$=++I?O "W
M<;L+2'I?\_':6'JE4WJXC;NXD=NE>><X8MHA-?9$\5!%]7!D2N9%@_IZ?OJZ
MM?MDY7JIO;N[P5NIPWNNR=N<G+HRH-I1Q'N]$ZVNS^BJ,2(?4C(WM?J4Y:1W
M&\BM^0VNOYN]^[MUTW& [AHB2COH.&(6U5J23N)JFMFVGCFQ58*Q'?NS1@*E
MEN(>V&3.+/O,(F*M_[-QP=FI+3V;])BB&!DB5RU-)6J6FV/U4P;/Q ^:>^SQ
MMU^[I&L<N''\E8A;N9-[QWW\N'D\R"GDXD38N3G6W- -B4*6W7AZNTOVB*S;
MR:5\1L?[OZV\RK'<O[.\O+?<4\X; -+[L;A<R]_)O2FHP)=B&\+A*=I+31B[
M4 ;/T@S(U#B5R?B[R_&<S"\JP,,GTAJ[)%K+;D_<+S"['0A35_,H6_V4(OZO
MEQ^"&RM5);CPSQLS\>0Q)/ A'91Q"==!L16B95EBO[).BPV=I-(AT=FIGNU;
M,4N<)N9A2P] ':(8*/(A'8!5*;:A"[)K)8#K+]#7B=0WQVE\V&V<V(7=6O^
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MX^X=_/?NX\.3%X_^O'KS[,N[3]\>_OOU\^/3EX__OG[[_.O[S]\?@/_M-V"
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M$WE\3G'>$HKGNJ? 4.5J>^L GS_PH0X!:B-@J#-+PP2R, =R4(1?^=X((?C
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M\[9'IKZ0,($5<1FV@,3#A7VQ@NHIQQ&S9S.7W"-0JM*BZ[RH$"B&KR+<&,?
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MRUN&(WNT.9N\C_FRU=N]TQN^G=FSW]N\Z7N][?MB9_(1T+FU<=N_M_J_^QO
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M%NNP)NN+U@I6*FNP9FNJ5FBB?&5TMN5TCF6YMFMS;KUD'F9CWNM=!N:_)F;
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MY_R+XO7+WWS0[_S?)/9$9_N[1WW3E^SNGFUH5W"?D %L!WCVL78 RO:<V'8
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M>F=&N66:<;:YYIMUSIGGG_]W_NFHB_3IV6B@?=ZY+JSJ:6I?@<CA!JM[6CH
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M$ CIQHN0"<^"0B6K;1OFX23(* !A\K8>4/!*4KI.4@ASLB3C#9G002:^\29
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M=7K5DGK#]WO"5X9#\WIGJ(; 1X;%5GMK:(9L"(=M.'N])X=W&(=Y2(=[6#)
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MMSKU5(#UBWN0T_80A 1!Q_;@AGS(CWY@6/_YB"8#D<UP: 7^\"AD*4&YV+P
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MB/' \"PHA8WHGW[4J/[KG_8\-0Y6'XY7C_7W\/>\&&W#".=<?X]MN(RGEP&
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MS7 **'<0?2@V)VK1BF)4FQFEJ$99E#SR<-0[S?S@=?J14/'Y QUP64Y>LA$
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M<F)9G9D;LF$\PN,\#ET]4(L@C!T^WF,^RL,^AI$^DAT_^F- #B1 XN,_]F-
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M%-51$0>)[:A3=(<@U,1O%.EV1"9T"%E%+&95O%A%M*M%:"D8@FFVMJFV$NS
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M6;"+!<D#:B!ER6I,/]P#/>"#-/7#\]8#\^9G/LP#/ES_;;PXG#QXUFT0U#M
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MYVJ\R_N[5[>[]V=0Q7>J6YE6EU#4UAW VQ1H"SRO0_QM.3R'#GS8BC97K<7
M3[S$^_O'K\RRT[:Q.WO)D_S),[O()SO*CWS*/_O*N[S)Q^5MOU?@@MO@GKNZ
MBWOQ '>Z[_^\SD/4M_M\SO]\T9O(<AO]T"L]T+,IR'.\TWM\Q.?ZC9,+U$_]
MTTO]KE_])3(\P4<]UH/]UXM]JV'\V&O]V7O]UJO]V<-\R[M]V\-]L[-\W*N\
MW,?\W-O]V^<]W5,;S7N;S;,>SB]]TC-]AO1\X1-^XG>(T",^T3O^X"<.TC]^
MXT-^Y8NAU:-]QZ\] *0R/" ,"7@0J\W#."0IG=/1/9-Y:<B#DHX#1/L+ZG-E
MOV=]:I'U]#922L7[4>L&ZKHZ)-+#OD[9?SITQ=,ZOJ!^;_'^[%^,/WCSR!!U
M-O1=:3Q_V&^^YF<^YE/,ZO^HZ^<G9%^_\F._]:?]]]L1W\N\WM?_??J__-ZS
MO_J?O_GCO?O'__K+OPGZ?6X+/N7KO^)?R.'S__X#Q"Q__OH))&BPX,"$!Q4B
M=-@0(D.)"RD^G&BQ8L2,%S4:S-<JGSY^&$EV-,D1Y4:5)5.R7'GR94N8+FG.
MM"D39TR=-7/RW'GS9T^@/HD.M<GO8\B@2XL*=<K4Z-.F4*5&I7IU:E:K6JMV
MQ;H5K%>$ ,B6!>#/;%FT:<^R;<MV;=JX9N>J=5N7+-ZW<N_VA>N7[U_!@0G3
M!6QX,.+"9;=E<^RX\>-L]<J2D*PM+XO'L_*:);?9[+K'\^3*D)P-7#I!\-;2
M>[PNK6C'I#L#J/<ZKK]PCP/(*SO/VV-N__WL?I:<+A\ ?O"T/9:1V*Y9UX_5
M\2/;KYQDSFV-/T:NG+ESL_TB9_,FCW,^=<T?N]N+>-[IYXMKDX7W&)YGR=O@
M<>ZWKKP#T-*+P++>>>R=OKIS[)MUY)&'. "F<RR=[?A!1S)]WHN.+W5.\TVP
M["0+1YUY^K/M-;IN\XX?M/HQ1[+DRKK/L?SHFS";"LFZ,,.W1'P-'P#TD4<R
M<\9C+QMNZ$$+GRY.<Z? L@XX3:19^.EGI"OY0=(QLW9S;*ZUQGFLG[5^=&R=
M((<L<CS)N!&$22<E:R<N<(1#Y+HK) NRK#.S(='$[11#T;L(^8'Q,0WSHC$;
M;5A#BQYN'@,G+O]W)(/PK'HD=0P<+Q\[@)Z\/'Q,1K0.? Q3"<O[QBQ&'6UM
M4]3,&O-3>5IL1;;]WK%N%DL?,U(MS1P#]:Q91G4,'S-/2U-((G^-;30.!RTK
MRS /DQ;;^J;5-ML-N?W6VW"CI$_<:\$==]MRH3O77'7)1;=;>-E=U]UT\;JH
MS(KR=6C?AOH]Z-^" IYEX(+Q/5A?A/E5V%^& 7988(@)EMC@A"U>^.*&,WYX
MXX@[GOCCBC$>66.2.3;98Y1!5EGDDET^^>648UYYYI9AOEEFG&G6V>:<?=[Y
MYYZ!'EKHHBD^.F2D65:Z9J9Y=CIHJ(F6VNBDK5[ZZJ:S?GKKJ+N>^NO_JDE^
MM]TH:3V-K=,<"Y5>></]2JRPX)Z;*[KEKAOON_6.FZ%^DJIR;[OY%ISPO <W
MO/# $3?\[Y$4?_QPR!./G/+)+5]<<LPKU_PEI$#2Y_+,1=]\]-!)/]WTU#E?
MO73$RWZ];=C)CIWVV6VW5W;<:T^WO"[;TH?+TS [2]ALMILK5D$!R)4VM4QS
M[/BT)H0MM&AK6S&;==;R-7L"G<U&G<ZZTW"N6<:_'0!$DZPGMU;$XR[1#7]4
ME-$K_OK>O2CY4=LZQ-KY<$;XT8]C%!6=+V4C6;([5382])?SX05#CO$&V]J2
MC\>4HUYV.99C0!28'[6(+=BC7EZ>EXT#4"8N_Q9T# 8#6*-U1= \%$2+"K.!
M064Y!H1IF1]9%A@^P_AC@5 ZS)0D8RTIH:TL!S1B ,ATPVSDT"P[! "C?!B=
M^#B&3@#XGV/,H8]\\$,?7OS<%T'7I\?T;UYD*>$)TX*/"V8+'^LH'A<+A(]V
MA(-++)13-F00QK^148S$T<L]NG# %?HECG/,!K#(<K8"QN5\;.F.C+:8#73\
M$8QB#$G_/H@7*9*%>?%R2[5TA[XTEA*5HMR=*DV9P5.R,I6OE*4K:>DV6^8.
MEMFBVB[#QDNL_5)KP.2:,+U&3+ 94VS!5.8PEUG,9A[SF<EDYC2=24UH6E.:
MU=3F-;>936Y^TYOA]/]E-,>)S7)V\YS@3*<X>]E.9*X3GEEKY2T!<#;)I$UM
M%(PE+577.G^BCG4 _6<_X^:WSSE.H DEZ$(#RM"!-K0IC8/H0RFJT(E:M*(.
MQ>A&$^<YI5Q4HR$%Z4@S2E*.FE2D \7E+.DYSY76\J4MW:=,<TF6WF7C6_<X
MS39JXP]T!*\<]SB6\LCRTWN>I801JHM.T<07&(*)+$S-1A;ET@XB/F8;ZB J
M_'#XGEE(<1:/80&]Z$$.+GTC5 <D#5JZ8YVZJ*^ >4&$(;/Q#4'LSS'Y*]LL
MUA$K-Y4#3^]A5 <!,#YX!&=$]YBI@1"DH#.*"Q'CZ)TW\'2V>=PR5QST2R?_
MV2+5=B"F'N%@HF.T\0W*%(^"@VU;9"=;V=$X$8IE@:MA[D%7<,##C7E%UU5]
M)RW>XI0NLWBJ8V2 CW0TD2R<3<ML[1+:TX#C08^A:EGZT8Z;+E*Q.GQL34,[
M6@:Q#[6UZ4<ZO.L8;HPCL'7A1SINR@UR9%<NLVB'7QME#C[5AQ_JN.DV@NJM
M?J"CO$E"+UO.AL:X?#**I(K.?WY;PU(E]XQX86YGANLV4M84IJMD:4PYK.$,
MN]3#--UPB#L,8A.KQ9WD3+$Y5XS.%JOSQ>Q\9XSC.6,;J_C&+,ZQBW<,XQ[+
M&,=!UK&0>4QD'QL9R$-6<I&7?.0F)YG)47:RE)-Y_V)5VO,Q^#R-/C'LMI2>
MM*1A!O.84VK03:(4S6+^\IK33&:/'+3-;%9SG.D\9SN[.<P>!5V=\=QG.?N9
MSW\6=* Q4N+%DAC15AZQHC]\:$:+N-%=-C0LK=2/"#UZTHMV="KEL0YU=*$N
MD!9UIB.M:4DG>M.2)LA(3-WJ4JNK'^]8!SG*@8XNQ/75HT;UJ3&]:U?KNM?D
MNO"O20WL5!/;U[DN]K*3;6Q>;ZO&2([VDZ=-Y6I/&=M0SO:UM=UM;G^;QN'^
M,;C'+6YIFYO:Z+:VNK?-;F^[F]SG%DBP$8/EWI9%;=G@,K+3,N@[^QO0_R8T
M020J<(,''.$ 5_B;SWSPA?\[?. )C_C#,:IGBE]\XAF'^,8ESG&*,)O>SQ8Y
MOX^M[&:#O.3.)GFE+YURE(_<Y"$G.<Q5'G.7GSQVJXX>SF5N<YJ_?.9!][G0
M:P[I80\=Z44'>M*7KG2>W[SG]X+WU,M==7E?/=U6SSK6UZWUKG.]W5X/.]C?
M+?:RDSW>6U?[U]<^]K:?_>UI_WK4&YEO+4MFWTC'N,<UWG&_?\7,@/M[W_<^
M>+[OK>"&5WSA&4]XQV_<XH]?O.0;?_C)6WYN3=?\TW_.>:)OGNZ>;S3+00]U
MTW<^]*D__>=%/VJ=LU[UJ%\]TUM?>MG?WM5'=WKL83_[W?O>]KW'O;?D[G:V
M']__^,F'._*7K_SB-Q_ZSY<^U=%._;A;G_G3-[OVJ[]][#M?GL"OI]W3DN^\
MU[SREU=_^N4<>(2RG_+QQ[SD$P__^=]__?+/_^,BCW_[[Q\ _T\ 42KX:(_W
M#%#\#O#WAN_W2*_V'E !"W !A8\"$5#5L&3G(A "$Y #&5 "/W #J<5*C$@#
M2[ #*W "+1 %@X_[KL_[7K#[8M %93#[OB_Z;+ %:Q &9Y '=9 &P6\'?; '
M@? ';S (:2;T[ VXS"+?1FCV!M#_] \*2<?]I- *HQ +$:[^KC  N7 *O_#Q
M^J\+LQ ,R= +SS!P0- $/3 $5[ -51 .R^=*6HX-U] -_^TP#M7P!)7M]?+P
M#5,0$/6P#O<P$-E"]P3Q#@D1$?T0#PN1/G*0"(?0"(L0$B=1$BL1$W%0$X_0
M$H70$R/Q$SL1%$=1%$LQ$X$I"<FO_-0FL!3Q#Q?1$5VQ$6&1%E_1%F?Q%F51
M%P>1%Q.Q%QEQ%WU1&('Q%V.Q&&L1%Y,Q&(EQ&(VQ&9%Q&9V1&:=1&JL1&H\Q
M%[%1&;4Q&J_Q&;/Q&[<Q'+L1'*G1&\VQ'*TQ'<]1'<41'=VQ'<D1'MF1'M?1
M'N?Q'N51'[G1 T-MV3(KR]R"+/+ML_AQ' WR'??Q(!<R(1$R'AVR'O%1(A6R
M(1GR(2TR(BGR(BN2(S?2(S,2(O_S,20G<B0U$B0Q4B11DB15TB13LB-/\B5=
M\B-E$B9G<B5C\B9MLB5SLB9[DB9_DB>!<B>'LB2+DB6-$B>)<B!542"9,-_8
MQR>#4BJ5,BF14B>M,BJI\BJ/DBNKLBNWTBO#$BS',BNQ4BC-<BK14BO+\BO9
M4BS=DBS/LBWE\BWI,B[3<B[QLB[U\B[7TB[A$C#_4C#Y,C )<S#]TC 3$S'E
M$2 #LBD?<RG5)AS4DC+S<C$K<R\OTS(QLR\YLS U,S,]\S!%4S%)$S0[<S-3
M,S15$S57TS5;$S8_TS1GDS5ELS9'\S9+,S=/TS9?LS=C$S=],SB!4S>%LSB)
MDS>'\QK_&],Q(=,Y!3+?)*,+=I,VC3,YC_,WLU,YMQ,[N?,ZO[,ZD3,\M;,[
MRQ,\J1,]K7,\O7,]S;,]SU,]TU,\Y9,\X7,^XQ,_[U,_Z_,]^Y,^V?,_W3-
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MZW-(\5F&'!!T'X>*.!1 _BLGS\(,&0>B/_/USR'_JU4.W?_W1=.%46W 1).
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MI1Y/:H<_9B$Q</ADE-W$RSD%=%#_DAS10I9$)&=LTD/.^%$FD10C9[BA3H,
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M@"*A1BNR4 W!#Q2'EX4CH/K9E/]1;$F!;NW7&6QB/!17,1@A ZM9#M#G$/[
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M&WR.(@Q"/!Q"(\Q#/MS#/@3$/Q1$/:2S_5,J)?0_0D/!1<1 $FQ$$_2J%DM
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M("S":NIE'IEFAEIML>K]SFK^QNK_WNK^%G"2Q8R%',MF4T1X[F=W]N8+'.>
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M0_,%1S,U3[,U9_ U2[.GG6<'IV=&2&VJ'2[ACO/S(J[@*M76DC,\>JU"M"W
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M17K#-_3W?Q^ ?P-X?Q,K_W)_G5%B,ETO>(]Y]5: M6"(]57,PKU)JB=VLEF
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M*+[3JE\#9QU2'V^!$X.['J[\-W/8JYM?C@[]>52$^JI67RY=^_3DW%7W6W>
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M4AM;.(=)SF'62Z$QT^9"VYDUA/(3HN*,*$4Q>E&-6I2C%>78*V\)(]?=#6\
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MPR%!!B(%0B+;$"(TK".,C2#&H1^^;#;<05[L1Q]#4!SAL@/C<AOELF.LD6Y
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M^J$=3+/_<O,SO0?-M $<P*)*Z^][4E,\JX<U^5?ADFD;UN%_P_/95O( +I:
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M<?S&B2=1H8K(/:B!D7S)A[S)A?S)=SS*TR>%I;P\.\<;,N< F1S*MUS;JO0
MG/PHU!JOJQPW85M=$.&O'9M,7H2PA001LF5-UN"P@6"($4&W:*B($<&(W3S/
MUR 1B'A,ZJ0,$.$1[IP,@LLS6@31>_\$V!9=S2&=39ZHC-&XTM78TMD8TZU8
MT[N8T\78TRG]TD4]TT=]TTN]TT_]TU,]U$F]U?>$:CGT':[V&.?A0T>IE)!'
M6ORA[%;IS&G[UWT]V'/)Q!N:V%/\Q(T]V9%]V8N=V8^]V:']V:5=V:.=VJ?=
MV:T]VYE]Q?TAHH5UHH'=1-!:K_-ZI]F:W,_=W#$+I^LUW0.Q% Q#;\^7(*I)
MJHI9PMD5/PA"^AJ#^@Q-IG\CRJ+F'K3ZQXHJ+-2[P\LZ#K\1(B@<*20-W_6N
MW-&0J9_:K=6]KM']XC=>XS-^W#\^L\C'XRF>-=#/<S$BOV>#=IQ#'^B[X:UU
M-3PYP6?CX5?_0]'2[ #:=#7Z8:[K3!T0OKO10MFX^VB4(C0;/B))XWQ]>W-4
MHZ=A&C&CK^-!_C7"G5TX+M(?N\V1I$M69$T,VV\:&T?\1DITA S2Q+Y2Q.SG
MG&[ZW+=LA-"KY.O77.MUQ(E$&[3U/N_Y_K/[?K0!?^_]?O #_^\%O_ )?V@I
MT[3E>!Y*01GMN!GSF%K47MAC_/*O/O-1Z-JK'=L]O_-!G_-%7]M#G_1'__-/
MO_11W_19?_5=7_5!G]M;'&_X,MS#O,MQ__9U7SQU//>OYZ4G1"3Z89'!@7J2
M5R8<]BGFN^'X?2MV61N:;W!:V"D'9_AP.'#PP: ?SG(2GAP,IW,/__DW/^(>
M%EGO:L?(DYK+T4?)=[_,W=_WW[_]X=\VLU/^+>Y2V6(IVJTQFR>_9[7L *+?
M+'\ ZFG+AO"@/($$&;;+=A"AC'X &%:<=>]@Q&SS&@Z\Z"TA0F_]/'I4)Q)A
M/9,7]6E$F&T=2X'T7B+L,I,;3&WD+II\!Q'F@7P^?:8+BO# S(_?-BHM:E%@
M2*3A/D9%M!-B/JL?\6T\."[JQWL'LF9SQW6I6JAIV:X5^[8M7+=%"0( 8!?O
M7;UW\_K=^[<OX,&"R0 !PN$P8L6)#S=>[)BQY,B4(5M^C'GR92!\.P?&.\LP
MD#6" :RQ/*MTY<1!R*Q!] @1X2"($WF>Q?_O=&8@_ 8G*D,&>!E]@T7OWASD
M<\/5FH\[;PZ=N?3-CG-8T,%!QW4.UK%KQ]X]^_;PW[EO+T]^_'GUWMF+![\>
M?GOY[\W/MU\_/7WT\?'SOZ^??^[]EU]_ 1YH8(( *EC@@@XV""&!$@Y(X7X5
M"FAAAAANB."#$VK88807AO@AAPR62.*()ZKH(8LB@K@BC"W*^**),]I88XHT
MHA@CCCS>J*./+DKHQ3ORP"//._/(LR0]\]1##S[WX(.//OGPH\\L)5FD'&&>
M>=EE:5^*&>:89I:))IAJDKGFF6VFR6:<;I*II3\";5GGG7;FR2>>?N[YIYZ"
M]@EHH8,&2NBAAB;_RBBBCB[ZJ**2-@III9-&2NFEEF;**::>;OJIIJ)V"FJI
MHX9*ZJFFILHJJJZN^JJJLK8*:ZVSQDKKK;;FRBNNON[ZJZ["]@ILL<,&2^RQ
MQB;+;*!O/BNG7^28E<U>>\&T4SUS;INF/WN:]*U/X3(T[D#E>@O7N>JFRVY:
MZ[K;+KCQBCLON?6:>R^Z\.XK+[_T^FLOP/@*K&^_!O][L+W]Y&,E/W@F/##$
M!2-,<< )SX-M-NU8#$ Z&W%4\2SP9&Q.Q/3FDY4[8@&%;3HF!XQ/2M^XBPZV
MVNCS[C@B;<.N3@F1<RY*V [UKL3A8,O-RTI/S''32Q<=,L/X\-.;TTP__YTO
MU%9KC37!7%\-]M=B9TVVUV5+/+;9:J-]=LAAM[TUW%W+RP_#5[Z]MMMILYTW
M/!^O@S!*&ZU4\3H9?[,5W@8;[A11<;OKCLWJ0.T5MN#0RW)0*OM[#S?:;)/-
M ?C0ZS-$0,OM[4/9JOO-T&%G#M'D\0H.$SXFC=PRWO6DA!;?ONN-^MYU0<LM
M\8$]0EWRSTVWO/+1+>89;<PK5D9I9:"F6FV>/4(&;:GQ11MF9#S2&YN) !'8
M0.K[LWYHTS-/1F?Z-$__\_6_3QU]X>WO'O_Z]P_ _PD0/_XC8  -., "*O"
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MNJCF)'>M!):56G?ZH&8R)1+E4)B1:JF0^JDD!Y6A2JJ.ZJFF6JJ@BJJK6I(
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M$2Y#',2 [,JM',10/,6S[,127,NT+,NWK,NYS,NV[+>PC!<&>Y_NJ[ 5?,$
M/,');,S*K&3YB\S+#,T8;,',_,Q<(\#17,W9C,#'O,W4W,W8#&4.+,T%)F<(
ML6,D@#3@G,'J'&"+AA [R<XQ*P\3!L_C[,TLP<K>*3V&/,C\7,B'',)(&L,T
M3- S;- #?= UK- %C= -O= )S= /#4'F=L/_ZP:]9[H5N.11P?7*19S/']W1
MS>7+(XW+)+W+)MW+):W2)[W2*<W2#PG,_E"H]GFH6)R=;3S'.8W3.WT18,S3
M? S4.NW'IG3&0_W30AW41ZW4(.FJ1NT67)<-])1U"&%Z2>W4_;1H!P'/5VUR
MY\+5&@G2VHL( /W/_4S6_IR:V8')G\S6E>S6:_W6GAS7D"S7<&W7=8W7=*W7
MFKS7G=S7!Y(DSIF.B&"N.YRN\@;$'AW2BQW3C T:* W9+1W9+^W2E3W9EBW9
MF4W9#KF^5MR^-MW*\7S/TRS:I6W/_^G,WWS:JZW-Z\S: G/-K^W:K4W:LEW;
MM,W-DR;.N UAY1S5_TZ&SEKW+?1 #C) #N5 #AT1,O2 W,9=#I6'+O)PW,7-
M4P+A#N& =T(1#C*Y8_0@ YFJ#=Z #O>@-^_@W.1@BOY0#^3 A+WU$>8]W6P&
M #$&#J*X#>3@3?7BSMFPD_A@#K/D4.LP8GQ3#^H X##A#>; E&E#W%,-$>#@
M#HFS#L5]W/+P,NDPW3+0#L"##^G0.E_!#>DP#Z.=HXH-RZ%QUBENUBM>UI&A
MUA -XPX=T3,>XQ)MXS0NXS6.XS>NXST.0#]TPV!+1*BL#V6[RAS=V$ENXDL>
MULR%V9NMV4\NY9=-Y5%>Y5".Y5-N*E7,<0A;D<7\U6%NU6-.N3XMYDB-YO]+
MW<5%3>9JGN9G[N9QSA9-W>8^ =52K7@LT0Y?$0ZGEQ5G9A59S4WE  XZ,5';
M@)9PL4Q9$0[FL [E8% [H0T*UA: %U,BX=Y_-U$B\0WC, Y,F!#:L-51(>B(
M1 [@8!/(1$DP*13CL [I( ,1L1';<(90T0^ROA/;X.DTM^GK8$V>2!?NL.G:
M4 [JH [C<$TF)N=GJ^2LW&HJWN)H#>W^/-=\;>U^?>V<K.UM?==_S>UYG>W?
M[NW5CNWEONWDWB$437]-4JYF*KU*%(_5V^3S[MCTWNQ@HN59?N7YSN_[[N]6
M#O#Z'O#FV]E=?BWX6<RVG=NWK=J\;=KLDMJSW?#_$R_Q%<_P(QO;#J_P),[Q
M#T_Q%P_R<;/;'T_.M6CRJ2C<8C%AB1,N(+439V@G0A,4"\$O#[$1X2 O,I 5
MW-TO+D$5)[83XP UE@YF(;/?,\,T^QT62K-GV(+TX8+J+U\Q.H\M]6P1+@\3
M\! RAX80OLXT,]92$>-3,(&7'$,.'_.6&Z^C]LZS*,[BTO[VTSY\+Y[C=<_C
M=K_C>>_C=\_W>H_W>^_W?3]N@8TDXVK1AMW#B'WD]\[X3%[OCY^ _R[PD]_O
M R_YE4_YEZ_YEB^>7#Z17BZX-PWGHU_GI7][9F[ZR_[FJ7^5;+[ZKZ_ZL4_Z
M.4WGL'_GH>3@59T6M*.*_QX1H1'Q>3,AZ*/>%@:Q$X!C$;"W$]X #M\0#M_0
M_,\?_=_PX8S&$I9^,Z*$_6_I%JT($SP%%<.?29/W4W%!#^@ #KPN4W=F$KR?
M#?00%ZB(%%X_=<!.2HA@#LB^Z5_.^LSN^$H.$/J # 3"@:#!@0@+'F28L.%"
MAQ$A3E18\:%%B1@I7N28L>-&CR%!CM1HD(..DQ90YE"9<F5+'2U9HHSYDJ9,
MF#AOVG3)86;/GS5]YN0I-*A.H$2'[ER:E.G1HDB-*H7:=.I3JEFQ;G7:]:I7
MJ6&CCK4JMBS9JFFU@D6[]NM;LVJYPFT[-Z[;NW;KLCW;5R[?OW3]XMTK.'!>
MP/^$!^M=G)CQX<*(#2L^VD7>N\OSX,F#1V^>9T3U\-W3EX^?OG[\_/&;Y0^
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MB:I2VF!,'Y$'WN#B;*A2]16DOOT1+0Z.SBH8H,%>'C&'W.A7R[4-QN41QP6
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M_W :W_$9[W$=]_$<AY7_+G !+_]RUBG6M2[6WGCGRL4-E_F1JU9DW7 B+P:
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MWKI]\_XM/#CQW<:!'Q^>O#CRYLJ=,W\N/3KUY=:A7Y^>O3KV[MH1^ZT[#NO
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M1W##BO!#,&T#OO+(/&P#^1_9-JQ#\D>(/!Q ^7/$-L!#AOP[_D/*-@!$NGH
M^LWR1] @PH,%%R9DJ!#B0XD.*3:T&+$BQHL%\^G+QX^?1I$3-V8D.=)DRO^2
M*U&R//E294N9,%W&I#G39LZ:.W'RO/E39T^A0'T&)8JP(S1^19D.-?JTZ5&I
M3_FYVZ8M6U:L6K-F.^"N']!T7+/E@^HTZEF:_K)MS58N;5RT<Z?*K4OW[$$
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M2!,7"R RFK %L<7ET!O&>Q+/&!<5=Q)81A4X:[2,_,B3K)V%.9R4S,J2/,L
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M_X5TWWW:H[W?PWW? _[?MT34/_U(G_@O,5 V? /%^X.ZWZ&2^/_ZPH,<KP.
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M?36E.1&V2UNV8YL[0WNU:1O$39P63UO$0WRV49RU:=NU6WS$:7S&;3S%69S
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MQ.V/?X?;%]__]\?F.LBK#?)P-4D%@-G #8!R,ORP#787#OJ0,.YP9NK +^4
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M,L*I2\&$G6VX!_8:APZKGF_XPL1QJ,>,D2=HG7M8AU",EF\"P/59/A<$@':
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M5^F"=?\!%VT0EY-]69.-V<,*49H=49L%T9L549S=V26L0GBX29]=O,4CK9%
M(B],+1R=41Y56J:-"AMMVAV%VJ5-6JK%BC-5/0HRE'F02ZK4P#=ECBWMTE%Z
M.#B]VCH4R^X0V^KRUFQ(A]3H5)PRV[*=6S>5V[J-2]TK1#K%2U8CT,7QAP\$
MCW$JP<H!59W;G/_\Q\$Y5!R;FUJ4H=W;ALYY!]B1!\%IO[C%'(8<!_"1FU 5
MT,(!3= ]/GV($41IG'P 4K0,3];UVP%]W?UYJ0>$W=:E7?$B%.!YD,8IW?+
M.@/I/O03*MC)!\'!ARMSGG#8-\5A6^VT7><=W?KY3NA]WMK_G5[KK=[_H<^!
ME$S7O=X:$[U\H- $%=\IXMCNJ ?T3=%UN,WOF)8*'%GRC=\+?= N P]!>)4,
MY(8'G=\)Y5\^NX>:Y=D UED"'F #SMD#QB.;G$*?5;PLY",_@I6?_ ]1B]JJ
MG5H+SN":>-H+EEH/[F 0?D.[Y;6L_8ZM/0YY^#D.V@9$F9HB=8=W(AYNV%K8
MH <5ACYRJ >LP8<$@KZ/#5O2F >X=9X<A@SJB<T3L@P;-L]LR&', %YX$][R
M %B^,(=,Z0</Y*!O4$>^T(=L=9X#H ?08,B>>XSR/( 2<4SHTP;;F8UZ,%S=
M&0?&1 T>7N%V .+K>&,FS@9O0(3,_V!?'#[.("V/>0"-)>8@)\X,**8Z*?8.
M*JZ-19Z%1H:11R8,(9;.(G:,*HT1#QJ-0<T&SD6,;R'4TSAD'-9AQ6@AO^0,
M5LR&$[8,]43ENYWEKY4N.74V\8"VODW7+LG:[NC3OM#3[QA.%OE3\ C4#\F^
M<J,0QH6318$XB9T/JP./;<V/4M0^,>'-&.'>#?%<&3G7M"I57HYF ,D'S!VF
M=BE4<R7GB)W8==;$9VUG= 5G>>Z1@)*14 FG:"EC!/'%&.$&=Y@' ,:>]>B'
MK(*1$W*/?IADAIL0MA6P>6;G=XYH"BG7<7;GBZ9HC0Y7CF[G<%I94)[HCA;I
M3EE*/('9C_],Z9$L"?/-AE0AEO<UE'# !Y'=4\)<46.1U+LACW'@0EA)7'2^
MEEB!*H5S$GE0Z6;1(':3V95&690>: 2.:@&6Z@*FZ@2NZB0LT2H\47E8/!7M
MPI(Y#,K#8++^8 UN2@X^ZQ NZ[4VZ\^[VIA6.&^0,EDJ85?VC4S-%(;ZBWN8
MYAC9L>GH6N]8!R/U!WI 3,"&C*H2)X8]SG8 4D1YCIR#)WLRC!-4*"ZEC,6.
MEG!@'<M>%T39#+(%C<4NE'%H['YX;':)[,3P9YQR!WD8:,6PXG;QAGI0";_@
MA^<;IFV8!Y;@"WZ@AWON#C9U#&LI8\4H3_)(!Z(2C'L(7/*8X\G_6#?R  <_
M+HP"LI;]HHPO!8]OJ.R^2.WO6!>UM0U^:&ENV%;"@(8,S(9VP(R'?EMO.HW2
M%ES45NUH8>W"<&T9@6W9+HY%!@^ CFV!4(S-EFG/AE705HP>]@[<?HQ\T];*
M&.7N*%3+J.\*OV_(=@R9ZPYPH QX6%EWG Q?1%2ZK>41#IN\G=-<]KV^I5Z7
M.&\* YQ^,-]MR!PX'@=T* =S*(<=+P=PB.&KRX?#9!=$Y9RCF^( '$UV(=;^
MV.3N>&_,*:@805C2\691A?'V AWDU'+O]7+L[=XPAY_E%',S!_,#-9<J Q_*
M',C?-1>@.C%U@!W#7!#F/?,OS_,S QT\_Q]S/>]S0$=S0?]S_"E#_QW?0R_?
M/7Z><-"AF/X.<W"6!W/I59F'=W"'+G"'=S M'8KA:6D%;>X.=;"5+EB'=EB'
M6\V'[GX2(B('V.D6'U260EE,#-W?6N_?-[-J79]J7L=J7[]J8!>M$D6\H)V'
MH2TM)")RE0#*MFYVM7[VT4MKMH9VMZYV9Y\DN(S.QR2'NF:75UX-W/4.A22-
M52>ZX'@R"].,#2H/>/T+WO6.316-&X8WX\BQ?PX-/#8,WMV=T*A+T;[BS7AW
M&(EWS)AWJFMM.%<-VO:.>/0,F8N1!*<,<^%VR"!CRBA/\P"--A_2Q&B20@D'
MTS!<!SP,>X_;T?_(=U(":FG)C/@NC7G/*<T0>&T@^,PP>,18Y'K(&IPWC7WO
MCG8;#7]O##4UE")+C!>)D1O/# H'Y<>0>9JO#)M/C%RLQ<1 .$+]^.0&>!0_
M\10?FUOF/3H]Q%VF9S"I/M04$28'C_=K$6,6.J&K/R]I9C6Y9_%;#Z8"Z4)I
MZ![)AQBNL#'I+_"0\@U1SPED$RPG>RD19\1??(G.Z)%V_'J._'@F:<J'_$]Y
MYF-BEP]?$%_,5WCH<)O6-X<V%XA^?,;'Z-,O$(M.?=-O?-:/_,I__=AW?=I/
MQASE!Z8N2:<&R98.!W#P_7$8!W- AWD8EYK^#FZAE7>C=%?9KIUF%Y'_295[
M6/Z[>1="P?N.A8>,K&GO" ?=1^FF?MEZV/5?)_]@[_7S+W_T#YB?9>"<Q$(M
MC&!/\T(7+=!KMW9JOW^XD7;\GW;_[W^ \ =@H$"" P$41'@P(<.%#@U"5!BQ
MX<2'$B\RG-7/7S^-'#UVW!CRHTB0)DNB)*ER),N3*L%IRR9S9K:8,A&E;)G3
MI<Z5[F;&G->S9SB:W';F5$<SF[ZA/$$JE1F3G].-]VS*-*=R'$VL79=*G>D.
MZ4J3Y9;B>RH2$=!L[UJ2 ^NUK=QL8UU^HWF +%>Z2^>&E3F69-295,NF-.=5
M'^*/?65NJ^J/&\UP.[V6ZXEN<>..<6=&/GD6_W!-L*67KC/YV69:LOW8TGRK
MMK/)=^#^FL:*$[&^T]G6N=98=":WV8]]?ZTK&&5AF8<E0]>H%.OSIY^3XZY[
M%Z4WFN1 ]FN['?&VT^-<'B>M7FS*=$9+=B_=-'Q8JAK=VWPR.WKP_K3]\_>?
M@ $2N)^! !XX8((%YF0111@Y&"%!CV%UT$&!U50/A!5QN"&$ G4$XBPBD@A
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M&35/,VK)T"/-+Q21IU3(0R_1EOXZK"=VTOIF0R0),*J&;"9V<TP$63%QH'/
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M+7LX+G\X*V>B(L=JAX/X*CVR.4D;5K0O)7M%M6JBL#:QB(_19FO# 6P#-Y
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M)LM/Q,@#MH@\2-BAG^F-I!Z)0M3+QSRYI0@_X-TV,).0R,,BTN:=9*!4P$/
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M#M_ #=Z@E J12_0TH]DP,%MQ&#@* %,5EV)A5$8I&5J3%A7:$OJ "/10#_1
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M"R52I([G[+'H_,[N',^]5;'M+++UC++WS+'P;,_IO"(@N\_XW,_Y7,[R'-
MK<\:Y,P*S<&-\;+9\!@TV9$M,96U^Z':,FT^*ZUBX<(,H3$GV<9%.\G=I&@Y
MO!5W^[0_# #&F@W@\!F:J+=* <M8F\09$5-16TG"VY:@P0_$\KAJ05%J"Y?N
MA#8Z[,6A9+=9FQ<X#=-*D4E]6Y: *[I($=* RM0+-9>+ZQE+;;W9X-2C*]6/
M?,Q5;=5>:JF.W+G_]@M47+W)BPS6@/PRFI33L+MI9P4WB52:LIL@0)K3O 0
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M*$U\PQ.B>(QS \D+.3O=V_-2C&^CZ@MYND/\SG2^#^3L:5=(X3O^<8:$O?$
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M4F*#1GXY/')URA?@\@1.=@?A[X1;>QY.*/4[S(1/RU>$^V3D?V3IX\0X K-
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M_?6/SSX;U5UC7>CQP3<<?(<)RIQ4MZ7'D"LE#!TCX_^=[2*7D<EEI'+M$T@
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M/_G1SWWUMS_^[W<_^ZV$>M6/=OB^[S___R]\ ?A[ NA_! B  XB !9B !ZB
M#<B #VB $?AZD6=\^V=Z%XB!&:B!&\B!'>B!'PB"(2B"(TB")>AY^?=QZ.:
M$KB""\B"$.B",=B",_\(@S3X@C<H@S6H@SAH@SG(@SOH@WE2? NF%_#G??5'
M?_=G?_-WA$J8A$PH?T88A4LHA4C8A%!HA5/XA%7HA%?(A5C8A5KHA51(AEM8
MAF-HAFF(AFLHAFV8A6\8AJZ$@B/T@W48A#V(AT"8AW:XAW>HAW_(AX#HAX%(
MB(-HB'V(B(((1A1(A,<G+_W@#P0!B9(8B0 PB998B9>HB9G(B93HB9CXB9L8
MBIT(BJ4HBJ9(BJ>HBJG(BJ/HBJCXBJL8BZT(B[4HB[9(B[>HB[G(B[/(#_H
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M?WOROQ_?_-Q++>K\\,MO'WWXWY>???K=KS_^^^>W?W_\,Y_P_\N]28 1(B
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M)PW?SJ!'P&<U7W,V;W,WQV<RV.?=7@A_[NTYOW,[]PZ"/O,\YVVZG5L^]_-
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MO^X]^W?QX<ES'V^^/'CTZ]6W/^\^_7OY\>FSGV^_/GS\^_7WO^\_O_\$#)!
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M05$U4^R7?Y!DO=5-.?VK3KI'K6]T$,EF0P6@Y%7ZSR24SB!J!:R$C@!GA!P
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MYZ'^K0P[ZJ:>&_TP#Y"KL@Z,8<OQD@%5EQ*AD1G3T:&1LLJ\' ^F,>['&^M
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MAIP'?."5#8,&?N"'64@0J3*6<$0Q<?S(D/3(D7S D@3)%I.RE'RRB>G #_1
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M!^7T3N5,QMI,!SV !WF !SU8JN/<&NKDBFYK&F+KG:N83*/)!U:\0'>0!W=
M3:Y 'L&PS[19P&U8AU*X!WJ !\:TBE60&C,<G*MAS'!SFG$KM[KH!V6+'7E8
M!7R8AW:03ZL(SO+$3E*+2TO_LCCY\JX6#:']TB\7I2\9O9*%.XJ"*Z"G&"_Y
M>0I]R)(%0B "6A,(TH='*-(B=80):@HR@)^GR" QH5'\@M$IC5(6?5'O,J0L
MQ2,ZNJ,NS:,M!20P+20Q120RU5(OY=(O1=,P7=,Q;=,R?=,S5=,Y3=,Z95,Z
MO5,[=5,\W5,]A5,^_5,_E5-!-=-"C5-#!=1!S=,<( ->.3Q'NLB-9 @H2=%*
MM=1+Q=1,U:2!ZJ=]\M1.!=5_DHCJ)-7?":A/%=5>DE!N$ZAZXM14_:=IM(JL
M1-53#55;A55<U=57W56; +;DX-5@==5A#0E9K0I:)=96M8C]E UP4$T]0(?K
M[-5[_TK66A56:L567>HU&LG5:U76;[76:KU5;PW7;"U7<!U7<?TE37V*O&Q
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M;YF47![3<<0TF.1$I$K.J8 <PSPGE,!!#A7<CAR:C-@SDS(.2?9#6K<C03C
M\<N0>0.5_B#7X\)A#G64XYT&T\;>^.E+R%GN"?F\G3'OR4])(C1D)""'.M3Q
MA/^!'DZ0ZM F/7GV!&VFPT3I6*DU$YK-<-R#D-Z,"3AMZ4E=[M&<\,Q&.D\I
M29_"\Y422V92EMG,BV))FAH!G3Y/F8^084N2XB0'+V^:C9R*,R;DU.-4#5:3
M>[KI<?70Z#Q"ADF-LG60&VUK).%ZS+BZ5:Z\-&A=\TK7O<ZUKW=]JU[]*E2[
M#C:P=<3C81-[1\.%;'E$BLD]/@0PR3XH90BQ[,4NNQ',:DRS$\&)3[21,7X<
M)1OAF AG^X&NH_31L_R(F<'"09&.U2P;GO/L;/T!VYA0;;.^1>UO1^G5WU+D
M'D1J56I3YL^8[ VWN)4:EH KW=Q.U[F9K1CKN)A<XEK_M[/7]2YX-]9=\7Z7
MO.'=;G7+BU[JLG>\ZW4O=]4;W_/.U[SV?:]\TTN0L&0DO^WU+WSU>]_ZXI>^
M B[P@(%+4FX@.&4A P=J>V6P=52WHT;AQE ZVTF9>,.Y897)6P L8@/_E\0!
M+G&"4=Q@ O^V:QA9\8%9'.,9JUC&-48M:2$W#FB<N,<C3K&/3?QC&-^XR$$&
M\I!M?&0B+YG E-709!D$&=-0N<I6OC*6LZSE+7.YRU[^,IC#+.8QDQDS^3GS
M?M*,YC6KN<UL?K.;XPSG.<NYSG2^LYWSC.<]Z[G/\9G'/>J1#RWV"4DC,LB_
MGIQH*"LZRHM^M*,CW>A),SI$__JZ%Z8O;2/C6LE@YLATOE;DS9GIZ[4/AE:+
MEFL43(::11M.BC?HL:6F/?2L*S*UP<A!H!65HK1 !76)\.'K<=SH'KO%78Z.
MG0VLTF@>OD92CAA+M%/A.BFZQE&O0Y;.$DDX*13^E"I](ML8T8-;V?@&M%WD
ME-*^8TN-\LFC8N3/HR!71?E0I$_>$B-_Y#-6ADQ1N9?ENA<).UG$II&QE66J
M5O>#<C'Y!CZV].IL@(-+'S9*2Z<$CJ-\(UO5CLFU>?WL%W4[)M_6-*\>:O)@
M*9O9+W*VME4$CV3)0T<LTP8)FELM@U7UUBW?-8NRC4X7"2HIIE01K8G4<1S!
M=B8'!_\VU%'.+ZE'G>%4O[K5LSYU>4&:THJIK5$<^[C(QK'L9C^[PX17O(ES
MDV**FW#;I)T-EZE,'^L@*4[!)O>;E6U/D5,[QX96-+9Q.BGMQIHW,QPWZ/+6
M>(['V=:Z5LCA4;YXE0?\XRVO><Q?/O.QRYNA/2_ZSI-^\ZJ#:DQZACJ'9J.W
M&2/JLLDFW)A(\V)^I_WGDF;ZTG-^][XW&NNZ]OO1#Y_W57,'.LCQA'7,PY3&
M?W[QH]_[Z1.?^M"W&]JSK_VS.P(XOIF>]ZD7_M20/S?@/__WTR]^]*]?_>7O
M3?OC__[=N-_\]8?__,<OG!\@$ C\3\[_*4< %L< &D<![E___QV@_R4@ P)@
M PK@ Q)@!!K@!"*@ UX@!&*@!&H@!7*@!68@"&Y@"';@"'Z@")X@":*@":8@
M"ZZ@"RZ@!\)@"<J@"M)@"]K@"RJ@#E8@#O;@#L;@#\Y@$-;@$-Y@$>8@#QZA
M#R8A$P)A$PKA$Q)A%!KA%"*A$UXA%'8!/=!#/=##/6@1/K!./UA#<T'(]ITA
M&J:A&JXA&[:A&[ZA]GW,T4P>':I,'<ZA'>:ASOQ4-NC;Q-PAQ0"BQ7P-4JW5
M(.KAT&1#1AVBSHS<'^IA(&K$.F4#XS#B0)1"R'P#(S)>3!ABQ'Q16465)8[B
M)RJ;/-PA)RKB',Y>-IQB'N:8M>6A_[1Y RJJ%1Y.3"BF7B#"GCU!(D%,8LT]
M8L[ 8E*T%!VB'B5.'DD]@3 JQ"1B53.F"$E]0S3VP^UEPSQ\(L?H0VDQHQP.
MA"F2HC^D8D8)HC9.3"(2R"BRHCZ,(C**SCD&XNS18BT:C"<V8RYFPSX-(B^:
M8S5&(R^*X\2PHBOB(3$N&\=PHC;<S!Y96#;4PRA>522.HRU.9('P3""*$^-@
M#";>SCKT45H9C%'YXS<*)$F>I"_&HTFFY#^6I$J^9$NBY"U:Y$K.9$W2)$S*
M(1RBH=S%A&,]"=EU7:4AB%X AE6$)%(4"D\\12E(Q6IQ"ZR00,2E!*G0'EQL
MV$QXS4'H0_\]S$-7=N46?J57BDM5C-),,)A6&-=12(E4%!WNE874^(2Z%"5=
MCD5VO=A?U&5>]H51ZF5?\J5?!B9@#N9>%N9^<1'=$>9?&J9@,J9B<H130,FC
MQ 5HR<120HGK.*8_S%Q.((Q'1*9,1(5F+B9I-F9I/F9'N!B/C:9IMB9JLN9K
MGB9LSJ9LUJ9KTN9MVF97>)VD98@^W!_]R9_]"2?^#6?^L=]Q N?X&2=S%J=S
M!F=R$B=TM@:?5:>?7:=U9B=V;J=V=B=W?J=WAB=XCJ=XEB=WTH,\T$,I;&&@
M 0C7>)&!' 1OSN=0]J90WJ=]YB=]XB>&5-W6_>?+P0J#:=V]](C_3Y!:O' F
M4JA#O-!*3LC6?W:23[0CN-&<BLA#LJS#E$B8-M@:O\S<4:1#M@1<J;0(AAY%
M.V2+A,8$1,8(8VG#@.8(AN:$AJ(*AWJH)#Z%+@7+O-E6DH#+4424CCB4-E"C
MC+P;R$%*LB!.D,2E9;X(/#Q%Q@6)6V8#/K@(B!;CB"X%@&J:.SR%K-T(:&(<
MO6Q<4BR=CLPH4M0HE]QHC7#HCOIGCD))G&[)B29%BI[*BCXDBTP4O+6(FQR%
MAG:)M<1$SZ6(FLX$F^+)4^"H/[S#4T3<B51*Y"1+NIG(BV(*@6)=EVZJIW8J
MJ,HIIXHJU^EG?0J&64*)V(6,9RK6&+%1_QI9']T@(X0%36U%U-(D(A_J(\*(
M36WQ7=K(':X"0$?"DZF(C>#%3>'%Q.%93>(!#B>ZGJSV3>19Q.1)7_5EZ_5I
M*[9NJ[<67^L,Z[1RZ[A^J]D@XVG]#5-):\? 'H6>#CV($NL14TT]S3MV*[Z6
M:[[F3/!9Q+Z:*[D&+, .[+\6K+X>K,".CAV]JARY*@#P _N\C\2FS\1&+,5>
MK,5F+/QH;,5NK,=V+,AB[,=*!A0M4111$<I:4<HZ416Q[,J>K,K&K,O*+,S.
MK,W6+,Z:K,Z6+,\^D<^V;,[V+-#N[,^^+-$.K= :;=+2[-$J;=$R[=+>;--"
M[=,R$!# PSQ@[?\\T(-79M$6;8V0=HP9HA%BW9'#PFK9,NS"DNW9-JS9OJW:
MIBW;PNUE_15AX15?V2T?V<Y/*0W>"M;?%B+@IDS2Q80CH=(UQF?>%M(D\M0A
M(:7);<S$@<,W@ ,XA$/E7F[FA@-390,\%%9<3:*6!-;;X4XF36+E8J[EJJ[F
M@L.\MALDU4R'[=7D;J[MKF[G?B[&N&M@J5/(B&LF12M@]0/KU6HF,=4^W9.J
M.5]=7:,D39PWL*[T9JZR?6Z*B.Y?E6XQ#>_@*@0]4!,W^!KDV)HD(6/& =:Q
MT:)>U>[JWN[EYFY/:5OO@N[7N.M@H6[KYJ_JOFXF+6LK!M+MT2(O717_)+&O
M_FXN_&Y,S91#BL12H3@<-&I$L1J%WB[NWU9P]\[O!=,O!G<P!W_P!H<P]WKP
MW[;MVJ)M3V;#3[+J?MHGDR59=3&5-F0$@=#P+"#.UB0+-8;74\8$/H#AH.4#
M/BBH3T16@M76;<D74S%80T"N^!I%.P38[*$EBDW54>3.>DWB+!09)\YED]%8
M@-UE(RD9#!M9&7^Q&0N9&B/9&K]P&Y/Q&X/Q&9<7?]&=&[,Q'M^Q'L-Q'K,8
MZTEK&/-,A)76&.M7/3S3$R=R-GBF>%V<-H18'*=Q'\MQ)*.Q)>>7:NXQ)4^R
M)&MR)_.Q)U]R)<_Q*)<R)XOR*9-R*IMR<K7P_WZ6&2S'LBS/,BW7LBW?,IF9
MIRZ3)R_OLB_W,C#_LC ',S$/LS$7,S)W@3R\@SS(PSRLIU=ZX3WH0Q@B"= M
M!'^>JC9G,S>;:C>[<J61:JBBG(,^5E(PZ*CJRZCA2\W$:+88*(M&J/Q^"LCD
M!+:D2 HK,N?X+;\ :5+\VXP$'+*Y2 ^'C#Y/6+3A4J;D,^0D,C_/:5+4J8Z$
MFX\VJ5*(UJ<<FY&V")+&GKPM:9(X:=B]2,T<M,K%1)Z.2")N\:F0:#%U*C[@
M6T,W=)C2B"-/*9>8Z<-]"D-S3D,_M#]TFT1WZ3K-\+L4]$D;]..<W(FHPU%L
MPXXJ:$P,'*'RG(O.M/]/[_.FL6I!+&O%$<30P$.)L%Z]C?.GBC-:I_-9J[59
MMW6_>+.I@IUH.0SDD-U.:A_"+LW$[>HBA8VPXHS_9H.L0<W>S8U#,C#U)>O<
MA$Q+8<WML6O;""_!JDVU>DU>&VS"7K9F9S9GDQ[H >]D=S9F7UXJWLKI.%PV
MZ,'3\.ZYBF^@U /S-AQ7VZON;79HW[;I]2M5X[9MC[9O]S9PBW9P\S:WWG4;
M+N=S(O=T)C=R-N=R/[=R1W=S,[=R3C=T6W?X42$62N%V:S<4=K<5?K=X<_=X
M>S=YG[=YIW=XH_=ZJ_<2@O=[EW=[SW=\LW=]N[<2YG<5WC=]ZS=\^[=\\[?_
M@ .X?1,X?N^W@?<W@O//&+P#/,"#/$#XUI9"/7@M%QV=V!JWAF\XAW>XA\.A
M2\8D2X8XB<LDQ>"#LBGBB)LX(PHN3CZBM&V#/ZI:K\IDX]ID/UP<36AC;7T#
M-WB#-_@XD MYD/]XD7L#M8CXT21NB6N$]JHBQ<C=D!LYD5<YE2^B-LYB'?8X
ME7?YE']YDD^,_:;D).+JY$EV'1:O,LI2-4ZB\TW>8T>CLATYG5OYE+?;%S&Y
M.#YY.:YXQ/1#5V7# :2#H#5DR+1H--YK3OK#/#8YEW]YG7MYF/O#F..XD@\$
M:[>DE$<ZI%<YEC_B IM(/Y26E-BD1![BHW,ZIT^Z_T84+C36S)7BXN_Z ^2J
M@*4W^:VS^*+[>:[S^HOC^J_K^J7?)+'O>J^GT8>G\ IW)CC_"VZ.!4+!"E0F
M139^1$%O\4?0RE,P14E4I6UI1:!B23O29JI2<5>$;U)M14?7*ERFBVX:IABG
M5FSF)KW/N[T_.[Z_N[[391WG>[W[^[T#!C[H\%K(=.=<IDR,NTKX0Z$:A9R0
M!!$O<DB,*50$_+_ON\4KIFIF/,!W/,9[_,6'/,=_/,F+/,@[1+-[<QE(IW17
MM\NS/';'_,M')\T[=\O#_,S;O,S+GPX@\S'_O,\'/= /O= 7/=$?O=$G/=)'
MAX-#.#.GYWIZ87],<Q?IP_\-PPBBP77*;_TV:WW7<WTVI_5:C[U;XP@\MR*^
M].B5KDO34; \*\6[Z@CES$2*7J^EDKV2%,51!...N+0BM@B3',71=>J+NK.-
M4/2E6AV<UDN/,JF2B/1<9LIN%:F[.8J2YH3C;PE0A!:-F(..CJK>)P7? XG?
M+]R^^&E2>$J7?"F4U/2+4#Q.=XE.GUN%"L6F+OY:XWZ0!+[1D6HHSD0V8F4O
MHDK#'ZKOVCZH@HY/T ,1U\2)($M,B&C,+'_9XSU;BWWU9S_V;S^.?'.&I*IE
MTO78G;#;,BQP#[S!%-3<=-6[KLRL_PPT^%J>XLROKHU 4_NV*K;; $+(L G8
M2#7_0&1[Y\\?@'X$#2(\6' AN6P/LY%0.)$AQ805,5[4N'"CQ8/\]$'3E\\?
M1Y,>468\J3)E1Y8O7<9<*;/E3)LU<<*\J3,G39X_?0;=*;3GT(4A1_8S6I0I
MT*5.FQ*%.I5F.H@/OQ7]=E7@3#U<]?FLQ]6=3JM7[\V$QE6=5+=/WT:%.U=N
M79;ZD.:+2Y4N7[M[ ?<-_%=P8<*'_28>K-@P8\1N"P*0/#GR9,F5+6.F;'DS
MYT= 0', #41TZ-&E29]6;9IUZM:H8:]V/3OV:]FU:=_6;9MW[MZX@>_V/3SX
M;^'%B1]7SCH'A^8Y@$!_[CQZ=.?4I5^7;OUY]>G;OWO7_RZ^>_;RW+&C!S_>
M?/KP[=>??Z^>O'OV].'7CV]?_OWY__T+L+\!^2MPOP/U2S"_!?%K$$ "$63P
M00,5=%! "B6\,$(+(:QPP@T_]%!#$3O,L$0.,401Q!%-3#'$%E<\\4452721
M11H7A <>>=Z11YYY2IEGGGI6J><>?.[)1Q^0E-*H,LTNXRQ**:$$H,HKI;0R
M2RRIW-+++L'DC$LQOR0SS,S*1/-,+0]J<R(W*X(S(3G=/(G.DO",,\\Y]ZSS
MS3[QM!/0.^]LAZM2 OW3I'NX&L=//?N1AZMT!*UTHK,@@B912,/A"A^3)+V*
MG$?YM!1210G"I]%3*Z*'K$WGX?^*'%9+194A<*[RIE:&0H5HU$UW#?:KJ\(B
MM4Y,'U+*5H<@DHC6?KRY"IQ=N;EJ'$75X8H?4\OAZD]X5C4UV#95M990/,>Z
MJJQG@3THUJOT:!=/=+BJ9U!_UKHJG7LYV@HB;Y[M]:%?SQ5W6(B*E;?@/P]^
M2!]^"7K75W87K@A<B PHY:IM^AD73Q)$I5/@; B&F&)#(5)AXX[KQ!4B9,LQ
M5F&3/:ZX9IIEMCEGG&<6=V>?>[;U9J!U#KJB-:<T4VDT.^4J&RFST8:K>Y)^
MLC,MJ[[Z2878Y%JEKAD"VR"Q.X[S *Y(&OOKBNZ1&B)NO#:H4[>SZ1/L?D"^
MRARU-7+_&2)^^#8)@'JJ?<CM>C8B6_&U-7KB*K@#CWNAPA$.&Z-\N (X<LLW
M8O:A;38/O>S$&1>\=(3PRH<?33DWG?3778]=\ME;IUWTQ6&W?739:^_]]M-]
MWUWW?I+D1W?<>?\]]^"1/QYXY?L9:?6#EH?>^>J%9_[Y[*W7'OOFO3>IVXWG
M07XLNK-!9_9TT&===(D?0H?[C@66^IZO,8=(FW3 [][_^?L'P.T%D( #-*!&
M1*(Z]PGP>P=,'@,?6, &3C""#KQ>!2EX00TRA'BJV^#_)(A!$7Z0>%R!!P1)
M&,(46C!K+<3:"ZWFPB?-8C0UM.$-<9A#'>Z0ASWTX0^!&$0A_PZ1B$4TXA&1
MJ$/P>(>)2W1B$Z'X1"E&D8I3M&(5L7A%+6:1BUOT8A?!^$4QAI&,8S1C&=%X
M1C6FD8UK=&,;X?A&.<:1CG.T8QWQ>$<]YI&/7NQ"CWH$CWD(4A[T&%(]\%&/
M?"B0'\8S7D$@"4.M35*&E)1D)3%Y24W&<).6Y.0G/1G*3((RDVV:TRE-F<J2
MH'*5JF19*V'Y2EFR<I:NI.4M;9G+6)YR'5R1!RYWF:VKA&,6NGS'5;0AD5KN
MTI;T0ILN/1>U<NQR?!#Y1C&969)[D( <"5OF-Q."#O3-ZIO\<)H[6&D.] $,
MG,331CD>]LVF/429MZPF5K#YS6UVD_^5[+N*IMI9$DQ);5NX=(C;M ',?O@+
M*\S<1M0&1DMA0K2@N3RHX6CI3(B"(Z"$&T=%8:G1J)&3EN8TW$/0J4MP:NPJ
MY< E_*)&CVSFSW#["B@XZ,8-E0+@GMFXIDKWZ<V$^#-3V0SH,I&E#8 "4YVY
M,JI!V@;/I_9#I!!]2%JFZ@_TQ8R:7/FI48,*S(?J#R+T<"5-T9<-?1Q5H6W=
MZ5NSRE:XRC6N;JWK7.U*5[WFE:^D[.0H)^,W_4'-:53+TF$1FUC.-&8Q '"<
MNM[B#JZ88R7S3!9/^G$V4;'$LMFP!D7X00]Q.BT;XVCL4L;QN+GH(ZU/,-Y%
M^O%8_6VK*='_=-9I'_.1O #*,;T-C#ZXLHW/^I:QQ<UM3?HQ3N,2][C,?0E2
MUKI<W#IWNM65[C&=]H3[:>0>/7W(/&#2,+7ZQ!]Y>YM9%<*/JD)D'FIABW6;
M"U_J2I<N>$F@?/%+7XOD2W_*FF]\]?M?IR0W9  VL(!=PJBK#"2_!VZL8B$<
M80B3H34U1(V%<7AAV6#XAAJN\(9!_&$1(X(SB!#Q;#AL0P^C.,0L/O&*87Q#
M,JR!#!1.\8U;'.,.9YC'._9Q#;?S _< 0<A++#(3CQSD(2>Y.DR&CI.)O&0I
M&WG*2*ZRDJF<92MK&<M;]G*7P=SD*XN9RV3^LIG#_.0QJ[G,;#ZS_YO3'.4V
MR_G-=(XSE/&\9CNCF<]P[O.>_1QH0 \ZSW,N=)T/?6<])_K/C!:THPF]:$D;
M>M*(KK2B*9UI2VL:TYMF(B!U)(]2^(@>I:"'D5:!#WR$I)']>*0F)1QK6<^:
MUK6V]:UQG>L($V0EO/5UKX%-D5\+.]@8&;:QBWV18:,,(HA"-K$)(EFNR&\A
M>)+'6/_U2EY#^]G(^E<^JJV4=:0U',_VQWK'L5:"Y.EB^DO8MLVM['YX5P_4
M.XILU45L<V0W;>'&KOX6N.Y^[/LJ[2@VNM4-[W8;[MW^$&\\N6T0;_N7M[85
M.+&C!1%P\!;;V7C"Q1GB;=K"^R+W=!:@"/]N+9*<Y!UI?:3XG%9O>.N#H?DF
M>;BAW0_*/80;Y:LV--;[D%_BO"#\?4A;B*[LGK;CV @G^L*CUO"''UO>$7]X
MU9&=<H@\H=\"_[?A @[O\I(V7C<'.0#,2S)S.QWD4-=&PSG"4JY\W.P3O8HZ
MJ)YTO9]][V;W>][Y'OB_)[OO@!]\Q M/>,$;GO&*/[RN9=W9AT"-;O8#[.4E
MV3HV;5[SG0\<YPTB6;K%#/2[ _UCW992-LT-(L4L?=>\4?FL<,YEE2?K27&_
MCL][WO2\/_U)(=?[W0. ']&R/>ZMZE/ ^;YU%\T&Z(0?_=<S?_C"3]WJ)#?]
MZFM?^M3OOMK\YK;_:7V?_-PWO_?/OWWT=SY=$-4&X,J__L^G@QQ/&,<XY)?^
M^*N?__N/G@+M3?\$4/[\;P#[SP +D "USYF.+_EL#^^VCZBBSOST(>,<\/8N
M<%\^+Q\J3P\0\ ,5, 0/4 03< 3Y+X%6!P1-L 19\ -CCZS*;055L 5)< 9M
MT'+:3VK>3P9#4!WL;QS(P:5J< BKCU'HYH1ND >5D ;'!O/\Z@DW Q%T3,5Z
MC I_#,=>K,< BQ\LC,2B1 JK$ M=; RG4 S+4#:" '!<2!^N,,?"T W;, MQ
M:(_HL(_LL [Q\ [U, _Y< _]L \!\0\%,1 )<1 -L1 1\1 5T8MX1!YV_Z1'
M"LG4Z.$>)O$>]&'5UBJ>^ 8*G5"4_NH3.1$4/3$427$43;$3)0.O5/&N6'&O
M5M$55ZF7K&KH6!$?++ !CT_W7O&4&! #<3%^@*D>L.T7<6_C=M&44(88+S ;
M4FJ7Z$$'?=$7L^*;T.KVWH&5A#$:D4_\ F6H*F^I5&JB"*J=G _ZC(JAM&$:
M4>FAW(8<:$D6*:J=N@6A<,D(M?$"PP&<DO$>CZ\979$?MD$9<=$<9JKR; J8
MVB8:D5"5LG$;M=$884D"E:H5@4DBP?&IGG$9-3(=LRHA3XJC[$H;1D^7&G(C
M;P\BO\ESW$:H4LGXWL9X8#$F^>H8*9(F9=(F9_^R)G7R)I^J%%'1L;:1L*9F
M3-1D::[&,@*,*!2L6>R-*?JAX[(!'S BM:ZB*76BL[SAU0Y"L$B+*[2!'&2J
MP5B"*GE.,*PAFKJ29(9K+RP.P0P#)!*(M\02O[3N[MS2P9)R*>9A*[0AW?+2
M(O!-<_[R+OTA+_QK+@<3,?'R+U:!+-/R(9X@+(?BZI;B'FJ.M+@!49PF[ #
MZ+(!Z1:3,!53-)?"OD9B-%&S+X(N&\HN-4/3-:%B+Z/&+U^S'RQ+5Q*S,9;R
M(1@L-VNS)XCR*(4S:8H2*8WC.),#.9%C.3FI.*UD-+QP,DPL.:ES.9>C.J\3
M"#J&.*]F.JU3.:_S.['_$T?(<T;,\T;.4T;0<SW5LSUMQ#UCY#WE,S[ILT;J
M$T;L,S_Q<S_+DSWG4S_[$SX!-#W_DS\)]#X#M$ 3%$$/=$#]DT$?U$$%5$*
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M[)6O>^D+W_GBM[[Y_[VO?OO+W_^6=[SF#?!["6Q? ^\7P?Y5,( '[& !0[C
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M+5=T/5</7==T95=UA==WE=>?8LO.<\M,%2P?I5%]W5&N6=%]_5& %5C<^\N
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M_^DS'_,T9W.A1G,W7W,X5_,Y;W.=UJ"B7D[N?DM-;>L^9^L_-VNQ+M6H3NM
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MO6MA!SO7Q1ZVL5F:#V,3N]G,?C:RHWW_[&D[.TVLP]FU=79J;&];VS;S]LO
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MDB=!JB,[$J1Z!N1ZFN>9^)][QF=YSF=[TF?\]:-\UJ=^LB=_YF=_Q@D+!JB
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M_=7;<<']5MQRR3U7W637=39==N%U%]UY_]OMEMYX[:TW7'SWE5=?<_D%V-^
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M]$T_]4=_]4N?]5'?]:ORH!M9?ML156O]]C\][_H\]_O!'5!F'B:D'S@^B$A
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MA"EDX0I-Z,(8PG"&+:3A"VN(PQOJD('E*Y^WTJ0--H$L3A<IHA&/B!  )<I
M2VQBHYCX1"<J,8I4G*(5H7C_12EB<8M:[&(5N?A%+V8QC&0<HQG!>,8E\D,?
M$LN'B,2(QCC"<8Y5=,>NTEC%=;Q)'_=X4SO*&!]OO"E>8US%F\JQ*'*\J8OP
M>-,[EDBS-%E#CN5XDSSHB,=,RA&0_F!C9UC&R5!J$I.;'*4H2XE*4JKRE*LT
MI2M3R<I8OK*5L)RE>CK31EG6<I>T[*4NI1A)-,$#C^-2DSFBF#(UG<P?[P@'
M"=3$#7!<\I3U,,<S@?@-=-PCE?QP1SBJA282D$,>H+0B.LIA#G*4XX_M\8<Z
MT?D$D)GC">5 YS;]00]ZHI,<O/HB/=)93W.T@Y>_+*@M#PI&)"ITH0QMJ$,!
M,(^L_U5-HEN;*-<N:M&,5G2C%.TH39@"TJR$]"LC'4M)3RK2E))4I29E*4I7
M"M.6QO2E,JTI36_JTIS.5*<VY2E.=PK4G@;UIT(M*E&/ZM.D#E6I1F4J4I=R
MA7G$;G9LY,?)EAF\AVIUJUSMJE>_"M:PBG4X%1&K6<^*UK2J=:UL;:M;WXJ:
M-\I5B7-E8ET!=5=!Y;6==.VK7?V*5\#J5;!\_:MA WO8P2:VL(AMK&(=R]C'
M2C:RE,4382V[6,Q"5K.3Y6QEXW-9T&96M)LE;6=-^]F]>G:UJ&6M:EL+V]?*
M-K2S'6UM2WO;T^8VM;3MK6U]BUO@ZE:XO/VM<8-[W.$FM_^XR&VN<IW+W.=*
M-[K4=6V\X#J08*:)3=5R$Q%[V+U!Z6F\XBTOJ<A[7O,Z"KWK52][W^O>^*9W
MONVE+WSM*]_ZZO>^^\TO?__KWP #@%44$W!_\8O@ RL8OKHB5S;ZN6#QSJ.[
M[C!(@Y6US02/0V79:$>$\Y&9>VQFO/B ASO>\8YY*%B/U4)$?;5%+' I6%?5
M\C" $WSC"..X7>\B9(Y_;& @[WC(.BZRD(T<Y"03^<A,5C*2E^SD)D-YRO5M
MHZND_.0L8WG+41:O.[J+R !OV,'U&%3*JI5,#G<73>](L!W7[& RNS<?WP"B
MG>.<#7* J[S/(M<X]-0/-=]99?/_&$T^U P-^,[BSOF@,I<=W65(VY=\X@-O
M\N[A48UFFJ,8Y;2F.[WI4(-Z)5?HFND^=VK4I5IUJV;=Z5CM.E3'6M6SAO6K
M72WK6Z]NUZWF=:UQ36M=]WK8O_:UL(M-[&,K.]=CDX?L1/PNJ_H#J] ;G[4M
M?>U*:YO2W,YVMX_6//9]>]O>+C>VSTUN=(][W>9.M[O9;:<=VE"&.:2WO.L]
M[WSC>]_W[K>]_ZUO?P<<X/PFN, +/O"$(WSA!V^XP1^N<(=''.(,I[C$*TY!
M=5LOGFH6XILR3";T7 2AOB2Y00EJ\I2C?.4E9_G)U]C&-YZ\Y26WHYI4S,M
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MQ]E #Z*4P>MPM=^B1;!YEP;2=-S@#=[P#2H0T=\ T1)-T1)]T<,$1M#P#N1
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M=-/IAX.@@@^W\*A\%OH,D^1B#9*F]#SX0(MKEF*;O[1G*=R Z$%M"AGAY$-
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M/-<JPLDS0GVB!T20!WJ8!T1((:<HDKW["7K0DEF8BBI\D:G@$7IP"GXXDI^
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MD_=OQJ]RHK=YLW=G(RA,RW=ZQS=]S[=[US=^WW=[BU2 HN> "FB!!KA_O^>
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M^!BT>V0J'&[28SLRI0Y,3B2725%!TS+&CV1RBI^W7.6'&J>5;9#*C_S@EUE
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M\"@_\"9?\AT?\HG'#0O5\B=/G-/L(O @WM\M&?W@63L/(CE"K&BB&?3 (O2
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MI&I9G?4XNK24J43-QE.!Z@^I.B2M)J4@Y$!25H:I(W2'<6GK'/*ZH&*N:M\
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MES?#(^[PB4.<WA*_.,4S;G%])]SC#_]XQ4.^\9%W'.0G%SG*2:YRDZ=\XET
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MKLE;+X]2+!-3J?9KS\ B*LJ"J7N8O.F$G-&AK7=41KOZ*N@<B)D T*;*3FZ
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MH<T&MB4*M_W9?$ 'LMV&=L#5I.&'J?59?[#:GP6:?F@'%2@Q=%"<">6\CZ%
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MW=S/#YUG Q[ZO+GYO-XG-_^:H3G?FUG?GWG?_;W? 1[?_UW@ Y[?'U6 J'F
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MW'^?/?C;AT_^^.9[7S[ZYXNO?OOLOY\^_.O'3__\]B,?>NB"RJ?->WG2QY(
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M]P[O.__O]@Q6/H:-]-^TY2S3PBW8$H#5,H#;(H ):( *2(#2LH />" O BP
MZ("TDFWK05L(UQ[D,"K]L%O?<"!@Q![C("K^L&_AD"GNMEPUTESL@0Z8_T(/
M\@$./B)N_(8I^<<-JY)_VH!N%J(/\:$F7 (@2A0?Y(" $'B$_<%?2<B$!=B
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M3$B&[$>'C,AQM,9@K#L^M#;C0ACM,[(B2S(?^TB.)#*15+(C TF/#$F2[$@
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M;6F.2?P"8!A%B&VY[EP+Q94-"5^&8])8"YV;3;I;ZBNQM>V<Q<W$*E%EDC8
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MS*6F;17L#[2I3<$ECJV*3^M:%L.XO>*5\8MIW&+3XGC&*[9QC'?L8Q??6,=
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MUE>0YUW]T\G__,U__=T?1E"]_>?__>E?U7V]_O/__MF?UO5?_?<?(/P!Z =
M8#]_!@L.1#A0X<&$!AD2C AQ8<6'#2EFM+@1XT2.'STZE#CR(DF-(4^"+-E1
MI4B4+%.:G-F2ILR:.&_JC,D3IL^5/U\N!*"0J$"C1(LJ/;HT*=.G3J,BG=J4
M*E2K4JMJO;HU*]>O7L-B'=N5+%BS8LNJ/;LV+=NW;N-BY=</VE&X:/.VU8MW
MK]^^@.7^%1R8+^'#AO\3#U9<&("^?OP62VY,&?%DRY498]ZLN?-ESYDG0YY%
M$#3GSZA#JSZ]VK3KU*QCOV9[D&#MA;;]Y=Z-N_?MW[I]!P?.F[CPXL.3(U]^
MO+GQY\J=1X?.G+KTZM.S8]]^O;OU[]J]AP?/G;SX\N/3HU]_OKWY]^K=QX?/
MGK[\^O/SX]]_O[_]__KY%R" _!$H8($#)HC@@@?VUII:X&0CX83:))74A!C>
M8^&&'';HX8<@220B2B.&2.*))J;H48DKHMBBBBS&Z**,,,YH8XTXOJ@CC3O>
MV&../ ;)CS[0Z)./;D'ZF"202C;)Y),_1KFDE$Y2">646%:9Y94G$JG/8U;_
MAKFEF%J6R>699*(YYIIFINDFFVJV">>;6GY99#YQYDFGGG/V*>>?? *ZYZ!^
M!FHHH8(6BA&(C#;JZ*.01BKII)16:NFEF&:JZ::<8FH-9)V&*NJHI)9JZJFH
MIAJJ/W19H^JKL,8JZZRTUGII/Y\R9>NNO/;JZZ_ ?HA0BTA25*Q%QSZ4+$++
M#CMBL] 2*^VSTQI;+;+7*ILML]LZ:RVUX'XK+K;ADCNNMN6B>RZWZ;*[KK?F
MQJNNO.[2"^^\^-:;[[WZ]LOOO]&V"W"W ;];L+T'[YNPOPL/+'##$!,L\<,3
M&UPQPA<KG#'#&SML,<4@?RPRQB&3/++&):-\,L<I_[,+:S@83LAA-MI0F(V&
ML*%UD4,\[^QS1ST#_7-(01,]=-%('ZVTT$P;W7323R_M]-104RUUU5A?K;5C
M1O)CU]961RUVV&1G/;;998.-]MIJMWVVVVF_+3?974-ST-QLXPUWWG'WS???
M>P>N]^!^"UXXX8 C;CC4=WJ=^.&0/R[YXI0K;GGDE6-^^>2;9\ZYYE3/)EO.
MI#]H^NBGBZYZZ:@?QL\L^MS5^NJILT[[[+;G7OONN'-E=V2\WRZ\[KT7/WSP
MQ!]/&&3!*>]\\M C+[WQT5/_H('8*]A@]@QRO[WVWH</_OC=D_]]^>B?K[[X
MZ;._OOGNQP___.W3_W[]^/_?K[_\^?/?W?1$>8*$:C; F<7L9KK*BH422)4%
M=@A1AU*4!!-%P0A6$((8[-.0[M0L"WHP@Q><X =%",(1AM ?7LI'/TK(0A*Z
M\(0FC&$+83A#&;[P2G8RD@UI>,,:^K"'0.2A$'=(Q!\ZB8%*<2"'D,C$#C5Q
MB4Z,(A2GN*$G5E&*5Z2B$K/(Q2UZ48%@;& 8DSA&*WY1C&@D8QK-6$8LGE&-
M2OD4\-S81BW6L8MW?",;UTA'/MK1CW@$I![[",<]%I*0ADPD(A?YQT*R"E=Y
MC*0@)7G(1BK2DHP,9"4U>4E.9G*0F RE)T4)RE$&$E=W*Z4J*=G)54[RE9MT
M92S_6?E)6I+2EJ:492MQB93:+,N7$0$F;GY)S!4)TY?&+*:(CHFD9#ISF<H,
M9C2'^4QI5I.:T+PF,K/)36MV$YO>#"<XQ[E-<9:3G,W\YCG7F4YSMA.=S(SG
M--DI3VV^DY[SO*<^ZZG.?>:3G^X$*#S_25!["A2?!BUH/P_JSX0Z=*$*#6A$
M!_I0B5:4HA"]*$(SRE&+=A2C'@TI2$>Z47?>$I8"@=D!9T; ">%,>BZ)J4UZ
M I2:"N6F,LT)37$ZTZ#D="<^[:E-?[I3H@95IT<%ZE"%RE.NY<-K1ETJ4J6J
MU*96-:I6+2I3L<K5K7IUJEE-JE;!VE6R,K5N=PLK5<=Z_]6OMM6L<'VK7-E*
M5[':=:UW5:M>RSK7O/*UKG@-;%,;][6X G:O;CWL7_V:6,8:UK%]%>QB)=M8
MRC[6LI%%[&4UFY+G ;!ZGK6>:$-+6M VA2YV*>UG5SM:T[)6M:U]T&/F"-O:
MNC:VN+7M:V]KE=&4AK? W:UP<QM<XN[6?\BU7W+[I]SF,O>Y^W-N=*&[W.E:
MM[K8E6YVJ:O=[G+WN]?U;GC!N]W_M39",:O0A@YX,U@9L8A!A.\0WTM?%V[0
M2!VL[WSCJU_Y^K>_=/(2F/A+X/T:^+\%1O"! 9S@@^003PQ><(,G+.$**_C"
M$<8P0X+%X0Y[^,,@]A2H0DSB$O^;^,2\>J2K4,SB%KOXQ9A")1)A3.,:V[C%
M'C.9CE6V8Y:M+,<\#K*/>PSD(0NYR$B.6,N2W#$E_]C)1(;RD:5LY"HS><E4
MOO*3F\QE+'=YRUX.,YC''.4OEUG,9R;SE,V\9C2W^6,O8R]+;?92T7KNSIW+
M,^@^QV<\[]G/9OO24PO[9SWWV=" 3C2B%UWH1E<-K8IV=*0/+6E&4_K2D\ZT
MI37]$<)B>M.@KK2H/SUJ3I/ZU*9.-=YT:]Q6L_K5Q87U:EX7.UF[.M:X'JZM
M=ZV5W^7ZUKK^-:^#36RO,.^WQ1XVL)>M[&9#K[S0%F^TR2OM:E/[VN/-]K2U
M;6UN8WO_V^#N=KB_+>YRD_O<_?FL &E&(0/&[!Z[A&6&YTUA#5N8WG*Z[Y'P
M;>]^\_O?]293"E<8\(+?V^#^1CC #YZH!R><X0^/^,(EKO"*5S#>LT1I+35^
MTHQ['.,"D29=Z#+;67SJ(/Q@",@W_G&6K[SCG91CRV'N\IK3_.:YY*7..9YS
MGNO2YCW_N(IW/O.@O]SH0/\YSI6.]*43_>A,/Z.,FT[UJ#\]Z5=WNL^S7G6N
M6WWK8A1I24G:T(^._>QE%WO:R<[0MD\4[6[7Z-KA_O:YVSWN9K][W?&N=KZS
M?>^ E[O?Z2[XP.=]\'HOO.(/;_B^-_[OBW=\Y"'/^,D3OO(B_]+Z(54:LSEG
MR+.3Y:QB*RMZR(Y^LZ%//>E5C_JO"AJJJX]]ZV>?6=;77O:WI_WI<\_[G4(:
ML[L/ONF'#WSBE[[XR#^^\FTO_.0SW_@,(>SSG8_[YB^_^M#'/O5UGWWN;[_W
MW0>_9)V=;&$7Y)&-PX<^U*_^I[)__5U[?_OY(?_XPW_^T.!'RI'-;//S#K6R
M0W[]5WX$.( &N#JSY7\'J( "V( ,N!:^M8 %Z( 3^( 5V!?CYFT:F($<:&X;
MZ($=B&XA^($B"((F6((H2((J.((L>(+J\UGHA2'J92'LA3.J,G$X:'$4!W$_
MI&_YI8,YR(- .(0&)F $)X1(N(-*&/^$2TB$:N)P3!B%3BB%24B%37A@-Y:%
M#U071@)_^>"%8-A^8=B%8EB&9'B&7VB&:8B&ZZ=_&Z:%'"9S<#B'=%B'LS)T
M=IB'>KB'G#)U?/B'@!B(C:)E:5:(;V:(5I9EBLAFB<B(A'B(D-B(;B:):D:)
MB/B(EAB)F+B)BSB)G.B(G5B)G^B)H7B)I:B)IYB)JCB*HIB*HQAG*[5>+54S
M=:8\JE9JH89JN7B+NEAIKT=HO1B,O#B,NUB,N-AHOW>,PFB,RZB,Q.B,S/B,
MR^AITEB-T7B-T)B-S;B-UJB-"4&!$C@Z*Z0/7M.&^&>.=8..@Z:.Y8@/])>.
M[GB.\0B/[[C_CO-HC_4X8A88CG,!.P&XC^ 8D  YD)_E:Q?(CP2)D =)?L>F
MD XID N9D+;5@BE(D2OH@A:9D1BYD17)D1?9D2#YD2*ID2%)DB,9(.HV0.VV
M7@<$;UB71E88DU,XDU48(SXHDS69DU>XDP)W)T?(DS0)E#J)DT)I0U 8E$29
ME$BYE$/)E"D"=5X7E6!7=+KQ)6HXAFN8E5BYE5?9E6SHE5H)EOHGE47W=65Y
M1S('E5.IEF>YEB_9EG#)EG+YEG.Y1'@8EW29EYI7EUWGEGNIEWV)ER?EAV3)
MEV9IF(4)F(>IF(GYEW8D>9@'F9))>9-Y>969>)%)F9IIF9N)F9>)_WB@^7B<
M.9J>V9FA:7FE29JGF9FJ*9JI^9JK^9FN&9NF.9NVB9JTV9HKXIA7Q'D8XGDN
M!7K:=WW>1YSB9YS6-WW(&7ZG]XO*^9S#"9W%*9W'29W)&9T7D8S6R9S<^7W7
M.9W8"9[B69WA29[CR1+25Y[?:9[LN9[NV9W+Z9WPN9WR69_QF4H1F9]QH7_U
MYW[W9W_OYY\!^HX#VI\$ZH4'.G\&NJ#_*: (VI^SH)^V!H 0^9 2>:$2FCL)
MF*$<:J$=6J&S$8$@BJ$>6J(CVA@FF:(>J:(EN:(NVJ(P>I(QRJ(R6J,T>J,O
M:J/B!8,'-(,7TI+NY91*V91$FG W*:1(6O^D0_IP1KBD3IJD1?FD2AHC1SFE
M5AJE4"JE6&IA@C@K_0"67/F58AJ68QJF9'JF9IJF9OA;72HI<MBF<!JG=7B7
M<EJG=@ICA'FG>KJG)<:*I@B*@$J*@=J*@_JG@GJHA(JHAIJHC+JHCHJ*A0JI
MBBJIC4JIC[J*KIBID8JIF^JGEOJI+ .+G2>+=!9:W<B-V(BJWIBJE>.<I_JJ
MK!JKJSJKGY.,JGJKL$JKN8JKLLJK<4.-O;JKPAJLQ*JKQ>JKEW:B"P@9]]B.
M]>BL\OBL1=*LTRJM[%BMT9JM]*BM^,BMT$J/^F"BU4-K__BA)*JLZ'JN &"0
MXFJN[MJN\&H6#9G_KN]*K_%ZH3@ZHSF:KSJJK_[:KP#+KP*[KP3[KP-KL 7;
M("G);@7$DN^&F$2AI1*;I12K)$=ZI1.+L16[0P.7L5OZL1X;LA-6I2"[L2*K
ML2A;LD?$F'X9F"NG&V :LV4JLVA*LVHZLSA;LV=(6R[+LH() &GILQ#[LXO)
MFT7;LT;;F$C+27<YM$XKM%";M"U[M%2KM*Z4IT1KM5H[M5N;M5S[M5X;M@DD
MF[AYFZP)FV9+MF>;FVA;MFZ[MFE;FV^KMG0KMW [MW9;M[IYMWRKMVW;MWD;
MN'OKMVQ;N'4GM0KAFS)#JI\7/?1YGX\;N>HYGY-KGV7EJN=)N9EKN94+_[F=
M*[G%J9V?.[J;Z[FE"[KMJ;FIR[FG2Q/IV;JPN[JF*[NH^YZL2[NDB[NG:Z^J
MU0\.JJ -FJ  ^J#!RZ %6KS(>[S*2[S+"[S-.[SS%QF\.Q@4JJ[U:KWW>KT;
MFKW<.[W7>X$BBKW>V[WB^X '&[ )>[[JF[[LB[#NB[[ON[[QV[[P6[_^PZ/I
MY6Z->X,FV[\I>[(A<K$J.\  7, (T:3^2\ );,#_"T0DR\ *W, 2',%%R:>2
M<B<WJ[,:G,$<;+,>G+,=3(8I)Z=O:L$F?,(IUBHHO,(L+"M8V\(P',.KHJF3
MRJDU[*DV7*DY?*DXW,,TK,,^W*D_S,-##*I!?/_#1;S#1IS$1PS$3/S$0AS%
MARJJO\FX[%:+Q#.LQKK%R*K%NHBY7.S%8GRL8PPZMEK&74S&:AS&:YS&A0:L
M;!S';CS':%S';<R+XWL[S+JM?-RM??RM?AS(@#S(V/K'A2S(ATS(U[K(U*I#
MW^LZ*%2NY/O(>5R^N\6NE4S)ECS)QC6OFYS)G S*PR._]DN_I'S*IIS*\[O*
MI<S*J.S*JMS*V;:PLZB_+C6T$)S+"SR$ JS+$^S+0MFQN_S+PTS!P"PF#US,
MQZS,S$S,0_2TB'MTNK'!'TS-(%S-(6S-VIS-",I_E4R.*:?)XAS*GQQ<31NU
M2UNU8 O-Z=RU[*S.:H3_M>_LSN@,S_.\SO5,SX\IN']+N'$[N/QLN'@+T 3=
MSP']SP9=T (-N J-T OMSP.=T!+]T <=T13=T!;MT @=S0"@N!("G!*"Q;M3
MNZIKN[-KTB1]NR@M$&"\TK'KTKH;TS ]TR5M$*+[TC6MTCE]TCN=TCRMTT ]
M6'7CTT2=NS0=U$6-TTAMU#V]5:(L&4/RO+\+O50]U58MO%=MO,R[U<[+U56-
MU6"MU5U=6"&G$&5]UF:=UFB]UFK=UFS]UF[=UH\1.W!=UW%MUWA]UWJ=UWR]
MUW[=UX#]UX(=V(0]V(9=V(A]V(IMUP  .Z RSD\-V>6\.^$KV99-SI>].J\L
M_\N;W=FQ[-FP'-J<_=FD+=J@/=KHAK\R:,LA':3.;,S-#)2]'-O+_-I4B,"V
M3=NZG=N\#2/)W-NU#=O O=MYLL(8C,W(?<W*O<W)S=S+K:;Y0 _W, _U(-W4
M;=W5/=W9?=W:C=W>W=W@S=WBO=WD_=WC;=[E'=[I?=[JC=[NW=[PS=[RO=[T
M_=[S;=_U'=_Y?=_ZC=_^W=\ SM\"OM\$_M\#;N %'MYW\Q7H)\,._N"9\L(0
M/N$4#B)-3,12[,09CN%(O.%+[.%*'.(7_N$=7N(:;N(<?N(JGN(L3N(K[N(M
M+N(T3,6+2X.SV%[58\=RK.-T?,=.!7L^ON-!WN-"+O]J9SSD/)[D2+[D17YH
M<$SD4*[D32[E4<[D/!/9<L&%C;SEULKEWIK(8,[(73[F7R[F9>[EAFSF?%P/
MB$#=\]#FU0WG;W[=<@[G]%#G=.[F=H[G<:[G>5X/<][G@+[G?B[H@7[GA8[H
M@_[GA\[GBM[HB>[HDA[IE+[HAD[HEO[HF [IF3[IG5[IG![JFS[JC$[JEU[J
MJ'[JJJ[IJ<[JJ^[IHM[JL&[J=VX7N0$1*#26F3W9F-WKM./)NQ[LOL[KGG':
MQE[:J)WLQV[:R+[LRM[LT,[LTFY>S[-NM>RP&8++Q!W<W"Y!LSW<X"[<P>R3
MW1[NY2[N4OC;Z+[M[&[N[<[_$?<LMHO4#]S<W/7^W/:>[_B^[VN(#W;>W?_^
MY]X=\((^\.=-\(IN\.6-\ Q_\ Z_\ ^O\!(/\!%/\1!_\1,O\!:?\06_\1ZO
M\2#?\2&?\!\O\B9/\B/?\!A?\BA_\BK/\2T?\R_?W?EP<JPR'/0^)()AS_F,
MSQS]\^WL\T'OM?+<\_(.]#R/]/H\]/'.1A#-T!.MT1D]]5!_T5%/]4^?]15=
M]5+/]5B_]5J/T5X_]F%_]60/]F@O]I?)T1Z=#2"-XS#%U$NMU#]=]TDMTQK1
MTDU-]W=_U'8O]W_?$3>-]W-/^(%O^'V_]X@/^#GUNHO/]XP?^9 _^8]?^7[_
MG%@^_Q=AG;Q>G=6<W]6@_]5B+?J?3_I2O?FG/_K^7NB!WOI\[OJL__JR'_NT
M;^FP;_NSC_NU?_N\G_N]O_N^'_S /_RZ7_R_;_S"C_S$?_S,G_S-O_S.'_W0
M3_STD/,CMT)UH?,?(>R93^S>_Q:5/>S<__WB+QC.?O[1_NS3CO[KG_[LK_[P
M__[R'Q^JO9(T"*2O<N[Z_^YB\NWK[NX X0] /W\""1HL.##A084('3:$R%#B
M0HH/)UJL&#'C18T8/7;LJ ^:/GW].)[<F/(CRI4J0;)\Z1+F3)DU6]Z,B9.F
M3ILY?>[\V1/H4*%%>1Y52')DOJ!(B3HUVE3JTZE1J5ZUFO\5ZM:J7+%ZU=I5
M+%  9<V>19M6[5JV;=V^A6N6)#Y]^?31M8OW;MV]>?GJ!?Q7L%_"?0T'+HSX
M\.#%B1DKAOQ8LF/*C2TCSC>O'KU[FCE[[KPY]&?1H$V71DU:]6C6IU>[;ITZ
M]FO9L&W7QDU;]VS>MW?[[IT[^&_AP(T71TY<^7#FQY<[;U[/[LB2UOA"2RBP
MK/:XW;U_!Q]>_'CRY<V?1Y]>_?I^U@BNAQ]?_GSZ]>W?QR^^X$5__/U7[ _
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M+Q_1O<;@2:]T2A=_BC#S\D=S-1<AQ5^3<!@(]/:&IOB&"L)?GX"&"@('B$C
M->&&FY"'"@((>?X ]/,WL""X; H56C-(T&'!@P;7+53H3B+&AQDC:NS(\2/$
MD!M%>B0)TI\^:/_Z\O4[67(DS)<R7=(T:3-F39PW9^[,R5,GT)]"?1+M:31H
M4:1'ARY-RE0I5*;Z4JY\:M4IUJ9:HV;ENO7JUZY@O9(=:U8LVK!JRZ:-.1
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M..ZA39V4 S*EL(GL%M(0G=RC,M:49C;Q:1"JM#"?_GRF/M<9T('^4Z %)2A
M#ZI0M4Q%;P@U:$(C"M&)/K2B"Z7H12TJ48T&A9@>__TH2#V*DN0(9SDE):D^
M*B./X]1#'>M(QSK4 0^4CF\A[C"I9R S/,781B&KRVE%=GI2TH#& /5PC?4(
M<P^>*41#RWD,^91#&*@NI#-#S0=QC$-2X 7UJCA%:7+PP9VQNH>L\#'K>="J
MUK*R]:QM3>M;U^K6N<*5KG*M*U[OJM>X\M6N?<WK7_?JU\$"EK""+2QB#WM8
M1#Q'0X1I89/4>*204K:REKTL9C.KV<URMK.>_2QH0=J/)I4HM*8]+6I3J]K5
MLK:UKOVH04YRS=G*MK8BH>UM;8L1W.Y6MQKA[6]]&Q'@#E>X[C)N;'.KW-XN
M-[C-+>YSCQO=Y#*WNLZU+O]TL2M=[5+WNM[-[G>W&][N@K>\XC4O><^KWO2R
ME[CK=6][D0O?^<JWOM.E[WWMRUW\[E>_X^7O?_V+7@ /6,#O-7!\\ZO@_BXX
MP TN\(,/'.$$,YC!KP5 /"LR+IZ5"YBYS*+#X"7B$),89",V<8E==F(5IWC%
M+FXQC%$L8Q;/^,4UCC&-<VQC'>-XQS[N,9 !P#&/!9G'-SZRD9/\8G"VCF5(
M/G$]9I<-=(#L,3QKX8_Y00(IMTXAY'#'AY[<XW[PLL,E5EK,F*9C?11-RN\0
M,YR57.0?$R1KT-@:G>4<YSSS><Y^WO.?]2SH/@.ZT(,.-*$/;>A$,QK1!],;
MAQK_O6A'3[K2BKZTI#%-:4U;.M.>WO2G.PUJ4(=QBUY4R?=,AVK?[6TPK.:0
MJU6MCW1P6"'<6,?K6IUJ.\<:=QRV*JQWG0^NMFY#J^9FS,#!:NC-KAZHH0<^
MZL'8YE %'\0N%V5X-@]4JZ9<KL9>S,CQZE7+6MC!YD<[NUR^<J^OR]FXQW.>
M'6W&ENO*[+XWK\U-;GV\IW_]]L[__DT>?P>\X/L3.'@(?G"#+Q#A#F>XPAL.
M<8 OO.(2MWC$,T[QBW-<XP/?N,<3#O*1?[SD(C?YPS%.\I.S/.4=7SG"Y]$<
M?!"F0S3[D&0'\F%3[[S4/M?ESWL.]*$+O>@\YSD37QCT_Z,OO>E$9_K3G6YT
MJ4-]ZE'/X2UGF?5:PG+K7N\ZV+4>=JZ+O>QD/_O7S9YVM(]][6YO.]S5'G>V
MR[WN=+_[V^V>=[S/?>]^AZ/5=V@\=VO#E^;Z5I4 D]'%;Y3Q&&T\Y!__>&KJ
M[9H<O3Q-N+D0;ZJEI]]PR987PHVHN*.GF]&&.O@&32;++!\\X:5"QF&.<IBC
M"K,W!SB(#1EML"3RF+])-5TH^=\/W_'$/[[QD^][Y3^^H55A/O*7+_WB3S_Z
MU+^^];/O%,1GJ4T_8J%7P2I5J=Z#.+M'!\W'?YB:6N2KQ$E'.M21#G/H7F:C
M68SY0=,._%MO\ M1QV"8'F)0E?]"H$-AW ,\R,,[P$,"+F "'M50L5\V6)5)
MY=]N $?XJ=]7%0:$3 B"=."%5(@'BF (@B"%F. '/H@*6L@)KN (HB )MB +
MIN ,QB -OJ +EF .RB .UJ"SS5S->8@_?(C.>4GB>8OW=1\2+N$1-J$2.J$1
M/J$41B$5FDD25B&:%!-I0:$5,N$4=B$79F$8<A\6DB$8?J$8HJ$9IF$97N$9
MRLNQ1,NP9 NWU.$<;LL=:HL>VF$<TF$>\F&R^&$?XN$@[N$?'F(A J(<)B(B
M!B(A.J(A,J(D0J(B"B(E-N(B7N(D9B(G6F(G/N(G1J(FCF(H5B(HAH07MF&&
M+<2&F0O_U:%+Y3S.Y4 .+<ZB+3K.Y.!B+.:BY>ABY/BBD-G9+@[C+\(-ZV6#
MD]VB/[19Z]#,O]13\) #+O8#/*3;[E6$-]R3,N+#\DS9R< >E^E.98P#EO6B
M.<IBT-C9UA!C+0*C,J+C.?(B/,ZC/-8C.[ZC/18C/=XC,$*:ZK5C//)C0.IC
M/@+D/A*D0!ZD018D/B8D0[HC1$K$*U[=0#3/^Z@/1EZD/LA#/#'5_V4D^^V.
M1EI;-U[C0I #['1;]-B483#;0@2';IPD5EE/QTA@.B2/YGDD[<!/34+&NETD
M<>BDNZ7/2(9/1EHD89B04H(04Y904Y(05"ZE4TYE5#ZE5%8E_U5>I59:)5=F
M95=B)5CN3X88FQ 2(456'5I.9."EY5FJ)5NN91@QD1.Y)5VVI5W"Y5V^I5[6
M)5Y:W=_I7=\%)F .)M\1YE\6)F(>IF(*9F(RYF(:IF-&)F1.9F-2YF-6)F9>
MIF9*)B'UY8R ([D87D4 DVM!GVE6WVEB7VIJ7TA0WDI8WFHJE.8I!.=%A1Z0
MTTS,9C9$S3+I@SNL8F2$65)H&61X@_#Q!'!>H#FPYO7QTW'&)FI&IVI*)W-6
M)W1.IU<XG^M=IW52)W=^IW>&)W9VIT!=F&6-E :*7P:&GSS 3&5L TY)X$V!
ME056!@EH%5$%E7H"U4(@QC&2@  2AO]NHN1BZ"9D],90$> $JE]6757]X>=Z
M;N!0B55@5:AA66AB8:AB:2B'7JB'9NB';FB(=BB(EJB(FBB)GJB*1L<]B-6&
M]%.?L(MYSBB-UJB-WBB.QL5H.4F.]JB/_BB0!NF/4IB#55B1'BF$&6F2(JF$
M*6F3,BF1+JF4/NF41BF57JF59BF!8>F6:BF"=2F8?JF83EB8DNF8.JF7FJF:
MHFF9LNF90FF;PNF;5FF<TNF<<NF=IJF%O59RMN+L>-A>PI"H#2JG%6JH&>JH
M$>JA+FJBTMB0_2.B*NJH,5FY)&.>15FM<5FF=MFY1&HI? :'0<./S<+@\<P]
MZ!F:*82:C1C_,Y;+.#0JHUJ:.L(JK4JJK48JKL9JKM;JKMZJKOYJD/DCL/HJ
MKPYKKQZKL29KL2XKL38KLH887U*1/_::KHT;M9Z;JI$#.(P#.(0#.%1;\HS#
M\J1#M1*&.?Q:OK':M17'WEB9Z*F0L+FD\)1KOJUKK-73IGK;]] #E^%&ND)5
MS*R#M7Y/NL7,3Y8KJ/;GO26L0H3/OM$KQ&*KG>5#R+E<Q4X<RF%LRVFLQ<(<
MQWZLRF5LR&[LR':LR+[<R5YLR8(LRI)LRYJLRZKLR^)/8^U4"_63$Q5AM.YL
M7O*L9_ILH/ZL$B6=O@"MT?8LT@JMT@8MTQXMNVRF97(FU&:FU%9M_]1>+=5B
M[=1NK=5FK==RK=9V+=A^K=B6;=B>[=TM+5R4:O"(YD*HDQNR(5R YWC2+7G>
M+7BZIC79K6RN3%;P@U!>8$60P$9)8#D(Q6U"ACQD!3C.4TE8HT)X@W@27_#Q
M[>1:;MU>KN9F+N?JDW;B[>:";N=BKNB6+ND:TQJF+HFD)^NNYRJ2ZW&D V28
M TU!QGQ*558QA@1J0_KQGWZF)_L@1_T193Y0A.(NA^Q6A!Z,GP12($DU: 7J
M5(3NYWXZ&P_JH _NX UB;P]V+_=^[_6&[_:*KPV6+PR>K_::;_JB;_:VK_>*
M[RJT:#ZH!&2UA,;(:!NFXAONK]SVK^KJK___QNW_CJ$ %W"2["A>#+ :&C !
M [ "YV\#1_ ".S #3[ $#\DI9K HEB(F>J(':[ I;O 'BS (=W );^((A[ *
MFS )M_ *H_ )DV(*L_ +RW ,<S ,NS -[W .US .V[ .]S /"PL%(V&?ZL50
MOAM?.B03(Z03+V030_$3-^041^3C/&H44[$4H\PQ6FK&?,,X?H.WAH,8;VL9
MDS&7D</ ^,/R:,,;Y0SK! \)  PX\<PZ+ XXKNI&).]"' #3#.06:['+S*I"
M"K(5/R0@&W(B'W(6,W(5+S(D%S+9^&,C1S(B2[(E5S(F;_(E=[(F>_(C[Z/3
M<HX^\*0I'Z51J@[_/FB#1WJ#.:R#.8BK.,Z#188D[Z0R2<[.3AE&3,I,/22/
M2G(#-WP#-W@#-QQ ,0\S-]##\T@O^+ M;-Q.+\<,-YC#['V#3@JL^C3O*0<O
M4"954;H/4N)R8X3E5VZE5Z:S.:LS.J^S.[<S/)^S/+/S/+]S/6M0O*6?S1'M
M_39MTOJSVO[S* _T7<IET0HT0@>T0@,T0Q/T0O_<V$:TV9(MVDIT14^T15.T
M1F<T1V.T1U\T2&_T1XMT2'?T+ 4T:!8>$O_2A9UNZ+KTZ+ZT].DM;,HT-NEF
M;0Y%+]..4_"Q0JQ#2:RB'BQ%*4"&-+I$/7AD.:3%*CJN2R1N\/ #3(^%_W-.
MM57;M.EB]57'M%)\[E9G-5>#M5A_-5D#E)#V!?6VKH0.QC&&AC>\3NU6Q.V>
M5.XFAD\K1#WXKN B(_HHK&(8+S@O1NSL->V(GX(ZKV) [U9)[UJG=0:BZ(A&
M-F1/]HI*=F53=HIFMF5K-F9OMF=W-FC+53V@T$]U",XY!/Z>M6JO-FNW-F8A
ML&O'MFS/-FW;J)[*Z9KBMIOFMIWR-I[Z]FWW]FX/MVX7MW ;]V\3]W$O=W(C
M=W W-W,_MW37*717]W3G*75?-W!G-W=CMW=O]W?OJ6L=,5T0GA(GM+(Z:WH_
MJWHS*WN_-YUAL7NO]Y(MCQ?7F#QPV#?T64=F0_\]' P_9%OPT,..R2Z'$?BC
M 0_/?*NDI6HVZ#&*4:I/M3>%@Y_6S#>&5SA]9SA\<_B&:[B'QYBPACB(EWB'
MF_B'G[B*ISB+PZI#Z^BU/JS$1JR,[QL\M.I";,,3R(.^]1HZH"O$KJNQQ=K.
M! \$RFM)UAJTV6N/PT.MQ3B_J4/H<1@)E(,\S/BY :Q%#&R[V5NZ*H^7TSB4
M]SB9\T-SP"R:LZS,KKG'KJR;S^R;LWG*MCF<U[F<QRR=WWF:QWF>]_F<_SEX
MC&7'M-"'F&41/C1ZO[BB)SJC*S0_+SJB1WI#-_JD2WI=FC1)9SJF;_I(<WI)
M=SJH?[JH:WJHD_JH>[K_J:<ZJB]20$-S:*[TX57PD91U6-/Z6&OU$%933=?Z
M,N'T<%:&FC5%2E7$-CBU0TC@0H #.K1#*2B@.@PO7F^$+%?$$U@S.M">.:"#
M[64[MFM[MDMU2#2N48P39/SWK4-%Y>(ZKZ_[N;>[K5NN5ZN[N\O[N].[O;-[
M/CTP_^+%]*JU8S>VOP=\OP\\P!/\OQ^\P!>\PB/\55$L^[[O^$:\^KHO^$K\
MPU?\Q$-\QF/\Q9-OQUO\^H8\Q7M\=ZS":,_O85"3"X6(#%FPRT/PR^^[K,M\
M$5\PS=M\ !_P%L9\SN.\OO<\S_^\T,\\T,.\T=^\D-SP# LQTP.Q#R^]TP_Q
M_P]//=13O=)??1!'?=-;?=9S_=-C_==W?=6//=A+/=F+?=EO_=F'O1W6?/>1
M=UPD,:"JY2?7?2B#<B [<MYG\MT#CGSO/2<38Q?C#1AKV^(<(S@T33N8GE!Z
MI$"(#."N9&4T_KME1!XKSCP,93GU/><K#B'CO2('?N>'/NCK/>G;/>"7/M]O
M,26/ONF__NJ?ONO'/NR+?NJCONS?/N90>N;T@SB3\^\'?_P(_^V,,_&?<C@/
MO_(7/_ O/_(;O_.C\O%+?_0G/_-/O_7[3LS9,SUW/_=_?SQ[?_B#_SV7O_B;
M/_F?OP3!&PK9+ O9K\E8.N_/O_S7?Z6_I4'?/Z3K/__]\[_][S]   #@3^#
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M%W3DB[[IJ[[KR[[MRRV_)WR[%[^]UWFY-[_!5[_RF[_T"[_[B[_]"\#VZ[_
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M[5A'.J25<(%GW.$;W]7QC#)6C',\Y <G^<A-KO&2H_SD6AKWC%1KE*(:#:F
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M_R+BOXGZMW_^_;___^L_ !Q  2Q _CO  $1  E1  TQ !US !VQ ")Q ":Q
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MAQ23"1$+Q5-4Q%2<Q5$T15M$Q5K$Q5B$Q5N4Q5STQ5U415WLQ39$PKIX/JW
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MS1;;;;W5%MQNP^66W&_%Q=9$_:@UMUQ]6-6O'7";G,E;?,BAT,EV[J$J&V[
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M_@S8*/T\JH+.4]],\,2_@#WI>!!2&(\@B*^5C -[WYM)7?B'P)E@#SL\FMY
MZ+&-<=#P>!<L!_H&6*$"II!_$)%'A:I@0(JP9B8U>EZF]%.:'0* +Q-$H@4K
M_Y1!Z6U0?PCRX$Q Z$0SUJ\A8QS2_@9BPY5XL7H,=" $)9+#1-6(CL1+UTHH
MXZ(+PC&%8#RC/_98H7FD\$@2HR$:V9C'05XQA)%\9!(ER4A(3G*+CK0D)3&I
MR496\I-FW!WL3F>="C4++S.YQWP ]#<!N9(]*4H(A&8IRPS5\D"X9$@MR<&O
M=MCR0;@DGWXF]9 #D84JRM,E/U;(&V,Z2((SW.6!]%&/$<[(5<&\Y389TH]O
M\*LXN>0F+1G$CT0UY9EXZF6%C#--;3XH8!3493J!2<YWVA.?$BI5/OBQ*W?F
M4YSWK.=  PK0?Q+TG\B4&+]6XHV"S1.B_@!1*F<D,?]NF ./ )UH11-%G')D
M-*("+2A"C40H=(34H/0<Z4H/RE*5MA2FZ=12/WU$4I3:=)PX%6E,;^K2GO(T
MISZ]Y3#M0P[VY?(>\J,*/?)YFY7X\Z4-X9<V2!":!/7C@C21QRWS,:-%!16H
M.XWJ3\<*UK**E:QI-:LNL\1/J*H5K6OEJ@NUD<V&J,.7-BWB=6ZZKP0*-:X.
MXH>0QA'6E/[4CA8RK$X/*]>)MJ2F@&UL8"=;6<8RUINIZ=MB)7O9SK(2M*]L
MY6A#VQY^KHM;T\K6M52+VM.N=J:H9:UL8PO;U[JVM:FE[6UU:]O<SM:WN_UM
M;7$K7.,&%[G%36YOE=M<YC[_%[C.C2YTM90/D,T#9=B];G:YNUWOUD.[X.VN
M>+\;7O..][SE1>]ZU=M>\KXWO?!EKWS=&U_[SO>^]<7O?O7;7_K^-[\ YJ^
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M_, +W,!],:(2+$+25Z-NI**49PXEM&)1\DDDY \O"9]\MZ7=ET$L^QYI^4&
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MYCD+[*_#)GMLL^L1&^VRU3X[;;?7?KMMN.>6NVZV[XX;;[KUMCMOO_?^NV_
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MICW;/9T+Q]LD+[YB6XEPU:?GBI7]>_=AX<^7WX_^??OX]^OO?S;^?_4%F-^
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M;_FB[_F*K_JV+_N6HBJR8K#)*7;$XC !:Z[F;Z_B[_Y66;KYHOX.ZNX8JN]
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MZOATP+B,GWB U[>[ OE#K'B^0G)=43B36T^#"_E14/*0^SB1Q_>37WF*9SG
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MR<K#IE;)2@^NRHFQMU*4\C$;$ZWIIT:L1&RJ1R&SJB="%+/BAH3EPH*-2:S
MX@K&*V>L$$JLY''PRR&] 4T=L:XJD<5LM,%GPF^PTN8I*TETDRQ]A/2&*WR"
M\ZK,U)SDBL[>["0+3JP:!("WK+)L"D2LSDQ*G]FR(H'2K-()Z]%LDFQJ2R:[
M3&K)*YWL1TAN'IS2JT2= @W5IJ#I,\X_LW(QK'=Z6S.K=YH:)RNR."R(*WI
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M,0ZSHIHVQZSFB(K^*1MV"@"649KDS&#R+QL X)^T88_NZQN@8AKWQZNRX8X
M<8T8,2O4X1'C9)]$\7+T81FA M6F*HL.JF%ZPTF>8E',45=,:1J-BHD*RY3\
MX:-"*BJ"12DD#=B\**KNT2F4S2FF<:\L)\\0*2MD"7/$;2.;"*F4PZA@9'S:
M25C2!!PVBAVIPAZ9B)]&D:JRPA2CJ*NRP1S,(1W* 1UNTAQTDMR8@IG6A_B2
MHO^^BHP,TB4S1]+:@9+2ZHGTZB>!SYW( 1X,;G.(LAPEQR#SD ZY\@[K<"N]
MLBO!<BR_LBS%,BF2B[F6*RW_V1*YW'(MWU(MY;(MX;(NYS(NZ?(N[3(O^1(O
M_7(O_U(O!;,O ;,P!S,P"9.TPO**%D8KI@LTK(5QT++&*%/&+)/&+O/%,G/#
MT.LRU$LS,3,T07,T*U,T*S,[MH,T-W,U39,U5;,U8?,U9;,S3@P_9M,U2_,V
M8S,W>1,W?7,W65,RA7,XB;,XC;,L^(%#LB), & BFZ(3PT(?&(P$RB$=VD$/
MQ,W0).U&Q&(;$Z:=N!, V"P;0F[/X&PLJ PK<@TZDP+/8.X2JY(K.O)!H %>
MN($GUV$=LE-0LJ+1PH)#&DW2F%,L(#%A).32S((?X,4;GB =UJ$=JH#3QF(5
MTD$5_[-!S\2"'V2% <D"T2SDU<3"OPB*+-2HTPZM/RMDRTSC.7:I.,YG/-T%
MV[ E5)QS.\G".Z'M/*."'T8E/BDN0KCM'>2A%*X2V)H"PKBDK"91+-IIW7YE
M+!8R*5#-UB#D1[E"C3J%)<D"'[*"0\U3L,:B%",$VUS#KVX-*QAP4ZS%.9/"
M2M\,3,5B/M\%-"J$'!6+*Y 45-XT/IL"U>2!Y1X$W\8"']#!0O4L3X7$0(]S
M41FU41WU43MF;P9G4@^'4A,'<22U4C7U4BTU4SEU4STU5-U&<415;T854T^U
M4U,55%?U4UVU5$FU56$554VU5F/55FGU5G4U5WE557'55_]W%5A[E55_E5B#
MU5CYQCBC,E[" BN%\BQOZ8B "(FH=5JM55JQM8BN55N#!_ZD<%NK-5O#E5O)
M=5S-%5S155Q?, ;3M5S;]5S%]5WE-5[IU5WK%5[M%0"B<%[S%5_]E5__]5X!
M=F %MF#[%5W-<C')$EH5-F$7MF&WB%*>X["HPJ:T@D/'"9+>R-7^:Y&68M^R
M81$];@'=D4W^*) ZKI#()2/]3W/LQV,)49+TK9(N"2:5XR7A*AYOJ964*2J0
MJ2:5T16G@N&\QRF(Y7Z4J!9![1872!>9PA^$RMJ0(A^> QBU2!^J"HV@ AR>
M0QR=R)MZ]KFHZ7)@I**H*!V>X\S_K%%H-TL;E,,FE>.M"")RYH%K@9:1Y@F,
M,G9D\6>)L@H>;U;31@I.76J@("L?M2&A^"&PA.DIRE:QKBBKSB=S"M*C(B<A
M@R1R2JJPC.HA#5>F(L>A6 EIL<B_T!$ Q$UJDZ(CO<@?**4ZL:*:)DF3[LMJ
M[:5F ^IS;99P=Q=GL8@F-RN8UF<;PM;9XF1R&0LI"3)RT,$TFC)SGK*@^D&.
M0"HIRA9Y(39['W9[';9[&99[O]=[PS(QR1<QS=<PRQ=]S_<PU;=]V?=]TQ=^
MUS=^Z7=^[==]ZQ=_[U=^];=_%1-\-8<#X^0QO\+WF@[H=#.!>Q,X&5B!.ZPS
M,<.!&WB!_R6X@BDXQK(C'R[L-RV8@R_8@T%X@D.X@PVB-D7XA$DXA3\8A5=8
MA7_3@'VN]Z3N@&%XZ&8XAFGXAFU8A@7M*IES*?"!V[J$30& /9U"C2:W0?:S
M*6C%0"\083 GS9YB/,MS5*@T9]&4SE+I*=R37/:TR%@WQ[@4*\B!5=+S;D\4
M*_SS*0"T*50 BL7B6$(EZ1#TNC:%K"YG5$Q44;(">;EBRT(.*<2-&S92R3R4
MAP'@U5AE81)F'<=LU=1XAML+3I44-%+**2Y%49$"'U!N(I&BB2LMDW.4DIUB
MVGITXK)"VRB-VUHJ<[U"SVC%2#?G'NQD*1;M=+GB4KS-OW)MDO]6Y2F.1963
M(D*SI2FL]-[JJ2D6K3R;8AJ-+> T,LK$E(;;"46;XBJM@2H$1I2,.94K+IJK
M(HR3;.-R6!]8Y![ZX5(Z#@!B^;IH.2QZ5,F.97H2A9BS05O$Z3VWQ- P9QI_
MB9U]R9W#Q>ETF* 1&8<1>H=S^* 5.J$->J$AVJ&93J)K&/<^+_=L#Z,MFO1F
MKZ-W[Z,UVJ-#&J0ONJ0YFJ1/>J15VJ1U;Z53FJ4S&J8WNJ5E6J1K&J5I^J5U
M.J=Y.J9WVJ=[>J:!>JB%NJAM^J>-&J>)^JCM@J$?6LB6E1N;=?C$]XO:, W9
M< VKL RQ>JO/4 VY&JR_.JO#FJR]]:K_Q;JKT9JLQ]JKU5JKU]JMTWJNV;JK
MUY6NY;JN\3JN^1JN_;JL\SJP^QJP![NM"_NMR3 *#WNO_]JP&QNQ'9NP'YNQ
M);NR(_NR(3NS*1NSU:*J/3M\05M[/UNTN:A9=.6KO**,TU$0U4HYON%[$NI2
M2& >N ,>#I!]GD)#(\<;"*H?Z@$7(]$ITHPI*A%SLH>W54T>W);?EO>L8%O?
M^@$4>S=SIMF)+F4;Z($?^$$>Q"UN@Q8KBK>;8M)S+N4;@,0?[B&/;'&S@-MI
M,6?1O*$4+F@>E#,;9-<JHH0[]:&7(JIG+1:F+$,?E.<%M6,6Q!N\F3%VE>@;
MGF,;C"DI$(%6_T@@(:^1L_[,CZH"^ *Y*7P1'?OA'G#Q./(Y$'-;5GA;($!\
M@0"7=R6%'I%B2[S!-#!WBO(1T*BB'V0E))7"=85J_YP"'R ,G_S!Q.NA(.@!
MU3KJQ[NG'"*H'NK;&-/YU2C''0*K2U[\.6(\I2 0YEKJS[R!.TL!3I2#&] H
MD2*L<L1YL130RI5Y?=C\=KV8D;(BRT-*>4EQO N*)G,%--QD2[;!/S\-CTN9
MH7S<'X#\GG(V<*<HRK%B' ".RB/'RJ/WDX6*MM&274;1=3OD<PX]<O"I?/1D
MM %XU$6]U$.;U$_=U/.7?UE]U5U]?U_=?V.]U6&]UF7=UFG]UG4]U_]Y?=9]
M'==_W2Y).YURA8 9Q3A=F(5'N(69?=GS H(_L]F5?=J3O=HQ., WF-JEW=J=
M7=N[G=M)S(3!?=RWO=R_W=R]/=WA E+9O=W=G6/J(:K-I$&(& #.^$F38AM_
MT3C"XBH9)A!I9$G%4T=&N3%!8T##XM[CI8N#^TOY='7!V4&JN6"\PC\/^3^M
MN9E]A$X4%4(0U"R4.T;LF93IP4)]J5FQ!<S.-)(K!$3)(A],?D@B<^49[4+&
M^)S&PMQ<Z>6Y#32\;60[Y9K3!8[AT\=X-.*30N&KURQ86<>XS4L! !]B_AS'
M@AQ!X]-^OCY]1%82JBF"RD>"WM)Z(Y_>LRG_\H'!BF7FX_F;$5Q";C[4GV5@
MQJ+>E9Z8D+XIY-1!IKY.Z$0<^WU@2DWJA>3G'=XLOCY&PEY0AZ7G.W!0IY[P
M^\3OWWWR*;_R+;]B9E58-1]9-_]59?7SB]7S0S_S.;_T1?]83W]84[_S27_U
M3;_U81_T43_V1U_V59_V9]_V65_W7Y_W7?_W<?_V?1_WE?5QIEIRGE5[#39@
M#W;Y";;YH9_Y3>BLG;_ZH__YI1_[M7_Y[_KZK3_[OW_[O7_\P9_\Q=]X]C7\
MU=_\U[_\W?_\X;_]XU]X3'W84=W^Z__^'XL?\H$>_/\X ,(?@($""0X$4!#A
MP7[WY"'*=S"A/WWR__#UBXC1($%^]>K1XS=07;9LVMYE5*@1)4H9([/U$^@O
MW[Q[("6>9"CO'C0 _&;I*V@S95"50X/J*X4/YLFB2YL"Z$>/7KV73HE692KT
M(+Z95K,.Q%=O)DBO7<MB-7O5*=1Y'\^Z34OV[<:.\_)=E$NT7\>/(4>6A L
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M)$);2>-@$EE1#^/P2>$P#_"IGVY!#MRE#D-!H6X$$0+1BOJ)$CGK#0#@#M_
M7>0PLG&4J&P4H$&1LYV:#AJ+#QJ!#^.@L21!#J60'2'K(_- %A]+$OP0LFX4
M/2VK#2]+%'6;A20P#GYK$U_KH%BAN(FD#7E[$H#+#?Z #^102=L #FV;$??P
M3FX$#O-0D=H@H6@QLQ7:%*N;H?5"L2?!N8%[$)BKN;,[$IX+NAHANCZB#>"
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MAT1D7O1Z*+WE56][V?O>\[HWOO!=[WSM6U_\RC>_]-5O?_G[W_OZ-\  WN^
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M7WWYX9.?OOFD2];89.[#_UC\[<M?/_WWOV]__OC/O[___0-0?P'DGP +2/_
M _[/@ E$X  7Z, &0E"!$72+^D8"CH9U!C48S(;$;.3!#X(0-2#:4(A(:$(/
ME1"%)QQAA;!CN%>M,(4LG*$,:QC#&ZHPA\VA3_-HB$,?ZM"&0?RA$(%HQ"(B
M<4$-,MP0FWA$(D+1B4F48A2?2,4K5B>$6MPB%[OHQ2^",8QB'",9RVC&,Z(Q
MC6I$S9/XL<8WPC&.<IPC'>MHQSN&L4UOPB,?^^C'/P(RD(+<HJ%4-,A#(C*1
MBERD(E?3&QA"\I&2W$TD*3G)V%02DY>$328YN<G6=!*4GUQ-*$DY2D=:,I6:
M5*4G62E*5YH2EJA<)2U;6<M7WC*6N9RE+7N)2U__ZA*8O/PE,8-9S&$:,YG(
M7&8IF7G*9D+SF=*4932I.<U=5A.;UQ1F-KFYS6-V$YS?5&8XR3E.9UHSG=I4
MIS?9*4YWFA.>Z%PE'QF&P8=M)C.;Z6 %/]*SBP'TGP)56D ).E"D%12A!TTH
M0Q?J4(-"5*$1;>A$'RK1BU(4HQ;-*$<WZE$ #*UH-NMH14NJ49.2]*0J32E+
M/[I2E[84I3"=J4QK^M*(H@T::HOI37O*TY_2U*=!!:I-B2K4H@XUJ4A=ZE&;
M:E22&JYH3U6J4ZDZ5:9>M:I8M2I7M^I5K8(UJV+MZO?.9]9^HG5]:D7?6L_:
MUK1:AA^ST,="X.I6MN+U_ZYZM2M?W^K7D>C4C7W-ZV#W^E?#$O:PA;V=0'22
MV,<B-K*+52QE(3M9@S!0@IK-+&<?N%G/=G:"H!VM:$O[6=.&]K2J32UK2;M:
MU[86M;"=K6QKJY;"8@9B^GP8!D53J4EA=HI6'*YPBUM%XV)1-R[<#@R3>]SG
M.C>ZQ(6N@!QD'^1.5[K8W2YUN:O=[G9WB=OY+GFS:U[OGA>\Y44O>V4S*.#Z
M26'OS11\Y[NIW](WO_?%U'[E6ZDVQK>^^.VO@/D;8/T>F, (MF^"&\Q@&NEQ
MP0-V\(0?7.$+&]C"&<:P?S?LX2P5LL,B+O"()?QA$J/8Q"56,(LIC*F#O0MA
M!O\KF(QK'.,;TXM@.I[QCFV<8QX#V<<#"S*.ARQD&/_XR#0N,I*-S.0E)_G)
M/98RD:-L92=?N<E:AC*6N[SE*6>9RU^NLI?%_),3-\F>#<-GQ CKN=!)[LV;
M@W/G+A=G.]<9<W@&W9R3%E+$Z3G0=Q9TG@=MZ$(CFL]R7O2>Z:SHGN54;8PF
M]*,I[>A+]WG2AZ[TIC&MZ41[NM&9UEI4 =WI45L:U:?^-*=!K6I7LSK4J8[U
MJUNM:,M65K*YOJRN<>WK\N5N=[T>-J^+O>MC_]K8(VF>8)%-;&<K^]G)AC:T
MNU?6:&.;VM/>MK2[_;S8OM:VX!XW;<-M;G*+N]SH/K?_NMN=[G>S&][KGK>[
MXVUO>L>OL!=LF#9XVV8\IG>]Z@TXP=O;0@<UM^ #-[C"!>[P^_#PN@N?^,,9
M;G&*-SSC(1+O@S2.\8M7_.,B#SG)@<C(DZ,\Y2I?>1D!S/*7PSSF,C]DA&=N
M\YOC/.=E#+'.>^[SG_]\GNU<)]&';O1W%AWI1X]GTIF^=*$K/>I.ESK4IV[U
MJF.]G%D_I]:[SO6OR]/K80=[T[<^]K.77>QI)_O3U=YVME/=[7&'^]7E7G>Z
MH[.>&V2S/CF86+*.]:N!#RO@"R]XPQ.^IG\>*>('[_C&0_[PDD\\Y0<?Z<A7
M'O./G_SF,\]YS8/^\Z*_::D[_V_ZT'L^]:<?_>I5C_K6PWZCW,[V[+7M;=O3
M7G5RI6OM>W][W^<^^,X.[.^++WS@XS[YLV_LM95O?.<?__G(SRN^[UWOZF/_
M^MJ7]_:MS_WO>S_\V0?_^,7?_?*C__R&P6W?=ZO!WFHX3!XO.<CG;__B+I<[
M]Q_Y_NG/?^Y:5_\)8/T1X/\9H/^A$,<AX  >( ,N8 $^('3%7XJUV 2J& 6Z
MV(IE( 9:8 7^E_-P& >&X 62H >BF0EJ8 =NX(+5W JBH B>H O*H K2X B^
M8 F^",_A8 W&( ^FH W.(!#Z( R6V)@I&9B5&1(:(94=(9DM89@IH9E%X10Z
MH116(?\5-F$6,N$60N$5>J$6=B$8)N$7<N$8BN$3FF$9HN$:6N$9MJ$:GMD/
M_HB:@0;?<48[N)FHT=H>ZF$?SIH?KAH@PIH@#L[B$:*L!>(?*F(B,N(@+J(C
M-J*M[<3E(2(D6J(DUEHE8B(?/N(F'F(F@B+0E!HG1J(FFF(H?B(I7N(IJJ(G
M=B(KIN+T2=\L1E\M0I]:!5M=W:(LVB(O[B(MI@ZS :,O$N,P&F,O:H2U_2(R
M,N,R.F,Q.D3ZD9_Z36,UFI\U2N,U:F,V<B,U;J,W=B,V@N,XBF.^Y=J^@4:_
MO5_#X"' 0: #PN,[RF-YY%_"S6,$XF,\-N!N1)P^YN,]^F/_0 +D=BF@0.[C
M0?XC0AID0LX&T#GD0T+DRKE<1%)D15KD';7@16KD1G+D&.E@1X)D2(JDCMB=
MV:T=VKT=2LZ=2MX=2YID2IYD3,+D3*ZD3-8D3;:D3>8D3K[D3?KD3OYD3P+E
M4 IE49;D4>(=4KJD4NJD428EV/'1WMGA9HS#W['>ZV'E56JEZVUE[(%43C%>
M5V8E5Y*E5Y;E6%K>X>P46K*E6+KE6;ZE6<IE6R9>Z='E7,;E7>IE7O(E7/HE
M7C8?-#[C,0YF,];>[NFB8"HF82ZF8>H5\3EF9!;F9#:F8C$?93)F9DIF95(?
M.7YC.7YF:(:C:'KF:)IF::(F:)ZF_VJF)FFRIC4.UCUP1CYE@P=M$#T(88\@
MQ&X^!&_Z9F\"YV\*9W 2YW :9W$BYW$J9W(RYW(Z9W-"YW-*9W12YW1:9W5B
MYW':AS[PPT!<YW=F9WB"YWB*9WF2YWF:9WJBYWJJ9W'J3G<>"GO*9WO.9WW2
MYWW:9W[BYW[J9W_RYWWF#G<VFW\2Z'\6Z($::((BZ((J:(,R*(/V8&Y&Z(3*
M8842X87NH(2*6.[$#(5BZ V":!!Z:(:.:(@.(43DA!N9J(9^J(A:*(F^Z(J6
MJ NV":>P*(RVZ(G*:(RZ:([>J)PHY$ &Z9 RY$(:J9 6*9(>*9$N:9(RJ9(2
MX(SZ0SM(I?^)T"9GU(-F8N9F:BEG=NF7<FF8;NF8>JF8EBF9@BF:FFF:GFF;
MLNF;KFF<JNF<NJF<UBF=PBF>VFF>WFF?\NF?[FF@ZNF@^JF@%BJA BJB&FJB
M'FJC,NJC+FJD*JKPD$.5KN.:C62F:NJF<FJG>NJG@FJHBNJHDFJIFNJIHFJJ
MJNJJLFJKNNJKPFJLRNJLTFJMVNJMXFJNZNJN\FJOHJH>6*J_T:8[2*JC%BND
M3JJQ)BNR*FNS,NNS'FNT+JNT.BNU0NNT8FNU9NNU:FNW<NNW6FNX;JNX>BNY
M@NNXHFNYINNYJFN[LNN[FFN\KJN\JFLXT&8^@= &94.6^JB4_FC_C^)HP.YH
MO_*HC@+LP KLP2JLP3+LOS:LOT)LP3KLQ$8LP5ILPCZLQ%8LQE*LQGKLQ2)L
MR"YLQX+LR&ZLR&9LR:8LQYZLR7XLR[XLRI(LS*KLS,ILRZ[LS<:LR]8LSMHL
MS])LT.ILS^YLS@+MT KMT2JMT3+MSS:MST)MT3KMU$8MT5IMTCZMU%:MFE#I
M/840!FD#.,SKV+HKO<(KV9YMV:*MV;+MVKJMVL)MVLIMV\8MW<[MV]YMW>*M
MW?+MWOJMW@)NW@INWP8NX0[NWQYNX2*NX3+N8=%#^SF,%FU05?IJY5KNY6)N
MYFKNYG)NYWKNYX)NZ(KNZ))NZ9KNZ:)N_^JJ[NJR;NNZ[NO"[J?J*Q?IEFZ%
M0^+B;N,J[N[F[N+Z+N_J;N\"[^\*;_$&[_$2+_(.[_(:;_(Z+_,J;_-"[_-*
M;_5&[_52+_9.[_9:;_:^SKU&+NU.+M*2[])2K=:B[]66;]:JK_EN[?J>;_NR
M+];&+_V^K_NFK_WF+_S>[_SR[_[BK_S6[_\*</\.< #K;P$#L/\B, $G\ ,[
M< 0W\ 0S< 4?L 4;< 8O\ 5SL 8K\ =#, 5W\ 9[< AC, FC, A+\ FKL B7
ML,[.[A?-)F@\@?=RK_9V[PW;< [S, [[\ [_L X+<0\#<1$/<1 3\1$;<1(S
M,1([\1(_L1)+<?\30W$53W$4\_#C\EMMAI&^9L,JQ&X8B_$8DW$9F_$9HW$:
MJ_$:LW$;N_$;PW$<R_$<TW$=V_$=QV[7>NT8@6]F$*L54_$5 S(6$_(@&[(@
M(W(@*W(A)S(C+_(A/W(C0[(C4_(D6[(D8W(D:W(E9S(G;_(E:ZF]SG!FG)$7
MI[ )CW +LS JO[ +G_(*IS(KO[(KJW(LPW(KK_(MSW(NT[(LUS(NVW(OZ_(O
M[W(P\_(Q&W,R _,R%S,S$_,S^W(T#[,T"W,U([,S4_,U-_,V0_,T>[,U*S,W
M9W,X=S,X8[,#KX,IHQ'89L;M>O([@S(\=W(\T_,\V_,GW[,\X_,^ZW/_/]<S
M/_^S/^=S0!/T0!LT0!^T0"/T0BNTL=5#.M;A&WGQ.N!Q15OT16-T1FOT1G-T
M1WOT1X-T2(OT2)-T29OT2:-T'#^T.L<1Y.:3.Q<T0\=T0\]T32>T3<OT3>MT
M3O,T3>^T3_<T3@/U4 MU4?^T40?U42MU4C-UX]9#'T.,'7EQ9K3C-VMS.5_U
M.)^S.8NS59.S5G<U5V/U5WOU5F=U68?U68LU6(^U69/U6J-U6Z?U6ZMU7=/U
M7;MU7L^U7LMU7[/U7\<U8,/U8-LU7PMV8>]U8OMU8#,V8>/UBZ8S2]_1!M'F
M..#F4A,U9B-U9C?U9GNV9H-V9X<V9Y/V9XOV_VF7]FB;=FJC]FJ[MFK#=FO'
M]NG()D1'-"!--56G]&[S=F_[]F\#=W +]W 3=W$;]W$C=W(K]W(S=^L":VXG
MDDN/\CK\\6R_MFQC-VMK]W5OMW5[=W9S=WA_=W>#]WB+=WFC-WFK]WFOMWF[
M]R.O U2#+\KE-FBT T4OMF,;=F,C=G[W]V$_MG\'.(#OMWXK-H$?.'\/N((7
M^'\S>((;N( W^()'.()+.(0[>(4_^(5SN(5[^(9_N(:+>(:3.(67^(2C.(:;
M^(J?\SWD5GUS,<O9]A8W#'6K S^Q=XZ_=WNGMX[W^([[.(\+>9 3.9 ;^8\C
M^9 ?N9(G>9$W^9([N?_9TL,]K$.ELO.5Q[C-P?B6<WF7>_F7@WF8B_F8DWF9
MF_F9HWF:J_F:LWF;N_F;PWF<R_F<TWF=V_F=XWF>Z_F>\WF?^_F? WJ@"_J@
M$WJA&_JA(WJB*_JB,WJC._JC0WJD2_JD4WJE6_JE8WJF:_JF<WJG>_JG@WJH
MB_JHDWJIF_JIHWJ<0Z1\CW+MLKITP[JKM_JKRWJLT_JMSWJNV[JNUWJOX_JN
M [NO\_JO"WNP$_NQ#WNR&[NR%WNS(_NR0[NS,_NS2WNT4_NU3WNV6[NV5WNW
M8_NV@[NW<_NWBWNXD_NYCWNZF[NZEWN[H_NZP[N[L_N[RWN\T_N]SWN^V[O_
MOM=[O^/[O@.\O_/[OPM\P!/\P0]\PAN\PA=\PR/\PD.\PS/\PTM\Q%/\Q4]\
MQEN\QE=\QV/\QH.\QW/\QXM\R)/\R8]\RIN\RI=\RZ/\RL.\R[/\R\M\S-/\
MS<]\SMN\SM=\S^/\S@.]S_/\SPM]T!/]T?,[2*;ZTC-]TSO]TT-]U$O]U%-]
MU5O]U6-]UFO]UG-]UWO]UX-]V(O]V)-]V9O]V:-]VJO]VK-]V[O]H)?JC,M]
MJ\\]Y-9][=[]E=+]WML]W^.]W^M]WPO^WP]^X!/^X1M^XE/VXF-YWC,^C4.^
MXS<^X#^^Y$<^Y4]^X5<^YE^^YF<^XF^^YW<^Z'^^_^*7?NB3_NB;ONJC_NI;
M_NMS/NR+ONRG/NV[?NSC_NSG?NWO_NWK_N_S/O#[?O 3__ ;?^LC_^DK/^LO
MO^TG/_-#O_,W?^\_O_1'/_5/O_!7/_9?O_9G?_%OO_=W/_A___&7?_B3__B;
MO_JC__I;__MS/_R+O_RG/_V[?_SC__SG?_WO__WK__\#1#9MV0@6%&BPX$"$
M!Q<J1.C0(,2$"QD^I"B1(,:*$2]V;.C1XD>1(4ER'&FRY,23*E-F!(D2)LN8
M+E?2;+E19DZ;,W'NU-D3J$:A+W\.K1F4J$^E2(\:O>F4)]2B29D^I2IU*=:J
M4:]V;>K5ZE>Q8<ER'6NV[$?4LVK39@6+%B[;N&[7TFV[56Y>NW/Q[M7;%[!6
MP6__#JX;F+!?Q8@/&[[KF"_DPHD9/Z8L>3'FRI$+ O#\&71HT:-)ES8=$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img8190679_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img8190679_4.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "0 IX# 2(  A$! Q$!_\0
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MHHHN@"BBBBZ ****8!111D'H:5T 444472 **,CUHHYD $@=2*0X..,UXO\
MMT_M#>,_V8/@5=?%GP=X;M=4FM+F-)K>[<JH1C@GBOA1?^"]_P 8P./@SHW_
M (&O_A77A\!B,52YX'%B,?0PU3DF?JF50=?YTO3BO%_V%OVDO$'[5'P-M?BI
MXDT&WT^YGNGB-O:N64!>^37M![5S3A.E4<)=#IISC4@I1ZA102!U-&0>AI&@
M4444 %%%% !1110 4444 %%%(SA!D@T 0:C?VVF6LE]=R!(HHR\CG^$#DG\L
MU^(?_!37]J63]IS]I:_U#2;EFT+0/^)?I46<HPC8EI<>K-GGTK]$O^"L_P"U
M?;_ 3]G^Y\(>'=76+Q#XFC-M:A2-T<!R)']LC('UK\9%=Y"9'))8DEFZD^IK
MZ')L(FO:R^1\_F^*M:G$2-6$85SD@?,0.IIU%%?1[JY\]JW<#TK[#_X(W_M4
MQ_!GXZ_\*J\2ZDD&B^*R(@T[X6.Y7/ED9Z9SC\17QX>E.T^\O]-OH=2L+EX;
MB"1)(94QF.1>0RGJ#D5CB:$<30E!F^'K.A7C-/8_I'C>*104;((R*?7@O_!.
MO]IFQ_:>_9PT?Q?-=!M7L8EL=<B9@7%RB#=(?0-P?SKWJOA*E.5*HX/H?;4J
MBJTU-=0HHHJ+W- HHHH **1F"]:!(I&<T!<6BD5@PR*6@ ZTW<BC=NQ[GBEW
M#UKY?_X*0_MR^)?V*_"N@ZKX/\-:=J=[K-_+%Y.H"0HJ*N<@(ZFKI49UY^SA
MN8UJL*,.>6Q]0;U_OBC>/[ZU^5'_  _K^/\ W^#GA?\ []77_P >I?\ A_3^
MT#_T1OPO_P!^KK_X]7=_9..[(XO[5PG=GZK;Q_?6DWJ.2XK\JO\ A_5^T!_T
M1KPO_P!^KK_X]2-_P7K^/ZC+?!SPN!W)BN>/_(U']D8[L@_M7!]V?JMYB'HX
MI001D$'Z5^66@_\ !?;XLIJ<,GB3X,Z!-99S,MBTR28]07D8?I7W=^R#^V1\
M,?VO? W_  E/@:1K>Z@ &HZ7.1YMNY]?4>]85LOQ>'7-..G<WHX_"XAV@]3V
M"D9@O)8#ZTH()(':OFW_ (*/_MK^(/V+O >B^)_"F@V.IWVJZLML;6_W[1%M
M8LWRL#G.*PITJE:?)#<WK5H4*?/+8^D"ZCJZCZT;U/21:_*F/_@O3^T 4R?@
MYX7/TCN3S_W]I3_P7J_:!'!^#7AC_OS=?_'J[O[(QMMD</\ :F$[L_5;>/[Z
MT;Q_?6ORI_X?U?M _P#1&O"__?JZ_P#CU-/_  7N^/HX;X/>%@<=#%=?_'J7
M]DXU*]D/^U,)W9^K!8 X+#\J4$'D'KTK\K-'_P""^GQA^VH?$'P;\/2VF0)5
MLWG5SDXX+28K[I_8Y_;7^&O[8_@V3Q%X-CDLKZS8+J.E7$@,D1/<$'D5E7P&
M*PRO..AM0QV&Q#Y8/4]I8A1D]*:9HE?8\B@^AXIT@)0@#)KY+_X*1?MU_%?]
MB>X\-W_A'P;HVJ6>MF=)#J(F+1NFTC&R11T)[5A2HU,14Y(6N;U:U.C'FGL?
M68D0]'%()48X#CIW%?E9;?\ !>_XW_:(_MWPC\+B#>/.*+<9"YYQ^^/.,UM?
M$?\ X+T^+;3Q&\/PI^$VF2Z6B*/M&LF5I)'[D;)!@<'%=O\ 9&/ZHX/[6P7=
MGZ=%TR"T@H\R(D .N3TYK\IQ_P %\_CM@[OA'X4&.IV7/_QZNW_9R_X+1_%K
MXR_&?0/AOXB^&_AVTL]7OE@DN;5+C>F>XS,1^E3/*<="/,UHBH9K@I244]6?
MI$C;AG/Z4$IG!(SZ5' 4";E3&>N*^;/VX_\ @I)\.?V.)HO#<FE2:WXAN8?,
MBTV"4*(E[,Y]*Y*5&K7GR16IV5*U.C3YI/0^E]RCC<!1O']]:_*F;_@OA\<?
M/<6?PA\+B/<=OF?:&('N1*!^E'_#^K]H C(^#GA<CVBNO_CU=G]DXWL<7]JX
M.^Y^JV\?WUKG?BJ^_P"&GB J<C^Q;D<#_IF:_,L?\%Z/V@C_ ,T:\+_]^KK_
M ./5>T7_ (+F^+?$>GZAX>^*OPAT^*SO;*6W6YT<RAXRR$ D2NP/-7#*<;S)
MV1,LTP;BU=GP+K[J-=O1_P!/LG;_ &C7Z(?\$ CC6O&Y_P"G"#_T):_.K5;H
M7NJW%_"&"RW#/C/8D_XU^BG_  0$.-9\;G_IPM__ $):]_,_^1=(\7+/]\B?
MIGN7.,T@<%OO#!Z<US'Q@U+XAZ)\.M7USX8:?8W6MVEH\ME:WZL8YV49V'8R
MGD=.1SBOS6US_@NO^T7X=U:YT/6O@MX8@N[2<Q31.ET-KC@@@S>M?*4,%5Q;
M]P^EQ&+I8;XS]4=P]: 03UZU\(_L'?\ !5_QA^U+\;XOA/\ $+PAHND17=M*
M]I+8>:'>1%R%^>1ASST&:^[()#(I;MGCZ4J^'J8:7+-:E4,13Q$>:(^BBD+
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M*<DZ4OD?3.X[MM+2=QD<^M+7SZV/>5PI&8*0,$Y/;M2Y ZFDR=PP/K0,\O\
MVA?VMOA!^S8+:/XA:E.;FZ7?#9640DE*9QNP2!C/O70_"7XR>!/C=X0B\;>
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M?B;+#*A62.2ZNB&'H<YI+ 5D[^W7WC>-HM?P7]QX5^T!X<T;PC\:_$_A?P[
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M%;:__P %7[N!;B#7?B<4<94_:+G_  KUYY9BHM.5:U_,\J./PTE[M*Y^K/\
MPQ-^R7_T07PS_P""]:KW_P"Q%^R3<VLEK-\!/#BJZ$,5L0#CZ]J_+,:I_P %
M9",_\)#\3Q[?:;G_  J&YNO^"K%]:R6UWK'Q+>-U*NOGW//XU'U"LE?V^WF-
MXNE)65$\4_:2\+^'_!GQT\5>&?"L2I866LSI9QQM\J*K\ 5],_\ !#SQ3JFD
M_M53^'[:X9;74-&F\^'/#,N"&/OUKX^\4V7B+3?$-Y9^,!<+J4=UF^^UY\T2
ME_FSGG-?5W_!%+'_  V);\?\PFX_E7MX^-\"];V1Y.$J)X]65C]DZ_.__@OV
M!_P@_@)@>?[4NQT[;$K]$*_._P#X+]_\B-X"_P"PI=_^BTKYC+/]]B?0YE_N
MC/S$CC::184ZN<5^HW[,?_!&?]G_ ,7?!3P_XT^)6N:O>:GK.EP7L_V>54CC
M:1 Q5?ESWK\O;#_D(6Y/:93^M?T&?LRQD?L]>"@Q_P"99LO_ $2M>UG=>M0I
MQY':YX^4T:=:H^97L?.O_#D?]D+=N$FM_3[6O/\ X[4GAC_@C1^SUX#\<Z5X
M_P# _BK7K&]TF]2XA4S1LCE3G!!6OL AL\$8I1GO7S_US%-6<SWE@\->ZCL0
MI&8(@A.[CECU)%?A/_P4?\8:KXU_;#\8WFH3NQMM0-K$"WW$0]!^M?NW.=J%
ML= :_ []NHG_ (:U\=$#_F.S?^A5ZN0P4L3)OL>=G<FL/&*[G5_\$Q_@SX(^
M./[5VE>%?B%I27VFPPR7#6<H^23!X5AZ<C]:_72/]B3]DZ- @^ /AL@#K]@%
M?EM_P1G7_C,NQ!_Z!DH_5:_9S:3SGC%99O4G'%63:T'E%*,J#DTGJ>7#]B;]
MDO&#\ O#7_@ *Y#XY_L(?LJZS\*M>AC^"VB6LL>ESR075G;".2-E0E2&'TKZ
M!V"N>^*JC_A6WB #_H#W/_HMJ\VE7J\Z]YGI3HT^1^ZC^=K4[9+'5)[2+.V&
M=U&?0?\ ZJ_13_@@'SK7C@8Z64"GZ[EK\[]?R=?OCZ7<@_4U^B'_  0"R=:\
M<G_IT@/_ (^!_2OK,S_Y%TCYC++?7(GZ9. RE2,@CI7XY_\ !9#]F=?@[\?Q
M\4- T_9I7B]#*P1#MBN5^\/09ZU^QC D8'K7@_\ P45_9NMOVDOV9M=\.062
MOJ^GVS7NC.H^;SHP6V@_[0R*^:RW$?5L0F]$SZ#,,/\ 6*#MNC\2?A7\2/$'
MPC^(&D_$3PQ<M%>:7=I-&RD_-SRO'J,C\:_?G]GCXMZ-\<OA!H7Q0T*YCDAU
M;3HY9!&V1'+C#K^#9%?STZC87=AJ$UA>1M%-;R.C*3\P(.TGZ[@WY>]?I#_P
M0U_:B2!M1_9D\17HW2R-?Z$7<G/&98QZ=-WXFO>SK"NI252*U2O\CQLHK^RJ
MNG(_2O/.,4R5PI P3TSCTS_2A)=Z;]O7I7G'[6/QYT#]G+X)ZS\3M=N0OV6W
M\NTC+8\R=@=BCUS@_E7RM.+K248]=#Z6I.-.+D^A^=O_  6>_:7U#XL_&&P_
M9F\#3&>WT:91=Q0D-YUZXP$P#R0"/QK[A_X)V_LQVG[,W[.6D^&[BT5-6U(&
M]UB4\EI')95S[*0,5^=W_!+[X'ZU^U7^US/\9/&L;W-GHUR=2O;B4;_-N2V8
MU)/^<"OV*B")$H10% P !P!7KYA4CAZ4<-#IOZGE8&#Q%66(E\B.:%9HFAD4
M$."K\\8Q7DB_L*?LE+JEUK5U\$=#GO;R=Y[N>YM][22,2S,<^I)->H^*/$%C
MX5\/WOB359 EM8VSS3.>@55+$_I7XV_M6_\ !57]I+XI?$;44^&OCV^\-Z!:
MWDD6FV^D7;0O)&K$!W=,$D@ X]ZY,#A<3B;JC*QTXW%8:A;VJN?J</V*/V3"
M.?@+X:_\ %H_X8F_9+_Z(+X9_P#!>M?D!\.OV@_^"BGQ9,H^'?Q.\?ZN(,>?
M)8ZA<2+']2N0#[5U7]K?\%9/^@[\3O\ P(N?\*[Y9;B(.TJ]GZG&L=1DKJEH
M?JHW[$W[)FWCX"^&OPL%KY$_X+!?LO\ [/WPU_9RM_&W@+X?:3HFJ0:K%'$]
MA"(FE5G56!'\6 37S,VK?\%8RI!UOXF'CHT]R17GW[0&G_MLZCX:BU;]HR;Q
ME<Z3:RKY+Z]+,T4<AX ^;@<D?I6V$P56&(3=:_E<PQ6*I3H-*E8\;=GCQ)&/
MF4_+S7[Q?\$\?%>H>,_V-? 6M:G*SS#0TA=W/+["5!_("OP=;+ 'L:_<W_@E
M^"?V'O H_P"H:?\ T-JVSZ,?81?9F>2RE[=KI8]\NP/LTG&05.X>V*_GB^/"
M"/XX>,D P!XGO@!_V\/7]#UW_P >LG^X?Y5_/%\?CCXZ>,QCKXHOO_1[US9!
M_%F;Y[_#B>H_\$[/V0]#_;#^-DW@CQ/KT]AINGV)N[UK;'F2*&P$7((&3U-?
MH1!_P1&_9%$0$DFMD_\ 7VO_ ,37R_\ \$'P&_:.\1+CG_A'?_:E?K,OW>.Y
MK+,\7B*6+Y82LK&F6X6A4H<THW/C:Y_X(A_LDS0-'!>:[$6Z.ETI(_-:]G_9
M!_8W\'?L=^&-5\'^!O$%_?6.I7PN -0V;HSMQ@%0,U[&H(&#2UY4\5B*D.2;
MNCTZ>%HTI\T59GS=_P %7@1^Q3XF!_O0_P#H1K\0QTZ5^WG_  5?_P"3*O$W
M^]#_ .A&OQ#SM4L>V:^BR+_=V?/9S_O!^SG_  1LPG[&6G'=DG49\$?6NH_;
M0_X*)_!O]D;19[.ZU*#5_$[)_HN@VTP+*>QE(/[L?K[5^<'PN_X*8^-/@1^R
MA;_ /X4:4+;5;AI_M.LRGF!).GE#U]_6OF;Q3JWB?Q)KTVO^+]1NKK4+U_.G
MN[QR\DA89!8MRV.WI4T\J=;%SG4VO]YJ\S5+"1C2WL?1.M>+?VQ_^"IWQ<30
M+%;JXLA/O%G"66PTF)FV[I" >@[\D^E?HK^Q9_P3(^#W[+FGVNOZ]9V^O^*0
MH:34[B'Y;=_2)2.![U^;'_!.7]LK4_V0_C-'<ZI(9?#.N&.VURW/.P;O]>/<
M?RK]L_!?BO0?'7AVR\7>&+^.ZL=0MEFMIXFRKH1P:Y\UJ8K#I4X+EB;Y7&C7
M3G/61J1Q[,#T&.G6GTT!\Y/\Z=7@ZH]Q;!1113&%%%% !113)G9 "H!.>] &
M=XR\3:5X-\,WOBG7+I8+.PMGGN97( 5%4DY_*OP9_;._:*US]IKX_:S\0+^^
M9[-;IH-(C!.R*W5B%P.V1R:_0C_@M;^U[)\.?AS:?L\>$KH#4_$T+R:PZ2#-
MO: @!3Z%\D_1?>ORAB&X[RV2<'.W&:^ER3"<E+VTMWL?-9QB5*:IQ?J/1!&N
MU>E!SGBEII+%B!@8/4^E>[)7L>*G8FTVRO=8U"+2],M6FN+B41011@EG<G &
M/J17Z3?%_P#X)<:;X:_X)WV-GINB0MXYT.$ZOJ%W%"#++(PW/#GDE0#QUZ5X
M_P#\$<?V34^,_P :'^,/BO3BVB>%2)+0R+\DUV<A!SP=N<G\*_7NXL+>\M)+
M&YC#12(4=&&01C&,5X&:9@Z>(C&#VW/:R[ 1K4'*?78_FYD$L,C02PE)%;!C
M;@YZ8_/BEKZ2_P""I7[*TO[-'[2-[<Z-IWEZ!XE=M0T<KT4EP9$SV*MV]&KY
MMKW*%55Z,9KJ>36INC5<'T$<[5)KZ(_X)D_M62?LN_M&6-UKEZR>']=06&L
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M5\O_ &!Y/ZU\W_M.ZG8ZU^T-XQU'3KE)8)?$%RT4B-D,-_7Z5]'_ /!$;/\
MPU?(1C_D$2#^=?8XK3+7YH^2PR3QZ79G[!8. 0:_(;_@N7//+^U?86\C[DB\
M/0E%8$@9>3-?KR2P   K\A_^"YEK=0?M6Z?<RP'9/X=B\MNQVR/G^=>#E#3Q
MMGV9[N;+_8G\CQK_ ()P:99:K^V+X.M-0MHYHQJ ?;)&#DCIU%?NW%%%%&$
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M/9'Q,YSFW.6S'5>\*>%M8\<>*;#PAH5JT]WJ5[';6\:#)W.P'X^M9S2%<#<
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M5Y KVZ>0XZ<4[Q3?2ZN?GM?Q/X<HRE:-248_:C3DX_>?H#17A'[(W[;G@_\
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M=Z;N7H2.:\Y>9]8V]EN8?Q%\6MX-\"ZSXK$08Z9ILUR%(X.Q"V/TK\B?B_\
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MR:":\D8DS,NX%LMS7ZBC[P%7Q%'_ &BG9W]U:KKH<GA#.<\JQ7-'EM6G[O\
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M)W1]41;&WYV]S7-_&"PN-3^%^NV%FI:672Y54 <D[374U'+;Q30M!(F492K
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M#+\LK5756(2AV>_H=4^)N,<'A8X/^S)3JI6]I&2]GZ]SB?@%::Y^U=^W4OQ
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MA_P6>_:CU7X/_!.V^%/A*>6"_P#%1*7,\8'%LH^9>>F[H?8FOR-C#@!<@A0
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img82710889_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img82710889_0.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "= A8# 2(  A$! Q$!_\0
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M?@+_ +$OPM_Z8[&O\;NOTML?^"QG_!3S3;*STZQ_;0^,EM8V%K;V5G;1ZEI
MCM[6UB2"W@C!T<D)%#&D:Y).U1DD\U_.'!7%6#X9GF4L7A\3B%C8X14_J_LK
MP^KO$.7/[6I3^)5ER\M]G>VA_KE](OP3S_QDH\(TLBS7)\K?#U7.YXEYL\:E
M76:0RJ-%4/J>%Q3O3> J>T]IR?'#EYO>Y?\ 5+HK_*^_X?,_\%1_^CU_C/\
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M_P!8WB$XO_@T?_Y*)^V__P!B7\#/_3Y\3:_MPK^(_P#X-'_^2B?MO_\ 8E_
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M%\7?V$/&>J;;3Q.EU\;O@HMS(BJFOZ7:6>E_%/PI;,[---/JNA6_A[Q?I5A
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M]:C[#XOU/Q3+9P6_BGQ%HEU?>%;+PM+=Z!9WNLZIKFI?\(O^%7_!#O\ 8_\
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M-E\7>)M%\-QZA):ZW\2&NH[%]9O;);M[99X&G2W,C0K-$9 HD0G^SG_AH_\
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M2ERSC&7*VFD[6;3[!1115&(4444 %%%% !1110 4444 %%%% !1110 4444
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M3*EALOGB)T'2PE;%5H56\3.I4]I-XJ2DN;EM&-DG<****]T_- HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\
MI!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X
M?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_
M /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7
M_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^
MD&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_
M #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@
M#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##
M>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5
M_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\
M=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F
M\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P##
M#>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&
MW_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y
M\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_
M **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\
M^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__
M /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!
MM_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\
MA]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/
M_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5_
M_P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=
MO^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #
M_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O*
M /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW
M@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_
MP5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?'
M;_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO
M*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\
M,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_
M  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A
M]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z
M*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__
M )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_
M  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG;17FGZC8W4+/#<VEY:317%O/&S)+%(CJ2"*4E9^70J+NO/J:M%%%2,_*/\
M;I_X*M_#[]A?XM^'?A)XK^$_C'QWJ/B+X<Z1\18=7\/:WHFFV5M9:OXF\7>&
M8]-E@U)&G>ZAG\(W-T\J'RFBO($4;XY*]H_8,_;S\)?MY>$O'OBWPEX"\1^
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M$_MWHK^)3_A^M^WW_P!#%\,/_#:Z9_\ )E'_  _6_;[_ .AB^&'_ (;73/\
MY,J>27E]_P#7])^5ZYX^?W?U_2?E?^VNOQ)_X+[?\F-:1_V7CP!_ZCGCROQ*
M_P"'ZW[??_0Q?##_ ,-KIG_R97SM^T[_ ,%-/VI?VN?AQ!\*_C'JW@N]\)6W
MB;2_%D4.@>#[/0KX:QI%IJ=E9NU[!<2N;=8-6O!)!MVR,T;$CRQD4'=/31I_
ME_7R!S33WU7]?UY/RO\ 1/\ P0I_Y/[\._\ 9,/B5_Z;+.O[:Z_B4_X(4_\
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MK:;QUHFNWJE_/B\N.ZL] GL)6\NYWQ7;P^0OF_:;?^7S_@DMX(M/'W_!0O\
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MO_@DK_RCN_9E_P"Q8\5?^K'\9U_')_P4+_Y/E_:P_P"R\?$?_P!2.]K^QO\
MX)*_\H[OV9?^Q8\5?^K'\9UI+X(_+\F9Q^.7S_-'Z+T445F:'PA_P4[_ .3!
M/VI?^R87W_ISTROXO/\ @GI_R?+^R?\ ]EX^''_J1V5?VA_\%._^3!/VI?\
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MN(+>\N+*1KFWDTS7;#1]<M9X%,AFTW[*S"WN[@-^NU)VN[;#5TE?>P5_"O\
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M66WNK6XBD@N())(I8WC=E+3L[B:NK?TC_,3K^LO_ (-U/^2,?M&?]E/\*_\
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K-INJZ'>S%?TW*JJJJJA54!550 JJ!@*H&      , <"BH;NV^Y:22LC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img82710889_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img82710889_1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   7$E$2  0    !   7$@
M  !!9&]B92!);6%G95)E861Y  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "= A8# 2(  A$! Q$!_\0
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M-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\
M?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"
M*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^
M)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%
M?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<
M>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$
MF^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BO
MLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/
M-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\
M?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"
M*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^
M)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%
M?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<
M>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$
MF^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BO
MLK?$F^3<>;[%?96^)!8"*O\ ?)N/-]BOLK?$F^3<>;[%?96^)!8"*O\ ?)N/
M-]BOLK?$B"P$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$%<[[E!\UU/VC58<;]TB:\#+6 .2S&M,TW[M#]!O<@^R(B O&Q+?XL.6L
M5TT#YF&01ZK" =H/+T+V5"-*GFBSZTSN<@^V'<?TN(KLVWQ4,T+G,<_7>X$;
M%,526C+SRC]1)W*[4!$1 1%\*JIBHZ2:IG=JQ0L+WNY !F4$9Q+CRBPW7LHY
M*>6HE,>N[<W :F? #GQKK632/07J[PV\4DU.Z;,,>]P(SRS ZU5%?5U6(\02
M3ZI=45DP#&9YY9G)K>K8%\*B"JLUVDA>3'54DV68XG-.PCV9J1I1%YEANL=[
MLE)7QY#=F9N:/DN&QP]N:]-0"(B OC/40TM.^>HE9%$P9N>]V0:/25]E2^D;
M$DUPO,EKAD(HZ1VJYH/QY!PD]'!U%!*+II4MM*]T=NI9:UPV;H3N;#T;"3[
MO!=I:NA<=2W48;Q EQ/>O.PI@.JQ#"*RHF]S46>37:N;Y,N'5')Z5.H]%^'6
M,#7"KD/\3IMI]@""-T^ENM:_^4VNGD;_ /CD<P_?FI99=(5DO#VPN>^DJ7;!
M'-D X\@=P>W)>77:*+5+&XT574T\G%KD/;[,@?O5:WZP5N':[W-6,'E#6CD8
M<VO'*/T4C1:*O=&N)IKE2R6FLD,D],W7B>XYET?!D>@D=1]"L)0"@-PTH45O
MN551/MM0]]/,^(N#AD2TD9_<I\J]N&BZ&X72KK7762,U$SY2P0 ZNLXG+//T
MH/GON4'S74_:-3?<H/FNI^T:OEO10?/,GV \2\?$VCR*P6.:XLN+YS&YHU#$
M&YYD#AS]*#W=]R@^:ZG[1J;[E!\UU/VC57>'+0V^WZEMCIC"V;7SD#=;+)I=
MP=2G^]%!\\R?8#Q*1]=]R@^:ZG[1JEN&K_%B.UFNA@?"P2&/5>03L Y.E0W>
MB@^>9/L!XE+\,8?;AJU&@;4.G!D,FN6:O" ,LLSR*![B(B"!W/2;1VRYU5"^
MWSO?3R.C+@\9'(J5V6Z,O-HI[C'&Z-DX)#'',C(D?DJ*Q9YW7;ZU)WJXL!^9
M-L^@[\;D$D1$0=&[W%EIM-37OC=(V!FN6-.1*@^^Y0?-=3]HU2?&GF==/4'O
M"S^@TA:KI37FVPUU(_6AE&8SX6GC!](7?5$8*Q7)ARY:DQ<ZWSD"9@^0?XQZ
M1Q\HZE>44T<\3)8GM?&]H<US3F"#P%!]41$$2Q-CBEPS<HZ.:BEG<^$2AS'
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M@!P/7MZU[ZS;;KM<+1.9:"KEIWGAU';'=(X#UJ3TNE#$,&R;W+4CC,D61_\
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MI:F"LI(JBFD;)!(T.8YO 0ONLZ6O$-WLN8M]=+"PG,Q[',)^B<PI+2Z5+["
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M-S3G\7HY.3)%7^1)V GH"*4.%IFF_=H?H-[E7^]'0?.E3]FU6'$W<X6-!SR
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M0.8A><BSEU7<71M"G=-I5L<K1N\%9 [CS8'#V@Y_<OS=-%UHJW&2AGFHG/\
MDC*1@Z =OWJO[CA;WOFU!6:^W+,Q9?FI%B5&E.P1,SBCK)G<0;&!WE07%..Z
M[$47N2./W)19YF-KLW2<FL>3T=ZZUEPK[\3B,5NX@G+,Q:WYA6%:=&-FHGLE
MK))JZ3^%_D1_Y1M]I0131QAB:ONT=WJ(RVCI7:T9</YR3BR] X<^4#TJY5\X
MXV0L9'&QK&-&36M&0 Y,E]% (B("B6DGS)J_IQ_C"EJ\K$-FCOUGEMTLKHF2
M.:2]HS(R.:"G='GGW;?\7_2>KW4*L6CNDL-ZIKC%7SROBU@&.: #FTM_-35
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JAT^6J#Z&C9[<T$?T<X2U8I;K<H'!LS-2")PR);F"7$=0RZ_0BL]% __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 23, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001774857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Aardvark Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Mar. 23, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Depositary Shares<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Rights<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 400,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 55,240.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
(1) There are being registered hereunder such indeterminate amount of common stock, preferred stock, depositary shares, debt securities, warrants to purchase common stock, preferred stock or debt securities, rights to purchase common stock, preferred stock, units and other securities and units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $400,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $400,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The Registrant will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities the Registrant is registering under this registration statement. The securities registered also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

The proposed maximum aggregate offering price per unit will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to pursuant to Item 16(b) of Form S-3 under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 23, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 400,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">55,240.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 55,240.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="ck0001774857-exfiling_fees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ck0001774857-exfiling_fees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ck0001774857-exfiling_fees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ck0001774857-exfiling_fees.htm">ck0001774857-exfiling_fees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/ffd/2025q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ck0001774857-exfiling_fees.htm": {
   "dts": {
    "inline": {
     "local": [
      "ck0001774857-exfiling_fees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025q4/ffd-2025q4.xsd"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 15,
    "http://xbrl.sec.gov/ffd/2025q4": 13,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 9,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025q4": 47,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001774857-exfiling_fees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001774857-exfiling_fees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001774857-exfiling_fees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001774857-exfiling_fees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal8ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025q4",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001193125-26-119973-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-119973-xbrl.zip
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M_K9M$?5<ITX;8OM*Z$>[91^>"\"=0!5O/5DDUR/X&8BW<I>P6!U<Y"/1,N"
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M4$L! A0#%     @ 2(EW7$#]3FJ6#P  +IX  !X              ( !
M &-K,# P,3<W-#@U-RUE>&9I;&EN9U]F965S+FAT;5!+!08      0 ! $P
(  #2#P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>ck0001774857-exfiling_fees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025q4/ffd-2025q4.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <context id="offrl_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001774857</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-23</startDate>
            <endDate>2026-03-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-442">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-443">S-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-444">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-445">0001774857</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-446">Aardvark Therapeutics, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="7"
      id="ixv-450"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="7"
      id="ixv-451"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="7"
      id="ixv-452"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="7"
      id="ixv-453"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_5"
      decimals="7"
      id="ixv-454"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_6"
      decimals="7"
      id="ixv-455"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_7"
      decimals="7"
      id="ixv-456"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FormTp contextRef="rc" id="ixv-544">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-545">Aardvark Therapeutics, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-546">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-547">Common Stock, $0.00001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_1" id="ixv-548">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-549">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-550">Preferred Stock, $0.00001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_2" id="ixv-551">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-552">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-553">Depositary Shares</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_3" id="ixv-554">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-555">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-556">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_4" id="ixv-557">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_5" id="ixv-558">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_5" id="ixv-559">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_5" id="ixv-560">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_6" id="ixv-561">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_6" id="ixv-562">Rights</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_6" id="ixv-563">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_7" id="ixv-564">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_7" id="ixv-565">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_7" id="ixv-566">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_8" id="ixv-567">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_8" id="ixv-568">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="offrl_8" id="ixv-569">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_8"
      decimals="2"
      id="ixv-570"
      unitRef="USD">400000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_8"
      decimals="7"
      id="ixv-571"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_8"
      decimals="2"
      id="ixv-572"
      unitRef="USD">55240.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="2" id="ixv-573" unitRef="USD">400000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="2" id="ixv-574" unitRef="USD">55240.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="2" id="ixv-575" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="2" id="ixv-576" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="2" id="ixv-577" unitRef="USD">55240.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_8" id="ixv-578">
(1) There are being registered hereunder such indeterminate amount of common stock, preferred stock, depositary shares, debt securities, warrants to purchase common stock, preferred stock or debt securities, rights to purchase common stock, preferred stock, units and other securities and units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $400,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $400,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The Registrant will determine, from time to time, the proposed maximum offering price per unit in connection with its issuance of the securities the Registrant is registering under this registration statement. The securities registered also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

The proposed maximum aggregate offering price per unit will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to pursuant to Item 16(b) of Form S-3 under the Securities Act.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
